data_2l4k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l4k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.4 m95 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.91 126.47 41.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.172 1.389 . . . . 0.0 111.885 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -141.11 156.55 45.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.036 2.135 . . . . 0.0 108.904 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.86 32.76 2.1 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 123.412 2.823 . . . . 0.0 113.841 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -145.86 47.62 1.25 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.712 1.244 . . . . 0.0 110.522 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.252 7.0 tt -139.5 62.62 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 122.97 1.367 . . . . 0.0 108.357 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -47.89 153.37 0.64 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.619 1.967 . . . . 0.0 112.73 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -35.73 0.71 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -174.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.25 -33.7 61.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.66 -46.61 14.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.482 1.113 . . . . 0.0 112.322 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 p -63.99 -31.32 72.46 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.929 -1.107 . . . . 0.0 112.353 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -71.08 -16.41 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.734 1.152 . . . . 0.0 113.675 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -80.21 -35.15 36.66 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.03 0.932 . . . . 0.0 111.586 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.1 mp -88.95 -45.23 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.497 1.119 . . . . 0.0 112.649 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.06 -9.1 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.159 0.984 . . . . 0.0 111.533 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.35 -0.27 61.37 Favored Glycine 0 N--CA 1.472 1.086 0 O-C-N 120.019 -1.676 . . . . 0.0 115.62 -174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -80.75 -14.25 58.27 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.155 0.978 . . . . 0.0 109.354 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.03 157.27 22.97 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.732 2.013 . . . . 0.0 111.966 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.69 33.4 2.05 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 124.769 1.176 . . . . 0.0 114.718 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.45 -179.29 7.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.705 1.202 . . . . 0.0 112.875 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' GLY . 29.7 m -51.27 149.32 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.105 0.962 . . . . 0.0 111.819 174.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 1.2 m-20 -40.22 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 129.683 3.193 . . . . 0.0 116.717 -174.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -99.84 19.4 53.5 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 120.129 2.811 . . . . 0.0 120.129 -174.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.4 78.43 4.42 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 123.509 3.654 . . . . 0.0 105.596 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.41 170.29 8.51 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -172.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 tp -140.46 156.11 46.46 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.289 3.036 . . . . 0.0 108.821 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.06 79.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 122.872 1.32 . . . . 0.0 108.681 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.453 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -115.78 168.82 9.71 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.249 1.42 . . . . 0.0 110.806 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.75 -156.33 0.67 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.547 0.689 . . . . 0.0 110.394 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.5 p -134.52 154.3 51.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.923 2.089 . . . . 0.0 109.077 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.285 1.4 pp0? -99.53 6.05 45.92 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.625 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -99.78 -61.67 1.34 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 131.246 3.819 . . . . 0.0 113.038 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -64.14 125.15 87.52 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 123.786 2.994 . . . . 0.0 107.584 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.83 -6.84 19.58 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.143 2.562 . . . . 0.0 114.101 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -129.03 26.87 5.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.649 2.379 . . . . 0.0 111.737 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.17 127.01 9.01 Favored Glycine 0 C--N 1.356 1.692 0 N-CA-C 121.992 3.557 . . . . 0.0 121.992 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.424 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 33.3 m-85 -145.12 77.69 1.53 Allowed 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 133.602 4.761 . . . . 0.0 109.465 174.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.73 145.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.509 -1.995 . . . . 0.0 115.233 -173.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.95 128.38 48.39 Favored 'General case' 0 CA--C 1.542 0.672 1 N-CA-C 99.187 -4.375 . . . . 0.0 99.187 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 p -126.87 113.14 16.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.115 -1.615 . . . . 0.0 109.135 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.78 153.0 19.08 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.249 1.02 . . . . 0.0 111.421 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 53.6 t -124.94 114.63 19.41 Favored 'General case' 0 CA--C 1.496 -1.109 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.657 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.267 0.0 OUTLIER -113.41 -165.88 1.04 Allowed 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.024 1.453 . . . . 0.0 112.489 -173.054 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.657 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.462 0.3 OUTLIER -96.65 8.11 44.99 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 118.561 2.8 . . . . 0.0 118.561 -173.795 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -146.44 -27.02 0.42 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 125.202 1.564 . . . . 0.0 112.777 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -150.07 -177.96 6.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.953 0.901 . . . . 0.0 112.312 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 m -131.26 135.24 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.639 1.176 . . . . 0.0 109.43 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -140.96 158.25 44.2 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.774 0.83 . . . . 0.0 112.63 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.453 ' CG ' HH21 ' A' ' 46' ' ' ARG . 88.2 m-70 -111.57 149.03 32.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.197 1.399 . . . . 0.0 110.854 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 65.27 1.12 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.862 1.265 . . . . 0.0 113.252 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.4 tm? -141.81 129.85 22.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.355 1.462 . . . . 0.0 112.348 174.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.455 ' CD1' ' H ' ' B' 1142 ' ' GLN . 12.1 mt -140.66 -42.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.714 1.143 . . . . 0.0 110.964 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.99 147.41 46.32 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.92 -173.31 1.72 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.294 3.329 . . . . 0.0 110.945 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -57.76 130.0 44.47 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.308 -0.87 . . . . 0.0 112.95 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -110.96 179.14 4.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.695 1.198 . . . . 0.0 112.246 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.03 -11.52 21.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.398 1.079 . . . . 0.0 112.305 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.1 32.93 4.07 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.061 2.144 . . . . 0.0 111.52 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.29 -150.07 21.43 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.782 2.61 . . . . 0.0 110.323 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -128.22 -130.77 0.22 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.233 1.413 . . . . 0.0 107.247 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -57.38 122.82 13.48 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.787 1.63 . . . . 0.0 107.819 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.47 138.83 32.58 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.54 ' H ' ' HB3' ' A' ' 89' ' ' ARG . 5.3 m-85 -145.34 137.1 25.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.174 2.19 . . . . 0.0 112.349 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -140.44 1.48 1.77 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.5 ttp -29.81 144.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.55 2.432 . . . . 0.0 113.813 173.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.21 -31.89 34.01 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -112.25 4.13 17.57 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.778 1.231 . . . . 0.0 113.266 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.93 88.73 0.18 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.584 1.564 . . . . 0.0 113.286 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -97.44 53.24 1.14 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.785 1.234 . . . . 0.0 108.85 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.469 68.5 p -79.25 20.03 0.54 Allowed 'General case' 0 N--CA 1.47 0.546 1 N-CA-C 122.566 4.284 . . . . 0.0 122.566 -172.605 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.54 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -39.64 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 121.609 3.929 . . . . 0.0 121.609 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -140.24 174.37 10.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 129.836 3.254 . . . . 0.0 107.708 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 m -62.4 116.4 5.04 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.317 -1.489 . . . . 0.0 109.831 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.2 -32.72 74.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.272 0.629 . . . . 0.0 112.336 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.36 -33.23 75.08 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.5 -37.38 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 111.373 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -28.68 62.92 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.844 0.858 . . . . 0.0 113.257 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.53 -34.0 68.68 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.215 1.406 . . . . 0.0 112.152 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.7 -39.7 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.061 0.944 . . . . 0.0 111.766 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -80.59 -47.19 14.51 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.48 1.112 . . . . 0.0 111.954 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.29 -18.83 65.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -40.03 -49.96 2.55 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.601 1.96 . . . . 0.0 115.167 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -81.18 -47.73 13.04 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.277 1.031 . . . . 0.0 113.534 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.23 92.71 3.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.73 1.612 . . . . 0.0 109.223 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -70.77 176.93 3.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.699 1.2 . . . . 0.0 113.049 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -90.13 -5.18 56.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.58 -166.62 1.16 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.028 1.299 . . . . 0.0 115.261 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.5 tt -90.24 -174.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.294 1.437 . . . . 0.0 107.512 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.74 110.21 2.59 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 121.583 1.992 . . . . 0.0 108.652 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -102.96 157.47 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 N-CA-C 118.98 2.646 . . . . 0.0 118.98 -129.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.33 -43.5 1.16 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 130.735 3.614 . . . . 0.0 106.372 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.5 158.37 41.07 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.955 3.302 . . . . 0.0 107.368 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.268 0.0 OUTLIER -121.4 -22.54 5.93 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.411 2.745 . . . . 0.0 118.411 -174.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.65 142.02 33.12 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.838 1.654 . . . . 0.0 112.13 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -97.85 152.6 19.02 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.195 0.998 . . . . 0.0 112.764 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 170.11 16.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.03 2.532 . . . . 0.0 108.991 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 62.5 m -98.0 132.76 43.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.388 -1.445 . . . . 0.0 113.217 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.5 t -111.1 162.04 15.3 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 . . . . . 0 N--CA 1.478 0.942 0 C-N-CA 125.36 1.464 . . . . 0.0 112.297 178.564 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 CA--C 1.539 0.76 0 N-CA-C 112.77 0.258 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.052 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.357 69.4 m-20 122.66 -27.8 0.01 OUTLIER 'General case' 0 CA--C 1.59 2.506 4 C-N-CA 139.289 7.036 . . . . 0.0 92.801 -169.258 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' B' B 1142 ' ' GLN . . . . . 0.455 ' H ' ' CD1' ' A' ' 70' ' ' ILE 0.282 1.6 mp0 -130.69 -136.87 0.0 OUTLIER Pre-proline 0 C--N 1.381 1.962 0 C-N-CA 130.75 3.62 . . . . 0.0 115.154 168.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -91.68 122.04 0.66 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 123.046 2.123 . . . . 0.0 113.406 75.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -172.319 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m95 . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -75.74 127.79 33.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.1 1.36 . . . . 0.0 112.065 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -141.35 147.77 38.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.941 1.696 . . . . 0.0 110.364 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.46 40.71 1.3 Allowed Glycine 0 C--O 1.219 -0.789 0 CA-C-N 122.746 2.521 . . . . 0.0 110.805 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 47.13 1.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.808 1.289 . . . . 0.0 109.832 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tt -150.42 81.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.507 1.123 . . . . 0.0 109.303 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.443 ' HB2' ' HG ' ' A' ' 48' ' ' SER . 7.3 t -61.74 164.17 6.49 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.685 1.594 . . . . 0.0 113.884 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.65 -27.64 18.1 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.44 -44.43 19.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.156 0.982 . . . . 0.0 112.467 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.45 -32.02 32.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.667 1.187 . . . . 0.0 113.808 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 p -66.8 -35.52 80.26 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.219 -0.926 . . . . 0.0 112.101 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.273 6.1 pt20 -69.81 -13.71 62.41 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -77.43 -30.59 53.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.709 0.803 . . . . 0.0 111.257 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 mp -92.16 -62.28 1.44 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.795 1.238 . . . . 0.0 111.957 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 mt -70.45 -10.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 125.14 1.376 . . . . 0.0 111.938 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.15 -6.67 57.69 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 121.078 -1.014 . . . . 0.0 115.557 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -102.39 20.78 16.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.6 1.16 . . . . 0.0 110.656 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -105.12 141.84 35.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.642 3.177 . . . . 0.0 111.361 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.48 20.62 48.94 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.2 170.21 16.74 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.969 1.384 . . . . 0.0 112.923 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 41' ' ' GLY . 28.2 m -72.46 158.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.915 0.886 . . . . 0.0 111.119 173.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 4.5 m-20 -55.15 -7.02 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.694 2.398 . . . . 0.0 116.45 -174.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -104.06 1.54 44.28 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.866 -1.515 . . . . 0.0 116.456 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.17 84.51 4.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.058 2.429 . . . . 0.0 104.495 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.13 174.6 6.24 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.19 136.1 33.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.357 1.863 . . . . 0.0 110.82 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -101.12 99.78 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.511 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -141.06 167.37 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.428 1.891 . . . . 0.0 110.068 -174.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.87 -149.73 0.28 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.443 ' HG ' ' HB2' ' A' ' 25' ' ' SER . 9.2 t -140.72 164.62 29.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.84 1.305 . . . . 0.0 109.134 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.06 8.42 44.55 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.49 1.916 . . . . 0.0 106.827 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -98.58 -70.46 0.72 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 131.172 3.789 . . . . 0.0 109.251 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -63.87 123.25 81.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 122.028 2.194 . . . . 0.0 109.941 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -74.8 -14.64 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.071 2.514 . . . . 0.0 113.726 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.42 33.59 5.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.479 2.312 . . . . 0.0 110.284 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.63 124.89 8.31 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 120.803 3.081 . . . . 0.0 120.803 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.501 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 62.1 m-85 -144.2 77.46 1.55 Allowed 'General case' 0 CA--C 1.56 1.331 1 C-N-CA 131.835 4.054 . . . . 0.0 110.418 174.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -98.12 152.83 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.252 1.821 . . . . 0.0 113.863 -174.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.58 134.96 54.41 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 102.215 -3.254 . . . . 0.0 102.215 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 p -134.79 122.81 22.62 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.313 1.869 . . . . 0.0 109.391 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.07 159.93 14.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.432 0.693 . . . . 0.0 112.653 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 49.9 t -119.17 69.27 0.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.662 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.302 0.6 OUTLIER -81.07 -173.94 4.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.309 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.662 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.489 0.6 OUTLIER -97.96 8.27 45.02 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -174.088 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -145.94 -27.99 0.43 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 124.757 1.286 . . . . 0.0 112.765 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 171.39 16.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.714 0.806 . . . . 0.0 111.992 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.78 96.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.152 0.981 . . . . 0.0 108.475 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -99.4 160.39 14.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.675 1.59 . . . . 0.0 110.328 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.511 ' CG ' HH21 ' A' ' 46' ' ' ARG . 61.9 m-70 -119.2 137.87 53.34 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 124.455 1.102 . . . . 0.0 113.617 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.47 59.85 1.57 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 120.072 -1.643 . . . . 0.0 113.447 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.501 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -143.04 128.67 19.18 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.4 mt -140.71 -29.39 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 120.085 1.311 . . . . 0.0 112.269 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.04 159.49 71.86 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -87.85 -159.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 125.183 3.922 . . . . 0.0 111.838 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -65.41 143.63 57.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.004 -1.06 . . . . 0.0 113.452 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -130.75 -176.39 3.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.757 1.223 . . . . 0.0 112.392 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.51 -15.38 19.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.645 1.178 . . . . 0.0 113.662 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -102.13 31.84 3.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.816 1.646 . . . . 0.0 111.204 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 163.28 -159.0 31.52 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.023 2.249 . . . . 0.0 110.435 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -118.88 -125.66 0.28 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.11 110.88 1.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.16 112.41 18.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.556 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.377 32.3 p90 -151.21 171.76 16.9 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 119.393 3.108 . . . . 0.0 119.393 174.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' A' ' 88' ' ' THR . 65.8 p -150.88 -141.45 0.11 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.443 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -154.71 -164.92 1.93 Allowed 'General case' 0 CA--C 1.547 0.849 1 C-N-CA 131.863 4.065 . . . . 0.0 104.422 -173.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -78.1 -24.19 47.65 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.612 1.551 . . . . 0.0 110.01 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -140.54 57.39 1.58 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.196 1.798 . . . . 0.0 111.613 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 177.34 20.79 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 116.507 1.363 . . . . 0.0 116.507 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.52 49.15 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.501 1.92 . . . . 0.0 113.202 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.41 ' H ' ' HA ' ' A' ' 82' ' ' SER 0.495 70.5 p -79.1 6.25 9.99 Favored 'General case' 0 N--CA 1.487 1.395 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -173.362 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.556 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 16.7 ptt180 -39.73 16.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 2 C-N-CA 132.881 4.473 . . . . 0.0 122.088 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -107.9 176.78 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.959 1.704 . . . . 0.0 109.528 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -63.81 151.18 42.95 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.15 -1.594 . . . . 0.0 111.128 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -76.19 -36.97 58.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.0 tp -67.27 -46.95 72.14 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.652 0.66 . . . . 0.0 112.434 -174.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.5 -34.75 77.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.402 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -67.23 -43.63 81.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 111.851 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.27 -33.45 73.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.704 0.801 . . . . 0.0 111.993 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.8 t -79.12 -51.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.098 0.959 . . . . 0.0 112.231 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -71.46 -40.29 70.39 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.41 -1.431 . . . . 0.0 113.681 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -83.2 5.55 22.46 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -57.27 -34.13 68.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.52 -35.42 30.38 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.553 1.541 . . . . 0.0 113.262 -176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.7 mt -142.57 90.83 2.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.562 1.945 . . . . 0.0 109.372 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.66 -171.11 3.32 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.065 0.946 . . . . 0.0 113.348 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -100.13 -20.35 16.03 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 49.32 -165.76 0.34 Allowed Glycine 0 N--CA 1.476 1.319 0 C-N-CA 126.494 1.997 . . . . 0.0 116.382 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.8 tt -84.35 161.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.588 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -29.62 -59.1 0.27 Allowed Pre-proline 0 CA--C 1.564 1.515 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -123.61 -15.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 N-CA-C 117.668 2.141 . . . . 0.0 117.668 -165.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.9 m -103.28 -140.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 126.607 1.963 . . . . 0.0 113.111 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.48 133.81 45.96 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.304 1.411 . . . . 0.0 111.837 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.421 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -95.54 -17.47 21.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -86.09 163.67 17.75 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.221 -0.924 . . . . 0.0 111.649 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -136.43 148.96 48.02 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 173.2 11.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.173 2.589 . . . . 0.0 109.635 175.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 79.7 m -98.26 132.55 43.67 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.531 -1.356 . . . . 0.0 112.096 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -107.6 172.85 6.6 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 127.188 2.195 . . . . 0.0 109.315 174.49 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 CA--C 1.539 0.767 0 CA-C-O 120.85 0.271 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 124.386 1.074 . . . . 0.0 111.351 174.83 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 125.949 2.785 . . . . 0.0 106.771 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 158.86 -47.94 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.776 3 C-N-CA 144.495 9.118 . . . . 0.0 92.216 -173.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.342 2.6 mp0 -140.85 157.86 66.55 Favored Pre-proline 0 N--CA 1.43 -1.43 1 C-N-CA 134.025 4.93 . . . . 0.0 105.808 170.196 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.62 58.58 3.2 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 CA-C-N 122.206 1.824 . . . . 0.0 110.123 150.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B 1144 ' ' ASP . . . . . . . . . . . . 0.256 27.6 t70 . . . . . 0 C--O 1.253 1.276 1 C-N-CA 135.922 5.689 . . . . 0.0 117.377 -173.715 . . . . . . . . 2 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.4 m0 . . . . . 0 CA--C 1.552 1.047 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -132.84 136.73 46.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.982 1.313 . . . . 0.0 114.502 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -142.61 155.25 44.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.06 2.144 . . . . 0.0 109.76 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.75 33.01 2.08 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 122.927 2.603 . . . . 0.0 112.78 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 tpt85 -137.99 7.66 2.7 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 118.904 1.352 . . . . 0.0 114.387 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.313 7.1 tp -104.48 67.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 122.752 1.263 . . . . 0.0 110.182 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 m -46.45 152.18 0.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.651 1.981 . . . . 0.0 112.538 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -32.42 3.77 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.74 -30.9 40.99 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.691 0.996 . . . . 0.0 113.691 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -81.73 -43.36 18.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.486 1.114 . . . . 0.0 113.136 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -65.61 -32.53 74.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.16 -0.962 . . . . 0.0 112.621 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -67.68 -21.33 65.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -74.39 -28.69 61.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.718 0.807 . . . . 0.0 111.905 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.56 -51.83 4.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.106 1.362 . . . . 0.0 112.312 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.14 -12.72 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.614 1.566 . . . . 0.0 111.566 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.67 8.81 66.25 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.491 -1.381 . . . . 0.0 113.867 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -77.66 -10.56 59.59 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.773 1.229 . . . . 0.0 112.073 174.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.347 0.0 OUTLIER -140.45 136.52 33.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.407 1.483 . . . . 0.0 113.552 176.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.66 67.32 0.23 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.544 1.545 . . . . 0.0 114.983 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.06 -176.51 5.56 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.808 0.843 . . . . 0.0 110.827 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.26 142.12 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.461 -1.399 . . . . 0.0 108.425 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -45.91 -21.97 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.8 21.22 44.72 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.495 -1.229 . . . . 0.0 115.293 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.67 62.06 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -96.63 163.16 13.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 -170.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -122.61 150.27 42.87 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.452 1.901 . . . . 0.0 109.519 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.04 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.28 167.31 22.45 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 125.068 1.347 . . . . 0.0 109.011 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -142.89 -158.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -131.29 159.79 36.83 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 122.709 1.243 . . . . 0.0 108.747 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 113.475 -1.693 . . . . 0.0 107.861 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -98.25 -63.81 1.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 129.292 3.037 . . . . 0.0 108.133 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -60.66 121.04 58.11 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 120.606 1.548 . . . . 0.0 110.047 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.85 -15.18 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.773 2.316 . . . . 0.0 113.104 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -125.7 32.72 5.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.163 2.185 . . . . 0.0 110.895 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.28 128.17 9.46 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.503 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 58.6 m-85 -143.88 78.24 1.58 Allowed 'General case' 0 CA--C 1.558 1.288 1 C-N-CA 131.738 4.015 . . . . 0.0 110.492 174.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.45 142.73 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 126.291 1.836 . . . . 0.0 113.049 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.6 130.53 45.84 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 p -127.33 120.25 28.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.186 1.357 . . . . 0.0 109.152 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -96.04 151.13 19.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.203 1.001 . . . . 0.0 112.565 -172.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.8 t -117.03 65.55 0.72 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.599 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.257 24.7 t60 -81.33 178.82 8.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.599 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.423 3.1 pp -99.03 27.31 5.12 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.624 2.77 . . . . 0.0 117.843 -173.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -150.54 -43.72 0.12 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 112.06 -2.336 . . . . 0.0 111.649 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 179.71 7.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.496 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.02 122.61 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -129.93 167.36 18.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.64 1.176 . . . . 0.0 112.662 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -126.39 139.91 52.9 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -173.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -107.53 65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.275 1.83 . . . . 0.0 113.703 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.503 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.9 tm? -144.74 134.44 23.52 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.13 -1.606 . . . . 0.0 114.748 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 mt -141.42 -36.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 120.53 1.514 . . . . 0.0 112.948 170.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 160.12 61.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -77.39 -177.98 4.25 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.408 3.405 . . . . 0.0 111.752 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 p -61.15 144.76 53.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -129.84 -175.36 3.58 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.247 1.419 . . . . 0.0 110.808 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.56 -3.37 33.5 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -99.31 10.23 41.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.247 1.419 . . . . 0.0 111.702 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.68 -161.87 28.07 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 128.046 2.736 . . . . 0.0 109.66 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -115.1 -122.58 0.29 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 116.419 -1.753 . . . . 0.0 106.469 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -58.65 113.85 2.22 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -82.26 120.2 25.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.417 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.46 12.9 p90 -151.33 162.63 40.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 118.638 2.829 . . . . 0.0 118.638 173.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -150.98 -146.34 0.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 0.0 112.093 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 32.1 mtt -155.38 -171.41 3.78 Favored 'General case' 0 C--N 1.316 -0.865 1 C-N-CA 134.049 4.939 . . . . 0.0 106.653 -173.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.37 -30.63 68.67 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -140.65 61.23 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.277 1.431 . . . . 0.0 111.373 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.68 174.76 22.46 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -141.92 47.52 1.63 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.07 1.748 . . . . 0.0 113.11 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.51 9.4 p -75.25 -2.08 26.4 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 121.466 3.876 . . . . 0.0 121.466 -173.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.417 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 40.9 ptt180 -44.61 36.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 1 C-N-CA 133.534 4.733 . . . . 0.0 120.832 173.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -125.36 160.58 29.0 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.919 -1.738 . . . . 0.0 111.761 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.8 m -56.5 135.82 54.32 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.979 0.911 . . . . 0.0 111.623 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.17 -39.77 89.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.0 -42.34 98.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.937 0.335 . . . . 0.0 111.792 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.08 -41.99 81.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.28 0.632 . . . . 0.0 111.31 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -68.08 -33.05 73.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.37 -43.76 20.54 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.684 0.675 . . . . 0.0 112.23 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.2 t -69.91 -63.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 119.255 0.934 . . . . 0.0 110.324 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -83.45 -57.65 3.16 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.321 44.0 m-85 -81.47 22.23 0.72 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -79.54 -42.74 24.47 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 121.496 1.953 . . . . 0.0 113.705 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -18.92 60.36 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt -140.14 56.97 1.61 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.316 1.847 . . . . 0.0 110.178 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.04 -156.82 0.15 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.835 0.854 . . . . 0.0 110.454 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.46 4.42 9.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.704 1.602 . . . . 0.0 112.54 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.88 -141.72 0.69 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.437 2.446 . . . . 0.0 115.786 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.55 153.77 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 111.716 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mt -34.88 -56.12 0.89 Allowed Pre-proline 0 CA--C 1.563 1.467 0 CA-C-O 116.272 -1.823 . . . . 0.0 115.841 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -115.17 -33.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.37 0 N-CA-C 117.589 2.111 . . . . 0.0 117.589 -169.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.9 m -91.17 -125.89 0.08 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.042 1.737 . . . . 0.0 114.413 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.93 155.66 19.36 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.637 1.575 . . . . 0.0 111.82 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -8.51 10.24 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -115.87 148.24 40.19 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.874 1.67 . . . . 0.0 113.513 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -101.08 150.31 23.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.378 1.071 . . . . 0.0 111.26 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 76.9 m -130.38 -61.49 0.96 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 5.1 t -141.64 -158.48 0.87 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 111.232 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.2 m -134.19 135.85 43.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.866 2.467 . . . . 0.0 110.902 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 . . . . . 0 N--CA 1.478 0.955 0 C-N-CA 124.193 0.997 . . . . 0.0 111.057 174.401 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 CA--C 1.54 0.791 0 CA-C-O 120.974 0.323 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.049 1.339 . . . . 0.0 111.667 -175.234 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B 1140 ' ' VAL . . . . . 0.434 ' C ' ' N ' ' B' 1142 ' ' GLN . 2.2 t . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 115.777 -2.059 . . . . 0.0 115.588 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -54.89 -30.24 57.71 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1142 ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' 1140 ' ' VAL 0.342 4.1 mp0 -150.52 156.93 36.79 Favored Pre-proline 0 N--CA 1.424 -1.757 1 C-N-CA 136.69 5.996 . . . . 0.0 104.486 169.723 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.23 60.84 2.54 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 CA-C-N 120.95 1.375 . . . . 0.0 109.638 152.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 C--O 1.253 1.284 1 C-N-CA 134.719 5.207 . . . . 0.0 116.001 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -137.09 128.48 28.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.237 1.018 . . . . 0.0 112.33 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -140.11 138.18 35.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.453 2.701 . . . . 0.0 106.968 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.62 46.58 1.03 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-N 123.073 2.67 . . . . 0.0 114.06 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.22 48.3 1.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.48 1.609 . . . . 0.0 108.912 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.1 tp -150.67 68.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.126 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -50.61 157.2 0.78 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.733 1.613 . . . . 0.0 113.259 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.404 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -45.03 -37.37 4.05 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -77.35 -25.62 51.22 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.404 1.081 . . . . 0.0 113.859 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -81.55 -48.72 11.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.083 1.753 . . . . 0.0 111.66 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -68.56 -26.88 65.63 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.045 0.938 . . . . 0.0 112.895 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.41 -19.32 65.44 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.716 1.144 . . . . 0.0 113.555 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -77.79 -29.22 50.73 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.029 0.831 . . . . 0.0 111.735 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.54 -48.56 7.23 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 111.964 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.28 -9.42 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.973 0.909 . . . . 0.0 111.368 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.31 -0.05 59.84 Favored Glycine 0 N--CA 1.472 1.084 0 O-C-N 120.085 -1.635 . . . . 0.0 115.013 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.94 -13.36 58.97 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 117.833 0.817 . . . . 0.0 110.021 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.75 154.78 23.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.244 1.818 . . . . 0.0 112.094 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.41 26.36 2.56 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.75 1.167 . . . . 0.0 114.716 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.45 -166.95 1.29 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.163 1.385 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 m -53.91 151.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.026 0.93 . . . . 0.0 110.447 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 5.3 m-20 -50.7 -18.7 0.76 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.75 28.02 16.28 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.67 2.081 . . . . 0.0 116.526 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.59 74.21 3.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.294 2.047 . . . . 0.0 106.471 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.1 tp -141.01 145.24 35.67 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.824 1.65 . . . . 0.0 111.348 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -98.23 68.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 119.891 1.223 . . . . 0.0 110.393 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.67 158.35 15.83 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 124.032 0.933 . . . . 0.0 111.465 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.6 pm0 -141.64 -160.46 1.09 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.2 t -140.15 158.49 43.96 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 122.352 1.072 . . . . 0.0 109.658 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 1.5 pp0? -97.34 8.44 44.58 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.64 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -98.55 -68.29 0.81 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 129.07 2.948 . . . . 0.0 110.439 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.59 119.38 46.64 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 122.756 2.526 . . . . 0.0 109.419 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.49 -12.41 18.67 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.008 2.472 . . . . 0.0 114.866 -159.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -120.44 36.17 4.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.961 2.504 . . . . 0.0 109.203 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.46 123.23 7.8 Favored Glycine 0 C--N 1.349 1.293 1 N-CA-C 124.568 4.587 . . . . 0.0 124.568 -172.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.423 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 20.3 m-85 -144.49 77.57 1.54 Allowed 'General case' 0 CA--C 1.558 1.262 1 C-N-CA 132.665 4.386 . . . . 0.0 109.749 174.011 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.42 153.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 127.164 2.186 . . . . 0.0 112.724 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.25 129.58 56.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 p -111.55 118.09 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.3 mt -96.53 147.47 23.83 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.423 0.689 . . . . 0.0 111.865 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.8 t -114.76 66.03 0.68 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.589 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.28 0.4 OUTLIER -70.06 -168.18 0.2 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 112.852 -1.977 . . . . 0.0 112.394 -173.603 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.589 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.512 0.3 OUTLIER -96.85 4.39 51.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.836 3.273 . . . . 0.0 119.836 -173.507 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.329 7.1 pt20 -149.75 -16.14 0.27 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 118.361 -1.336 . . . . 0.0 114.372 169.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -150.57 173.11 14.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.518 1.127 . . . . 0.0 110.737 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.35 110.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -120.47 161.77 20.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.72 1.608 . . . . 0.0 112.03 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.404 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 90.9 m-70 -106.23 163.57 12.7 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.013 1.325 . . . . 0.0 112.783 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -117.48 13.44 14.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 118.259 2.688 . . . . 0.0 118.259 -172.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.423 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.3 tm? -113.27 133.65 54.99 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -173.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.1 mt -141.72 -42.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.695 0.798 . . . . 0.0 110.849 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -119.77 151.37 52.11 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -92.01 -174.31 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.901 3.734 . . . . 0.0 112.003 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 m -60.24 145.06 48.71 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.486 -0.759 . . . . 0.0 112.191 174.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -120.7 -170.06 1.93 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.276 1.43 . . . . 0.0 111.935 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.83 -14.47 19.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.115 0.966 . . . . 0.0 112.832 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -110.97 8.76 22.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.676 1.59 . . . . 0.0 113.659 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.42 168.74 38.82 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.778 1.656 . . . . 0.0 112.847 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -83.76 -145.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.948 1.299 . . . . 0.0 110.789 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -52.06 116.44 2.19 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.348 0.976 . . . . 0.0 109.16 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 134.95 36.12 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.408 ' H ' ' HB3' ' A' ' 89' ' ' ARG 0.293 28.9 m-85 -142.0 134.02 27.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.115 1.766 . . . . 0.0 113.602 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -140.45 20.7 2.38 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.0 ttp -26.98 149.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -52.63 -23.11 5.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -126.19 19.26 7.62 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.256 1.422 . . . . 0.0 112.61 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.06 162.34 26.77 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.511 1.529 . . . . 0.0 115.591 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -141.03 50.99 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.194 1.798 . . . . 0.0 108.506 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.563 10.5 p -76.38 10.97 1.74 Allowed 'General case' 0 N--CA 1.477 0.876 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -172.329 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.408 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 6.4 ptt180 -38.76 49.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 130.643 3.577 . . . . 0.0 120.609 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -137.29 165.12 26.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.213 2.605 . . . . 0.0 109.899 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -57.41 141.71 46.35 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.57 -33.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.86 -32.13 72.45 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -79.61 -33.94 41.12 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.745 0.702 . . . . 0.0 111.918 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.44 -35.35 60.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.552 2.341 . . . . 0.0 111.882 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.22 -40.11 67.34 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.775 2.03 . . . . 0.0 112.376 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.81 -50.26 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.877 0.871 . . . . 0.0 110.485 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.84 -88.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.012 1.325 . . . . 0.0 112.87 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -47.91 0.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 121.396 3.85 . . . . 0.0 121.396 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -56.08 -37.11 68.89 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 121.891 2.132 . . . . 0.0 113.392 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -15.77 61.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.63 39.86 1.86 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.206 1.403 . . . . 0.0 112.575 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -75.56 -161.8 0.17 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 125.34 1.456 . . . . 0.0 113.449 -174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -90.9 -0.38 57.71 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.883 1.673 . . . . 0.0 113.712 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.64 -152.2 12.91 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.87 1.7 . . . . 0.0 115.229 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.75 175.28 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.048 1.339 . . . . 0.0 111.686 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -41.56 -59.65 2.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -109.93 -46.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 122.613 1.969 . . . . 0.0 116.682 -166.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 74.3 m -94.68 -127.68 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -48.07 134.91 13.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.645 1.978 . . . . 0.0 115.082 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 -8.69 55.36 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -116.86 148.59 41.14 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.216 -0.927 . . . . 0.0 113.072 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -113.68 165.09 12.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.636 1.974 . . . . 0.0 110.499 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 5.9 m -136.87 -170.41 2.69 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.755 1.622 . . . . 0.0 112.066 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 82.8 m -99.13 135.61 40.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.28 1.032 . . . . 0.0 110.086 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -125.75 171.29 10.76 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.88 1.272 . . . . 0.0 113.054 -173.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 . . . . . 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 110.575 174.559 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.54 0.81 0 CA-C-O 120.82 0.258 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 CA--C 1.554 1.098 0 C-N-CA 125.876 1.67 . . . . 0.0 110.543 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B 1140 ' ' VAL . . . . . 0.413 ' C ' ' N ' ' B' 1142 ' ' GLN . 2.7 t . . . . . 0 N--CA 1.507 2.414 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.278 11.8 m-80 -56.41 -27.95 57.92 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B 1142 ' ' GLN . . . . . 0.413 ' N ' ' C ' ' B' 1140 ' ' VAL 0.314 4.3 mp0 -158.62 157.86 28.94 Favored Pre-proline 0 N--CA 1.433 -1.304 1 C-N-CA 135.932 5.693 . . . . 0.0 104.962 168.554 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.67 60.67 2.18 Favored 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 121.891 1.711 . . . . 0.0 109.392 149.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.254 1.33 1 C-N-CA 134.044 4.938 . . . . 0.0 115.896 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 121.827 0.823 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -150.56 112.92 4.65 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.162 1.385 . . . . 0.0 111.508 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -140.97 155.62 46.2 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.636 1.974 . . . . 0.0 109.962 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.8 0.65 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 122.261 2.3 . . . . 0.0 111.949 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.255 32.9 tpt85 -148.63 42.06 0.97 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.008 1.385 . . . . 0.0 111.096 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.78 63.77 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.563 1.145 . . . . 0.0 110.071 -174.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 t -55.38 151.03 10.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.424 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -48.31 -30.79 5.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.029 2.531 . . . . 0.0 116.756 -173.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -79.79 -35.43 38.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.147 0.979 . . . . 0.0 112.713 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.71 -40.36 22.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.034 . . . . 0.0 112.376 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.04 -37.37 71.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.484 1.114 . . . . 0.0 112.319 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.22 -16.77 64.28 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -80.12 -27.59 39.11 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.239 1.016 . . . . 0.0 111.557 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.5 -49.75 5.28 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.582 1.553 . . . . 0.0 112.135 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.12 -12.46 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 124.309 1.044 . . . . 0.0 111.657 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.23 1.18 60.51 Favored Glycine 0 N--CA 1.474 1.172 0 O-C-N 120.45 -1.406 . . . . 0.0 114.948 -174.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -79.65 -13.9 59.17 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 117.973 0.887 . . . . 0.0 109.629 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.53 164.19 19.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.929 2.091 . . . . 0.0 112.291 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.64 30.2 3.83 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.306 1.431 . . . . 0.0 114.148 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.24 -172.45 3.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.896 1.678 . . . . 0.0 113.596 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.19 155.61 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.166 1.387 . . . . 0.0 111.28 174.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -49.3 -16.04 0.16 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.917 1.687 . . . . 0.0 115.283 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.75 7.19 70.62 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 127.02 2.248 . . . . 0.0 114.473 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.68 57.52 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.57 172.61 7.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.5 tp -138.74 139.5 38.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.802 2.041 . . . . 0.0 109.84 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.39 107.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.437 ' HD2' ' C ' ' A' ' 46' ' ' ARG . 5.3 ppt_? -141.3 176.18 9.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.08 2.152 . . . . 0.0 110.621 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.99 -146.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -141.72 168.77 18.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 125.338 1.455 . . . . 0.0 110.259 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.57 10.87 40.02 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.667 172.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -99.06 -82.25 0.44 Allowed 'General case' 0 N--CA 1.481 1.109 1 C-N-CA 133.94 4.896 . . . . 0.0 108.756 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -54.62 118.13 15.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 121.216 1.825 . . . . 0.0 111.034 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.99 -12.33 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.99 2.46 . . . . 0.0 113.26 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -116.52 33.0 5.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.801 2.44 . . . . 0.0 110.16 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.8 128.62 9.61 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 121.773 3.469 . . . . 0.0 121.773 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.444 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 46.9 m-85 -142.64 66.93 1.32 Allowed 'General case' 0 CA--C 1.56 1.356 1 C-N-CA 132.139 4.175 . . . . 0.0 110.759 174.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.41 146.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.799 1.761 . . . . 0.0 114.109 -174.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 tt -105.01 121.15 43.16 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p -108.91 118.19 36.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.0 160.42 14.47 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -171.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.5 t -122.57 53.39 1.26 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.597 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.299 2.5 t-80 -66.11 178.81 1.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -172.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.597 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.467 0.5 OUTLIER -97.9 12.34 34.41 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -172.832 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -147.07 -27.32 0.39 Allowed 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 125.211 1.569 . . . . 0.0 112.112 170.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 173.88 13.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.68 93.23 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.54 1.162 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.34 170.07 8.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.515 1.526 . . . . 0.0 112.154 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.424 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 87.0 m-70 -117.19 163.13 16.76 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.491 1.516 . . . . 0.0 112.336 -173.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.31 14.92 14.83 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -172.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.444 ' HG ' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -114.13 140.63 48.35 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.064 -2.273 . . . . 0.0 116.032 -173.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mm -141.38 -44.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.994 0.918 . . . . 0.0 110.059 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -121.32 158.91 52.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -89.71 -148.08 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.873 3.715 . . . . 0.0 110.225 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -66.55 152.44 45.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.789 1.236 . . . . 0.0 112.682 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -139.89 -177.36 4.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.241 1.416 . . . . 0.0 111.74 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.68 -18.15 18.2 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -108.88 18.5 20.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.862 1.265 . . . . 0.0 112.666 174.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.06 -161.34 23.92 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.483 2.468 . . . . 0.0 110.096 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -116.87 -127.27 0.29 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.3 112.99 1.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -76.97 132.39 38.99 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . 0.252 25.0 m-85 -142.9 141.4 31.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.142 2.177 . . . . 0.0 112.553 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 p -149.66 21.59 0.91 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -27.82 152.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -28.02 3.3 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 119.19 3.033 . . . . 0.0 119.19 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.99 18.48 14.66 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.323 1.42 . . . . 0.0 113.628 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.24 172.81 23.64 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.304 1.681 . . . . 0.0 117.304 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.81 55.2 1.58 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 128.722 2.809 . . . . 0.0 107.207 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.487 16.1 p -71.89 2.1 6.06 Favored 'General case' 0 N--CA 1.474 0.767 1 N-CA-C 122.933 4.42 . . . . 0.0 122.933 -171.969 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -38.74 29.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 2 N-CA-C 122.96 4.429 . . . . 0.0 122.96 173.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.71 161.68 26.75 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.845 2.058 . . . . 0.0 110.154 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -62.03 140.41 58.37 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.07 -34.12 71.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.639 0.776 . . . . 0.0 112.479 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.84 -27.5 69.38 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.46 -35.61 63.32 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.606 0.762 . . . . 0.0 111.502 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -75.6 -37.95 59.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 111.436 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.5 tt -51.35 -42.3 61.22 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.95 1.7 . . . . 0.0 113.1 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.48 -42.35 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.602 0.761 . . . . 0.0 111.599 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -80.37 -32.91 37.58 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.051 1.34 . . . . 0.0 113.006 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -80.34 -13.14 59.41 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -58.47 -42.57 87.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.916 1.689 . . . . 0.0 113.757 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -82.14 -39.97 22.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.703 1.201 . . . . 0.0 113.346 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.5 mt -145.33 83.5 1.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.592 1.557 . . . . 0.0 111.614 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -70.71 133.57 46.73 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -73.24 -3.43 26.76 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 49.99 -157.87 1.71 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.641 2.067 . . . . 0.0 114.82 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.422 HG13 ' H ' ' A' ' 107' ' ' LEU . 4.0 tp -80.73 -175.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.473 0.709 . . . . 0.0 112.216 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.422 ' H ' HG13 ' A' ' 106' ' ' ILE . 15.7 mt -42.15 136.02 2.3 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.472 1.509 . . . . 0.0 110.839 173.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -80.16 51.53 3.95 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 N-CA-C 118.431 2.435 . . . . 0.0 118.431 -130.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 85.5 m -68.5 -55.77 10.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -179.53 5.93 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 129.418 3.087 . . . . 0.0 108.306 174.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.305 0.0 OUTLIER -139.03 -51.85 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.705 2.483 . . . . 0.0 117.705 -174.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -68.46 144.18 54.76 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.347 1.43 . . . . 0.0 113.323 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -107.58 165.78 11.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.217 1.407 . . . . 0.0 113.992 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 84.5 m -140.62 -157.23 0.75 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 128.029 2.532 . . . . 0.0 109.798 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.17 134.27 53.81 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.985 1.314 . . . . 0.0 109.782 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -109.62 170.09 8.29 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 124.713 1.205 . . . . 0.0 110.647 176.155 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 CA--C 1.539 0.767 0 CA-C-O 121.191 0.413 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 109.71 176.885 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.507 2.41 0 N-CA-C 118.425 2.75 . . . . 0.0 118.425 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.348 9.9 m-80 -61.75 -25.85 67.71 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.314 3.9 mp0 -155.76 154.38 27.83 Favored Pre-proline 0 N--CA 1.424 -1.762 1 C-N-CA 134.918 5.287 . . . . 0.0 105.196 168.381 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.81 58.51 2.67 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 CA-C-N 121.861 1.7 . . . . 0.0 109.256 151.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.3 t0 . . . . . 0 C--O 1.254 1.317 1 C-N-CA 134.606 5.162 . . . . 0.0 115.984 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.2 m0 . . . . . 0 CA--C 1.543 0.673 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -150.81 124.98 9.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -141.5 146.58 36.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.977 2.511 . . . . 0.0 109.128 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.7 24.96 4.04 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 123.427 2.831 . . . . 0.0 113.856 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -137.92 15.77 2.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.358 1.063 . . . . 0.0 113.122 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -100.84 70.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -46.28 151.73 0.49 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 112.995 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.283 0.0 OUTLIER -44.19 -40.3 4.97 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -73.83 -28.42 61.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.462 1.105 . . . . 0.0 113.237 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -81.04 -46.89 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.785 1.234 . . . . 0.0 111.396 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -68.11 -33.06 73.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 118.44 -0.791 . . . . 0.0 112.419 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.295 2.0 pt20 -68.77 -11.23 60.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 -80.94 -37.43 29.52 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.63 1.172 . . . . 0.0 110.704 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.3 mp -88.6 -45.06 10.18 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.779 1.632 . . . . 0.0 112.643 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.25 -12.64 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.399 1.079 . . . . 0.0 110.832 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.96 2.07 61.51 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.429 -1.419 . . . . 0.0 114.869 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 -12.81 59.34 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.783 0.833 . . . . 0.0 110.709 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.66 151.96 28.71 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.59 1.556 . . . . 0.0 112.873 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.15 20.19 4.52 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.127 1.346 . . . . 0.0 115.454 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.43 -173.04 3.85 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.21 150.96 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.165 0.986 . . . . 0.0 111.607 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 9.1 m-20 -49.11 -19.7 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -174.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.65 22.65 39.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 127.502 2.477 . . . . 0.0 116.852 -173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.12 77.81 4.05 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 121.743 2.771 . . . . 0.0 106.689 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.79 165.48 11.93 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -173.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.5 tp -126.77 148.84 49.89 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.315 2.646 . . . . 0.0 109.178 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.02 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.19 165.84 26.42 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 125.714 1.606 . . . . 0.0 108.662 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HA ' HG11 ' A' ' 56' ' ' VAL 0.265 5.3 pt-20 -141.56 -164.32 1.75 Allowed 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.486 -0.758 . . . . 0.0 110.422 173.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.12 148.09 52.46 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.266 1.2 pp0? -95.47 15.12 20.51 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.703 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -98.16 -72.7 0.64 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 131.959 4.104 . . . . 0.0 111.224 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -57.87 141.05 81.04 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-N 121.248 1.84 . . . . 0.0 113.605 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -85.54 -17.55 4.25 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.9 3.066 . . . . 0.0 115.121 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -118.34 26.41 9.63 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.997 2.119 . . . . 0.0 110.308 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.19 126.07 8.76 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 121.825 3.49 . . . . 0.0 121.825 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -143.58 94.19 2.57 Favored 'General case' 0 CA--C 1.545 0.777 1 C-N-CA 132.044 4.138 . . . . 0.0 103.384 173.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 47' ' ' GLU 0.283 1.3 m -99.0 138.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 121.261 1.846 . . . . 0.0 114.233 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.02 121.2 40.66 Favored 'General case' 0 CA--C 1.539 0.535 1 N-CA-C 99.901 -4.111 . . . . 0.0 99.901 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.3 p -119.33 122.13 41.14 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -95.28 177.53 5.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 32.2 t -129.57 66.07 1.47 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.601 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.265 0.4 OUTLIER -71.81 -171.64 0.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.16 -173.985 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.601 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.487 0.3 OUTLIER -97.03 6.65 48.22 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -173.521 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -146.08 -26.13 0.44 Allowed 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 124.961 1.413 . . . . 0.0 113.259 170.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -150.52 -178.03 6.31 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.834 0.854 . . . . 0.0 111.417 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.32 114.08 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.97 0.89 . . . . 0.0 109.749 173.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -110.98 162.51 14.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.707 2.403 . . . . 0.0 111.816 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.81 159.26 32.9 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -130.97 86.22 2.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.948 -1.72 . . . . 0.0 112.852 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.75 28.63 1.76 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 122.216 4.154 . . . . 0.0 122.216 -173.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.35 -14.23 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 -170.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 mt -127.73 144.85 52.69 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.45 -170.61 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 125.014 3.81 . . . . 0.0 111.718 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -72.03 147.82 46.46 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.473 -1.392 . . . . 0.0 112.9 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -130.92 -177.38 4.35 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.943 0.897 . . . . 0.0 112.552 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.71 -5.09 32.17 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 111.903 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -99.51 15.81 25.32 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.3 1.84 . . . . 0.0 111.664 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.47 -156.72 25.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 127.153 2.311 . . . . 0.0 109.707 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -115.64 -126.16 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -59.87 115.25 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.75 131.2 39.66 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.401 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 16.3 m-85 -143.82 155.55 44.17 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 175.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -145.88 -164.24 1.91 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.261 2.224 . . . . 0.0 109.894 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.445 ' HA ' ' CG1' ' B' 1140 ' ' VAL . 67.1 mtm -156.73 -173.67 4.58 Favored 'General case' 0 C--N 1.314 -0.95 1 C-N-CA 136.424 5.89 . . . . 0.0 109.089 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.94 -29.5 65.54 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.49 44.62 1.85 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.48 1.112 . . . . 0.0 112.846 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.36 171.87 24.09 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.956 1.543 . . . . 0.0 116.956 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 56.7 1.48 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.801 2.041 . . . . 0.0 112.301 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 32.2 p -76.98 5.31 8.22 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 121.766 3.987 . . . . 0.0 121.766 -173.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.401 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 37.8 ptt180 -38.91 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 2 C-N-CA 132.875 4.47 . . . . 0.0 122.423 173.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -126.5 159.89 32.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.325 1.85 . . . . 0.0 111.182 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 m -64.23 137.64 58.04 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.441 -0.787 . . . . 0.0 110.665 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.56 -47.49 47.67 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -64.32 -33.72 76.49 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.93 -32.59 69.55 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.342 0.657 . . . . 0.0 112.289 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.75 -28.81 36.37 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.975 1.31 . . . . 0.0 112.296 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.88 -29.04 69.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.359 1.064 . . . . 0.0 113.29 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.6 t -70.11 -76.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.28 0.946 . . . . 0.0 110.832 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -81.9 -44.5 16.73 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.82 -0.84 49.89 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -66.1 -42.65 89.0 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 122.788 2.54 . . . . 0.0 113.81 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -80.16 -11.79 59.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.32 1.448 . . . . 0.0 114.361 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 65.08 1.34 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.536 1.534 . . . . 0.0 109.689 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -101.71 -163.56 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.311 1.444 . . . . 0.0 111.871 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -96.63 -1.6 46.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.569 1.548 . . . . 0.0 111.23 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.24 -146.29 15.45 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 126.631 2.062 . . . . 0.0 114.298 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.24 179.17 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.737 1.615 . . . . 0.0 112.023 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 mt -40.32 -55.9 3.85 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.395 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.433 ' HD2' ' H ' ' A' ' 109' ' ' CYS . 68.4 Cg_endo -122.44 -41.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 N-CA-C 118.191 2.343 . . . . 0.0 118.191 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.433 ' H ' ' HD2' ' A' ' 108' ' ' PRO . 71.6 m -90.39 -127.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.507 1.923 . . . . 0.0 115.967 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.56 142.19 23.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.833 1.653 . . . . 0.0 114.649 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -6.88 45.18 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -110.95 152.67 26.51 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.522 1.129 . . . . 0.0 112.55 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -125.06 160.14 29.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.417 1.487 . . . . 0.0 111.706 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 28.0 m -141.06 -162.82 1.43 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 130.025 3.33 . . . . 0.0 108.135 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.2 m -125.75 133.54 52.05 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.879 -1.138 . . . . 0.0 112.121 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -99.28 176.11 5.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.149 0.98 . . . . 0.0 111.678 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 125.754 1.622 . . . . 0.0 113.329 -175.651 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 CA--C 1.539 0.737 0 CA-C-O 121.291 0.455 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 42.6 mp0 . . . . . 0 CA--C 1.551 0.992 0 C-N-CA 124.849 1.26 . . . . 0.0 112.597 178.147 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B 1140 ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 83' ' ' MET . 54.1 t . . . . . 0 N--CA 1.499 2.001 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.56 -29.5 51.33 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 102.193 -3.262 . . . . 0.0 102.193 169.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1142 ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' 1140 ' ' VAL 0.317 1.0 OUTLIER -161.44 157.34 21.47 Favored Pre-proline 0 N--CA 1.427 -1.621 1 C-N-CA 135.165 5.386 . . . . 0.0 105.574 168.443 . . . . . . . . 5 4 . 1 . 006 nuclear orig core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.79 52.65 0.72 Allowed 'Trans proline' 0 CA--C 1.554 1.502 0 C-N-CA 122.6 2.2 . . . . 0.0 111.381 152.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B 1144 ' ' ASP . . . . . 0.427 ' H ' ' C ' ' B' 1142 ' ' GLN . 22.5 t70 . . . . . 0 C--O 1.255 1.364 1 C-N-CA 134.873 5.269 . . . . 0.0 114.793 -173.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.886 0.85 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -143.29 134.45 25.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.196 1.398 . . . . 0.0 112.531 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -142.0 157.6 44.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.357 1.863 . . . . 0.0 109.694 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.96 23.4 2.61 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 121.956 2.162 . . . . 0.0 114.145 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -147.13 52.92 1.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.61 1.205 . . . . 0.0 110.952 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.261 7.4 tt -140.63 59.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 123.407 1.575 . . . . 0.0 109.101 174.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 t -43.58 153.19 0.12 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.844 2.458 . . . . 0.0 114.907 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HE ' ' HG2' ' B' 1138 ' ' GLU . 0.0 OUTLIER -46.83 -34.31 5.22 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 -174.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.76 -27.73 36.66 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.35 -48.59 11.76 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.609 1.564 . . . . 0.0 113.473 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -63.53 -33.31 75.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.97 -17.31 63.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -75.61 -30.89 59.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.725 0.81 . . . . 0.0 112.085 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.3 -60.5 1.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.301 1.44 . . . . 0.0 111.803 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mt -81.37 -3.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.494 1.918 . . . . 0.0 112.974 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.79 8.33 68.19 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.155 -1.591 . . . . 0.0 115.028 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -80.39 -4.01 51.91 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.447 1.099 . . . . 0.0 112.637 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -71.66 145.78 48.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.562 1.145 . . . . 0.0 113.28 -175.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.18 15.73 39.28 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 125.584 1.564 . . . . 0.0 114.145 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.54 177.57 8.91 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.362 1.865 . . . . 0.0 113.544 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 41' ' ' GLY . 35.1 m -72.08 169.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 126.302 1.841 . . . . 0.0 115.27 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 35.1 m-20 -58.41 22.27 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.889 2.876 . . . . 0.0 115.425 174.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -141.81 10.79 2.62 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.52 71.62 2.31 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.931 2.366 . . . . 0.0 108.441 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -98.46 168.26 10.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.8 tp -138.48 153.26 48.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.804 2.442 . . . . 0.0 109.584 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.6 t -116.07 101.53 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.158 0.983 . . . . 0.0 108.739 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.19 28.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.546 1.938 . . . . 0.0 109.506 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -142.76 -154.16 0.51 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.697 0.761 . . . . 0.0 113.012 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -120.85 147.66 45.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 132.704 4.402 . . . . 0.0 108.277 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 7.51 46.17 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.573 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.35 -68.1 0.82 Allowed 'General case' 0 C--N 1.352 0.691 0 C-N-CA 130.184 3.394 . . . . 0.0 111.083 -174.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -78.85 116.79 62.59 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 122.997 2.635 . . . . 0.0 108.464 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.8 -15.96 51.15 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.758 2.306 . . . . 0.0 114.846 -168.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.64 13.98 9.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.632 2.373 . . . . 0.0 111.833 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.71 124.12 7.99 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 122.726 3.85 . . . . 0.0 122.726 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.488 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 60.0 m-85 -144.0 84.08 1.76 Allowed 'General case' 0 CA--C 1.564 1.505 1 C-N-CA 132.455 4.302 . . . . 0.0 110.595 174.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.24 144.11 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 119.817 -1.802 . . . . 0.0 113.299 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 122.83 42.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 101.017 -3.698 . . . . 0.0 101.017 171.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 p -116.3 105.28 12.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.91 158.32 15.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.56 125.83 51.79 Favored 'General case' 0 CA--C 1.497 -1.079 1 N-CA-C 96.508 -5.367 . . . . 0.0 96.508 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.616 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.359 0.0 OUTLIER -112.7 -146.34 0.41 Allowed 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.881 1.363 . . . . 0.0 111.521 -171.348 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.616 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.271 14.6 tp -95.79 -7.09 38.07 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.275 5.4 pt20 -151.03 -17.9 0.21 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -150.4 -160.37 1.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.681 0.792 . . . . 0.0 111.792 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.96 141.79 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.746 1.218 . . . . 0.0 109.376 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -138.05 150.3 46.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.705 0.802 . . . . 0.0 111.363 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.19 144.24 43.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.178 0.991 . . . . 0.0 113.572 -173.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.91 69.42 1.27 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.5 tm? -142.16 123.04 14.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 115.584 -2.15 . . . . 0.0 111.925 174.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.566 HD13 ' H ' ' B' 1141 ' ' ASN 0.255 38.7 mt -139.53 -41.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 122.843 2.565 . . . . 0.0 112.921 173.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.3 148.88 71.62 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 120.351 1.432 . . . . 0.0 114.162 -175.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -81.35 179.57 5.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.172 3.248 . . . . 0.0 111.387 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.07 139.52 56.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.93 -167.59 1.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.132 1.773 . . . . 0.0 111.369 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.33 -7.97 27.95 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -122.66 20.59 10.21 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.808 1.643 . . . . 0.0 112.845 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.07 -171.48 39.92 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.345 1.926 . . . . 0.0 111.381 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -121.73 -137.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 108.109 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.43 123.22 6.28 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.338 1.426 . . . . 0.0 107.725 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.89 137.26 36.86 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -146.09 130.79 17.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.489 1.916 . . . . 0.0 111.733 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 m -141.61 0.99 1.5 Allowed 'General case' 0 N--CA 1.492 1.672 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 -173.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -29.91 156.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 174.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.9 -31.0 16.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.53 2.21 13.78 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.615 1.166 . . . . 0.0 114.112 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.78 105.38 0.41 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.224 1.393 . . . . 0.0 114.757 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 54.1 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.014 1.726 . . . . 0.0 109.535 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.499 68.9 p -77.77 12.83 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 121.569 3.915 . . . . 0.0 121.569 -172.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -39.47 35.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 131.629 3.972 . . . . 0.0 121.049 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.77 174.57 9.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.281 2.632 . . . . 0.0 109.281 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -68.93 155.23 40.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.711 -1.243 . . . . 0.0 111.368 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.8 -41.13 65.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.582 -0.699 . . . . 0.0 112.653 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.03 -40.53 96.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.71 -33.91 60.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.943 0.497 . . . . 0.0 112.218 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -73.86 -34.03 64.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.534 1.134 . . . . 0.0 112.347 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.744 1.217 . . . . 0.0 112.646 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.4 -37.88 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.679 0.792 . . . . 0.0 111.812 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -80.4 -34.77 36.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.789 1.235 . . . . 0.0 112.691 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -80.63 -15.27 57.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.69 -48.83 63.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.585 1.154 . . . . 0.0 113.752 -174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -81.93 -44.62 16.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.673 1.189 . . . . 0.0 113.267 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.43 88.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.945 1.698 . . . . 0.0 110.747 -175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -69.56 172.58 7.12 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.975 0.91 . . . . 0.0 110.328 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -101.31 4.81 41.99 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.779 1.632 . . . . 0.0 112.32 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.17 -141.78 0.52 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 128.0 2.714 . . . . 0.0 115.067 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.0 tp -107.93 161.37 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.231 1.812 . . . . 0.0 109.245 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -31.33 -45.68 0.32 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 119.007 2.966 . . . . 0.0 119.007 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -75.36 -157.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.581 2.854 . . . . 0.0 116.829 -173.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 92.4 m -45.8 -59.21 2.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.639 3.176 . . . . 0.0 118.186 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.99 156.34 19.81 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.84 1.2 . . . . 0.0 111.91 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -14.89 3.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -108.54 141.19 40.81 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.77 1.623 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -93.69 169.57 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 86.4 m -136.36 -154.78 0.58 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.65 2.38 . . . . 0.0 109.307 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.0 m -121.06 123.37 42.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.587 1.155 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 t -103.61 168.52 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.7 1.2 . . . . 0.0 112.74 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 124.44 1.096 . . . . 0.0 112.24 175.675 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 CA--C 1.539 0.762 0 N-CA-C 111.497 -0.232 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B 1138 ' ' GLU . . . . . 0.489 ' HG2' ' HE ' ' A' ' 26' ' ' ARG . 8.3 tt0 . . . . . 0 CA--C 1.546 0.789 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.805 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1140 ' ' VAL . . . . . 0.414 ' C ' ' N ' ' B' 1142 ' ' GLN 0.319 95.2 t . . . . . 0 N--CA 1.504 2.262 0 N-CA-C 119.852 3.278 . . . . 0.0 119.852 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B 1141 ' ' ASN . . . . . 0.566 ' H ' HD13 ' A' ' 70' ' ' ILE . 1.2 m-80 -67.15 -17.91 65.06 Favored 'General case' 0 CA--C 1.579 2.087 1 N-CA-C 99.14 -4.393 . . . . 0.0 99.14 165.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B 1142 ' ' GLN . . . . . 0.414 ' N ' ' C ' ' B' 1140 ' ' VAL . 49.6 mm-40 -132.44 4.43 0.04 OUTLIER Pre-proline 0 C--N 1.384 2.078 1 N-CA-C 125.509 5.374 . . . . 0.0 125.509 173.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo 6.16 58.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.892 1.728 . . . . 0.0 113.567 -126.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 133.05 4.54 . . . . 0.0 116.993 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 . . . . . 0 CA--C 1.544 0.725 0 CA-C-O 121.372 0.606 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -141.07 150.23 42.66 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -141.03 148.23 39.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 128.398 2.679 . . . . 0.0 108.912 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.36 41.28 1.3 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 123.15 2.705 . . . . 0.0 112.532 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -142.58 31.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.004 1.383 . . . . 0.0 110.721 174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.09 79.67 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.67 1.188 . . . . 0.0 108.141 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 m -52.58 154.57 2.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.678 1.591 . . . . 0.0 112.325 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.445 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -47.15 -39.35 13.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.48 -34.61 74.6 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.916 1.286 . . . . 0.0 112.779 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -81.75 -43.98 17.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.275 1.03 . . . . 0.0 111.598 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 t -62.15 -36.45 81.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.521 1.128 . . . . 0.0 112.361 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.9 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttp-105 -79.12 -35.64 41.89 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.914 0.779 . . . . 0.0 111.54 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -83.39 -45.27 13.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.251 1.42 . . . . 0.0 112.574 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.26 -7.5 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.923 0.889 . . . . 0.0 111.236 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.37 -0.97 59.36 Favored Glycine 0 N--CA 1.471 0.997 0 O-C-N 119.966 -1.709 . . . . 0.0 116.46 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.48 -3.78 58.96 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.93 1.365 . . . . 0.0 111.219 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.56 152.78 29.93 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.92 1.688 . . . . 0.0 111.743 174.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.6 22.42 3.17 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.667 1.127 . . . . 0.0 115.086 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.13 -170.5 2.76 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.398 1.479 . . . . 0.0 112.032 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -54.87 156.92 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.951 1.3 . . . . 0.0 111.392 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 6.9 m-20 -46.54 -24.3 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' HA2' ' CD2' ' A' ' 113' ' ' HIS . . . -99.63 43.46 1.81 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 119.804 2.682 . . . . 0.0 119.804 -173.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.87 75.43 0.96 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -98.26 171.65 8.07 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 117.278 2.325 . . . . 0.0 117.278 -172.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -141.47 142.69 33.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 0.0 110.107 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.53 93.51 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.07 161.77 24.88 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.36 1.464 . . . . 0.0 110.039 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -141.56 -158.62 0.88 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -140.48 163.39 32.96 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 123.475 1.607 . . . . 0.0 109.862 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.26 1.3 pp0? -96.11 11.97 32.34 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.836 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -97.49 -73.85 0.59 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 131.632 3.973 . . . . 0.0 108.321 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.89 120.58 47.63 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 121.399 1.909 . . . . 0.0 109.588 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.29 -13.87 23.05 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.919 2.413 . . . . 0.0 113.976 -168.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -125.59 30.88 5.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.278 2.231 . . . . 0.0 110.467 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.48 132.32 10.93 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 122.505 3.762 . . . . 0.0 122.505 -172.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -144.02 76.29 1.5 Allowed 'General case' 0 CA--C 1.559 1.303 1 C-N-CA 131.786 4.034 . . . . 0.0 109.019 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.44 154.79 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.129 2.172 . . . . 0.0 113.046 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.36 131.45 55.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.5 p -113.74 113.52 25.08 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -97.2 153.27 18.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 41.8 t -115.03 63.31 0.68 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -66.8 -170.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.706 -173.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.593 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.504 0.3 OUTLIER -97.01 7.83 45.8 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 119.696 3.221 . . . . 0.0 119.696 -173.582 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -142.29 -28.57 0.6 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.034 1.459 . . . . 0.0 112.554 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.8 179.75 7.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.943 0.897 . . . . 0.0 111.243 174.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.48 116.69 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -128.93 160.08 33.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.807 1.643 . . . . 0.0 112.705 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.445 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 91.3 m-70 -101.31 165.24 11.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.522 1.529 . . . . 0.0 113.689 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -133.63 47.6 2.44 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -142.47 135.48 28.48 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.513 -1.992 . . . . 0.0 113.993 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.431 HD13 ' H ' ' B' 1142 ' ' GLN . 52.4 mt -140.36 -43.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.245 0.929 . . . . 0.0 111.05 171.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.98 155.3 68.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -83.32 -176.12 2.65 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.754 3.636 . . . . 0.0 111.877 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -54.03 141.13 29.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.478 1.111 . . . . 0.0 113.861 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -123.56 -170.82 2.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.882 1.273 . . . . 0.0 111.714 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.16 -13.86 20.68 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.015 1.326 . . . . 0.0 112.3 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -99.1 5.58 46.88 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.618 1.567 . . . . 0.0 113.517 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -170.1 -157.7 12.8 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.107 1.337 . . . . 0.0 113.478 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -106.93 -137.14 0.36 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.844 1.258 . . . . 0.0 108.79 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.69 123.22 16.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.87 132.11 37.82 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -150.17 161.65 41.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.178 1.791 . . . . 0.0 114.698 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . 0.253 1.5 m -145.31 -160.54 1.15 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.905 1.282 . . . . 0.0 108.746 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.444 ' HA ' ' CG1' ' B' 1140 ' ' VAL . 9.0 ttm -155.65 -179.93 8.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 129.398 3.079 . . . . 0.0 107.952 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.62 -30.56 70.17 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.12 -0.988 . . . . 0.0 110.13 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.31 40.19 1.91 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.914 1.286 . . . . 0.0 112.669 174.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 179.48 19.56 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 63.83 1.42 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.173 2.189 . . . . 0.0 111.919 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.545 24.6 p -78.4 2.44 18.74 Favored 'General case' 0 N--CA 1.487 1.377 1 N-CA-C 123.352 4.575 . . . . 0.0 123.352 -172.795 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -40.36 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 1 C-N-CA 132.377 4.271 . . . . 0.0 119.872 172.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.86 159.79 35.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.499 1.919 . . . . 0.0 112.69 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 m -61.36 136.61 58.1 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.092 1.357 . . . . 0.0 112.715 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.19 -30.16 68.3 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.67 -41.28 99.0 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.903 0.774 . . . . 0.0 112.412 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.4 -39.52 74.44 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.756 -0.59 . . . . 0.0 111.085 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -64.19 -30.56 71.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.437 1.095 . . . . 0.0 112.748 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -76.43 -45.23 32.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.417 1.087 . . . . 0.0 111.94 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.9 -57.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.726 0.694 . . . . 0.0 111.853 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -82.77 -51.03 8.06 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.309 54.3 m-85 -79.85 7.04 9.53 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -173.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -54.72 -29.51 53.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 121.408 1.913 . . . . 0.0 112.941 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.51 -26.59 51.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.692 1.997 . . . . 0.0 114.572 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.6 mt -147.02 71.92 1.24 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.06 2.544 . . . . 0.0 106.773 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.09 159.85 16.49 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 59.59 3.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.93 2.092 . . . . 0.0 111.548 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.27 -154.02 2.04 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 125.54 1.543 . . . . 0.0 113.687 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 tp -79.5 -179.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.836 1.654 . . . . 0.0 111.987 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.4 mt -40.1 139.23 1.03 Allowed Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.769 -1.586 . . . . 0.0 110.586 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -56.17 71.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 125.025 3.817 . . . . 0.0 119.894 -159.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.6 m -103.54 -128.98 0.24 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 129.069 2.948 . . . . 0.0 107.592 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.55 73.5 8.59 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.619 -1.3 . . . . 0.0 108.909 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -2.81 6.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -84.42 56.05 3.64 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.803 1.241 . . . . 0.0 111.103 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.513 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -60.97 141.43 57.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.768 1.627 . . . . 0.0 114.26 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.98 -171.33 2.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 129.402 3.081 . . . . 0.0 109.282 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.79 140.12 33.45 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.1 t -99.85 175.99 5.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.109 1.764 . . . . 0.0 111.865 174.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 . . . . . 0 N--CA 1.476 0.827 0 C-N-CA 125.487 1.515 . . . . 0.0 112.647 -174.757 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 CA--C 1.54 0.792 0 CA-C-O 120.767 0.236 . . . . 0.0 112.653 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 . . . . . 0 CA--C 1.542 0.661 0 C-N-CA 124.992 1.317 . . . . 0.0 112.427 -179.483 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B 1140 ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 83' ' ' MET . 26.7 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 116.079 -1.915 . . . . 0.0 114.7 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -28.5 67.95 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 169.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B 1142 ' ' GLN . . . . . 0.431 ' H ' HD13 ' A' ' 70' ' ' ILE 0.352 3.7 mp0 -154.25 158.42 32.39 Favored Pre-proline 0 N--CA 1.435 -1.212 1 C-N-CA 137.216 6.206 . . . . 0.0 104.348 169.775 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 60.26 2.06 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 CA-C-N 121.585 1.602 . . . . 0.0 110.261 152.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.1 t0 . . . . . 0 C--O 1.254 1.322 1 C-N-CA 134.446 5.098 . . . . 0.0 115.652 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -117.75 138.09 52.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -141.92 177.84 7.92 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.598 2.759 . . . . 0.0 108.607 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.16 -130.3 3.81 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 121.913 2.142 . . . . 0.0 112.773 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 61.3 ttp85 -51.03 122.49 7.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.315 2.057 . . . . 0.0 115.929 -172.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.87 78.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 1 N-CA-C 99.146 -4.39 . . . . 0.0 99.146 173.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -30.91 121.18 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.977 2.511 . . . . 0.0 115.051 -171.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -24.93 63.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.45 1.9 . . . . 0.0 113.65 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -80.98 -39.2 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.166 1.386 . . . . 0.0 112.805 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.88 -40.62 22.13 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.105 1.362 . . . . 0.0 113.695 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -56.01 -32.65 64.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.193 1.397 . . . . 0.0 113.781 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.465 ' HA ' ' CG2' ' A' ' 65' ' ' VAL 0.266 1.5 pt20 -64.14 -15.84 60.61 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 174.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -80.61 -28.38 37.04 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.117 0.967 . . . . 0.0 112.038 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.13 -59.02 1.81 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.502 1.521 . . . . 0.0 112.588 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.15 -6.47 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 126.431 1.892 . . . . 0.0 111.63 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.53 7.06 65.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 119.965 -1.709 . . . . 0.0 114.348 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -7.78 59.11 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.021 0.911 . . . . 0.0 110.126 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 142.63 50.19 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.256 1.422 . . . . 0.0 110.355 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.73 27.76 5.37 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.709 1.147 . . . . 0.0 115.586 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.57 179.58 7.68 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.343 1.071 . . . . 0.0 112.357 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' A' ' 41' ' ' GLY . 27.1 m -57.25 149.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.422 0.689 . . . . 0.0 111.68 174.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 7.1 m-20 -55.16 2.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -113.37 15.76 22.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.439 2.447 . . . . 0.0 116.911 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.64 71.16 4.23 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.196 2.498 . . . . 0.0 105.147 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.39 174.24 6.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -140.52 162.27 35.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.33 2.652 . . . . 0.0 109.033 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.28 107.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.299 1.04 . . . . 0.0 109.31 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.54 164.92 28.91 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.624 1.97 . . . . 0.0 107.899 -177.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 15.4 pt-20 -141.05 -172.53 3.5 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.2 t -98.37 138.55 35.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.429 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' H ' ' HB2' ' A' ' 23' ' ' ARG 0.358 0.0 OUTLIER -98.2 5.53 48.37 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.661 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -113.47 -43.37 3.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 128.46 2.704 . . . . 0.0 113.999 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -76.37 127.22 85.18 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 120.558 1.526 . . . . 0.0 111.733 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -69.67 -25.5 28.96 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.989 2.459 . . . . 0.0 116.664 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -110.39 23.97 13.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.929 . . . . 0.0 111.171 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.91 129.75 10.0 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 122.16 3.624 . . . . 0.0 122.16 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -144.32 121.54 11.53 Favored 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.899 4.879 . . . . 0.0 102.181 173.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.464 ' CG1' ' HA ' ' A' ' 47' ' ' GLU 0.325 0.9 OUTLIER -125.11 138.94 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 123.552 2.887 . . . . 0.0 112.787 -174.954 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 tt -98.6 126.11 44.07 Favored 'General case' 0 CA--C 1.536 0.438 1 N-CA-C 99.546 -4.242 . . . . 0.0 99.546 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 p -125.64 112.05 15.69 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.873 1.215 . . . . 0.0 108.243 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.31 167.16 11.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.607 1.163 . . . . 0.0 111.502 -173.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 49.7 t -126.33 94.97 4.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 174.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.651 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.326 0.0 OUTLIER -90.72 -161.84 0.84 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.008 -173.077 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.651 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.532 0.3 OUTLIER -96.88 13.07 30.0 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 -174.287 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -147.4 -36.24 0.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.107 -1.861 . . . . 0.0 112.16 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -151.1 -177.55 6.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 30' ' ' GLN . 5.0 m -100.03 127.41 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 173.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -128.96 146.4 50.98 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.206 1.402 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -117.66 159.93 22.13 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -172.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -131.87 84.05 2.14 Favored 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.596 1.558 . . . . 0.0 115.196 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.3 19.51 3.16 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 121.745 3.98 . . . . 0.0 121.745 -174.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 mt -93.07 4.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 118.949 -2.344 . . . . 0.0 116.534 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.4 mt -135.78 138.95 29.31 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.749 1.159 . . . . 0.0 111.85 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -84.93 -176.95 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.297 3.331 . . . . 0.0 111.195 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 m -62.56 147.01 50.41 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.707 -1.246 . . . . 0.0 112.331 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -125.03 -176.67 3.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.336 1.054 . . . . 0.0 111.963 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -97.54 -8.72 28.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.75 0.82 . . . . 0.0 112.786 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -99.39 0.18 42.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.075 1.35 . . . . 0.0 112.552 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -162.4 -155.8 8.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.261 1.41 . . . . 0.0 114.233 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.64 -135.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.921 1.688 . . . . 0.0 108.794 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.98 117.33 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -84.12 126.45 33.1 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.442 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 25.9 m-85 -143.04 157.23 44.73 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.9 p -148.73 -159.2 1.0 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.839 2.056 . . . . 0.0 110.751 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.406 ' HA ' ' CG1' ' B' 1140 ' ' VAL . 46.9 mtt -155.54 -169.08 3.01 Favored 'General case' 0 C--N 1.314 -0.97 1 C-N-CA 137.309 6.244 . . . . 0.0 107.335 -172.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.21 -34.75 78.16 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.43 ' H ' HD23 ' A' ' 107' ' ' LEU . 25.3 t0 -141.18 60.76 1.5 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.937 1.695 . . . . 0.0 110.367 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.14 172.41 22.08 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -141.24 42.84 1.78 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.142 1.777 . . . . 0.0 114.01 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 2.3 p -70.95 -1.45 11.99 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 120.632 3.568 . . . . 0.0 120.632 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.442 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 2.5 ptm180 -43.21 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 1 C-N-CA 131.868 4.067 . . . . 0.0 119.817 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.81 166.35 24.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.805 2.442 . . . . 0.0 110.466 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -66.17 132.99 49.75 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.05 -1.031 . . . . 0.0 109.667 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.98 -46.2 24.81 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.75 -40.0 82.6 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.69 -28.28 68.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.58 0.752 . . . . 0.0 112.562 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -88.01 -20.63 25.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 112.329 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 tt -69.21 -55.29 11.03 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.92 -1.112 . . . . 0.0 111.192 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.76 -60.11 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.856 0.753 . . . . 0.0 112.297 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -82.28 -64.0 1.27 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.265 99.6 m-85 -69.94 -5.55 26.92 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -172.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -53.32 -29.48 34.01 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 123.452 2.842 . . . . 0.0 113.608 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -64.38 -32.06 73.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.132 1.773 . . . . 0.0 114.139 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -151.44 74.71 1.14 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.105 2.162 . . . . 0.0 106.532 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -107.3 -167.23 1.24 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.92 1.288 . . . . 0.0 114.12 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -104.03 76.6 1.37 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.676 1.99 . . . . 0.0 108.861 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.99 -157.94 1.04 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.797 1.189 . . . . 0.0 113.362 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.76 158.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.659 1.184 . . . . 0.0 113.816 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 85' ' ' ASP . 12.5 mt -28.73 -64.16 0.18 Allowed Pre-proline 0 CA--C 1.566 1.585 0 CA-C-O 115.281 -2.295 . . . . 0.0 115.764 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 107' ' ' LEU . 11.8 Cg_endo -119.59 -21.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.637 0 CA-C-N 124.252 2.554 . . . . 0.0 117.308 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.2 m -86.22 -145.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.18 1.792 . . . . 0.0 114.145 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.86 141.89 47.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.468 1.107 . . . . 0.0 113.261 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -9.43 17.99 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -174.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -106.32 146.89 29.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.509 1.124 . . . . 0.0 112.478 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -111.51 153.26 26.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.255 1.422 . . . . 0.0 114.169 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.06 -179.92 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.065 2.146 . . . . 0.0 110.843 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 95.3 m -98.96 124.04 43.66 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.895 -1.128 . . . . 0.0 113.094 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t -102.69 -177.44 3.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.039 1.736 . . . . 0.0 114.413 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 123.942 0.897 . . . . 0.0 110.85 175.575 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 CA--C 1.547 1.142 0 CA-C-O 120.743 0.226 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.55 -174.899 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B 1140 ' ' VAL . . . . . 0.41 ' C ' ' N ' ' B' 1142 ' ' GLN 0.281 77.6 t . . . . . 0 N--CA 1.509 2.518 0 N-CA-C 117.988 2.588 . . . . 0.0 117.988 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.33 -28.45 65.07 Favored 'General case' 0 CA--C 1.583 2.221 1 N-CA-C 99.696 -4.187 . . . . 0.0 99.696 167.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1142 ' ' GLN . . . . . 0.506 ' C ' ' H ' ' B' 1144 ' ' ASP . 4.4 mp0 -146.79 169.48 9.38 Favored Pre-proline 0 C--N 1.369 1.45 0 C-N-CA 130.103 3.361 . . . . 0.0 113.272 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.24 41.22 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.647 0 C-N-CA 124.466 3.444 . . . . 0.0 113.947 146.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B 1144 ' ' ASP . . . . . 0.506 ' H ' ' C ' ' B' 1142 ' ' GLN . 42.1 t0 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 132.564 4.345 . . . . 0.0 115.396 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.9 m95 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.85 143.78 31.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 -173.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -141.36 149.78 41.58 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.766 3.226 . . . . 0.0 107.839 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.91 39.87 1.41 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-N 123.532 2.878 . . . . 0.0 114.912 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -146.29 30.93 1.02 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.928 0.891 . . . . 0.0 112.352 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 tp -128.19 75.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.479 1.112 . . . . 0.0 109.954 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -45.32 150.16 0.47 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.008 1.723 . . . . 0.0 113.756 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -31.57 32.9 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -174.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.0 -33.16 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -81.49 -49.97 9.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.027 1.331 . . . . 0.0 112.37 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 p -66.47 -29.05 69.09 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.401 -0.812 . . . . 0.0 112.514 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.14 -14.57 63.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.488 1.495 . . . . 0.0 113.723 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -79.86 -34.26 39.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.292 1.037 . . . . 0.0 111.335 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mp -86.98 -42.77 12.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.438 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.23 -10.74 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 111.168 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.59 -1.41 58.96 Favored Glycine 0 N--CA 1.469 0.879 0 O-C-N 120.436 -1.415 . . . . 0.0 116.112 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -88.02 -0.14 56.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.771 1.285 . . . . 0.0 111.868 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.76 158.99 19.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.083 1.753 . . . . 0.0 111.308 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.15 25.51 2.64 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.405 1.002 . . . . 0.0 114.995 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.5 -170.73 2.93 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.458 1.103 . . . . 0.0 111.644 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 41' ' ' GLY . 28.3 m -54.72 154.99 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.759 0.823 . . . . 0.0 110.542 173.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 17.8 m-20 -55.66 -10.4 0.69 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -98.54 13.03 63.01 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.14 2.781 . . . . 0.0 116.445 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.41 78.92 4.4 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 122.193 2.997 . . . . 0.0 105.843 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.17 170.65 8.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.6 tp -133.97 153.23 51.91 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.768 2.027 . . . . 0.0 109.768 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.41 102.55 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.33 163.91 31.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.825 1.25 . . . . 0.0 109.252 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -143.06 -159.26 0.95 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.579 1.181 . . . . 0.0 112.797 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -120.53 150.85 40.2 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 130.781 3.633 . . . . 0.0 108.021 174.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.85 5.82 48.57 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -98.99 -64.33 1.05 Allowed 'General case' 0 C--N 1.357 0.896 0 C-N-CA 131.411 3.884 . . . . 0.0 113.756 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -58.38 123.9 68.54 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 122.478 2.399 . . . . 0.0 111.459 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.86 -21.13 38.37 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.308 2.672 . . . . 0.0 113.89 -170.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -111.14 21.46 16.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.826 2.45 . . . . 0.0 112.182 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.96 123.32 7.64 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 120.718 3.047 . . . . 0.0 120.718 -173.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -143.48 103.93 4.16 Favored 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 132.69 4.396 . . . . 0.0 102.606 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.311 0.8 OUTLIER -110.79 138.9 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 121.346 1.884 . . . . 0.0 114.177 -173.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.21 128.03 45.28 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.9 p -127.11 113.73 16.8 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.859 1.209 . . . . 0.0 109.005 -173.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.96 153.45 17.76 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.212 1.005 . . . . 0.0 112.382 -172.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 48.5 t -113.64 75.7 0.94 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.568 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.323 2.5 t60 -82.81 -172.35 4.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.266 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.568 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.559 0.2 OUTLIER -98.5 22.3 10.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -173.763 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -149.96 -39.36 0.14 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.748 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 175.83 10.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.045 0.938 . . . . 0.0 110.512 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.0 m -118.16 112.53 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -110.86 158.07 19.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.95 1.7 . . . . 0.0 112.87 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -120.76 160.06 24.13 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.465 1.506 . . . . 0.0 114.517 -173.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -131.24 87.2 2.44 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.89 23.36 2.25 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -175.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.472 HD13 ' H ' ' B' 1142 ' ' GLN . 5.8 mt -92.07 -3.26 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 118.326 -2.733 . . . . 0.0 118.065 -168.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -136.77 136.46 21.58 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 120.913 1.688 . . . . 0.0 113.214 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.38 170.24 16.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.952 3.101 . . . . 0.0 112.495 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -57.48 141.06 48.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.659 1.184 . . . . 0.0 113.658 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -131.34 178.82 6.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.647 1.179 . . . . 0.0 112.795 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -99.08 -7.18 27.11 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.91 1.284 . . . . 0.0 111.441 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -106.99 45.1 1.0 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.947 2.499 . . . . 0.0 107.295 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 148.32 -160.53 28.38 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.121 2.772 . . . . 0.0 109.09 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -124.18 -123.33 0.26 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.22 116.8 5.3 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.59 136.05 40.52 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -146.88 154.57 41.46 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 m -146.47 -172.93 4.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.245 2.618 . . . . 0.0 109.226 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.2 mtp -154.48 176.92 11.77 Favored 'General case' 0 C--N 1.311 -1.085 1 C-N-CA 138.95 6.9 . . . . 0.0 107.175 -172.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.45 -25.52 65.94 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.329 -0.857 . . . . 0.0 111.235 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.45 36.52 2.05 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.344 1.058 . . . . 0.0 112.833 174.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 170.12 24.84 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -141.37 60.24 1.5 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.639 1.976 . . . . 0.0 112.418 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.507 41.3 p -76.97 9.75 2.75 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -173.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -38.14 31.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 2 C-N-CA 133.482 4.713 . . . . 0.0 122.756 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -113.81 169.63 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.629 1.571 . . . . 0.0 110.795 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -56.26 140.21 45.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.481 1.113 . . . . 0.0 111.915 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.16 -47.1 30.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.449 0.7 . . . . 0.0 112.75 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.6 -38.79 87.72 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.809 -0.557 . . . . 0.0 111.842 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.28 -37.05 86.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.866 0.466 . . . . 0.0 111.408 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -68.66 -41.68 79.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.458 -0.777 . . . . 0.0 112.121 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 tt -65.82 -39.65 91.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.508 0.595 . . . . 0.0 111.912 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.32 -69.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.756 -0.59 . . . . 0.0 111.204 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.15 -41.26 20.66 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.51 -27.83 34.29 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 121.294 1.861 . . . . 0.0 115.348 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -39.3 -42.42 1.02 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -21.11 58.91 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -146.47 56.96 1.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.013 2.125 . . . . 0.0 110.913 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -91.18 -154.78 0.37 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.116 0.966 . . . . 0.0 112.187 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.89 -4.48 27.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.304 1.842 . . . . 0.0 113.601 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 44.71 -145.27 2.12 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.523 2.011 . . . . 0.0 116.543 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -79.56 159.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.999 1.719 . . . . 0.0 111.199 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mt -35.17 -54.22 1.12 Allowed Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 116.318 -1.801 . . . . 0.0 115.525 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -118.73 -33.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 -172.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.31 -131.95 0.13 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 126.591 1.956 . . . . 0.0 115.31 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.49 137.68 52.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.9 1.28 . . . . 0.0 113.559 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.51 -13.49 32.04 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -99.81 161.73 13.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.927 1.291 . . . . 0.0 112.373 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -132.21 154.32 49.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 113.314 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 168.11 20.54 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.882 2.473 . . . . 0.0 108.742 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.2 m -98.09 130.0 44.89 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 119.922 -1.736 . . . . 0.0 112.673 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -99.22 178.16 4.99 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.577 1.151 . . . . 0.0 112.441 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 . . . . . 0 N--CA 1.478 0.939 0 C-N-CA 124.478 1.111 . . . . 0.0 112.791 -179.773 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.538 0.704 0 CA-C-O 120.911 0.296 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 116.214 -1.85 . . . . 0.0 113.922 174.539 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B 1140 ' ' VAL . . . . . . . . . . . . 0.326 78.2 t . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -59.57 -29.86 68.24 Favored 'General case' 0 CA--C 1.581 2.168 1 N-CA-C 99.048 -4.427 . . . . 0.0 99.048 167.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B 1142 ' ' GLN . . . . . 0.472 ' H ' HD13 ' A' ' 70' ' ' ILE 0.263 1.9 mp0 -151.72 172.53 5.33 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 130.657 3.583 . . . . 0.0 114.037 171.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.02 59.1 0.3 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.396 2.064 . . . . 0.0 110.93 141.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B 1144 ' ' ASP . . . . . . . . . . . . 0.255 30.0 t70 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 131.472 3.909 . . . . 0.0 117.448 -174.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 m -134.88 150.96 74.71 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.39 1.476 . . . . 0.0 112.09 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.47 156.4 61.58 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.384 2.723 . . . . 0.0 112.792 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.44 158.06 43.84 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.381 1.472 . . . . 0.0 112.208 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -94.51 151.26 19.49 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.563 1.145 . . . . 0.0 112.233 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.5 -6.92 88.15 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.593 1.092 . . . . 0.0 115.636 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -62.85 140.77 58.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.438 1.495 . . . . 0.0 112.425 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.2 p -130.29 162.71 28.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.965 1.706 . . . . 0.0 112.44 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.2 tp -141.83 142.31 33.15 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.118 1.367 . . . . 0.0 111.519 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -97.24 10.11 40.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.866 1.666 . . . . 0.0 114.81 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.8 160.78 27.58 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.167 1.387 . . . . 0.0 114.018 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 174.19 3.65 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.364 1.466 . . . . 0.0 113.484 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.3 mm -69.94 -42.36 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.332 -0.855 . . . . 0.0 111.582 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -79.71 57.36 2.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.53 1.532 . . . . 0.0 112.724 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -116.61 -2.54 11.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.0 p -141.67 175.96 9.28 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 128.226 2.611 . . . . 0.0 110.134 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.07 9.85 0.65 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -57.15 -22.65 41.74 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -124.15 22.53 8.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.335 1.854 . . . . 0.0 112.854 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.91 126.47 41.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.172 1.389 . . . . 0.0 111.885 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -141.11 156.55 45.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.036 2.135 . . . . 0.0 108.904 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.86 32.76 2.1 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 123.412 2.823 . . . . 0.0 113.841 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -145.86 47.62 1.25 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.712 1.244 . . . . 0.0 110.522 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.252 7.0 tt -139.5 62.62 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 122.97 1.367 . . . . 0.0 108.357 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -47.89 153.37 0.64 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.619 1.967 . . . . 0.0 112.73 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -35.73 0.71 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -174.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.25 -33.7 61.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.66 -46.61 14.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.482 1.113 . . . . 0.0 112.322 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 p -63.99 -31.32 72.46 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.929 -1.107 . . . . 0.0 112.353 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -71.08 -16.41 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.734 1.152 . . . . 0.0 113.675 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -80.21 -35.15 36.66 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.03 0.932 . . . . 0.0 111.586 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.1 mp -88.95 -45.23 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.497 1.119 . . . . 0.0 112.649 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.06 -9.1 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.159 0.984 . . . . 0.0 111.533 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.35 -0.27 61.37 Favored Glycine 0 N--CA 1.472 1.086 0 O-C-N 120.019 -1.676 . . . . 0.0 115.62 -174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -80.75 -14.25 58.27 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.155 0.978 . . . . 0.0 109.354 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.03 157.27 22.97 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.732 2.013 . . . . 0.0 111.966 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.69 33.4 2.05 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 124.769 1.176 . . . . 0.0 114.718 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.45 -179.29 7.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.705 1.202 . . . . 0.0 112.875 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' GLY . 29.7 m -51.27 149.32 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.105 0.962 . . . . 0.0 111.819 174.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 1.2 m-20 -40.22 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 129.683 3.193 . . . . 0.0 116.717 -174.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -99.84 19.4 53.5 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 120.129 2.811 . . . . 0.0 120.129 -174.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.4 78.43 4.42 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 123.509 3.654 . . . . 0.0 105.596 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.41 170.29 8.51 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -172.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 tp -140.46 156.11 46.46 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.289 3.036 . . . . 0.0 108.821 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.06 79.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 122.872 1.32 . . . . 0.0 108.681 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.453 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -115.78 168.82 9.71 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.249 1.42 . . . . 0.0 110.806 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.75 -156.33 0.67 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.547 0.689 . . . . 0.0 110.394 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.436 ' HG ' ' P ' ' B' 1139 ' ' PTR . 87.5 p -134.52 154.3 51.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.923 2.089 . . . . 0.0 109.077 174.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.285 1.4 pp0? -99.53 6.05 45.92 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.625 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -99.78 -61.67 1.34 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 131.246 3.819 . . . . 0.0 113.038 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -64.14 125.15 87.52 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 123.786 2.994 . . . . 0.0 107.584 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.83 -6.84 19.58 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.143 2.562 . . . . 0.0 114.101 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -129.03 26.87 5.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.649 2.379 . . . . 0.0 111.737 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.17 127.01 9.01 Favored Glycine 0 C--N 1.356 1.692 0 N-CA-C 121.992 3.557 . . . . 0.0 121.992 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.424 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 33.3 m-85 -145.12 77.69 1.53 Allowed 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 133.602 4.761 . . . . 0.0 109.465 174.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.73 145.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.509 -1.995 . . . . 0.0 115.233 -173.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.95 128.38 48.39 Favored 'General case' 0 CA--C 1.542 0.672 1 N-CA-C 99.187 -4.375 . . . . 0.0 99.187 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 p -126.87 113.14 16.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.115 -1.615 . . . . 0.0 109.135 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.78 153.0 19.08 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.249 1.02 . . . . 0.0 111.421 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 53.6 t -124.94 114.63 19.41 Favored 'General case' 0 CA--C 1.496 -1.109 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.657 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.267 0.0 OUTLIER -113.41 -165.88 1.04 Allowed 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.024 1.453 . . . . 0.0 112.489 -173.054 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.657 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.462 0.3 OUTLIER -96.65 8.11 44.99 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 118.561 2.8 . . . . 0.0 118.561 -173.795 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -146.44 -27.02 0.42 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 125.202 1.564 . . . . 0.0 112.777 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -150.07 -177.96 6.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.953 0.901 . . . . 0.0 112.312 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 m -131.26 135.24 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.639 1.176 . . . . 0.0 109.43 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -140.96 158.25 44.2 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.774 0.83 . . . . 0.0 112.63 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.453 ' CG ' HH21 ' A' ' 46' ' ' ARG . 88.2 m-70 -111.57 149.03 32.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.197 1.399 . . . . 0.0 110.854 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 65.27 1.12 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.862 1.265 . . . . 0.0 113.252 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.4 tm? -141.81 129.85 22.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.355 1.462 . . . . 0.0 112.348 174.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.455 ' CD1' ' H ' ' B' 1142 ' ' GLN . 12.1 mt -140.66 -42.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.714 1.143 . . . . 0.0 110.964 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.99 147.41 46.32 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.92 -173.31 1.72 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.294 3.329 . . . . 0.0 110.945 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -57.76 130.0 44.47 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.308 -0.87 . . . . 0.0 112.95 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -110.96 179.14 4.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.695 1.198 . . . . 0.0 112.246 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.03 -11.52 21.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.398 1.079 . . . . 0.0 112.305 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.1 32.93 4.07 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.061 2.144 . . . . 0.0 111.52 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.29 -150.07 21.43 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.782 2.61 . . . . 0.0 110.323 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -128.22 -130.77 0.22 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.233 1.413 . . . . 0.0 107.247 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -57.38 122.82 13.48 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.787 1.63 . . . . 0.0 107.819 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.47 138.83 32.58 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.54 ' H ' ' HB3' ' A' ' 89' ' ' ARG . 5.3 m-85 -145.34 137.1 25.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.174 2.19 . . . . 0.0 112.349 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -140.44 1.48 1.77 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.5 ttp -29.81 144.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.55 2.432 . . . . 0.0 113.813 173.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.21 -31.89 34.01 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -112.25 4.13 17.57 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.778 1.231 . . . . 0.0 113.266 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.93 88.73 0.18 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.584 1.564 . . . . 0.0 113.286 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -97.44 53.24 1.14 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.785 1.234 . . . . 0.0 108.85 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.469 68.5 p -79.25 20.03 0.54 Allowed 'General case' 0 N--CA 1.47 0.546 1 N-CA-C 122.566 4.284 . . . . 0.0 122.566 -172.605 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.54 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -39.64 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 121.609 3.929 . . . . 0.0 121.609 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -140.24 174.37 10.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 129.836 3.254 . . . . 0.0 107.708 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 m -62.4 116.4 5.04 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.317 -1.489 . . . . 0.0 109.831 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.2 -32.72 74.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.272 0.629 . . . . 0.0 112.336 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.36 -33.23 75.08 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.5 -37.38 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 111.373 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -28.68 62.92 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.844 0.858 . . . . 0.0 113.257 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.53 -34.0 68.68 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.215 1.406 . . . . 0.0 112.152 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.7 -39.7 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.061 0.944 . . . . 0.0 111.766 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -80.59 -47.19 14.51 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.48 1.112 . . . . 0.0 111.954 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.29 -18.83 65.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -40.03 -49.96 2.55 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.601 1.96 . . . . 0.0 115.167 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -81.18 -47.73 13.04 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.277 1.031 . . . . 0.0 113.534 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.23 92.71 3.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.73 1.612 . . . . 0.0 109.223 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -70.77 176.93 3.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.699 1.2 . . . . 0.0 113.049 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -90.13 -5.18 56.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.58 -166.62 1.16 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.028 1.299 . . . . 0.0 115.261 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.5 tt -90.24 -174.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.294 1.437 . . . . 0.0 107.512 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.74 110.21 2.59 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 121.583 1.992 . . . . 0.0 108.652 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -102.96 157.47 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 N-CA-C 118.98 2.646 . . . . 0.0 118.98 -129.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.33 -43.5 1.16 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 130.735 3.614 . . . . 0.0 106.372 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.5 158.37 41.07 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.955 3.302 . . . . 0.0 107.368 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.268 0.0 OUTLIER -121.4 -22.54 5.93 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.411 2.745 . . . . 0.0 118.411 -174.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.65 142.02 33.12 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.838 1.654 . . . . 0.0 112.13 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -97.85 152.6 19.02 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.195 0.998 . . . . 0.0 112.764 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 170.11 16.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.03 2.532 . . . . 0.0 108.991 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 62.5 m -98.0 132.76 43.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.388 -1.445 . . . . 0.0 113.217 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.5 t -111.1 162.04 15.3 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -68.94 146.25 52.93 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.36 1.464 . . . . 0.0 112.297 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -87.02 -37.83 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.621 0.769 . . . . 0.0 111.528 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.88 166.04 22.07 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.743 1.217 . . . . 0.0 113.297 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.376 1.47 . . . . 0.0 110.86 174.827 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 CA--C 1.542 0.886 0 N-CA-C 114.429 0.896 . . . . 0.0 114.429 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -150.84 156.61 35.87 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.284 1.434 . . . . 0.0 111.717 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.52 161.71 94.05 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.708 0.931 . . . . 0.0 112.77 -5.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.93 -92.62 0.06 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1139 ' ' PTR . . . . . 0.436 ' P ' ' HG ' ' A' ' 48' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 57.9 t -144.52 141.22 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 130.954 3.702 . . . . 0.0 101.706 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.357 69.4 m-20 122.66 -27.8 0.01 OUTLIER 'General case' 0 CA--C 1.59 2.506 4 C-N-CA 139.289 7.036 . . . . 0.0 92.801 -169.258 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' B' B 1142 ' ' GLN . . . . . 0.455 ' H ' ' CD1' ' A' ' 70' ' ' ILE 0.282 1.6 mp0 -130.69 -136.87 0.0 OUTLIER Pre-proline 0 C--N 1.381 1.962 0 C-N-CA 130.75 3.62 . . . . 0.0 115.154 168.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -91.68 122.04 0.66 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 123.046 2.123 . . . . 0.0 113.406 75.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -172.319 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -68.22 150.32 97.77 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.463 1.105 . . . . 0.0 113.022 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.98 157.0 63.59 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.406 2.737 . . . . 0.0 112.723 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.95 164.26 32.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.294 1.438 . . . . 0.0 112.44 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.1 p -140.25 162.6 34.9 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.813 1.645 . . . . 0.0 112.156 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.65 -148.14 46.32 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.803 0.716 . . . . 0.0 113.116 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -145.83 151.62 38.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.729 1.211 . . . . 0.0 112.378 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.9 p -89.53 -2.46 58.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.434 1.493 . . . . 0.0 113.586 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.2 tp -62.81 127.42 31.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.199 1.4 . . . . 0.0 111.586 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.7 p -91.48 -8.9 46.39 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.91 145.48 27.76 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.587 1.555 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.1 54.35 2.74 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.081 1.352 . . . . 0.0 112.547 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.5 mm -73.48 129.77 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.124 0.97 . . . . 0.0 110.706 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -98.49 159.03 15.22 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.499 1.519 . . . . 0.0 113.149 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -136.56 2.46 2.69 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 45.4 p -142.68 179.52 6.94 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.543 2.737 . . . . 0.0 110.527 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.19 18.73 0.08 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.381 1.472 . . . . 0.0 113.984 174.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.21 0.45 0.07 Allowed 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 118.753 2.871 . . . . 0.0 118.753 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -97.93 -8.68 27.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.879 1.272 . . . . 0.0 112.115 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -75.74 127.79 33.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.1 1.36 . . . . 0.0 112.065 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -141.35 147.77 38.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.941 1.696 . . . . 0.0 110.364 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.46 40.71 1.3 Allowed Glycine 0 C--O 1.219 -0.789 0 CA-C-N 122.746 2.521 . . . . 0.0 110.805 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 47.13 1.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.808 1.289 . . . . 0.0 109.832 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tt -150.42 81.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.507 1.123 . . . . 0.0 109.303 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.443 ' HB2' ' HG ' ' A' ' 48' ' ' SER . 7.3 t -61.74 164.17 6.49 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.685 1.594 . . . . 0.0 113.884 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.65 -27.64 18.1 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.44 -44.43 19.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.156 0.982 . . . . 0.0 112.467 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.45 -32.02 32.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.667 1.187 . . . . 0.0 113.808 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 p -66.8 -35.52 80.26 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.219 -0.926 . . . . 0.0 112.101 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.273 6.1 pt20 -69.81 -13.71 62.41 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -77.43 -30.59 53.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.709 0.803 . . . . 0.0 111.257 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 mp -92.16 -62.28 1.44 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.795 1.238 . . . . 0.0 111.957 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 mt -70.45 -10.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 125.14 1.376 . . . . 0.0 111.938 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.15 -6.67 57.69 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 121.078 -1.014 . . . . 0.0 115.557 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -102.39 20.78 16.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.6 1.16 . . . . 0.0 110.656 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -105.12 141.84 35.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.642 3.177 . . . . 0.0 111.361 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.48 20.62 48.94 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.2 170.21 16.74 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.969 1.384 . . . . 0.0 112.923 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 41' ' ' GLY . 28.2 m -72.46 158.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.915 0.886 . . . . 0.0 111.119 173.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 4.5 m-20 -55.15 -7.02 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.694 2.398 . . . . 0.0 116.45 -174.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -104.06 1.54 44.28 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.866 -1.515 . . . . 0.0 116.456 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.17 84.51 4.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.058 2.429 . . . . 0.0 104.495 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.13 174.6 6.24 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.19 136.1 33.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.357 1.863 . . . . 0.0 110.82 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -101.12 99.78 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.511 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -141.06 167.37 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.428 1.891 . . . . 0.0 110.068 -174.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.87 -149.73 0.28 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.443 ' HG ' ' HB2' ' A' ' 25' ' ' SER . 9.2 t -140.72 164.62 29.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.84 1.305 . . . . 0.0 109.134 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.06 8.42 44.55 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.49 1.916 . . . . 0.0 106.827 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -98.58 -70.46 0.72 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 131.172 3.789 . . . . 0.0 109.251 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -63.87 123.25 81.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 122.028 2.194 . . . . 0.0 109.941 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -74.8 -14.64 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.071 2.514 . . . . 0.0 113.726 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.42 33.59 5.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.479 2.312 . . . . 0.0 110.284 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.63 124.89 8.31 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 120.803 3.081 . . . . 0.0 120.803 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.501 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 62.1 m-85 -144.2 77.46 1.55 Allowed 'General case' 0 CA--C 1.56 1.331 1 C-N-CA 131.835 4.054 . . . . 0.0 110.418 174.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -98.12 152.83 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.252 1.821 . . . . 0.0 113.863 -174.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.58 134.96 54.41 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 102.215 -3.254 . . . . 0.0 102.215 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 p -134.79 122.81 22.62 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.313 1.869 . . . . 0.0 109.391 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.07 159.93 14.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.432 0.693 . . . . 0.0 112.653 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 49.9 t -119.17 69.27 0.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.662 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.302 0.6 OUTLIER -81.07 -173.94 4.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.309 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.662 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.489 0.6 OUTLIER -97.96 8.27 45.02 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -174.088 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -145.94 -27.99 0.43 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 124.757 1.286 . . . . 0.0 112.765 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 171.39 16.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.714 0.806 . . . . 0.0 111.992 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.78 96.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.152 0.981 . . . . 0.0 108.475 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -99.4 160.39 14.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.675 1.59 . . . . 0.0 110.328 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.511 ' CG ' HH21 ' A' ' 46' ' ' ARG . 61.9 m-70 -119.2 137.87 53.34 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 124.455 1.102 . . . . 0.0 113.617 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.47 59.85 1.57 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 120.072 -1.643 . . . . 0.0 113.447 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.501 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -143.04 128.67 19.18 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.4 mt -140.71 -29.39 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 120.085 1.311 . . . . 0.0 112.269 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.04 159.49 71.86 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -87.85 -159.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 125.183 3.922 . . . . 0.0 111.838 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -65.41 143.63 57.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.004 -1.06 . . . . 0.0 113.452 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -130.75 -176.39 3.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.757 1.223 . . . . 0.0 112.392 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.51 -15.38 19.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.645 1.178 . . . . 0.0 113.662 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -102.13 31.84 3.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.816 1.646 . . . . 0.0 111.204 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 163.28 -159.0 31.52 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.023 2.249 . . . . 0.0 110.435 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -118.88 -125.66 0.28 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.11 110.88 1.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.16 112.41 18.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.556 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.377 32.3 p90 -151.21 171.76 16.9 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 119.393 3.108 . . . . 0.0 119.393 174.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' A' ' 88' ' ' THR . 65.8 p -150.88 -141.45 0.11 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.443 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -154.71 -164.92 1.93 Allowed 'General case' 0 CA--C 1.547 0.849 1 C-N-CA 131.863 4.065 . . . . 0.0 104.422 -173.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -78.1 -24.19 47.65 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.612 1.551 . . . . 0.0 110.01 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -140.54 57.39 1.58 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.196 1.798 . . . . 0.0 111.613 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 177.34 20.79 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 116.507 1.363 . . . . 0.0 116.507 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.52 49.15 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.501 1.92 . . . . 0.0 113.202 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.41 ' H ' ' HA ' ' A' ' 82' ' ' SER 0.495 70.5 p -79.1 6.25 9.99 Favored 'General case' 0 N--CA 1.487 1.395 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -173.362 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.556 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 16.7 ptt180 -39.73 16.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 2 C-N-CA 132.881 4.473 . . . . 0.0 122.088 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -107.9 176.78 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.959 1.704 . . . . 0.0 109.528 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -63.81 151.18 42.95 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.15 -1.594 . . . . 0.0 111.128 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -76.19 -36.97 58.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.0 tp -67.27 -46.95 72.14 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.652 0.66 . . . . 0.0 112.434 -174.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.5 -34.75 77.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.402 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -67.23 -43.63 81.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 111.851 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.27 -33.45 73.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.704 0.801 . . . . 0.0 111.993 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.8 t -79.12 -51.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.098 0.959 . . . . 0.0 112.231 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -71.46 -40.29 70.39 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.41 -1.431 . . . . 0.0 113.681 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -83.2 5.55 22.46 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -57.27 -34.13 68.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.52 -35.42 30.38 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.553 1.541 . . . . 0.0 113.262 -176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.7 mt -142.57 90.83 2.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.562 1.945 . . . . 0.0 109.372 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.66 -171.11 3.32 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.065 0.946 . . . . 0.0 113.348 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -100.13 -20.35 16.03 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 49.32 -165.76 0.34 Allowed Glycine 0 N--CA 1.476 1.319 0 C-N-CA 126.494 1.997 . . . . 0.0 116.382 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.8 tt -84.35 161.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.588 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -29.62 -59.1 0.27 Allowed Pre-proline 0 CA--C 1.564 1.515 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -123.61 -15.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 N-CA-C 117.668 2.141 . . . . 0.0 117.668 -165.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.9 m -103.28 -140.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 126.607 1.963 . . . . 0.0 113.111 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.48 133.81 45.96 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.304 1.411 . . . . 0.0 111.837 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.421 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -95.54 -17.47 21.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -86.09 163.67 17.75 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.221 -0.924 . . . . 0.0 111.649 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -136.43 148.96 48.02 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 173.2 11.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.173 2.589 . . . . 0.0 109.635 175.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 79.7 m -98.26 132.55 43.67 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.531 -1.356 . . . . 0.0 112.096 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -107.6 172.85 6.6 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -117.63 145.52 44.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.188 2.195 . . . . 0.0 109.315 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.3 m -76.46 -177.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.388 1.075 . . . . 0.0 111.801 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.67 34.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.045 1.338 . . . . 0.0 114.255 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 C--O 1.252 1.214 0 C-N-CA 127.855 2.462 . . . . 0.0 110.939 179.386 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 N--CA 1.483 0.892 0 N-CA-C 113.953 0.713 . . . . 0.0 113.953 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -75.76 149.37 83.19 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.777 0.831 . . . . 0.0 112.602 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.97 145.06 35.2 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.971 2.448 . . . . 0.0 111.654 173.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -94.0 -95.16 0.16 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.386 1.074 . . . . 0.0 111.351 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1139 ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.67 118.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 131.273 3.829 . . . . 0.0 106.771 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 158.86 -47.94 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.776 3 C-N-CA 144.495 9.118 . . . . 0.0 92.216 -173.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.342 2.6 mp0 -140.85 157.86 66.55 Favored Pre-proline 0 N--CA 1.43 -1.43 1 C-N-CA 134.025 4.93 . . . . 0.0 105.808 170.196 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.62 58.58 3.2 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 CA-C-N 122.206 1.824 . . . . 0.0 110.123 150.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B 1144 ' ' ASP . . . . . . . . . . . . 0.256 27.6 t70 . . . . . 0 C--O 1.253 1.276 1 C-N-CA 135.922 5.689 . . . . 0.0 117.377 -173.715 . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 112.255 -0.338 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 p -146.99 154.64 47.05 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.469 1.508 . . . . 0.0 112.358 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.92 159.39 52.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.309 2.673 . . . . 0.0 112.682 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.37 153.62 43.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.965 0.906 . . . . 0.0 112.855 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.1 p -84.1 -7.21 59.44 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.89 164.29 51.63 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.759 1.171 . . . . 0.0 114.59 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -73.6 -8.49 56.17 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 m -75.09 -7.43 53.71 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.1 tp -72.86 143.19 47.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.069 1.348 . . . . 0.0 111.327 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.8 m -64.12 -13.18 46.12 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.75 -10.75 55.36 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.817 1.647 . . . . 0.0 113.895 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.42 -13.82 61.15 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.5 mm -80.32 143.98 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.459 1.504 . . . . 0.0 109.894 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -66.67 148.91 51.26 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -138.74 5.17 2.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.1 p -142.43 -175.13 4.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 129.171 2.988 . . . . 0.0 109.476 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 15.12 0.12 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.911 1.285 . . . . 0.0 114.12 174.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.256 2.2 pp -61.46 -9.68 6.14 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -114.82 17.87 16.8 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.197 1.799 . . . . 0.0 112.155 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -132.84 136.73 46.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.982 1.313 . . . . 0.0 114.502 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -142.61 155.25 44.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.06 2.144 . . . . 0.0 109.76 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.75 33.01 2.08 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 122.927 2.603 . . . . 0.0 112.78 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 tpt85 -137.99 7.66 2.7 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 118.904 1.352 . . . . 0.0 114.387 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.313 7.1 tp -104.48 67.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 122.752 1.263 . . . . 0.0 110.182 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 m -46.45 152.18 0.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.651 1.981 . . . . 0.0 112.538 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -32.42 3.77 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.74 -30.9 40.99 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.691 0.996 . . . . 0.0 113.691 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -81.73 -43.36 18.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.486 1.114 . . . . 0.0 113.136 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -65.61 -32.53 74.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.16 -0.962 . . . . 0.0 112.621 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -67.68 -21.33 65.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -74.39 -28.69 61.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.718 0.807 . . . . 0.0 111.905 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.56 -51.83 4.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.106 1.362 . . . . 0.0 112.312 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.14 -12.72 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.614 1.566 . . . . 0.0 111.566 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.67 8.81 66.25 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.491 -1.381 . . . . 0.0 113.867 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -77.66 -10.56 59.59 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.773 1.229 . . . . 0.0 112.073 174.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.347 0.0 OUTLIER -140.45 136.52 33.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.407 1.483 . . . . 0.0 113.552 176.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.66 67.32 0.23 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.544 1.545 . . . . 0.0 114.983 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.06 -176.51 5.56 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.808 0.843 . . . . 0.0 110.827 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.26 142.12 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.461 -1.399 . . . . 0.0 108.425 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -45.91 -21.97 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.8 21.22 44.72 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.495 -1.229 . . . . 0.0 115.293 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.67 62.06 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -96.63 163.16 13.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 -170.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -122.61 150.27 42.87 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.452 1.901 . . . . 0.0 109.519 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.04 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.28 167.31 22.45 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 125.068 1.347 . . . . 0.0 109.011 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -142.89 -158.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -131.29 159.79 36.83 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 122.709 1.243 . . . . 0.0 108.747 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 113.475 -1.693 . . . . 0.0 107.861 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -98.25 -63.81 1.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 129.292 3.037 . . . . 0.0 108.133 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -60.66 121.04 58.11 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 120.606 1.548 . . . . 0.0 110.047 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.85 -15.18 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.773 2.316 . . . . 0.0 113.104 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -125.7 32.72 5.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.163 2.185 . . . . 0.0 110.895 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.28 128.17 9.46 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.503 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 58.6 m-85 -143.88 78.24 1.58 Allowed 'General case' 0 CA--C 1.558 1.288 1 C-N-CA 131.738 4.015 . . . . 0.0 110.492 174.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.45 142.73 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 126.291 1.836 . . . . 0.0 113.049 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.6 130.53 45.84 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 p -127.33 120.25 28.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.186 1.357 . . . . 0.0 109.152 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -96.04 151.13 19.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.203 1.001 . . . . 0.0 112.565 -172.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.8 t -117.03 65.55 0.72 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.599 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.257 24.7 t60 -81.33 178.82 8.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.599 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.423 3.1 pp -99.03 27.31 5.12 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.624 2.77 . . . . 0.0 117.843 -173.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -150.54 -43.72 0.12 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 112.06 -2.336 . . . . 0.0 111.649 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 179.71 7.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.496 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.02 122.61 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -129.93 167.36 18.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.64 1.176 . . . . 0.0 112.662 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -126.39 139.91 52.9 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -173.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -107.53 65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.275 1.83 . . . . 0.0 113.703 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.503 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.9 tm? -144.74 134.44 23.52 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.13 -1.606 . . . . 0.0 114.748 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 mt -141.42 -36.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 120.53 1.514 . . . . 0.0 112.948 170.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 160.12 61.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -77.39 -177.98 4.25 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.408 3.405 . . . . 0.0 111.752 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 p -61.15 144.76 53.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -129.84 -175.36 3.58 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.247 1.419 . . . . 0.0 110.808 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.56 -3.37 33.5 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -99.31 10.23 41.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.247 1.419 . . . . 0.0 111.702 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.68 -161.87 28.07 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 128.046 2.736 . . . . 0.0 109.66 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -115.1 -122.58 0.29 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 116.419 -1.753 . . . . 0.0 106.469 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -58.65 113.85 2.22 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -82.26 120.2 25.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.417 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.46 12.9 p90 -151.33 162.63 40.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 118.638 2.829 . . . . 0.0 118.638 173.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -150.98 -146.34 0.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 0.0 112.093 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 32.1 mtt -155.38 -171.41 3.78 Favored 'General case' 0 C--N 1.316 -0.865 1 C-N-CA 134.049 4.939 . . . . 0.0 106.653 -173.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.37 -30.63 68.67 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -140.65 61.23 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.277 1.431 . . . . 0.0 111.373 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.68 174.76 22.46 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -141.92 47.52 1.63 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.07 1.748 . . . . 0.0 113.11 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.51 9.4 p -75.25 -2.08 26.4 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 121.466 3.876 . . . . 0.0 121.466 -173.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.417 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 40.9 ptt180 -44.61 36.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 1 C-N-CA 133.534 4.733 . . . . 0.0 120.832 173.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -125.36 160.58 29.0 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.919 -1.738 . . . . 0.0 111.761 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.8 m -56.5 135.82 54.32 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.979 0.911 . . . . 0.0 111.623 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.17 -39.77 89.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.0 -42.34 98.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.937 0.335 . . . . 0.0 111.792 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.08 -41.99 81.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.28 0.632 . . . . 0.0 111.31 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -68.08 -33.05 73.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.37 -43.76 20.54 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.684 0.675 . . . . 0.0 112.23 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.2 t -69.91 -63.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 119.255 0.934 . . . . 0.0 110.324 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -83.45 -57.65 3.16 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.321 44.0 m-85 -81.47 22.23 0.72 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -79.54 -42.74 24.47 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 121.496 1.953 . . . . 0.0 113.705 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -18.92 60.36 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt -140.14 56.97 1.61 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.316 1.847 . . . . 0.0 110.178 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.04 -156.82 0.15 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.835 0.854 . . . . 0.0 110.454 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.46 4.42 9.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.704 1.602 . . . . 0.0 112.54 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.88 -141.72 0.69 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.437 2.446 . . . . 0.0 115.786 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.55 153.77 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 111.716 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mt -34.88 -56.12 0.89 Allowed Pre-proline 0 CA--C 1.563 1.467 0 CA-C-O 116.272 -1.823 . . . . 0.0 115.841 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -115.17 -33.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.37 0 N-CA-C 117.589 2.111 . . . . 0.0 117.589 -169.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.9 m -91.17 -125.89 0.08 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.042 1.737 . . . . 0.0 114.413 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.93 155.66 19.36 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.637 1.575 . . . . 0.0 111.82 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -8.51 10.24 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -115.87 148.24 40.19 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.874 1.67 . . . . 0.0 113.513 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -101.08 150.31 23.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.378 1.071 . . . . 0.0 111.26 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 76.9 m -130.38 -61.49 0.96 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 5.1 t -141.64 -158.48 0.87 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 111.232 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.2 m -134.19 135.85 43.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.866 2.467 . . . . 0.0 110.902 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -132.77 138.02 47.02 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.193 0.997 . . . . 0.0 111.057 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.6 m -144.34 161.53 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.34 1.856 . . . . 0.0 111.42 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.87 156.39 39.34 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.546 0.738 . . . . 0.0 112.592 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.298 1.839 . . . . 0.0 111.722 179.134 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo . . . . . 0 N--CA 1.483 0.895 0 N-CA-C 113.948 0.711 . . . . 0.0 113.948 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -74.19 146.39 84.43 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.77 0.828 . . . . 0.0 112.606 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.22 141.0 35.03 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.278 2.652 . . . . 0.0 111.54 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -145.66 123.14 11.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.049 1.339 . . . . 0.0 111.667 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1139 ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B 1140 ' ' VAL . . . . . 0.434 ' C ' ' N ' ' B' 1142 ' ' GLN . 2.2 t -147.09 -15.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 115.777 -2.059 . . . . 0.0 115.588 -174.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -54.89 -30.24 57.71 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1142 ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' 1140 ' ' VAL 0.342 4.1 mp0 -150.52 156.93 36.79 Favored Pre-proline 0 N--CA 1.424 -1.757 1 C-N-CA 136.69 5.996 . . . . 0.0 104.486 169.723 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.23 60.84 2.54 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 CA-C-N 120.95 1.375 . . . . 0.0 109.638 152.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 C--O 1.253 1.284 1 C-N-CA 134.719 5.207 . . . . 0.0 116.001 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -72.68 146.79 88.73 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 121.463 -1.022 . . . . 0.0 112.359 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -83.35 -10.18 44.7 Favored 'Cis proline' 0 CA--C 1.543 0.927 0 N-CA-C 114.983 1.109 . . . . 0.0 114.983 4.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.54 -16.28 23.87 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.0 p -62.32 -22.8 66.35 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.441 1.897 . . . . 0.0 113.061 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.05 2.69 0.14 Allowed Glycine 0 CA--C 1.536 1.368 0 N-CA-C 116.841 1.496 . . . . 0.0 116.841 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -108.99 2.18 21.13 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 119.453 1.627 . . . . 0.0 114.59 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.3 m -58.61 147.57 32.02 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.253 1.021 . . . . 0.0 112.891 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.91 153.74 39.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.278 1.031 . . . . 0.0 112.096 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.0 m -68.56 152.3 45.56 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.721 1.208 . . . . 0.0 113.346 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.91 160.66 39.75 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.555 1.542 . . . . 0.0 111.809 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.78 147.27 49.13 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.781 0.832 . . . . 0.0 113.047 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.6 -22.69 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.578 1.151 . . . . 0.0 112.851 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -124.36 160.34 28.32 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.03 2.132 . . . . 0.0 112.918 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -132.49 -1.52 3.5 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -142.79 178.53 7.58 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 129.066 2.947 . . . . 0.0 110.449 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 13.14 1.21 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.106 1.362 . . . . 0.0 114.358 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -52.8 149.84 5.88 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 -99.8 26.44 6.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.641 1.576 . . . . 0.0 113.801 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -137.09 128.48 28.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.237 1.018 . . . . 0.0 112.33 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -140.11 138.18 35.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.453 2.701 . . . . 0.0 106.968 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.62 46.58 1.03 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-N 123.073 2.67 . . . . 0.0 114.06 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.22 48.3 1.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.48 1.609 . . . . 0.0 108.912 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.1 tp -150.67 68.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.126 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -50.61 157.2 0.78 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.733 1.613 . . . . 0.0 113.259 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.404 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -45.03 -37.37 4.05 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -77.35 -25.62 51.22 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.404 1.081 . . . . 0.0 113.859 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -81.55 -48.72 11.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.083 1.753 . . . . 0.0 111.66 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -68.56 -26.88 65.63 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.045 0.938 . . . . 0.0 112.895 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.41 -19.32 65.44 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.716 1.144 . . . . 0.0 113.555 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -77.79 -29.22 50.73 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.029 0.831 . . . . 0.0 111.735 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.54 -48.56 7.23 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 111.964 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.28 -9.42 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.973 0.909 . . . . 0.0 111.368 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.31 -0.05 59.84 Favored Glycine 0 N--CA 1.472 1.084 0 O-C-N 120.085 -1.635 . . . . 0.0 115.013 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.94 -13.36 58.97 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 117.833 0.817 . . . . 0.0 110.021 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.75 154.78 23.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.244 1.818 . . . . 0.0 112.094 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.41 26.36 2.56 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.75 1.167 . . . . 0.0 114.716 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.45 -166.95 1.29 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.163 1.385 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 m -53.91 151.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.026 0.93 . . . . 0.0 110.447 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 5.3 m-20 -50.7 -18.7 0.76 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.75 28.02 16.28 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.67 2.081 . . . . 0.0 116.526 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.59 74.21 3.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.294 2.047 . . . . 0.0 106.471 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.1 tp -141.01 145.24 35.67 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.824 1.65 . . . . 0.0 111.348 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -98.23 68.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 119.891 1.223 . . . . 0.0 110.393 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.67 158.35 15.83 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 124.032 0.933 . . . . 0.0 111.465 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.6 pm0 -141.64 -160.46 1.09 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.2 t -140.15 158.49 43.96 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 122.352 1.072 . . . . 0.0 109.658 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 1.5 pp0? -97.34 8.44 44.58 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.64 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -98.55 -68.29 0.81 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 129.07 2.948 . . . . 0.0 110.439 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.59 119.38 46.64 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 122.756 2.526 . . . . 0.0 109.419 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.49 -12.41 18.67 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.008 2.472 . . . . 0.0 114.866 -159.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -120.44 36.17 4.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.961 2.504 . . . . 0.0 109.203 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.46 123.23 7.8 Favored Glycine 0 C--N 1.349 1.293 1 N-CA-C 124.568 4.587 . . . . 0.0 124.568 -172.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.423 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 20.3 m-85 -144.49 77.57 1.54 Allowed 'General case' 0 CA--C 1.558 1.262 1 C-N-CA 132.665 4.386 . . . . 0.0 109.749 174.011 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.42 153.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 127.164 2.186 . . . . 0.0 112.724 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.25 129.58 56.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 p -111.55 118.09 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.3 mt -96.53 147.47 23.83 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.423 0.689 . . . . 0.0 111.865 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.8 t -114.76 66.03 0.68 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.589 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.28 0.4 OUTLIER -70.06 -168.18 0.2 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 112.852 -1.977 . . . . 0.0 112.394 -173.603 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.589 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.512 0.3 OUTLIER -96.85 4.39 51.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.836 3.273 . . . . 0.0 119.836 -173.507 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.329 7.1 pt20 -149.75 -16.14 0.27 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 118.361 -1.336 . . . . 0.0 114.372 169.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -150.57 173.11 14.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.518 1.127 . . . . 0.0 110.737 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.35 110.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -120.47 161.77 20.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.72 1.608 . . . . 0.0 112.03 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.404 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 90.9 m-70 -106.23 163.57 12.7 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.013 1.325 . . . . 0.0 112.783 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -117.48 13.44 14.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 118.259 2.688 . . . . 0.0 118.259 -172.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.423 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.3 tm? -113.27 133.65 54.99 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -173.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.1 mt -141.72 -42.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.695 0.798 . . . . 0.0 110.849 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -119.77 151.37 52.11 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -92.01 -174.31 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.901 3.734 . . . . 0.0 112.003 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 m -60.24 145.06 48.71 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.486 -0.759 . . . . 0.0 112.191 174.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -120.7 -170.06 1.93 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.276 1.43 . . . . 0.0 111.935 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.83 -14.47 19.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.115 0.966 . . . . 0.0 112.832 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -110.97 8.76 22.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.676 1.59 . . . . 0.0 113.659 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.42 168.74 38.82 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.778 1.656 . . . . 0.0 112.847 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -83.76 -145.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.948 1.299 . . . . 0.0 110.789 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -52.06 116.44 2.19 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.348 0.976 . . . . 0.0 109.16 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 134.95 36.12 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.408 ' H ' ' HB3' ' A' ' 89' ' ' ARG 0.293 28.9 m-85 -142.0 134.02 27.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.115 1.766 . . . . 0.0 113.602 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -140.45 20.7 2.38 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.0 ttp -26.98 149.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -52.63 -23.11 5.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -126.19 19.26 7.62 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.256 1.422 . . . . 0.0 112.61 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.06 162.34 26.77 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.511 1.529 . . . . 0.0 115.591 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -141.03 50.99 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.194 1.798 . . . . 0.0 108.506 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.563 10.5 p -76.38 10.97 1.74 Allowed 'General case' 0 N--CA 1.477 0.876 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -172.329 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.408 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 6.4 ptt180 -38.76 49.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 130.643 3.577 . . . . 0.0 120.609 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -137.29 165.12 26.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.213 2.605 . . . . 0.0 109.899 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -57.41 141.71 46.35 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.57 -33.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.86 -32.13 72.45 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -79.61 -33.94 41.12 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.745 0.702 . . . . 0.0 111.918 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.44 -35.35 60.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.552 2.341 . . . . 0.0 111.882 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.22 -40.11 67.34 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.775 2.03 . . . . 0.0 112.376 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.81 -50.26 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.877 0.871 . . . . 0.0 110.485 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.84 -88.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.012 1.325 . . . . 0.0 112.87 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -47.91 0.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 121.396 3.85 . . . . 0.0 121.396 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -56.08 -37.11 68.89 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 121.891 2.132 . . . . 0.0 113.392 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -15.77 61.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.63 39.86 1.86 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.206 1.403 . . . . 0.0 112.575 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -75.56 -161.8 0.17 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 125.34 1.456 . . . . 0.0 113.449 -174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -90.9 -0.38 57.71 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.883 1.673 . . . . 0.0 113.712 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.64 -152.2 12.91 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.87 1.7 . . . . 0.0 115.229 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.75 175.28 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.048 1.339 . . . . 0.0 111.686 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -41.56 -59.65 2.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -109.93 -46.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 122.613 1.969 . . . . 0.0 116.682 -166.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 74.3 m -94.68 -127.68 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -48.07 134.91 13.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.645 1.978 . . . . 0.0 115.082 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.94 -8.69 55.36 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -116.86 148.59 41.14 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.216 -0.927 . . . . 0.0 113.072 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -113.68 165.09 12.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.636 1.974 . . . . 0.0 110.499 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 5.9 m -136.87 -170.41 2.69 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.755 1.622 . . . . 0.0 112.066 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 82.8 m -99.13 135.61 40.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.28 1.032 . . . . 0.0 110.086 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -125.75 171.29 10.76 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.88 1.272 . . . . 0.0 113.054 -173.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 -63.4 144.22 57.15 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 110.575 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 m -69.64 161.26 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.558 1.143 . . . . 0.0 111.851 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.27 34.63 0.31 Allowed 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.1 tp . . . . . 0 C--O 1.255 1.363 0 C-N-CA 126.004 1.722 . . . . 0.0 113.24 -175.291 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 CA--C 1.541 0.863 0 N-CA-C 113.996 0.729 . . . . 0.0 113.996 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -76.83 -46.46 2.98 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-O 117.45 -1.262 . . . . 0.0 114.367 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.45 125.41 7.65 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.078 1.852 . . . . 0.0 111.99 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.91 -114.11 0.31 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.876 1.67 . . . . 0.0 110.543 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1139 ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B 1140 ' ' VAL . . . . . 0.413 ' C ' ' N ' ' B' 1142 ' ' GLN . 2.7 t -140.48 -28.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -177.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.278 11.8 m-80 -56.41 -27.95 57.92 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B 1142 ' ' GLN . . . . . 0.413 ' N ' ' C ' ' B' 1140 ' ' VAL 0.314 4.3 mp0 -158.62 157.86 28.94 Favored Pre-proline 0 N--CA 1.433 -1.304 1 C-N-CA 135.932 5.693 . . . . 0.0 104.962 168.554 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.67 60.67 2.18 Favored 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 121.891 1.711 . . . . 0.0 109.392 149.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.254 1.33 1 C-N-CA 134.044 4.938 . . . . 0.0 115.896 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.2 -0.36 . . . . 0.0 112.2 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.6 p -146.59 155.78 48.94 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.372 1.469 . . . . 0.0 112.502 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.54 157.84 98.74 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 CA-C-N 119.468 0.846 . . . . 0.0 112.896 -5.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.11 -25.03 64.21 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 m -90.49 14.87 11.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.843 1.657 . . . . 0.0 113.766 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.28 -16.84 75.57 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 124.389 0.995 . . . . 0.0 115.505 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.0 p -86.95 154.45 20.79 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.152 1.381 . . . . 0.0 112.598 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 82.1 p -147.92 161.57 41.05 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.774 1.23 . . . . 0.0 113.15 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.4 tp -145.79 147.4 31.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.946 1.698 . . . . 0.0 110.696 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.6 m -138.88 155.78 47.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.839 1.256 . . . . 0.0 112.394 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.64 158.06 43.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.449 1.499 . . . . 0.0 111.889 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.23 151.88 46.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.1 0.96 . . . . 0.0 112.505 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 tp -75.99 -21.72 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -78.54 47.44 0.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.384 1.874 . . . . 0.0 113.105 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -123.32 -10.19 8.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 p -142.62 175.77 9.54 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 129.518 3.127 . . . . 0.0 110.531 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.62 60.62 0.68 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.603 1.561 . . . . 0.0 112.208 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.41 37.18 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 130.833 3.653 . . . . 0.0 120.292 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -97.89 53.26 1.09 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 119.69 -1.881 . . . . 0.0 110.049 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -150.56 112.92 4.65 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.162 1.385 . . . . 0.0 111.508 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -140.97 155.62 46.2 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.636 1.974 . . . . 0.0 109.962 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.8 0.65 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 122.261 2.3 . . . . 0.0 111.949 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.255 32.9 tpt85 -148.63 42.06 0.97 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.008 1.385 . . . . 0.0 111.096 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.78 63.77 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.563 1.145 . . . . 0.0 110.071 -174.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 t -55.38 151.03 10.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.424 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -48.31 -30.79 5.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.029 2.531 . . . . 0.0 116.756 -173.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -79.79 -35.43 38.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.147 0.979 . . . . 0.0 112.713 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.71 -40.36 22.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.034 . . . . 0.0 112.376 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.04 -37.37 71.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.484 1.114 . . . . 0.0 112.319 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.22 -16.77 64.28 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -80.12 -27.59 39.11 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.239 1.016 . . . . 0.0 111.557 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.5 -49.75 5.28 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.582 1.553 . . . . 0.0 112.135 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.12 -12.46 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 124.309 1.044 . . . . 0.0 111.657 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.23 1.18 60.51 Favored Glycine 0 N--CA 1.474 1.172 0 O-C-N 120.45 -1.406 . . . . 0.0 114.948 -174.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -79.65 -13.9 59.17 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 117.973 0.887 . . . . 0.0 109.629 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.53 164.19 19.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.929 2.091 . . . . 0.0 112.291 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.64 30.2 3.83 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.306 1.431 . . . . 0.0 114.148 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.24 -172.45 3.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.896 1.678 . . . . 0.0 113.596 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.19 155.61 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.166 1.387 . . . . 0.0 111.28 174.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -49.3 -16.04 0.16 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.917 1.687 . . . . 0.0 115.283 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.75 7.19 70.62 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 127.02 2.248 . . . . 0.0 114.473 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.68 57.52 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.57 172.61 7.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.5 tp -138.74 139.5 38.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.802 2.041 . . . . 0.0 109.84 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.39 107.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.437 ' HD2' ' C ' ' A' ' 46' ' ' ARG . 5.3 ppt_? -141.3 176.18 9.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.08 2.152 . . . . 0.0 110.621 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.99 -146.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -141.72 168.77 18.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 125.338 1.455 . . . . 0.0 110.259 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.57 10.87 40.02 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.667 172.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -99.06 -82.25 0.44 Allowed 'General case' 0 N--CA 1.481 1.109 1 C-N-CA 133.94 4.896 . . . . 0.0 108.756 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -54.62 118.13 15.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 121.216 1.825 . . . . 0.0 111.034 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.99 -12.33 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.99 2.46 . . . . 0.0 113.26 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -116.52 33.0 5.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.801 2.44 . . . . 0.0 110.16 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.8 128.62 9.61 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 121.773 3.469 . . . . 0.0 121.773 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.444 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 46.9 m-85 -142.64 66.93 1.32 Allowed 'General case' 0 CA--C 1.56 1.356 1 C-N-CA 132.139 4.175 . . . . 0.0 110.759 174.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.41 146.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.799 1.761 . . . . 0.0 114.109 -174.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 tt -105.01 121.15 43.16 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p -108.91 118.19 36.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.0 160.42 14.47 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -171.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.5 t -122.57 53.39 1.26 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.597 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.299 2.5 t-80 -66.11 178.81 1.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -172.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.597 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.467 0.5 OUTLIER -97.9 12.34 34.41 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -172.832 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -147.07 -27.32 0.39 Allowed 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 125.211 1.569 . . . . 0.0 112.112 170.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 173.88 13.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.68 93.23 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.54 1.162 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.34 170.07 8.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.515 1.526 . . . . 0.0 112.154 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.424 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 87.0 m-70 -117.19 163.13 16.76 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.491 1.516 . . . . 0.0 112.336 -173.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.31 14.92 14.83 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -172.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.518 ' H ' ' HD1' ' B' 1139 ' ' PTR . 2.1 tm? -114.13 140.63 48.35 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.064 -2.273 . . . . 0.0 116.032 -173.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mm -141.38 -44.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.994 0.918 . . . . 0.0 110.059 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -121.32 158.91 52.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -89.71 -148.08 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.873 3.715 . . . . 0.0 110.225 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -66.55 152.44 45.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.789 1.236 . . . . 0.0 112.682 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -139.89 -177.36 4.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.241 1.416 . . . . 0.0 111.74 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.68 -18.15 18.2 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -108.88 18.5 20.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.862 1.265 . . . . 0.0 112.666 174.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.06 -161.34 23.92 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.483 2.468 . . . . 0.0 110.096 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -116.87 -127.27 0.29 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.3 112.99 1.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -76.97 132.39 38.99 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . 0.252 25.0 m-85 -142.9 141.4 31.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.142 2.177 . . . . 0.0 112.553 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 p -149.66 21.59 0.91 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -27.82 152.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -28.02 3.3 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 119.19 3.033 . . . . 0.0 119.19 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.99 18.48 14.66 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.323 1.42 . . . . 0.0 113.628 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.24 172.81 23.64 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.304 1.681 . . . . 0.0 117.304 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.81 55.2 1.58 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 128.722 2.809 . . . . 0.0 107.207 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.487 16.1 p -71.89 2.1 6.06 Favored 'General case' 0 N--CA 1.474 0.767 1 N-CA-C 122.933 4.42 . . . . 0.0 122.933 -171.969 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -38.74 29.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 2 N-CA-C 122.96 4.429 . . . . 0.0 122.96 173.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.71 161.68 26.75 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.845 2.058 . . . . 0.0 110.154 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -62.03 140.41 58.37 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.07 -34.12 71.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.639 0.776 . . . . 0.0 112.479 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.84 -27.5 69.38 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.46 -35.61 63.32 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.606 0.762 . . . . 0.0 111.502 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -75.6 -37.95 59.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 111.436 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.5 tt -51.35 -42.3 61.22 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.95 1.7 . . . . 0.0 113.1 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.48 -42.35 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.602 0.761 . . . . 0.0 111.599 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -80.37 -32.91 37.58 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.051 1.34 . . . . 0.0 113.006 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -80.34 -13.14 59.41 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -58.47 -42.57 87.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.916 1.689 . . . . 0.0 113.757 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -82.14 -39.97 22.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.703 1.201 . . . . 0.0 113.346 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.5 mt -145.33 83.5 1.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.592 1.557 . . . . 0.0 111.614 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -70.71 133.57 46.73 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -73.24 -3.43 26.76 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 49.99 -157.87 1.71 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.641 2.067 . . . . 0.0 114.82 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.422 HG13 ' H ' ' A' ' 107' ' ' LEU . 4.0 tp -80.73 -175.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.473 0.709 . . . . 0.0 112.216 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.422 ' H ' HG13 ' A' ' 106' ' ' ILE . 15.7 mt -42.15 136.02 2.3 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.472 1.509 . . . . 0.0 110.839 173.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -80.16 51.53 3.95 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 N-CA-C 118.431 2.435 . . . . 0.0 118.431 -130.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 85.5 m -68.5 -55.77 10.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -179.53 5.93 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 129.418 3.087 . . . . 0.0 108.306 174.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.305 0.0 OUTLIER -139.03 -51.85 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.705 2.483 . . . . 0.0 117.705 -174.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -68.46 144.18 54.76 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.347 1.43 . . . . 0.0 113.323 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -107.58 165.78 11.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.217 1.407 . . . . 0.0 113.992 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 84.5 m -140.62 -157.23 0.75 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 128.029 2.532 . . . . 0.0 109.798 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.17 134.27 53.81 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.985 1.314 . . . . 0.0 109.782 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -109.62 170.09 8.29 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -86.93 125.38 34.0 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.713 1.205 . . . . 0.0 110.647 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.0 t -93.83 -37.84 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.957 0.903 . . . . 0.0 111.886 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.95 162.48 27.54 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.601 1.161 . . . . 0.0 113.63 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.365 1.866 . . . . 0.0 111.807 175.789 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo . . . . . 0 CA--C 1.542 0.88 0 N-CA-C 113.956 0.714 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -71.5 147.48 92.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.949 0.899 . . . . 0.0 112.352 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.27 158.61 48.44 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.232 2.621 . . . . 0.0 111.692 172.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -133.22 -112.86 0.22 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 109.71 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1139 ' ' PTR . . . . . 0.518 ' HD1' ' H ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 3.1 t -140.3 -25.88 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 118.425 2.75 . . . . 0.0 118.425 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.348 9.9 m-80 -61.75 -25.85 67.71 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.314 3.9 mp0 -155.76 154.38 27.83 Favored Pre-proline 0 N--CA 1.424 -1.762 1 C-N-CA 134.918 5.287 . . . . 0.0 105.196 168.381 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.81 58.51 2.67 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 CA-C-N 121.861 1.7 . . . . 0.0 109.256 151.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.3 t0 . . . . . 0 C--O 1.254 1.317 1 C-N-CA 134.606 5.162 . . . . 0.0 115.984 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 CA-C-O 121.081 0.267 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.8 m -68.68 149.46 97.94 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 124.453 1.101 . . . . 0.0 112.898 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.71 -21.0 19.5 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.264 2.643 . . . . 0.0 113.588 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.66 41.99 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.972 1.709 . . . . 0.0 111.433 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.9 m -75.54 -17.47 60.07 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.53 -173.31 44.39 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.071 1.32 . . . . 0.0 113.437 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.0 p -131.8 156.21 46.41 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.85 1.66 . . . . 0.0 111.845 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.7 p -76.06 146.67 39.24 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.163 0.985 . . . . 0.0 112.842 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.3 tp -150.24 148.58 29.06 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.41 1.484 . . . . 0.0 111.08 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 t -72.43 165.28 24.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.837 0.855 . . . . 0.0 112.568 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.63 156.93 37.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.742 0.817 . . . . 0.0 112.898 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.51 160.4 38.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.504 1.522 . . . . 0.0 111.948 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.0 pt -70.02 155.44 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.836 0.854 . . . . 0.0 112.81 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -64.88 142.97 58.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.226 1.41 . . . . 0.0 112.415 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -102.7 -3.85 25.92 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.8 p -142.34 -173.43 3.84 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 129.28 3.032 . . . . 0.0 108.437 174.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.51 8.19 8.3 Favored 'General case' 0 CA--C 1.552 1.048 0 O-C-N 120.572 -1.33 . . . . 0.0 113.875 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -54.36 -23.76 16.79 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 117.73 2.492 . . . . 0.0 117.73 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -127.38 6.3 6.34 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.597 1.559 . . . . 0.0 114.19 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -150.81 124.98 9.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -141.5 146.58 36.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.977 2.511 . . . . 0.0 109.128 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.7 24.96 4.04 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 123.427 2.831 . . . . 0.0 113.856 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -137.92 15.77 2.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.358 1.063 . . . . 0.0 113.122 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -100.84 70.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -46.28 151.73 0.49 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 112.995 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.283 0.0 OUTLIER -44.19 -40.3 4.97 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -73.83 -28.42 61.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.462 1.105 . . . . 0.0 113.237 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -81.04 -46.89 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.785 1.234 . . . . 0.0 111.396 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -68.11 -33.06 73.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 118.44 -0.791 . . . . 0.0 112.419 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.295 2.0 pt20 -68.77 -11.23 60.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 -80.94 -37.43 29.52 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.63 1.172 . . . . 0.0 110.704 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.3 mp -88.6 -45.06 10.18 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.779 1.632 . . . . 0.0 112.643 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.25 -12.64 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.399 1.079 . . . . 0.0 110.832 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.96 2.07 61.51 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.429 -1.419 . . . . 0.0 114.869 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 -12.81 59.34 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.783 0.833 . . . . 0.0 110.709 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.66 151.96 28.71 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.59 1.556 . . . . 0.0 112.873 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.15 20.19 4.52 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.127 1.346 . . . . 0.0 115.454 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.43 -173.04 3.85 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.21 150.96 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.165 0.986 . . . . 0.0 111.607 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 9.1 m-20 -49.11 -19.7 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -174.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.65 22.65 39.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 127.502 2.477 . . . . 0.0 116.852 -173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.12 77.81 4.05 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 121.743 2.771 . . . . 0.0 106.689 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.79 165.48 11.93 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -173.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.5 tp -126.77 148.84 49.89 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.315 2.646 . . . . 0.0 109.178 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.02 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.19 165.84 26.42 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 125.714 1.606 . . . . 0.0 108.662 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HA ' HG11 ' A' ' 56' ' ' VAL 0.265 5.3 pt-20 -141.56 -164.32 1.75 Allowed 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.486 -0.758 . . . . 0.0 110.422 173.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.12 148.09 52.46 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.266 1.2 pp0? -95.47 15.12 20.51 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.703 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -98.16 -72.7 0.64 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 131.959 4.104 . . . . 0.0 111.224 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -57.87 141.05 81.04 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-N 121.248 1.84 . . . . 0.0 113.605 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -85.54 -17.55 4.25 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.9 3.066 . . . . 0.0 115.121 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -118.34 26.41 9.63 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.997 2.119 . . . . 0.0 110.308 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.19 126.07 8.76 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 121.825 3.49 . . . . 0.0 121.825 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -143.58 94.19 2.57 Favored 'General case' 0 CA--C 1.545 0.777 1 C-N-CA 132.044 4.138 . . . . 0.0 103.384 173.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 47' ' ' GLU 0.283 1.3 m -99.0 138.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 121.261 1.846 . . . . 0.0 114.233 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.02 121.2 40.66 Favored 'General case' 0 CA--C 1.539 0.535 1 N-CA-C 99.901 -4.111 . . . . 0.0 99.901 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.3 p -119.33 122.13 41.14 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -95.28 177.53 5.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 32.2 t -129.57 66.07 1.47 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.601 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.265 0.4 OUTLIER -71.81 -171.64 0.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.16 -173.985 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.601 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.487 0.3 OUTLIER -97.03 6.65 48.22 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -173.521 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -146.08 -26.13 0.44 Allowed 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 124.961 1.413 . . . . 0.0 113.259 170.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -150.52 -178.03 6.31 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.834 0.854 . . . . 0.0 111.417 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.32 114.08 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.97 0.89 . . . . 0.0 109.749 173.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -110.98 162.51 14.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.707 2.403 . . . . 0.0 111.816 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.81 159.26 32.9 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -130.97 86.22 2.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.948 -1.72 . . . . 0.0 112.852 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.535 ' HG ' ' CE1' ' B' 1139 ' ' PTR . 0.0 OUTLIER -141.75 28.63 1.76 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 122.216 4.154 . . . . 0.0 122.216 -173.733 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.35 -14.23 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 -170.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 mt -127.73 144.85 52.69 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.45 -170.61 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 125.014 3.81 . . . . 0.0 111.718 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -72.03 147.82 46.46 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.473 -1.392 . . . . 0.0 112.9 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -130.92 -177.38 4.35 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.943 0.897 . . . . 0.0 112.552 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.71 -5.09 32.17 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 111.903 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -99.51 15.81 25.32 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.3 1.84 . . . . 0.0 111.664 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.47 -156.72 25.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 127.153 2.311 . . . . 0.0 109.707 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -115.64 -126.16 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -59.87 115.25 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.75 131.2 39.66 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.401 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 16.3 m-85 -143.82 155.55 44.17 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 175.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -145.88 -164.24 1.91 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.261 2.224 . . . . 0.0 109.894 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.445 ' HA ' ' CG1' ' B' 1140 ' ' VAL . 67.1 mtm -156.73 -173.67 4.58 Favored 'General case' 0 C--N 1.314 -0.95 1 C-N-CA 136.424 5.89 . . . . 0.0 109.089 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.94 -29.5 65.54 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.49 44.62 1.85 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.48 1.112 . . . . 0.0 112.846 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.36 171.87 24.09 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.956 1.543 . . . . 0.0 116.956 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 56.7 1.48 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.801 2.041 . . . . 0.0 112.301 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 32.2 p -76.98 5.31 8.22 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 121.766 3.987 . . . . 0.0 121.766 -173.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.401 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 37.8 ptt180 -38.91 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 2 C-N-CA 132.875 4.47 . . . . 0.0 122.423 173.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -126.5 159.89 32.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.325 1.85 . . . . 0.0 111.182 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 m -64.23 137.64 58.04 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.441 -0.787 . . . . 0.0 110.665 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.56 -47.49 47.67 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -64.32 -33.72 76.49 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.93 -32.59 69.55 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.342 0.657 . . . . 0.0 112.289 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.75 -28.81 36.37 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.975 1.31 . . . . 0.0 112.296 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.88 -29.04 69.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.359 1.064 . . . . 0.0 113.29 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.6 t -70.11 -76.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.28 0.946 . . . . 0.0 110.832 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -81.9 -44.5 16.73 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.82 -0.84 49.89 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -66.1 -42.65 89.0 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 122.788 2.54 . . . . 0.0 113.81 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -80.16 -11.79 59.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.32 1.448 . . . . 0.0 114.361 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 65.08 1.34 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.536 1.534 . . . . 0.0 109.689 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -101.71 -163.56 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.311 1.444 . . . . 0.0 111.871 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -96.63 -1.6 46.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.569 1.548 . . . . 0.0 111.23 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.24 -146.29 15.45 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 126.631 2.062 . . . . 0.0 114.298 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.24 179.17 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.737 1.615 . . . . 0.0 112.023 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 mt -40.32 -55.9 3.85 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.395 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.433 ' HD2' ' H ' ' A' ' 109' ' ' CYS . 68.4 Cg_endo -122.44 -41.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 N-CA-C 118.191 2.343 . . . . 0.0 118.191 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.433 ' H ' ' HD2' ' A' ' 108' ' ' PRO . 71.6 m -90.39 -127.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.507 1.923 . . . . 0.0 115.967 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.56 142.19 23.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.833 1.653 . . . . 0.0 114.649 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -6.88 45.18 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -110.95 152.67 26.51 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.522 1.129 . . . . 0.0 112.55 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -125.06 160.14 29.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.417 1.487 . . . . 0.0 111.706 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 28.0 m -141.06 -162.82 1.43 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 130.025 3.33 . . . . 0.0 108.135 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.2 m -125.75 133.54 52.05 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.879 -1.138 . . . . 0.0 112.121 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -99.28 176.11 5.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.149 0.98 . . . . 0.0 111.678 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -123.64 165.0 17.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.754 1.622 . . . . 0.0 113.329 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.62 156.29 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.93 1.692 . . . . 0.0 112.093 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.24 150.83 44.88 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.703 0.801 . . . . 0.0 112.366 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.3 tp . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.083 1.753 . . . . 0.0 111.888 -179.441 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo . . . . . 0 N--CA 1.484 0.939 0 N-CA-C 114.058 0.753 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -133.9 151.99 77.83 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.516 1.526 . . . . 0.0 111.327 177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.03 164.74 32.72 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.754 2.97 . . . . 0.0 112.929 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -81.45 -106.21 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.849 1.26 . . . . 0.0 112.597 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1139 ' ' PTR . . . . . 0.535 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1140 ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 83' ' ' MET . 54.1 t -140.69 -32.88 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.56 -29.5 51.33 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 102.193 -3.262 . . . . 0.0 102.193 169.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1142 ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' 1140 ' ' VAL 0.317 1.0 OUTLIER -161.44 157.34 21.47 Favored Pre-proline 0 N--CA 1.427 -1.621 1 C-N-CA 135.165 5.386 . . . . 0.0 105.574 168.443 . . . . . . . . 5 4 . 1 . 006 nuclear orig full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.79 52.65 0.72 Allowed 'Trans proline' 0 CA--C 1.554 1.502 0 C-N-CA 122.6 2.2 . . . . 0.0 111.381 152.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B 1144 ' ' ASP . . . . . 0.427 ' H ' ' C ' ' B' 1142 ' ' GLN . 22.5 t70 . . . . . 0 C--O 1.255 1.364 1 C-N-CA 134.873 5.269 . . . . 0.0 114.793 -173.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.846 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.0 p -77.31 159.84 76.81 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.635 1.174 . . . . 0.0 113.103 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -59.53 151.13 71.38 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.387 2.725 . . . . 0.0 114.238 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.39 -22.69 51.25 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -150.21 160.88 43.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.827 1.651 . . . . 0.0 111.185 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.08 18.1 79.64 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.166 0.889 . . . . 0.0 115.07 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.7 p -63.74 -20.48 65.78 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.615 1.208 . . . . 0.0 114.128 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 m -72.83 -7.09 49.16 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.6 mt -98.67 -2.51 38.15 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.623 1.569 . . . . 0.0 113.786 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.3 m -66.74 141.41 57.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.516 1.126 . . . . 0.0 112.911 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.81 165.33 20.97 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.67 1.188 . . . . 0.0 113.188 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.27 158.48 34.91 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.124 0.969 . . . . 0.0 112.652 174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.0 mt -73.69 140.9 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.996 0.918 . . . . 0.0 109.66 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -74.97 41.46 0.16 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.477 1.911 . . . . 0.0 115.044 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -134.69 14.24 3.69 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 127.435 2.294 . . . . 0.0 114.329 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 p -102.57 -74.33 0.63 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.032 2.133 . . . . 0.0 112.753 -173.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -79.48 -12.15 59.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.607 0.763 . . . . 0.0 111.424 174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.26 -14.24 60.13 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 -123.55 44.78 2.61 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.666 1.987 . . . . 0.0 110.494 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -143.29 134.45 25.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.196 1.398 . . . . 0.0 112.531 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -142.0 157.6 44.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.357 1.863 . . . . 0.0 109.694 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.96 23.4 2.61 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 121.956 2.162 . . . . 0.0 114.145 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -147.13 52.92 1.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.61 1.205 . . . . 0.0 110.952 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.261 7.4 tt -140.63 59.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 123.407 1.575 . . . . 0.0 109.101 174.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 t -43.58 153.19 0.12 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.844 2.458 . . . . 0.0 114.907 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HE ' ' HG2' ' B' 1138 ' ' GLU . 0.0 OUTLIER -46.83 -34.31 5.22 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 -174.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.76 -27.73 36.66 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.35 -48.59 11.76 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.609 1.564 . . . . 0.0 113.473 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -63.53 -33.31 75.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.97 -17.31 63.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -75.61 -30.89 59.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.725 0.81 . . . . 0.0 112.085 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.3 -60.5 1.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.301 1.44 . . . . 0.0 111.803 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mt -81.37 -3.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.494 1.918 . . . . 0.0 112.974 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.79 8.33 68.19 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.155 -1.591 . . . . 0.0 115.028 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -80.39 -4.01 51.91 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.447 1.099 . . . . 0.0 112.637 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -71.66 145.78 48.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.562 1.145 . . . . 0.0 113.28 -175.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.18 15.73 39.28 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 125.584 1.564 . . . . 0.0 114.145 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.54 177.57 8.91 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.362 1.865 . . . . 0.0 113.544 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 41' ' ' GLY . 35.1 m -72.08 169.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 126.302 1.841 . . . . 0.0 115.27 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 35.1 m-20 -58.41 22.27 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.889 2.876 . . . . 0.0 115.425 174.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -141.81 10.79 2.62 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.52 71.62 2.31 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.931 2.366 . . . . 0.0 108.441 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -98.46 168.26 10.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.8 tp -138.48 153.26 48.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.804 2.442 . . . . 0.0 109.584 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.6 t -116.07 101.53 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.158 0.983 . . . . 0.0 108.739 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.19 28.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.546 1.938 . . . . 0.0 109.506 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -142.76 -154.16 0.51 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.697 0.761 . . . . 0.0 113.012 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.447 ' HG ' ' P ' ' B' 1139 ' ' PTR . 2.0 p -120.85 147.66 45.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 132.704 4.402 . . . . 0.0 108.277 174.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 7.51 46.17 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.573 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.35 -68.1 0.82 Allowed 'General case' 0 C--N 1.352 0.691 0 C-N-CA 130.184 3.394 . . . . 0.0 111.083 -174.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -78.85 116.79 62.59 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 122.997 2.635 . . . . 0.0 108.464 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.8 -15.96 51.15 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.758 2.306 . . . . 0.0 114.846 -168.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.64 13.98 9.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.632 2.373 . . . . 0.0 111.833 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.71 124.12 7.99 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 122.726 3.85 . . . . 0.0 122.726 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.488 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 60.0 m-85 -144.0 84.08 1.76 Allowed 'General case' 0 CA--C 1.564 1.505 1 C-N-CA 132.455 4.302 . . . . 0.0 110.595 174.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.24 144.11 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 119.817 -1.802 . . . . 0.0 113.299 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 122.83 42.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 101.017 -3.698 . . . . 0.0 101.017 171.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 p -116.3 105.28 12.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 mt -97.91 158.32 15.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.56 125.83 51.79 Favored 'General case' 0 CA--C 1.497 -1.079 1 N-CA-C 96.508 -5.367 . . . . 0.0 96.508 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.616 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.359 0.0 OUTLIER -112.7 -146.34 0.41 Allowed 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.881 1.363 . . . . 0.0 111.521 -171.348 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.616 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.271 14.6 tp -95.79 -7.09 38.07 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.275 5.4 pt20 -151.03 -17.9 0.21 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -150.4 -160.37 1.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.681 0.792 . . . . 0.0 111.792 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.96 141.79 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.746 1.218 . . . . 0.0 109.376 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -138.05 150.3 46.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.705 0.802 . . . . 0.0 111.363 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.19 144.24 43.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.178 0.991 . . . . 0.0 113.572 -173.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.91 69.42 1.27 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.5 tm? -142.16 123.04 14.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 115.584 -2.15 . . . . 0.0 111.925 174.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.566 HD13 ' H ' ' B' 1141 ' ' ASN 0.255 38.7 mt -139.53 -41.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 122.843 2.565 . . . . 0.0 112.921 173.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.3 148.88 71.62 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 120.351 1.432 . . . . 0.0 114.162 -175.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -81.35 179.57 5.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.172 3.248 . . . . 0.0 111.387 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.07 139.52 56.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.93 -167.59 1.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.132 1.773 . . . . 0.0 111.369 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.33 -7.97 27.95 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -122.66 20.59 10.21 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.808 1.643 . . . . 0.0 112.845 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.07 -171.48 39.92 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.345 1.926 . . . . 0.0 111.381 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -121.73 -137.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 108.109 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.43 123.22 6.28 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.338 1.426 . . . . 0.0 107.725 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.89 137.26 36.86 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -146.09 130.79 17.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.489 1.916 . . . . 0.0 111.733 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 m -141.61 0.99 1.5 Allowed 'General case' 0 N--CA 1.492 1.672 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 -173.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -29.91 156.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 174.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.9 -31.0 16.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.53 2.21 13.78 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.615 1.166 . . . . 0.0 114.112 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.78 105.38 0.41 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.224 1.393 . . . . 0.0 114.757 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 54.1 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.014 1.726 . . . . 0.0 109.535 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.499 68.9 p -77.77 12.83 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 121.569 3.915 . . . . 0.0 121.569 -172.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -39.47 35.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 131.629 3.972 . . . . 0.0 121.049 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.77 174.57 9.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.281 2.632 . . . . 0.0 109.281 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -68.93 155.23 40.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.711 -1.243 . . . . 0.0 111.368 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.8 -41.13 65.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.582 -0.699 . . . . 0.0 112.653 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.03 -40.53 96.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.71 -33.91 60.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.943 0.497 . . . . 0.0 112.218 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -73.86 -34.03 64.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.534 1.134 . . . . 0.0 112.347 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.744 1.217 . . . . 0.0 112.646 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.4 -37.88 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.679 0.792 . . . . 0.0 111.812 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -80.4 -34.77 36.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.789 1.235 . . . . 0.0 112.691 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -80.63 -15.27 57.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.69 -48.83 63.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.585 1.154 . . . . 0.0 113.752 -174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -81.93 -44.62 16.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.673 1.189 . . . . 0.0 113.267 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.43 88.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.945 1.698 . . . . 0.0 110.747 -175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -69.56 172.58 7.12 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.975 0.91 . . . . 0.0 110.328 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -101.31 4.81 41.99 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.779 1.632 . . . . 0.0 112.32 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.17 -141.78 0.52 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 128.0 2.714 . . . . 0.0 115.067 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 8.0 tp -107.93 161.37 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.231 1.812 . . . . 0.0 109.245 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -31.33 -45.68 0.32 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 119.007 2.966 . . . . 0.0 119.007 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -75.36 -157.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.581 2.854 . . . . 0.0 116.829 -173.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 92.4 m -45.8 -59.21 2.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.639 3.176 . . . . 0.0 118.186 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.99 156.34 19.81 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.84 1.2 . . . . 0.0 111.91 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -14.89 3.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -108.54 141.19 40.81 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.77 1.623 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -93.69 169.57 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 86.4 m -136.36 -154.78 0.58 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.65 2.38 . . . . 0.0 109.307 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.0 m -121.06 123.37 42.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.587 1.155 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 t -103.61 168.52 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.7 1.2 . . . . 0.0 112.74 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -87.61 155.91 19.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.44 1.096 . . . . 0.0 112.24 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.97 -39.02 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.595 1.158 . . . . 0.0 112.535 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.0 154.07 40.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.749 0.82 . . . . 0.0 112.506 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 tm? . . . . . 0 C--O 1.254 1.317 0 C-N-CA 126.06 1.744 . . . . 0.0 110.685 -179.673 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo . . . . . 0 N--CA 1.482 0.844 0 N-CA-C 114.406 0.887 . . . . 0.0 114.406 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -75.36 -54.53 2.39 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.639 -1.172 . . . . 0.0 113.055 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.05 160.84 42.19 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.432 2.088 . . . . 0.0 111.497 169.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1138 ' ' GLU . . . . . 0.489 ' HG2' ' HE ' ' A' ' 26' ' ' ARG . 8.3 tt0 -136.74 -72.4 0.44 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.805 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B 1139 ' ' PTR . . . . . 0.447 ' P ' ' HG ' ' A' ' 48' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1140 ' ' VAL . . . . . 0.414 ' C ' ' N ' ' B' 1142 ' ' GLN 0.319 95.2 t -81.48 -0.5 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 1 C-N-CA 132.207 4.203 . . . . 0.0 119.852 -172.165 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' B' B 1141 ' ' ASN . . . . . 0.566 ' H ' HD13 ' A' ' 70' ' ' ILE . 1.2 m-80 -67.15 -17.91 65.06 Favored 'General case' 0 CA--C 1.579 2.087 1 N-CA-C 99.14 -4.393 . . . . 0.0 99.14 165.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B 1142 ' ' GLN . . . . . 0.414 ' N ' ' C ' ' B' 1140 ' ' VAL . 49.6 mm-40 -132.44 4.43 0.04 OUTLIER Pre-proline 0 C--N 1.384 2.078 1 N-CA-C 125.509 5.374 . . . . 0.0 125.509 173.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo 6.16 58.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.892 1.728 . . . . 0.0 113.567 -126.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 34.7 t70 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 133.05 4.54 . . . . 0.0 116.993 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.864 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 m -69.69 147.39 96.4 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.445 1.098 . . . . 0.0 112.579 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.97 -16.9 46.06 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.459 2.773 . . . . 0.0 114.402 -173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.99 0.37 27.9 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.839 1.256 . . . . 0.0 114.125 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -64.15 140.8 58.91 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.269 1.028 . . . . 0.0 112.878 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.03 163.25 53.17 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.313 0.959 . . . . 0.0 113.932 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -89.25 137.23 32.51 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.958 1.303 . . . . 0.0 112.229 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.8 m -106.51 -3.65 20.62 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.2 tp -82.08 136.12 35.24 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.729 1.211 . . . . 0.0 111.517 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.7 t -95.48 137.29 34.75 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.204 1.001 . . . . 0.0 112.288 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.06 -3.18 35.34 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.166 1.387 . . . . 0.0 113.383 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.13 -1.62 58.12 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.7 pt -68.83 153.21 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.504 1.121 . . . . 0.0 112.931 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -74.32 152.65 39.58 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.504 1.122 . . . . 0.0 112.72 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -133.12 0.94 3.48 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.4 p -142.04 -176.0 4.63 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 128.613 2.765 . . . . 0.0 109.691 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -78.78 16.09 0.94 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.932 1.293 . . . . 0.0 113.963 174.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -57.52 147.4 26.87 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -131.88 38.11 3.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.926 1.29 . . . . 0.0 112.301 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -141.07 150.23 42.66 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -141.03 148.23 39.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 128.398 2.679 . . . . 0.0 108.912 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.36 41.28 1.3 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 123.15 2.705 . . . . 0.0 112.532 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -142.58 31.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.004 1.383 . . . . 0.0 110.721 174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.09 79.67 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.67 1.188 . . . . 0.0 108.141 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 m -52.58 154.57 2.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.678 1.591 . . . . 0.0 112.325 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.445 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -47.15 -39.35 13.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.48 -34.61 74.6 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.916 1.286 . . . . 0.0 112.779 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -81.75 -43.98 17.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.275 1.03 . . . . 0.0 111.598 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 t -62.15 -36.45 81.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.521 1.128 . . . . 0.0 112.361 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.9 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttp-105 -79.12 -35.64 41.89 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.914 0.779 . . . . 0.0 111.54 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -83.39 -45.27 13.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.251 1.42 . . . . 0.0 112.574 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.26 -7.5 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.923 0.889 . . . . 0.0 111.236 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.37 -0.97 59.36 Favored Glycine 0 N--CA 1.471 0.997 0 O-C-N 119.966 -1.709 . . . . 0.0 116.46 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.48 -3.78 58.96 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.93 1.365 . . . . 0.0 111.219 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.56 152.78 29.93 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.92 1.688 . . . . 0.0 111.743 174.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.6 22.42 3.17 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.667 1.127 . . . . 0.0 115.086 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.13 -170.5 2.76 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.398 1.479 . . . . 0.0 112.032 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -54.87 156.92 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.951 1.3 . . . . 0.0 111.392 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 6.9 m-20 -46.54 -24.3 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' HA2' ' CD2' ' A' ' 113' ' ' HIS . . . -99.63 43.46 1.81 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 119.804 2.682 . . . . 0.0 119.804 -173.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.87 75.43 0.96 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -98.26 171.65 8.07 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 117.278 2.325 . . . . 0.0 117.278 -172.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -141.47 142.69 33.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 0.0 110.107 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.53 93.51 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.435 HH22 ' P ' ' B' 1139 ' ' PTR . 0.0 OUTLIER -124.07 161.77 24.88 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.36 1.464 . . . . 0.0 110.039 174.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -141.56 -158.62 0.88 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -140.48 163.39 32.96 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 123.475 1.607 . . . . 0.0 109.862 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.26 1.3 pp0? -96.11 11.97 32.34 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.836 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -97.49 -73.85 0.59 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 131.632 3.973 . . . . 0.0 108.321 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.89 120.58 47.63 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 121.399 1.909 . . . . 0.0 109.588 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.29 -13.87 23.05 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.919 2.413 . . . . 0.0 113.976 -168.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -125.59 30.88 5.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.278 2.231 . . . . 0.0 110.467 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.48 132.32 10.93 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 122.505 3.762 . . . . 0.0 122.505 -172.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -144.02 76.29 1.5 Allowed 'General case' 0 CA--C 1.559 1.303 1 C-N-CA 131.786 4.034 . . . . 0.0 109.019 174.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.44 154.79 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.129 2.172 . . . . 0.0 113.046 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.36 131.45 55.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.5 p -113.74 113.52 25.08 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -97.2 153.27 18.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 41.8 t -115.03 63.31 0.68 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -66.8 -170.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.706 -173.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.593 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.504 0.3 OUTLIER -97.01 7.83 45.8 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 119.696 3.221 . . . . 0.0 119.696 -173.582 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -142.29 -28.57 0.6 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.034 1.459 . . . . 0.0 112.554 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.8 179.75 7.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.943 0.897 . . . . 0.0 111.243 174.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.48 116.69 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -128.93 160.08 33.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.807 1.643 . . . . 0.0 112.705 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.445 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 91.3 m-70 -101.31 165.24 11.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.522 1.529 . . . . 0.0 113.689 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -133.63 47.6 2.44 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.494 ' H ' ' HD1' ' B' 1139 ' ' PTR . 1.7 tm? -142.47 135.48 28.48 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.513 -1.992 . . . . 0.0 113.993 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.431 HD13 ' H ' ' B' 1142 ' ' GLN . 52.4 mt -140.36 -43.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.245 0.929 . . . . 0.0 111.05 171.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.98 155.3 68.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -83.32 -176.12 2.65 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.754 3.636 . . . . 0.0 111.877 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -54.03 141.13 29.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.478 1.111 . . . . 0.0 113.861 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -123.56 -170.82 2.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.882 1.273 . . . . 0.0 111.714 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.16 -13.86 20.68 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.015 1.326 . . . . 0.0 112.3 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -99.1 5.58 46.88 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.618 1.567 . . . . 0.0 113.517 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -170.1 -157.7 12.8 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.107 1.337 . . . . 0.0 113.478 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -106.93 -137.14 0.36 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.844 1.258 . . . . 0.0 108.79 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.69 123.22 16.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.87 132.11 37.82 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -150.17 161.65 41.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.178 1.791 . . . . 0.0 114.698 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . 0.253 1.5 m -145.31 -160.54 1.15 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.905 1.282 . . . . 0.0 108.746 173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.444 ' HA ' ' CG1' ' B' 1140 ' ' VAL . 9.0 ttm -155.65 -179.93 8.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 129.398 3.079 . . . . 0.0 107.952 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.62 -30.56 70.17 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.12 -0.988 . . . . 0.0 110.13 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.31 40.19 1.91 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.914 1.286 . . . . 0.0 112.669 174.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 179.48 19.56 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 63.83 1.42 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.173 2.189 . . . . 0.0 111.919 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.545 24.6 p -78.4 2.44 18.74 Favored 'General case' 0 N--CA 1.487 1.377 1 N-CA-C 123.352 4.575 . . . . 0.0 123.352 -172.795 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -40.36 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 1 C-N-CA 132.377 4.271 . . . . 0.0 119.872 172.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.86 159.79 35.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.499 1.919 . . . . 0.0 112.69 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 m -61.36 136.61 58.1 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.092 1.357 . . . . 0.0 112.715 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.19 -30.16 68.3 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.67 -41.28 99.0 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.903 0.774 . . . . 0.0 112.412 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.4 -39.52 74.44 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.756 -0.59 . . . . 0.0 111.085 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -64.19 -30.56 71.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.437 1.095 . . . . 0.0 112.748 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -76.43 -45.23 32.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.417 1.087 . . . . 0.0 111.94 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.9 -57.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.726 0.694 . . . . 0.0 111.853 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -82.77 -51.03 8.06 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.309 54.3 m-85 -79.85 7.04 9.53 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -173.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -54.72 -29.51 53.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 121.408 1.913 . . . . 0.0 112.941 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.51 -26.59 51.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.692 1.997 . . . . 0.0 114.572 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.6 mt -147.02 71.92 1.24 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.06 2.544 . . . . 0.0 106.773 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.09 159.85 16.49 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 59.59 3.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.93 2.092 . . . . 0.0 111.548 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.27 -154.02 2.04 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 125.54 1.543 . . . . 0.0 113.687 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 tp -79.5 -179.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.836 1.654 . . . . 0.0 111.987 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.4 mt -40.1 139.23 1.03 Allowed Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.769 -1.586 . . . . 0.0 110.586 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -56.17 71.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 125.025 3.817 . . . . 0.0 119.894 -159.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.6 m -103.54 -128.98 0.24 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 129.069 2.948 . . . . 0.0 107.592 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.55 73.5 8.59 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.619 -1.3 . . . . 0.0 108.909 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -2.81 6.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -84.42 56.05 3.64 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.803 1.241 . . . . 0.0 111.103 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.513 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -60.97 141.43 57.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.768 1.627 . . . . 0.0 114.26 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.98 -171.33 2.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 129.402 3.081 . . . . 0.0 109.282 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.79 140.12 33.45 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.1 t -99.85 175.99 5.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.109 1.764 . . . . 0.0 111.865 174.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -68.83 147.8 51.2 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.487 1.515 . . . . 0.0 112.647 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -118.1 153.47 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.865 1.666 . . . . 0.0 112.25 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.08 152.6 32.82 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.96 0.904 . . . . 0.0 112.427 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.9 tp . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.552 1.941 . . . . 0.0 111.391 177.705 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo . . . . . 0 CA--C 1.54 0.79 0 N-CA-C 114.843 1.055 . . . . 0.0 114.843 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -82.32 159.88 63.68 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.628 1.571 . . . . 0.0 112.905 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.12 142.77 63.36 Favored 'Cis proline' 0 C--N 1.354 0.843 0 CA-C-N 119.597 0.892 . . . . 0.0 112.653 -3.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -108.79 -105.98 0.35 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.992 1.317 . . . . 0.0 112.427 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1139 ' ' PTR . . . . . 0.494 ' HD1' ' H ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1140 ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 83' ' ' MET . 26.7 t -143.17 -16.89 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 C-N-CA 126.653 1.981 . . . . 0.0 114.7 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -28.5 67.95 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 169.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B 1142 ' ' GLN . . . . . 0.431 ' H ' HD13 ' A' ' 70' ' ' ILE 0.352 3.7 mp0 -154.25 158.42 32.39 Favored Pre-proline 0 N--CA 1.435 -1.212 1 C-N-CA 137.216 6.206 . . . . 0.0 104.348 169.775 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 60.26 2.06 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 CA-C-N 121.585 1.602 . . . . 0.0 110.261 152.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.1 t0 . . . . . 0 C--O 1.254 1.322 1 C-N-CA 134.446 5.098 . . . . 0.0 115.652 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 m -68.4 148.39 98.18 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 124.373 1.069 . . . . 0.0 112.936 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.74 156.21 61.21 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.517 2.811 . . . . 0.0 112.705 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.93 154.46 38.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.086 0.954 . . . . 0.0 112.606 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 m -69.35 142.68 53.93 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.211 1.005 . . . . 0.0 112.458 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.02 172.11 55.12 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.139 0.876 . . . . 0.0 113.958 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -81.13 -18.75 45.32 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.348 1.059 . . . . 0.0 113.38 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 p -81.33 158.66 24.63 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.491 1.517 . . . . 0.0 113.03 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -130.08 161.76 30.3 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.999 1.72 . . . . 0.0 111.281 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 m -61.32 132.71 54.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.127 0.971 . . . . 0.0 112.247 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.1 160.74 17.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.422 1.089 . . . . 0.0 113.424 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.3 145.29 38.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.655 1.582 . . . . 0.0 110.771 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 pt -79.26 -22.09 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -76.98 59.64 1.68 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.252 1.821 . . . . 0.0 113.899 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -121.48 -0.15 9.84 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.6 p -142.1 -180.0 6.57 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 128.772 2.829 . . . . 0.0 109.852 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -76.37 15.46 0.59 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.876 1.27 . . . . 0.0 114.244 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -62.25 -15.41 47.01 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -174.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -101.05 7.38 43.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.08 1.752 . . . . 0.0 112.989 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -117.75 138.09 52.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -141.92 177.84 7.92 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.598 2.759 . . . . 0.0 108.607 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.16 -130.3 3.81 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 121.913 2.142 . . . . 0.0 112.773 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 61.3 ttp85 -51.03 122.49 7.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.315 2.057 . . . . 0.0 115.929 -172.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.87 78.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 1 N-CA-C 99.146 -4.39 . . . . 0.0 99.146 173.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -30.91 121.18 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.977 2.511 . . . . 0.0 115.051 -171.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -24.93 63.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.45 1.9 . . . . 0.0 113.65 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -80.98 -39.2 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.166 1.386 . . . . 0.0 112.805 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.88 -40.62 22.13 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.105 1.362 . . . . 0.0 113.695 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -56.01 -32.65 64.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.193 1.397 . . . . 0.0 113.781 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.465 ' HA ' ' CG2' ' A' ' 65' ' ' VAL 0.266 1.5 pt20 -64.14 -15.84 60.61 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 174.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -80.61 -28.38 37.04 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.117 0.967 . . . . 0.0 112.038 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.13 -59.02 1.81 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.502 1.521 . . . . 0.0 112.588 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.15 -6.47 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 126.431 1.892 . . . . 0.0 111.63 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.53 7.06 65.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 119.965 -1.709 . . . . 0.0 114.348 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -7.78 59.11 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.021 0.911 . . . . 0.0 110.126 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 142.63 50.19 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.256 1.422 . . . . 0.0 110.355 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.73 27.76 5.37 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.709 1.147 . . . . 0.0 115.586 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.57 179.58 7.68 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.343 1.071 . . . . 0.0 112.357 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' C ' ' H ' ' A' ' 41' ' ' GLY . 27.1 m -57.25 149.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.422 0.689 . . . . 0.0 111.68 174.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 7.1 m-20 -55.16 2.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -113.37 15.76 22.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.439 2.447 . . . . 0.0 116.911 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.64 71.16 4.23 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.196 2.498 . . . . 0.0 105.147 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.39 174.24 6.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -140.52 162.27 35.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.33 2.652 . . . . 0.0 109.033 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.28 107.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.299 1.04 . . . . 0.0 109.31 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.54 164.92 28.91 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.624 1.97 . . . . 0.0 107.899 -177.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 15.4 pt-20 -141.05 -172.53 3.5 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.2 t -98.37 138.55 35.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.429 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' H ' ' HB2' ' A' ' 23' ' ' ARG 0.358 0.0 OUTLIER -98.2 5.53 48.37 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.661 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -113.47 -43.37 3.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 128.46 2.704 . . . . 0.0 113.999 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -76.37 127.22 85.18 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 120.558 1.526 . . . . 0.0 111.733 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -69.67 -25.5 28.96 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.989 2.459 . . . . 0.0 116.664 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -110.39 23.97 13.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.929 . . . . 0.0 111.171 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.91 129.75 10.0 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 122.16 3.624 . . . . 0.0 122.16 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -144.32 121.54 11.53 Favored 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.899 4.879 . . . . 0.0 102.181 173.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.464 ' CG1' ' HA ' ' A' ' 47' ' ' GLU 0.325 0.9 OUTLIER -125.11 138.94 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 123.552 2.887 . . . . 0.0 112.787 -174.954 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 tt -98.6 126.11 44.07 Favored 'General case' 0 CA--C 1.536 0.438 1 N-CA-C 99.546 -4.242 . . . . 0.0 99.546 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 p -125.64 112.05 15.69 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.873 1.215 . . . . 0.0 108.243 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.31 167.16 11.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.607 1.163 . . . . 0.0 111.502 -173.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 49.7 t -126.33 94.97 4.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 174.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.651 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.326 0.0 OUTLIER -90.72 -161.84 0.84 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.008 -173.077 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.651 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.532 0.3 OUTLIER -96.88 13.07 30.0 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 -174.287 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -147.4 -36.24 0.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.107 -1.861 . . . . 0.0 112.16 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -151.1 -177.55 6.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.465 ' CG2' ' HA ' ' A' ' 30' ' ' GLN . 5.0 m -100.03 127.41 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 173.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -128.96 146.4 50.98 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.206 1.402 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -117.66 159.93 22.13 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -172.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -131.87 84.05 2.14 Favored 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.596 1.558 . . . . 0.0 115.196 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' B' 1139 ' ' PTR . 0.0 OUTLIER -136.3 19.51 3.16 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 121.745 3.98 . . . . 0.0 121.745 -174.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 mt -93.07 4.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 118.949 -2.344 . . . . 0.0 116.534 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.4 mt -135.78 138.95 29.31 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.749 1.159 . . . . 0.0 111.85 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -84.93 -176.95 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.297 3.331 . . . . 0.0 111.195 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 m -62.56 147.01 50.41 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.707 -1.246 . . . . 0.0 112.331 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -125.03 -176.67 3.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.336 1.054 . . . . 0.0 111.963 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -97.54 -8.72 28.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.75 0.82 . . . . 0.0 112.786 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -99.39 0.18 42.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.075 1.35 . . . . 0.0 112.552 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -162.4 -155.8 8.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.261 1.41 . . . . 0.0 114.233 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.64 -135.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.921 1.688 . . . . 0.0 108.794 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.98 117.33 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -84.12 126.45 33.1 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.442 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 25.9 m-85 -143.04 157.23 44.73 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.9 p -148.73 -159.2 1.0 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.839 2.056 . . . . 0.0 110.751 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.406 ' HA ' ' CG1' ' B' 1140 ' ' VAL . 46.9 mtt -155.54 -169.08 3.01 Favored 'General case' 0 C--N 1.314 -0.97 1 C-N-CA 137.309 6.244 . . . . 0.0 107.335 -172.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.21 -34.75 78.16 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.43 ' H ' HD23 ' A' ' 107' ' ' LEU . 25.3 t0 -141.18 60.76 1.5 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.937 1.695 . . . . 0.0 110.367 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.14 172.41 22.08 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -141.24 42.84 1.78 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.142 1.777 . . . . 0.0 114.01 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 2.3 p -70.95 -1.45 11.99 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 120.632 3.568 . . . . 0.0 120.632 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.442 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 2.5 ptm180 -43.21 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 1 C-N-CA 131.868 4.067 . . . . 0.0 119.817 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.81 166.35 24.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.805 2.442 . . . . 0.0 110.466 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -66.17 132.99 49.75 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.05 -1.031 . . . . 0.0 109.667 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.98 -46.2 24.81 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.75 -40.0 82.6 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.69 -28.28 68.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.58 0.752 . . . . 0.0 112.562 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -88.01 -20.63 25.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 112.329 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 tt -69.21 -55.29 11.03 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.92 -1.112 . . . . 0.0 111.192 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.76 -60.11 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.856 0.753 . . . . 0.0 112.297 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -82.28 -64.0 1.27 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.265 99.6 m-85 -69.94 -5.55 26.92 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -172.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -53.32 -29.48 34.01 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 123.452 2.842 . . . . 0.0 113.608 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -64.38 -32.06 73.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.132 1.773 . . . . 0.0 114.139 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -151.44 74.71 1.14 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.105 2.162 . . . . 0.0 106.532 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -107.3 -167.23 1.24 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.92 1.288 . . . . 0.0 114.12 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -104.03 76.6 1.37 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.676 1.99 . . . . 0.0 108.861 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.99 -157.94 1.04 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.797 1.189 . . . . 0.0 113.362 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.76 158.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.659 1.184 . . . . 0.0 113.816 -174.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 85' ' ' ASP . 12.5 mt -28.73 -64.16 0.18 Allowed Pre-proline 0 CA--C 1.566 1.585 0 CA-C-O 115.281 -2.295 . . . . 0.0 115.764 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.418 ' HD3' ' CB ' ' A' ' 107' ' ' LEU . 11.8 Cg_endo -119.59 -21.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.637 0 CA-C-N 124.252 2.554 . . . . 0.0 117.308 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.2 m -86.22 -145.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.18 1.792 . . . . 0.0 114.145 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.86 141.89 47.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.468 1.107 . . . . 0.0 113.261 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -9.43 17.99 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -174.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -106.32 146.89 29.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.509 1.124 . . . . 0.0 112.478 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -111.51 153.26 26.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.255 1.422 . . . . 0.0 114.169 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.06 -179.92 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.065 2.146 . . . . 0.0 110.843 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 95.3 m -98.96 124.04 43.66 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.895 -1.128 . . . . 0.0 113.094 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t -102.69 -177.44 3.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.039 1.736 . . . . 0.0 114.413 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -64.4 128.75 37.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.942 0.897 . . . . 0.0 110.85 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.9 157.63 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.864 0.866 . . . . 0.0 113.005 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.12 0.5 31.86 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.255 1.381 0 C-N-CA 126.119 1.768 . . . . 0.0 112.773 -179.894 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 CA--C 1.539 0.762 0 N-CA-C 113.575 0.567 . . . . 0.0 113.575 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 36.11 92.74 0.05 OUTLIER Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 128.159 2.584 . . . . 0.0 116.781 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -78.54 -171.03 9.31 Favored 'Cis proline' 0 CA--C 1.547 1.142 0 CA-C-N 119.963 1.022 . . . . 0.0 112.162 -6.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -137.76 -71.2 0.43 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.55 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1139 ' ' PTR . . . . . 0.458 ' CD1' ' HG ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1140 ' ' VAL . . . . . 0.41 ' C ' ' N ' ' B' 1142 ' ' GLN 0.281 77.6 t 46.39 -23.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.518 1 C-N-CA 139.6 7.16 . . . . 0.0 117.988 174.61 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.33 -28.45 65.07 Favored 'General case' 0 CA--C 1.583 2.221 1 N-CA-C 99.696 -4.187 . . . . 0.0 99.696 167.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1142 ' ' GLN . . . . . 0.506 ' C ' ' H ' ' B' 1144 ' ' ASP . 4.4 mp0 -146.79 169.48 9.38 Favored Pre-proline 0 C--N 1.369 1.45 0 C-N-CA 130.103 3.361 . . . . 0.0 113.272 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.24 41.22 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.647 0 C-N-CA 124.466 3.444 . . . . 0.0 113.947 146.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B 1144 ' ' ASP . . . . . 0.506 ' H ' ' C ' ' B' 1142 ' ' GLN . 42.1 t0 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 132.564 4.345 . . . . 0.0 115.396 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 CA-C-O 121.114 0.285 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.0 p -76.92 160.66 75.96 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.723 1.209 . . . . 0.0 113.095 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.79 151.48 76.7 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.357 2.705 . . . . 0.0 114.318 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.51 162.71 28.08 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.338 1.055 . . . . 0.0 113.041 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -136.83 156.06 48.99 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.541 1.536 . . . . 0.0 112.472 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.18 155.77 47.97 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.356 0.979 . . . . 0.0 114.44 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -71.41 145.45 49.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.784 1.234 . . . . 0.0 111.427 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.4 t -132.6 150.27 52.18 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.092 1.357 . . . . 0.0 112.203 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -117.08 11.97 14.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.073 1.749 . . . . 0.0 113.698 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 t -66.15 151.89 45.97 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.306 1.042 . . . . 0.0 112.776 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.11 165.69 26.84 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.515 1.526 . . . . 0.0 112.68 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.34 -0.22 35.84 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.05 150.37 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.824 1.25 . . . . 0.0 112.264 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -64.78 145.58 56.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.497 1.119 . . . . 0.0 112.547 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -130.65 2.48 4.5 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 p -142.04 -173.9 3.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 128.337 2.655 . . . . 0.0 109.616 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.27 9.35 1.7 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -61.06 149.03 38.29 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -114.29 15.19 18.11 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.457 1.503 . . . . 0.0 113.373 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.85 143.78 31.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 -173.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -141.36 149.78 41.58 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.766 3.226 . . . . 0.0 107.839 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.91 39.87 1.41 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-N 123.532 2.878 . . . . 0.0 114.912 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -146.29 30.93 1.02 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.928 0.891 . . . . 0.0 112.352 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 tp -128.19 75.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.479 1.112 . . . . 0.0 109.954 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -45.32 150.16 0.47 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.008 1.723 . . . . 0.0 113.756 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.24 -31.57 32.9 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -174.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.0 -33.16 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -81.49 -49.97 9.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.027 1.331 . . . . 0.0 112.37 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 p -66.47 -29.05 69.09 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.401 -0.812 . . . . 0.0 112.514 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.14 -14.57 63.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.488 1.495 . . . . 0.0 113.723 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -79.86 -34.26 39.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.292 1.037 . . . . 0.0 111.335 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mp -86.98 -42.77 12.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.438 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.23 -10.74 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 111.168 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.59 -1.41 58.96 Favored Glycine 0 N--CA 1.469 0.879 0 O-C-N 120.436 -1.415 . . . . 0.0 116.112 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -88.02 -0.14 56.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.771 1.285 . . . . 0.0 111.868 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.76 158.99 19.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.083 1.753 . . . . 0.0 111.308 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.15 25.51 2.64 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.405 1.002 . . . . 0.0 114.995 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.5 -170.73 2.93 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.458 1.103 . . . . 0.0 111.644 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 41' ' ' GLY . 28.3 m -54.72 154.99 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.759 0.823 . . . . 0.0 110.542 173.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 17.8 m-20 -55.66 -10.4 0.69 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -98.54 13.03 63.01 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.14 2.781 . . . . 0.0 116.445 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.41 78.92 4.4 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 122.193 2.997 . . . . 0.0 105.843 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.17 170.65 8.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.6 tp -133.97 153.23 51.91 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.768 2.027 . . . . 0.0 109.768 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.41 102.55 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.33 163.91 31.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.825 1.25 . . . . 0.0 109.252 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -143.06 -159.26 0.95 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.579 1.181 . . . . 0.0 112.797 174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -120.53 150.85 40.2 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 130.781 3.633 . . . . 0.0 108.021 174.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.85 5.82 48.57 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -98.99 -64.33 1.05 Allowed 'General case' 0 C--N 1.357 0.896 0 C-N-CA 131.411 3.884 . . . . 0.0 113.756 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -58.38 123.9 68.54 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 122.478 2.399 . . . . 0.0 111.459 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.86 -21.13 38.37 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.308 2.672 . . . . 0.0 113.89 -170.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -111.14 21.46 16.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.826 2.45 . . . . 0.0 112.182 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.96 123.32 7.64 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 120.718 3.047 . . . . 0.0 120.718 -173.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -143.48 103.93 4.16 Favored 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 132.69 4.396 . . . . 0.0 102.606 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.311 0.8 OUTLIER -110.79 138.9 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 121.346 1.884 . . . . 0.0 114.177 -173.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.21 128.03 45.28 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.9 p -127.11 113.73 16.8 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.859 1.209 . . . . 0.0 109.005 -173.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.96 153.45 17.76 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.212 1.005 . . . . 0.0 112.382 -172.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 48.5 t -113.64 75.7 0.94 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.568 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.323 2.5 t60 -82.81 -172.35 4.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.266 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.568 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.559 0.2 OUTLIER -98.5 22.3 10.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -173.763 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -149.96 -39.36 0.14 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.748 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 175.83 10.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.045 0.938 . . . . 0.0 110.512 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.0 m -118.16 112.53 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -110.86 158.07 19.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.95 1.7 . . . . 0.0 112.87 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -120.76 160.06 24.13 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.465 1.506 . . . . 0.0 114.517 -173.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -131.24 87.2 2.44 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' HG ' ' CD1' ' B' 1139 ' ' PTR . 0.0 OUTLIER -140.89 23.36 2.25 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.472 HD13 ' H ' ' B' 1142 ' ' GLN . 5.8 mt -92.07 -3.26 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 118.326 -2.733 . . . . 0.0 118.065 -168.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -136.77 136.46 21.58 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 120.913 1.688 . . . . 0.0 113.214 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.38 170.24 16.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.952 3.101 . . . . 0.0 112.495 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -57.48 141.06 48.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.659 1.184 . . . . 0.0 113.658 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -131.34 178.82 6.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.647 1.179 . . . . 0.0 112.795 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -99.08 -7.18 27.11 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.91 1.284 . . . . 0.0 111.441 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -106.99 45.1 1.0 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.947 2.499 . . . . 0.0 107.295 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 148.32 -160.53 28.38 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.121 2.772 . . . . 0.0 109.09 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -124.18 -123.33 0.26 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.22 116.8 5.3 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.59 136.05 40.52 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -146.88 154.57 41.46 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 m -146.47 -172.93 4.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.245 2.618 . . . . 0.0 109.226 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.2 mtp -154.48 176.92 11.77 Favored 'General case' 0 C--N 1.311 -1.085 1 C-N-CA 138.95 6.9 . . . . 0.0 107.175 -172.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.45 -25.52 65.94 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.329 -0.857 . . . . 0.0 111.235 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.45 36.52 2.05 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.344 1.058 . . . . 0.0 112.833 174.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 170.12 24.84 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -141.37 60.24 1.5 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.639 1.976 . . . . 0.0 112.418 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.507 41.3 p -76.97 9.75 2.75 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -173.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -38.14 31.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 2 C-N-CA 133.482 4.713 . . . . 0.0 122.756 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -113.81 169.63 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.629 1.571 . . . . 0.0 110.795 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -56.26 140.21 45.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.481 1.113 . . . . 0.0 111.915 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.16 -47.1 30.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.449 0.7 . . . . 0.0 112.75 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.6 -38.79 87.72 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.809 -0.557 . . . . 0.0 111.842 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.28 -37.05 86.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.866 0.466 . . . . 0.0 111.408 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -68.66 -41.68 79.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.458 -0.777 . . . . 0.0 112.121 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 tt -65.82 -39.65 91.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.508 0.595 . . . . 0.0 111.912 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.32 -69.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.756 -0.59 . . . . 0.0 111.204 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.15 -41.26 20.66 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.51 -27.83 34.29 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 121.294 1.861 . . . . 0.0 115.348 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -39.3 -42.42 1.02 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -21.11 58.91 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -146.47 56.96 1.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.013 2.125 . . . . 0.0 110.913 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -91.18 -154.78 0.37 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.116 0.966 . . . . 0.0 112.187 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.89 -4.48 27.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.304 1.842 . . . . 0.0 113.601 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 44.71 -145.27 2.12 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.523 2.011 . . . . 0.0 116.543 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -79.56 159.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.999 1.719 . . . . 0.0 111.199 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 mt -35.17 -54.22 1.12 Allowed Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 116.318 -1.801 . . . . 0.0 115.525 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -118.73 -33.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 -172.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.31 -131.95 0.13 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 126.591 1.956 . . . . 0.0 115.31 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.49 137.68 52.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.9 1.28 . . . . 0.0 113.559 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.51 -13.49 32.04 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -99.81 161.73 13.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.927 1.291 . . . . 0.0 112.373 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -132.21 154.32 49.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 113.314 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 168.11 20.54 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.882 2.473 . . . . 0.0 108.742 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.2 m -98.09 130.0 44.89 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 119.922 -1.736 . . . . 0.0 112.673 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -99.22 178.16 4.99 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.577 1.151 . . . . 0.0 112.441 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -62.78 152.33 36.18 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.478 1.111 . . . . 0.0 112.791 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.8 m -79.61 164.93 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.942 1.297 . . . . 0.0 112.68 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.96 163.45 27.84 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.381 0.672 . . . . 0.0 112.776 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 C--O 1.255 1.345 0 C-N-CA 126.314 1.846 . . . . 0.0 112.166 -178.184 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 113.981 0.724 . . . . 0.0 113.981 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -135.15 150.29 72.46 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.644 1.578 . . . . 0.0 111.063 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.47 152.32 78.82 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.526 2.817 . . . . 0.0 112.524 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -143.64 -60.05 0.4 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 116.214 -1.85 . . . . 0.0 113.922 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1139 ' ' PTR . . . . . 0.419 ' CD1' ' HG ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1140 ' ' VAL . . . . . . . . . . . . 0.326 78.2 t 46.42 -22.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.269 1 C-N-CA 139.215 7.006 . . . . 0.0 118.21 174.184 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -59.57 -29.86 68.24 Favored 'General case' 0 CA--C 1.581 2.168 1 N-CA-C 99.048 -4.427 . . . . 0.0 99.048 167.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B 1142 ' ' GLN . . . . . 0.472 ' H ' HD13 ' A' ' 70' ' ' ILE 0.263 1.9 mp0 -151.72 172.53 5.33 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 130.657 3.583 . . . . 0.0 114.037 171.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.02 59.1 0.3 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.396 2.064 . . . . 0.0 110.93 141.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B 1144 ' ' ASP . . . . . . . . . . . . 0.255 30.0 t70 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 131.472 3.909 . . . . 0.0 117.448 -174.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.4 m95 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.91 126.47 41.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.172 1.389 . . . . 0.0 111.885 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -141.11 156.55 45.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.036 2.135 . . . . 0.0 108.904 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.86 32.76 2.1 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 123.412 2.823 . . . . 0.0 113.841 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -145.86 47.62 1.25 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.712 1.244 . . . . 0.0 110.522 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.252 7.0 tt -139.5 62.62 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 122.97 1.367 . . . . 0.0 108.357 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -47.89 153.37 0.64 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.619 1.967 . . . . 0.0 112.73 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -35.73 0.71 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -174.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.25 -33.7 61.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.66 -46.61 14.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.482 1.113 . . . . 0.0 112.322 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 p -63.99 -31.32 72.46 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.929 -1.107 . . . . 0.0 112.353 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -71.08 -16.41 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.734 1.152 . . . . 0.0 113.675 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -80.21 -35.15 36.66 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.03 0.932 . . . . 0.0 111.586 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.1 mp -88.95 -45.23 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.497 1.119 . . . . 0.0 112.649 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.06 -9.1 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.159 0.984 . . . . 0.0 111.533 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.35 -0.27 61.37 Favored Glycine 0 N--CA 1.472 1.086 0 O-C-N 120.019 -1.676 . . . . 0.0 115.62 -174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -80.75 -14.25 58.27 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.155 0.978 . . . . 0.0 109.354 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.03 157.27 22.97 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.732 2.013 . . . . 0.0 111.966 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.69 33.4 2.05 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 124.769 1.176 . . . . 0.0 114.718 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.45 -179.29 7.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.705 1.202 . . . . 0.0 112.875 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 m -51.27 149.32 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.105 0.962 . . . . 0.0 111.819 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 1.2 m-20 -40.22 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 129.683 3.193 . . . . 0.0 116.717 -174.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.84 19.4 53.5 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 120.129 2.811 . . . . 0.0 120.129 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.4 78.43 4.42 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 123.509 3.654 . . . . 0.0 105.596 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.506 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -100.41 170.29 8.51 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -172.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 tp -140.46 156.11 46.46 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.289 3.036 . . . . 0.0 108.821 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.06 79.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 122.872 1.32 . . . . 0.0 108.681 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.459 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -115.78 168.82 9.71 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.249 1.42 . . . . 0.0 110.806 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HA ' HG13 ' A' ' 56' ' ' VAL . 8.6 pt-20 -142.75 -156.33 0.67 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.547 0.689 . . . . 0.0 110.394 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.5 p -134.52 154.3 51.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.923 2.089 . . . . 0.0 109.077 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.285 1.4 pp0? -99.53 6.05 45.92 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.625 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -99.78 -61.67 1.34 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 131.246 3.819 . . . . 0.0 113.038 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -64.14 125.15 87.52 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 123.786 2.994 . . . . 0.0 107.584 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.83 -6.84 19.58 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.143 2.562 . . . . 0.0 114.101 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -129.03 26.87 5.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.649 2.379 . . . . 0.0 111.737 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA2' ' HG ' ' A' ' 69' ' ' LEU . . . -96.17 127.01 9.01 Favored Glycine 0 C--N 1.356 1.692 0 N-CA-C 121.992 3.557 . . . . 0.0 121.992 -172.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.486 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 33.3 m-85 -145.12 77.69 1.53 Allowed 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 133.602 4.761 . . . . 0.0 109.465 174.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -98.73 145.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.509 -1.995 . . . . 0.0 115.233 -173.582 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.95 128.38 48.39 Favored 'General case' 0 CA--C 1.542 0.672 1 N-CA-C 99.187 -4.375 . . . . 0.0 99.187 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 p -126.87 113.14 16.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.115 -1.615 . . . . 0.0 109.135 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 43' ' ' PHE . 11.2 mt -98.78 153.0 19.08 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.249 1.02 . . . . 0.0 111.421 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.417 ' HA ' HG12 ' A' ' 65' ' ' VAL . 53.6 t -124.94 114.63 19.41 Favored 'General case' 0 CA--C 1.496 -1.109 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 40' ' ' ASP 0.267 0.0 OUTLIER -113.41 -165.88 1.04 Allowed 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.024 1.453 . . . . 0.0 112.489 -173.054 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.542 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.462 0.3 OUTLIER -96.65 8.11 44.99 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 118.561 2.8 . . . . 0.0 118.561 -173.795 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -146.44 -27.02 0.42 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 125.202 1.564 . . . . 0.0 112.777 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -150.07 -177.96 6.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.953 0.901 . . . . 0.0 112.312 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 60' ' ' CYS . 4.1 m -131.26 135.24 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.639 1.176 . . . . 0.0 109.43 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -140.96 158.25 44.2 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.774 0.83 . . . . 0.0 112.63 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.459 ' CG ' HH21 ' A' ' 46' ' ' ARG . 88.2 m-70 -111.57 149.03 32.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.197 1.399 . . . . 0.0 110.854 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 65.27 1.12 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.862 1.265 . . . . 0.0 113.252 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.4 tm? -141.81 129.85 22.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.355 1.462 . . . . 0.0 112.348 174.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' B' 1141 ' ' ASN . 12.1 mt -140.66 -42.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.714 1.143 . . . . 0.0 110.964 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 80' ' ' TYR . 13.1 mt -120.99 147.41 46.32 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.92 -173.31 1.72 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.294 3.329 . . . . 0.0 110.945 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -57.76 130.0 44.47 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.308 -0.87 . . . . 0.0 112.95 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -110.96 179.14 4.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.695 1.198 . . . . 0.0 112.246 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.03 -11.52 21.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.398 1.079 . . . . 0.0 112.305 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.1 32.93 4.07 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.061 2.144 . . . . 0.0 111.52 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.29 -150.07 21.43 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.782 2.61 . . . . 0.0 110.323 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -128.22 -130.77 0.22 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.233 1.413 . . . . 0.0 107.247 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -57.38 122.82 13.48 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.787 1.63 . . . . 0.0 107.819 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -84.47 138.83 32.58 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -174.114 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.534 ' H ' ' HB3' ' A' ' 89' ' ' ARG . 5.3 m-85 -145.34 137.1 25.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.174 2.19 . . . . 0.0 112.349 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -140.44 1.48 1.77 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.5 ttp -29.81 144.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.55 2.432 . . . . 0.0 113.813 173.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.21 -31.89 34.01 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -112.25 4.13 17.57 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.778 1.231 . . . . 0.0 113.266 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.93 88.73 0.18 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.584 1.564 . . . . 0.0 113.286 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -97.44 53.24 1.14 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.785 1.234 . . . . 0.0 108.85 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.469 68.5 p -79.25 20.03 0.54 Allowed 'General case' 0 N--CA 1.47 0.546 1 N-CA-C 122.566 4.284 . . . . 0.0 122.566 -172.605 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.534 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -39.64 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 121.609 3.929 . . . . 0.0 121.609 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -140.24 174.37 10.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 129.836 3.254 . . . . 0.0 107.708 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 m -62.4 116.4 5.04 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.317 -1.489 . . . . 0.0 109.831 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.2 -32.72 74.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.272 0.629 . . . . 0.0 112.336 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.36 -33.23 75.08 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.5 -37.38 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 111.373 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -28.68 62.92 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.844 0.858 . . . . 0.0 113.257 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.53 -34.0 68.68 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.215 1.406 . . . . 0.0 112.152 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.7 -39.7 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.061 0.944 . . . . 0.0 111.766 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -80.59 -47.19 14.51 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.48 1.112 . . . . 0.0 111.954 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.29 -18.83 65.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -40.03 -49.96 2.55 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.601 1.96 . . . . 0.0 115.167 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -81.18 -47.73 13.04 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.277 1.031 . . . . 0.0 113.534 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.23 92.71 3.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.73 1.612 . . . . 0.0 109.223 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -70.77 176.93 3.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.699 1.2 . . . . 0.0 113.049 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -90.13 -5.18 56.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.58 -166.62 1.16 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.028 1.299 . . . . 0.0 115.261 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.5 tt -90.24 -174.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.294 1.437 . . . . 0.0 107.512 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.74 110.21 2.59 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 121.583 1.992 . . . . 0.0 108.652 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -102.96 157.47 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 N-CA-C 118.98 2.646 . . . . 0.0 118.98 -129.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.33 -43.5 1.16 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 130.735 3.614 . . . . 0.0 106.372 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.5 158.37 41.07 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.955 3.302 . . . . 0.0 107.368 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.268 0.0 OUTLIER -121.4 -22.54 5.93 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.411 2.745 . . . . 0.0 118.411 -174.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.65 142.02 33.12 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.838 1.654 . . . . 0.0 112.13 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -97.85 152.6 19.02 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.195 0.998 . . . . 0.0 112.764 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 170.11 16.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.03 2.532 . . . . 0.0 108.991 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 62.5 m -98.0 132.76 43.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.388 -1.445 . . . . 0.0 113.217 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.5 t -111.1 162.04 15.3 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 . . . . . 0 N--CA 1.478 0.942 0 C-N-CA 125.36 1.464 . . . . 0.0 112.297 178.564 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 CA--C 1.539 0.76 0 N-CA-C 112.77 0.258 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.052 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B 1141 ' ' ASN . . . . . 0.412 ' HB2' HD12 ' A' ' 70' ' ' ILE 0.357 69.4 m-20 122.66 -27.8 0.01 OUTLIER 'General case' 0 CA--C 1.59 2.506 4 C-N-CA 139.289 7.036 . . . . 0.0 92.801 -169.258 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.282 1.6 mp0 -130.69 -136.87 0.0 OUTLIER Pre-proline 0 C--N 1.381 1.962 0 C-N-CA 130.75 3.62 . . . . 0.0 115.154 168.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -91.68 122.04 0.66 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 123.046 2.123 . . . . 0.0 113.406 75.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -172.319 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m95 . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -75.74 127.79 33.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.1 1.36 . . . . 0.0 112.065 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -141.35 147.77 38.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.941 1.696 . . . . 0.0 110.364 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.46 40.71 1.3 Allowed Glycine 0 C--O 1.219 -0.789 0 CA-C-N 122.746 2.521 . . . . 0.0 110.805 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 47.13 1.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.808 1.289 . . . . 0.0 109.832 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tt -150.42 81.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.507 1.123 . . . . 0.0 109.303 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.3 t -61.74 164.17 6.49 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.685 1.594 . . . . 0.0 113.884 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.65 -27.64 18.1 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.44 -44.43 19.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.156 0.982 . . . . 0.0 112.467 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.45 -32.02 32.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.667 1.187 . . . . 0.0 113.808 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 p -66.8 -35.52 80.26 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.219 -0.926 . . . . 0.0 112.101 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.273 6.1 pt20 -69.81 -13.71 62.41 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -77.43 -30.59 53.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.709 0.803 . . . . 0.0 111.257 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 mp -92.16 -62.28 1.44 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.795 1.238 . . . . 0.0 111.957 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 mt -70.45 -10.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 125.14 1.376 . . . . 0.0 111.938 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.15 -6.67 57.69 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 121.078 -1.014 . . . . 0.0 115.557 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -102.39 20.78 16.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.6 1.16 . . . . 0.0 110.656 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -105.12 141.84 35.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.642 3.177 . . . . 0.0 111.361 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.48 20.62 48.94 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.2 170.21 16.74 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.969 1.384 . . . . 0.0 112.923 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.46 158.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.915 0.886 . . . . 0.0 111.119 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.15 -7.02 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.694 2.398 . . . . 0.0 116.45 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.06 1.54 44.28 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.866 -1.515 . . . . 0.0 116.456 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.17 84.51 4.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.058 2.429 . . . . 0.0 104.495 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.13 174.6 6.24 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.19 136.1 33.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.357 1.863 . . . . 0.0 110.82 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -101.12 99.78 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.525 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -141.06 167.37 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.428 1.891 . . . . 0.0 110.068 -174.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -142.87 -149.73 0.28 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 t -140.72 164.62 29.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.84 1.305 . . . . 0.0 109.134 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.06 8.42 44.55 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.49 1.916 . . . . 0.0 106.827 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -98.58 -70.46 0.72 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 131.172 3.789 . . . . 0.0 109.251 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -63.87 123.25 81.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 122.028 2.194 . . . . 0.0 109.941 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -74.8 -14.64 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.071 2.514 . . . . 0.0 113.726 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.42 33.59 5.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.479 2.312 . . . . 0.0 110.284 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.63 124.89 8.31 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 120.803 3.081 . . . . 0.0 120.803 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 62.1 m-85 -144.2 77.46 1.55 Allowed 'General case' 0 CA--C 1.56 1.331 1 C-N-CA 131.835 4.054 . . . . 0.0 110.418 174.374 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -98.12 152.83 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.252 1.821 . . . . 0.0 113.863 -174.263 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.58 134.96 54.41 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 102.215 -3.254 . . . . 0.0 102.215 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 p -134.79 122.81 22.62 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.313 1.869 . . . . 0.0 109.391 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.07 159.93 14.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.432 0.693 . . . . 0.0 112.653 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 49.9 t -119.17 69.27 0.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.554 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.302 0.6 OUTLIER -81.07 -173.94 4.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.309 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.554 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.489 0.6 OUTLIER -97.96 8.27 45.02 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -174.088 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -145.94 -27.99 0.43 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 124.757 1.286 . . . . 0.0 112.765 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 171.39 16.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.714 0.806 . . . . 0.0 111.992 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.78 96.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.152 0.981 . . . . 0.0 108.475 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -99.4 160.39 14.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.675 1.59 . . . . 0.0 110.328 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.525 ' CG ' HH21 ' A' ' 46' ' ' ARG . 61.9 m-70 -119.2 137.87 53.34 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 124.455 1.102 . . . . 0.0 113.617 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.47 59.85 1.57 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 120.072 -1.643 . . . . 0.0 113.447 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -143.04 128.67 19.18 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.666 HD12 ' HB2' ' B' 1141 ' ' ASN . 20.4 mt -140.71 -29.39 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 120.085 1.311 . . . . 0.0 112.269 171.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.04 159.49 71.86 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -87.85 -159.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 125.183 3.922 . . . . 0.0 111.838 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -65.41 143.63 57.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.004 -1.06 . . . . 0.0 113.452 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -130.75 -176.39 3.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.757 1.223 . . . . 0.0 112.392 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.51 -15.38 19.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.645 1.178 . . . . 0.0 113.662 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -102.13 31.84 3.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.816 1.646 . . . . 0.0 111.204 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 163.28 -159.0 31.52 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.023 2.249 . . . . 0.0 110.435 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -118.88 -125.66 0.28 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.11 110.88 1.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.16 112.41 18.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.613 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.377 32.3 p90 -151.21 171.76 16.9 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 119.393 3.108 . . . . 0.0 119.393 174.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 88' ' ' THR . 65.8 p -150.88 -141.45 0.11 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.443 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.431 ' C ' HG12 ' B' 1140 ' ' VAL . 10.1 tmm? -154.71 -164.92 1.93 Allowed 'General case' 0 CA--C 1.547 0.849 1 C-N-CA 131.863 4.065 . . . . 0.0 104.422 -173.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -78.1 -24.19 47.65 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.612 1.551 . . . . 0.0 110.01 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -140.54 57.39 1.58 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.196 1.798 . . . . 0.0 111.613 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 177.34 20.79 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 116.507 1.363 . . . . 0.0 116.507 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.52 49.15 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.501 1.92 . . . . 0.0 113.202 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.427 ' H ' ' HA ' ' A' ' 82' ' ' SER 0.495 70.5 p -79.1 6.25 9.99 Favored 'General case' 0 N--CA 1.487 1.395 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -173.362 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.613 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 16.7 ptt180 -39.73 16.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 2 C-N-CA 132.881 4.473 . . . . 0.0 122.088 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -107.9 176.78 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.959 1.704 . . . . 0.0 109.528 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -63.81 151.18 42.95 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.15 -1.594 . . . . 0.0 111.128 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -76.19 -36.97 58.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.0 tp -67.27 -46.95 72.14 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.652 0.66 . . . . 0.0 112.434 -174.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.5 -34.75 77.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.402 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -67.23 -43.63 81.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 111.851 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.27 -33.45 73.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.704 0.801 . . . . 0.0 111.993 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.8 t -79.12 -51.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.098 0.959 . . . . 0.0 112.231 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -71.46 -40.29 70.39 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.41 -1.431 . . . . 0.0 113.681 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -83.2 5.55 22.46 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -57.27 -34.13 68.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.439 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -81.52 -35.42 30.38 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.553 1.541 . . . . 0.0 113.262 -176.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.7 mt -142.57 90.83 2.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.562 1.945 . . . . 0.0 109.372 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.66 -171.11 3.32 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.065 0.946 . . . . 0.0 113.348 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -100.13 -20.35 16.03 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 49.32 -165.76 0.34 Allowed Glycine 0 N--CA 1.476 1.319 0 C-N-CA 126.494 1.997 . . . . 0.0 116.382 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.8 tt -84.35 161.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.588 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -29.62 -59.1 0.27 Allowed Pre-proline 0 CA--C 1.564 1.515 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -123.61 -15.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 N-CA-C 117.668 2.141 . . . . 0.0 117.668 -165.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.9 m -103.28 -140.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 126.607 1.963 . . . . 0.0 113.111 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.48 133.81 45.96 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.304 1.411 . . . . 0.0 111.837 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.504 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -95.54 -17.47 21.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -86.09 163.67 17.75 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.221 -0.924 . . . . 0.0 111.649 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -136.43 148.96 48.02 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 173.2 11.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.173 2.589 . . . . 0.0 109.635 175.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 79.7 m -98.26 132.55 43.67 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.531 -1.356 . . . . 0.0 112.096 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -107.6 172.85 6.6 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 127.188 2.195 . . . . 0.0 109.315 174.49 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 CA--C 1.539 0.767 0 CA-C-O 120.85 0.271 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 124.386 1.074 . . . . 0.0 111.351 174.83 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B 1140 ' ' VAL . . . . . 0.431 HG12 ' C ' ' A' ' 83' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 125.949 2.785 . . . . 0.0 106.771 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B 1141 ' ' ASN . . . . . 0.666 ' HB2' HD12 ' A' ' 70' ' ' ILE . 2.3 m-80 158.86 -47.94 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.776 3 C-N-CA 144.495 9.118 . . . . 0.0 92.216 -173.146 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.342 2.6 mp0 -140.85 157.86 66.55 Favored Pre-proline 0 N--CA 1.43 -1.43 1 C-N-CA 134.025 4.93 . . . . 0.0 105.808 170.196 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.62 58.58 3.2 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 CA-C-N 122.206 1.824 . . . . 0.0 110.123 150.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B 1144 ' ' ASP . . . . . . . . . . . . 0.256 27.6 t70 . . . . . 0 C--O 1.253 1.276 1 C-N-CA 135.922 5.689 . . . . 0.0 117.377 -173.715 . . . . . . . . 2 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.4 m0 . . . . . 0 CA--C 1.552 1.047 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -132.84 136.73 46.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.982 1.313 . . . . 0.0 114.502 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -142.61 155.25 44.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.06 2.144 . . . . 0.0 109.76 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.75 33.01 2.08 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 122.927 2.603 . . . . 0.0 112.78 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 tpt85 -137.99 7.66 2.7 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 118.904 1.352 . . . . 0.0 114.387 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.313 7.1 tp -104.48 67.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 122.752 1.263 . . . . 0.0 110.182 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 m -46.45 152.18 0.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.651 1.981 . . . . 0.0 112.538 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -32.42 3.77 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.74 -30.9 40.99 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.691 0.996 . . . . 0.0 113.691 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -81.73 -43.36 18.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.486 1.114 . . . . 0.0 113.136 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -65.61 -32.53 74.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.16 -0.962 . . . . 0.0 112.621 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -67.68 -21.33 65.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -74.39 -28.69 61.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.718 0.807 . . . . 0.0 111.905 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.56 -51.83 4.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.106 1.362 . . . . 0.0 112.312 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.14 -12.72 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.614 1.566 . . . . 0.0 111.566 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.67 8.81 66.25 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.491 -1.381 . . . . 0.0 113.867 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -77.66 -10.56 59.59 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.773 1.229 . . . . 0.0 112.073 174.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.347 0.0 OUTLIER -140.45 136.52 33.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.407 1.483 . . . . 0.0 113.552 176.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.66 67.32 0.23 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.544 1.545 . . . . 0.0 114.983 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.06 -176.51 5.56 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.808 0.843 . . . . 0.0 110.827 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.26 142.12 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.461 -1.399 . . . . 0.0 108.425 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -45.91 -21.97 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 113' ' ' HIS . . . -94.8 21.22 44.72 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.495 -1.229 . . . . 0.0 115.293 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 42' ' ' LEU . 3.9 mm? -98.67 62.06 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 171.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -96.63 163.16 13.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 -170.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -122.61 150.27 42.87 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.452 1.901 . . . . 0.0 109.519 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.04 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.28 167.31 22.45 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 125.068 1.347 . . . . 0.0 109.011 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -142.89 -158.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -131.29 159.79 36.83 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 122.709 1.243 . . . . 0.0 108.747 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 113.475 -1.693 . . . . 0.0 107.861 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -98.25 -63.81 1.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 129.292 3.037 . . . . 0.0 108.133 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -60.66 121.04 58.11 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 120.606 1.548 . . . . 0.0 110.047 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.85 -15.18 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.773 2.316 . . . . 0.0 113.104 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -125.7 32.72 5.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.163 2.185 . . . . 0.0 110.895 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.28 128.17 9.46 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 58.6 m-85 -143.88 78.24 1.58 Allowed 'General case' 0 CA--C 1.558 1.288 1 C-N-CA 131.738 4.015 . . . . 0.0 110.492 174.459 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.45 142.73 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 126.291 1.836 . . . . 0.0 113.049 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.6 130.53 45.84 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 p -127.33 120.25 28.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.186 1.357 . . . . 0.0 109.152 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -96.04 151.13 19.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.203 1.001 . . . . 0.0 112.565 -172.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.8 t -117.03 65.55 0.72 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.472 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.257 24.7 t60 -81.33 178.82 8.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.304 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.472 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.423 3.1 pp -99.03 27.31 5.12 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.624 2.77 . . . . 0.0 117.843 -173.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -150.54 -43.72 0.12 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 112.06 -2.336 . . . . 0.0 111.649 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 179.71 7.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.496 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.02 122.61 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -129.93 167.36 18.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.64 1.176 . . . . 0.0 112.662 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -126.39 139.91 52.9 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -173.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -107.53 65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.275 1.83 . . . . 0.0 113.703 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.9 tm? -144.74 134.44 23.52 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.13 -1.606 . . . . 0.0 114.748 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' B' 1141 ' ' ASN . 7.9 mt -141.42 -36.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 120.53 1.514 . . . . 0.0 112.948 170.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 160.12 61.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -77.39 -177.98 4.25 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.408 3.405 . . . . 0.0 111.752 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 p -61.15 144.76 53.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -129.84 -175.36 3.58 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.247 1.419 . . . . 0.0 110.808 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.56 -3.37 33.5 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -99.31 10.23 41.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.247 1.419 . . . . 0.0 111.702 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.68 -161.87 28.07 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 128.046 2.736 . . . . 0.0 109.66 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -115.1 -122.58 0.29 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 116.419 -1.753 . . . . 0.0 106.469 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -58.65 113.85 2.22 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -82.26 120.2 25.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.481 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.46 12.9 p90 -151.33 162.63 40.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 118.638 2.829 . . . . 0.0 118.638 173.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -150.98 -146.34 0.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 0.0 112.093 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.461 ' HA ' HG12 ' B' 1140 ' ' VAL . 32.1 mtt -155.38 -171.41 3.78 Favored 'General case' 0 C--N 1.316 -0.865 1 C-N-CA 134.049 4.939 . . . . 0.0 106.653 -173.164 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.37 -30.63 68.67 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -140.65 61.23 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.277 1.431 . . . . 0.0 111.373 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.68 174.76 22.46 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -141.92 47.52 1.63 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.07 1.748 . . . . 0.0 113.11 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.51 9.4 p -75.25 -2.08 26.4 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 121.466 3.876 . . . . 0.0 121.466 -173.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.481 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 40.9 ptt180 -44.61 36.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 1 C-N-CA 133.534 4.733 . . . . 0.0 120.832 173.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -125.36 160.58 29.0 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.919 -1.738 . . . . 0.0 111.761 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.8 m -56.5 135.82 54.32 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.979 0.911 . . . . 0.0 111.623 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.17 -39.77 89.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.0 -42.34 98.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.937 0.335 . . . . 0.0 111.792 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.08 -41.99 81.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.28 0.632 . . . . 0.0 111.31 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -68.08 -33.05 73.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.37 -43.76 20.54 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.684 0.675 . . . . 0.0 112.23 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.2 t -69.91 -63.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 119.255 0.934 . . . . 0.0 110.324 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -83.45 -57.65 3.16 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.321 44.0 m-85 -81.47 22.23 0.72 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -79.54 -42.74 24.47 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 121.496 1.953 . . . . 0.0 113.705 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -18.92 60.36 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt -140.14 56.97 1.61 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.316 1.847 . . . . 0.0 110.178 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.04 -156.82 0.15 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.835 0.854 . . . . 0.0 110.454 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.46 4.42 9.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.704 1.602 . . . . 0.0 112.54 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.88 -141.72 0.69 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.437 2.446 . . . . 0.0 115.786 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.55 153.77 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 111.716 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mt -34.88 -56.12 0.89 Allowed Pre-proline 0 CA--C 1.563 1.467 0 CA-C-O 116.272 -1.823 . . . . 0.0 115.841 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -115.17 -33.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.37 0 N-CA-C 117.589 2.111 . . . . 0.0 117.589 -169.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.9 m -91.17 -125.89 0.08 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.042 1.737 . . . . 0.0 114.413 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.93 155.66 19.36 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.637 1.575 . . . . 0.0 111.82 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -8.51 10.24 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -115.87 148.24 40.19 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.874 1.67 . . . . 0.0 113.513 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 7.6 m-70 -101.08 150.31 23.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.378 1.071 . . . . 0.0 111.26 174.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 76.9 m -130.38 -61.49 0.96 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 5.1 t -141.64 -158.48 0.87 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 111.232 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.2 m -134.19 135.85 43.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.866 2.467 . . . . 0.0 110.902 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 . . . . . 0 N--CA 1.478 0.955 0 C-N-CA 124.193 0.997 . . . . 0.0 111.057 174.401 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 CA--C 1.54 0.791 0 CA-C-O 120.974 0.323 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B 1138 ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' B' 1143 ' ' PRO . 15.7 pt-20 . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.049 1.339 . . . . 0.0 111.667 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1140 ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 83' ' ' MET . 2.2 t . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 115.777 -2.059 . . . . 0.0 115.588 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B 1141 ' ' ASN . . . . . 0.593 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.5 m-80 -54.89 -30.24 57.71 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 169.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1142 ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' 1140 ' ' VAL 0.342 4.1 mp0 -150.52 156.93 36.79 Favored Pre-proline 0 N--CA 1.424 -1.757 1 C-N-CA 136.69 5.996 . . . . 0.0 104.486 169.723 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' B' B 1143 ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' B' 1138 ' ' GLU . 56.7 Cg_endo -71.23 60.84 2.54 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 CA-C-N 120.95 1.375 . . . . 0.0 109.638 152.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 C--O 1.253 1.284 1 C-N-CA 134.719 5.207 . . . . 0.0 116.001 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -137.09 128.48 28.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.237 1.018 . . . . 0.0 112.33 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -140.11 138.18 35.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.453 2.701 . . . . 0.0 106.968 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.62 46.58 1.03 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-N 123.073 2.67 . . . . 0.0 114.06 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.22 48.3 1.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.48 1.609 . . . . 0.0 108.912 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.1 tp -150.67 68.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.126 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -50.61 157.2 0.78 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.733 1.613 . . . . 0.0 113.259 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -45.03 -37.37 4.05 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -77.35 -25.62 51.22 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.404 1.081 . . . . 0.0 113.859 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -81.55 -48.72 11.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.083 1.753 . . . . 0.0 111.66 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -68.56 -26.88 65.63 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.045 0.938 . . . . 0.0 112.895 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.41 -19.32 65.44 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.716 1.144 . . . . 0.0 113.555 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -77.79 -29.22 50.73 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.029 0.831 . . . . 0.0 111.735 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.54 -48.56 7.23 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 111.964 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.28 -9.42 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.973 0.909 . . . . 0.0 111.368 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.31 -0.05 59.84 Favored Glycine 0 N--CA 1.472 1.084 0 O-C-N 120.085 -1.635 . . . . 0.0 115.013 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.94 -13.36 58.97 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 117.833 0.817 . . . . 0.0 110.021 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.75 154.78 23.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.244 1.818 . . . . 0.0 112.094 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.41 26.36 2.56 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.75 1.167 . . . . 0.0 114.716 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.45 -166.95 1.29 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.163 1.385 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 m -53.91 151.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.026 0.93 . . . . 0.0 110.447 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 5.3 m-20 -50.7 -18.7 0.76 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.75 28.02 16.28 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.67 2.081 . . . . 0.0 116.526 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.59 74.21 3.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.294 2.047 . . . . 0.0 106.471 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.468 ' CD2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.1 tp -141.01 145.24 35.67 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.824 1.65 . . . . 0.0 111.348 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -98.23 68.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 119.891 1.223 . . . . 0.0 110.393 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -99.67 158.35 15.83 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 124.032 0.933 . . . . 0.0 111.465 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.6 pm0 -141.64 -160.46 1.09 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.2 t -140.15 158.49 43.96 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 122.352 1.072 . . . . 0.0 109.658 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 1.5 pp0? -97.34 8.44 44.58 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.64 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -98.55 -68.29 0.81 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 129.07 2.948 . . . . 0.0 110.439 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.59 119.38 46.64 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 122.756 2.526 . . . . 0.0 109.419 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.49 -12.41 18.67 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.008 2.472 . . . . 0.0 114.866 -159.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' O ' HD21 ' A' ' 69' ' ' LEU . 94.4 mt-30 -120.44 36.17 4.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.961 2.504 . . . . 0.0 109.203 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' HG ' ' A' ' 69' ' ' LEU . . . -98.46 123.23 7.8 Favored Glycine 0 C--N 1.349 1.293 1 N-CA-C 124.568 4.587 . . . . 0.0 124.568 -172.456 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.462 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 20.3 m-85 -144.49 77.57 1.54 Allowed 'General case' 0 CA--C 1.558 1.262 1 C-N-CA 132.665 4.386 . . . . 0.0 109.749 174.011 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.601 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.42 153.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 127.164 2.186 . . . . 0.0 112.724 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.468 HD22 ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -113.25 129.58 56.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.25 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 p -111.55 118.09 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.3 mt -96.53 147.47 23.83 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.423 0.689 . . . . 0.0 111.865 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.461 ' HA ' HG12 ' A' ' 65' ' ' VAL . 33.8 t -114.76 66.03 0.68 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.28 0.4 OUTLIER -70.06 -168.18 0.2 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 112.852 -1.977 . . . . 0.0 112.394 -173.603 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.512 0.3 OUTLIER -96.85 4.39 51.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.836 3.273 . . . . 0.0 119.836 -173.507 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.329 7.1 pt20 -149.75 -16.14 0.27 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 118.361 -1.336 . . . . 0.0 114.372 169.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -150.57 173.11 14.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.518 1.127 . . . . 0.0 110.737 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 60' ' ' CYS . 16.5 m -123.35 110.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -120.47 161.77 20.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.72 1.608 . . . . 0.0 112.03 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 90.9 m-70 -106.23 163.57 12.7 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.013 1.325 . . . . 0.0 112.783 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -117.48 13.44 14.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 118.259 2.688 . . . . 0.0 118.259 -172.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 69' ' ' LEU . 2.3 tm? -113.27 133.65 54.99 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -173.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.1 mt -141.72 -42.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.695 0.798 . . . . 0.0 110.849 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -119.77 151.37 52.11 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -92.01 -174.31 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.901 3.734 . . . . 0.0 112.003 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 m -60.24 145.06 48.71 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.486 -0.759 . . . . 0.0 112.191 174.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -120.7 -170.06 1.93 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.276 1.43 . . . . 0.0 111.935 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.83 -14.47 19.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.115 0.966 . . . . 0.0 112.832 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -110.97 8.76 22.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.676 1.59 . . . . 0.0 113.659 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.42 168.74 38.82 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.778 1.656 . . . . 0.0 112.847 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -83.76 -145.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.948 1.299 . . . . 0.0 110.789 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -52.06 116.44 2.19 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.348 0.976 . . . . 0.0 109.16 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 134.95 36.12 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.436 ' H ' ' HB3' ' A' ' 89' ' ' ARG 0.293 28.9 m-85 -142.0 134.02 27.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.115 1.766 . . . . 0.0 113.602 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -140.45 20.7 2.38 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.0 ttp -26.98 149.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -52.63 -23.11 5.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -126.19 19.26 7.62 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.256 1.422 . . . . 0.0 112.61 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.06 162.34 26.77 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.511 1.529 . . . . 0.0 115.591 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -141.03 50.99 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.194 1.798 . . . . 0.0 108.506 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.563 10.5 p -76.38 10.97 1.74 Allowed 'General case' 0 N--CA 1.477 0.876 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -172.329 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 6.4 ptt180 -38.76 49.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 130.643 3.577 . . . . 0.0 120.609 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -137.29 165.12 26.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.213 2.605 . . . . 0.0 109.899 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -57.41 141.71 46.35 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.57 -33.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.86 -32.13 72.45 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -79.61 -33.94 41.12 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.745 0.702 . . . . 0.0 111.918 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.44 -35.35 60.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.552 2.341 . . . . 0.0 111.882 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.22 -40.11 67.34 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.775 2.03 . . . . 0.0 112.376 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.81 -50.26 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.877 0.871 . . . . 0.0 110.485 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.84 -88.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.012 1.325 . . . . 0.0 112.87 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -47.91 0.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 121.396 3.85 . . . . 0.0 121.396 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -56.08 -37.11 68.89 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 121.891 2.132 . . . . 0.0 113.392 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -15.77 61.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.63 39.86 1.86 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.206 1.403 . . . . 0.0 112.575 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -75.56 -161.8 0.17 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 125.34 1.456 . . . . 0.0 113.449 -174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -90.9 -0.38 57.71 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.883 1.673 . . . . 0.0 113.712 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 54.64 -152.2 12.91 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.87 1.7 . . . . 0.0 115.229 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.75 175.28 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.048 1.339 . . . . 0.0 111.686 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -41.56 -59.65 2.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -109.93 -46.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 122.613 1.969 . . . . 0.0 116.682 -166.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 74.3 m -94.68 -127.68 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -48.07 134.91 13.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.645 1.978 . . . . 0.0 115.082 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.447 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -87.94 -8.69 55.36 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -177.131 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -116.86 148.59 41.14 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.216 -0.927 . . . . 0.0 113.072 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -113.68 165.09 12.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.636 1.974 . . . . 0.0 110.499 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 5.9 m -136.87 -170.41 2.69 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.755 1.622 . . . . 0.0 112.066 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 82.8 m -99.13 135.61 40.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.28 1.032 . . . . 0.0 110.086 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -125.75 171.29 10.76 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.88 1.272 . . . . 0.0 113.054 -173.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 . . . . . 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 110.575 174.559 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.54 0.81 0 CA-C-O 120.82 0.258 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 CA--C 1.554 1.098 0 C-N-CA 125.876 1.67 . . . . 0.0 110.543 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B 1140 ' ' VAL . . . . . 0.413 ' C ' ' N ' ' B' 1142 ' ' GLN . 2.7 t . . . . . 0 N--CA 1.507 2.414 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.278 11.8 m-80 -56.41 -27.95 57.92 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B 1142 ' ' GLN . . . . . 0.413 ' N ' ' C ' ' B' 1140 ' ' VAL 0.314 4.3 mp0 -158.62 157.86 28.94 Favored Pre-proline 0 N--CA 1.433 -1.304 1 C-N-CA 135.932 5.693 . . . . 0.0 104.962 168.554 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.67 60.67 2.18 Favored 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 121.891 1.711 . . . . 0.0 109.392 149.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.254 1.33 1 C-N-CA 134.044 4.938 . . . . 0.0 115.896 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 121.827 0.823 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -150.56 112.92 4.65 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.162 1.385 . . . . 0.0 111.508 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -140.97 155.62 46.2 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.636 1.974 . . . . 0.0 109.962 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.8 0.65 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 122.261 2.3 . . . . 0.0 111.949 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.255 32.9 tpt85 -148.63 42.06 0.97 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.008 1.385 . . . . 0.0 111.096 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.78 63.77 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.563 1.145 . . . . 0.0 110.071 -174.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 t -55.38 151.03 10.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -48.31 -30.79 5.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.029 2.531 . . . . 0.0 116.756 -173.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -79.79 -35.43 38.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.147 0.979 . . . . 0.0 112.713 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.71 -40.36 22.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.034 . . . . 0.0 112.376 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.04 -37.37 71.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.484 1.114 . . . . 0.0 112.319 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.22 -16.77 64.28 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -80.12 -27.59 39.11 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.239 1.016 . . . . 0.0 111.557 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.5 -49.75 5.28 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.582 1.553 . . . . 0.0 112.135 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.12 -12.46 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 124.309 1.044 . . . . 0.0 111.657 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.23 1.18 60.51 Favored Glycine 0 N--CA 1.474 1.172 0 O-C-N 120.45 -1.406 . . . . 0.0 114.948 -174.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -79.65 -13.9 59.17 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 117.973 0.887 . . . . 0.0 109.629 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.53 164.19 19.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.929 2.091 . . . . 0.0 112.291 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.64 30.2 3.83 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.306 1.431 . . . . 0.0 114.148 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.24 -172.45 3.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.896 1.678 . . . . 0.0 113.596 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.19 155.61 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.166 1.387 . . . . 0.0 111.28 174.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -49.3 -16.04 0.16 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.917 1.687 . . . . 0.0 115.283 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.75 7.19 70.62 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 127.02 2.248 . . . . 0.0 114.473 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.68 57.52 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.507 ' CG ' HD21 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -98.57 172.61 7.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.5 tp -138.74 139.5 38.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.802 2.041 . . . . 0.0 109.84 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.39 107.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.539 ' C ' ' HD2' ' A' ' 46' ' ' ARG . 5.3 ppt_? -141.3 176.18 9.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.08 2.152 . . . . 0.0 110.621 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -145.99 -146.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -141.72 168.77 18.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 125.338 1.455 . . . . 0.0 110.259 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.57 10.87 40.02 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.667 172.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -99.06 -82.25 0.44 Allowed 'General case' 0 N--CA 1.481 1.109 1 C-N-CA 133.94 4.896 . . . . 0.0 108.756 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -54.62 118.13 15.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 121.216 1.825 . . . . 0.0 111.034 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.99 -12.33 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.99 2.46 . . . . 0.0 113.26 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -116.52 33.0 5.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.801 2.44 . . . . 0.0 110.16 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.8 128.62 9.61 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 121.773 3.469 . . . . 0.0 121.773 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.473 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 46.9 m-85 -142.64 66.93 1.32 Allowed 'General case' 0 CA--C 1.56 1.356 1 C-N-CA 132.139 4.175 . . . . 0.0 110.759 174.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.41 146.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.799 1.761 . . . . 0.0 114.109 -174.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.507 HD21 ' CG ' ' A' ' 43' ' ' PHE . 1.9 tt -105.01 121.15 43.16 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 172.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p -108.91 118.19 36.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.0 160.42 14.47 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -171.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.5 t -122.57 53.39 1.26 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.43 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.299 2.5 t-80 -66.11 178.81 1.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -172.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.467 0.5 OUTLIER -97.9 12.34 34.41 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -172.832 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -147.07 -27.32 0.39 Allowed 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 125.211 1.569 . . . . 0.0 112.112 170.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 173.88 13.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.68 93.23 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.54 1.162 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.34 170.07 8.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.515 1.526 . . . . 0.0 112.154 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.457 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 87.0 m-70 -117.19 163.13 16.76 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.491 1.516 . . . . 0.0 112.336 -173.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.31 14.92 14.83 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -172.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -114.13 140.63 48.35 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.064 -2.273 . . . . 0.0 116.032 -173.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mm -141.38 -44.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.994 0.918 . . . . 0.0 110.059 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -121.32 158.91 52.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -89.71 -148.08 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.873 3.715 . . . . 0.0 110.225 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -66.55 152.44 45.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.789 1.236 . . . . 0.0 112.682 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -139.89 -177.36 4.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.241 1.416 . . . . 0.0 111.74 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.68 -18.15 18.2 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -108.88 18.5 20.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.862 1.265 . . . . 0.0 112.666 174.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.06 -161.34 23.92 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.483 2.468 . . . . 0.0 110.096 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -116.87 -127.27 0.29 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.3 112.99 1.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 89' ' ' ARG . 2.3 t80 -76.97 132.39 38.99 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -173.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . 0.252 25.0 m-85 -142.9 141.4 31.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.142 2.177 . . . . 0.0 112.553 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 p -149.66 21.59 0.91 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -27.82 152.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -28.02 3.3 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 119.19 3.033 . . . . 0.0 119.19 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.99 18.48 14.66 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.323 1.42 . . . . 0.0 113.628 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.24 172.81 23.64 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.304 1.681 . . . . 0.0 117.304 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.81 55.2 1.58 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 128.722 2.809 . . . . 0.0 107.207 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.487 16.1 p -71.89 2.1 6.06 Favored 'General case' 0 N--CA 1.474 0.767 1 N-CA-C 122.933 4.42 . . . . 0.0 122.933 -171.969 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.417 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 32.2 ptt180 -38.74 29.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 2 N-CA-C 122.96 4.429 . . . . 0.0 122.96 173.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.71 161.68 26.75 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.845 2.058 . . . . 0.0 110.154 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -62.03 140.41 58.37 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.07 -34.12 71.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.639 0.776 . . . . 0.0 112.479 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.84 -27.5 69.38 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.46 -35.61 63.32 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.606 0.762 . . . . 0.0 111.502 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -75.6 -37.95 59.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 111.436 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.5 tt -51.35 -42.3 61.22 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.95 1.7 . . . . 0.0 113.1 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.48 -42.35 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.602 0.761 . . . . 0.0 111.599 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -80.37 -32.91 37.58 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.051 1.34 . . . . 0.0 113.006 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -80.34 -13.14 59.41 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -58.47 -42.57 87.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.916 1.689 . . . . 0.0 113.757 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -82.14 -39.97 22.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.703 1.201 . . . . 0.0 113.346 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.5 mt -145.33 83.5 1.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.592 1.557 . . . . 0.0 111.614 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -70.71 133.57 46.73 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -73.24 -3.43 26.76 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 49.99 -157.87 1.71 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.641 2.067 . . . . 0.0 114.82 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.444 HG13 ' H ' ' A' ' 107' ' ' LEU . 4.0 tp -80.73 -175.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.473 0.709 . . . . 0.0 112.216 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.444 ' H ' HG13 ' A' ' 106' ' ' ILE . 15.7 mt -42.15 136.02 2.3 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.472 1.509 . . . . 0.0 110.839 173.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -80.16 51.53 3.95 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 N-CA-C 118.431 2.435 . . . . 0.0 118.431 -130.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 85.5 m -68.5 -55.77 10.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -179.53 5.93 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 129.418 3.087 . . . . 0.0 108.306 174.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.305 0.0 OUTLIER -139.03 -51.85 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.705 2.483 . . . . 0.0 117.705 -174.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -68.46 144.18 54.76 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.347 1.43 . . . . 0.0 113.323 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -107.58 165.78 11.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.217 1.407 . . . . 0.0 113.992 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 84.5 m -140.62 -157.23 0.75 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 128.029 2.532 . . . . 0.0 109.798 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.17 134.27 53.81 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.985 1.314 . . . . 0.0 109.782 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -109.62 170.09 8.29 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 124.713 1.205 . . . . 0.0 110.647 176.155 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 CA--C 1.539 0.767 0 CA-C-O 121.191 0.413 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 109.71 176.885 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.507 2.41 0 N-CA-C 118.425 2.75 . . . . 0.0 118.425 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.348 9.9 m-80 -61.75 -25.85 67.71 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.314 3.9 mp0 -155.76 154.38 27.83 Favored Pre-proline 0 N--CA 1.424 -1.762 1 C-N-CA 134.918 5.287 . . . . 0.0 105.196 168.381 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.81 58.51 2.67 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 CA-C-N 121.861 1.7 . . . . 0.0 109.256 151.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.3 t0 . . . . . 0 C--O 1.254 1.317 1 C-N-CA 134.606 5.162 . . . . 0.0 115.984 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.2 m0 . . . . . 0 CA--C 1.543 0.673 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -150.81 124.98 9.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -141.5 146.58 36.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.977 2.511 . . . . 0.0 109.128 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.7 24.96 4.04 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 123.427 2.831 . . . . 0.0 113.856 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -137.92 15.77 2.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.358 1.063 . . . . 0.0 113.122 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -100.84 70.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -46.28 151.73 0.49 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 112.995 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.283 0.0 OUTLIER -44.19 -40.3 4.97 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -73.83 -28.42 61.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.462 1.105 . . . . 0.0 113.237 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -81.04 -46.89 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.785 1.234 . . . . 0.0 111.396 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -68.11 -33.06 73.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 118.44 -0.791 . . . . 0.0 112.419 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.295 2.0 pt20 -68.77 -11.23 60.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 -80.94 -37.43 29.52 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.63 1.172 . . . . 0.0 110.704 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.3 mp -88.6 -45.06 10.18 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.779 1.632 . . . . 0.0 112.643 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.25 -12.64 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.399 1.079 . . . . 0.0 110.832 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.96 2.07 61.51 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.429 -1.419 . . . . 0.0 114.869 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 -12.81 59.34 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.783 0.833 . . . . 0.0 110.709 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.66 151.96 28.71 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.59 1.556 . . . . 0.0 112.873 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.15 20.19 4.52 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.127 1.346 . . . . 0.0 115.454 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.43 -173.04 3.85 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.21 150.96 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.165 0.986 . . . . 0.0 111.607 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 9.1 m-20 -49.11 -19.7 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -174.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 113' ' ' HIS . . . -97.65 22.65 39.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 127.502 2.477 . . . . 0.0 116.852 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.12 77.81 4.05 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 121.743 2.771 . . . . 0.0 106.689 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.79 165.48 11.93 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -173.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.5 tp -126.77 148.84 49.89 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.315 2.646 . . . . 0.0 109.178 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.02 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.19 165.84 26.42 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 125.714 1.606 . . . . 0.0 108.662 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.682 ' HA ' HG13 ' A' ' 56' ' ' VAL 0.265 5.3 pt-20 -141.56 -164.32 1.75 Allowed 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.486 -0.758 . . . . 0.0 110.422 173.432 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.12 148.09 52.46 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.266 1.2 pp0? -95.47 15.12 20.51 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.703 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -98.16 -72.7 0.64 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 131.959 4.104 . . . . 0.0 111.224 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -57.87 141.05 81.04 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-N 121.248 1.84 . . . . 0.0 113.605 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -85.54 -17.55 4.25 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.9 3.066 . . . . 0.0 115.121 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -118.34 26.41 9.63 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.997 2.119 . . . . 0.0 110.308 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.19 126.07 8.76 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 121.825 3.49 . . . . 0.0 121.825 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -143.58 94.19 2.57 Favored 'General case' 0 CA--C 1.545 0.777 1 C-N-CA 132.044 4.138 . . . . 0.0 103.384 173.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.682 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.283 1.3 m -99.0 138.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 121.261 1.846 . . . . 0.0 114.233 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.02 121.2 40.66 Favored 'General case' 0 CA--C 1.539 0.535 1 N-CA-C 99.901 -4.111 . . . . 0.0 99.901 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.3 p -119.33 122.13 41.14 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -95.28 177.53 5.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.433 ' HA ' HG12 ' A' ' 65' ' ' VAL . 32.2 t -129.57 66.07 1.47 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.51 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.265 0.4 OUTLIER -71.81 -171.64 0.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.16 -173.985 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.51 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.487 0.3 OUTLIER -97.03 6.65 48.22 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -173.521 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -146.08 -26.13 0.44 Allowed 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 124.961 1.413 . . . . 0.0 113.259 170.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -150.52 -178.03 6.31 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.834 0.854 . . . . 0.0 111.417 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 60' ' ' CYS . 16.5 m -125.32 114.08 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.97 0.89 . . . . 0.0 109.749 173.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -110.98 162.51 14.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.707 2.403 . . . . 0.0 111.816 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.81 159.26 32.9 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.431 ' CZ ' HG11 ' B' 1140 ' ' VAL . 12.8 m-85 -130.97 86.22 2.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.948 -1.72 . . . . 0.0 112.852 -174.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -141.75 28.63 1.76 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 122.216 4.154 . . . . 0.0 122.216 -173.733 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.35 -14.23 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 -170.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 mt -127.73 144.85 52.69 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.45 -170.61 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 125.014 3.81 . . . . 0.0 111.718 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -72.03 147.82 46.46 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.473 -1.392 . . . . 0.0 112.9 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -130.92 -177.38 4.35 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.943 0.897 . . . . 0.0 112.552 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.71 -5.09 32.17 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 111.903 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -99.51 15.81 25.32 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.3 1.84 . . . . 0.0 111.664 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.47 -156.72 25.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 127.153 2.311 . . . . 0.0 109.707 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -115.64 -126.16 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -59.87 115.25 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.75 131.2 39.66 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.486 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 16.3 m-85 -143.82 155.55 44.17 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 175.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -145.88 -164.24 1.91 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.261 2.224 . . . . 0.0 109.894 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.707 ' HA ' HG12 ' B' 1140 ' ' VAL . 67.1 mtm -156.73 -173.67 4.58 Favored 'General case' 0 C--N 1.314 -0.95 1 C-N-CA 136.424 5.89 . . . . 0.0 109.089 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.94 -29.5 65.54 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.49 44.62 1.85 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.48 1.112 . . . . 0.0 112.846 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.36 171.87 24.09 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.956 1.543 . . . . 0.0 116.956 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 56.7 1.48 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.801 2.041 . . . . 0.0 112.301 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 32.2 p -76.98 5.31 8.22 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 121.766 3.987 . . . . 0.0 121.766 -173.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.486 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 37.8 ptt180 -38.91 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 2 C-N-CA 132.875 4.47 . . . . 0.0 122.423 173.345 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -126.5 159.89 32.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.325 1.85 . . . . 0.0 111.182 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 m -64.23 137.64 58.04 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.441 -0.787 . . . . 0.0 110.665 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.56 -47.49 47.67 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -64.32 -33.72 76.49 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.93 -32.59 69.55 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.342 0.657 . . . . 0.0 112.289 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.75 -28.81 36.37 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.975 1.31 . . . . 0.0 112.296 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.88 -29.04 69.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.359 1.064 . . . . 0.0 113.29 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.6 t -70.11 -76.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.28 0.946 . . . . 0.0 110.832 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -81.9 -44.5 16.73 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.82 -0.84 49.89 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -66.1 -42.65 89.0 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 122.788 2.54 . . . . 0.0 113.81 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -80.16 -11.79 59.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.32 1.448 . . . . 0.0 114.361 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 65.08 1.34 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.536 1.534 . . . . 0.0 109.689 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -101.71 -163.56 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.311 1.444 . . . . 0.0 111.871 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -96.63 -1.6 46.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.569 1.548 . . . . 0.0 111.23 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 52.24 -146.29 15.45 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 126.631 2.062 . . . . 0.0 114.298 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.24 179.17 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.737 1.615 . . . . 0.0 112.023 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 mt -40.32 -55.9 3.85 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.395 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 109' ' ' CYS . 68.4 Cg_endo -122.44 -41.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 N-CA-C 118.191 2.343 . . . . 0.0 118.191 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.405 ' H ' ' HD2' ' A' ' 108' ' ' PRO . 71.6 m -90.39 -127.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.507 1.923 . . . . 0.0 115.967 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.56 142.19 23.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.833 1.653 . . . . 0.0 114.649 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.445 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -93.72 -6.88 45.18 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -174.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -110.95 152.67 26.51 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.522 1.129 . . . . 0.0 112.55 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 64.6 m-70 -125.06 160.14 29.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.417 1.487 . . . . 0.0 111.706 175.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 28.0 m -141.06 -162.82 1.43 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 130.025 3.33 . . . . 0.0 108.135 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.2 m -125.75 133.54 52.05 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.879 -1.138 . . . . 0.0 112.121 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -99.28 176.11 5.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.149 0.98 . . . . 0.0 111.678 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 125.754 1.622 . . . . 0.0 113.329 -175.651 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 CA--C 1.539 0.737 0 CA-C-O 121.291 0.455 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 42.6 mp0 . . . . . 0 CA--C 1.551 0.992 0 C-N-CA 124.849 1.26 . . . . 0.0 112.597 178.147 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B 1140 ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 83' ' ' MET . 54.1 t . . . . . 0 N--CA 1.499 2.001 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.56 -29.5 51.33 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 102.193 -3.262 . . . . 0.0 102.193 169.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1142 ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' 1140 ' ' VAL 0.317 1.0 OUTLIER -161.44 157.34 21.47 Favored Pre-proline 0 N--CA 1.427 -1.621 1 C-N-CA 135.165 5.386 . . . . 0.0 105.574 168.443 . . . . . . . . 5 4 . 1 . 006 nuclear build core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.79 52.65 0.72 Allowed 'Trans proline' 0 CA--C 1.554 1.502 0 C-N-CA 122.6 2.2 . . . . 0.0 111.381 152.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--O 1.255 1.364 1 C-N-CA 134.873 5.269 . . . . 0.0 114.793 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.886 0.85 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -143.29 134.45 25.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.196 1.398 . . . . 0.0 112.531 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -142.0 157.6 44.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.357 1.863 . . . . 0.0 109.694 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.96 23.4 2.61 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 121.956 2.162 . . . . 0.0 114.145 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -147.13 52.92 1.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.61 1.205 . . . . 0.0 110.952 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.261 7.4 tt -140.63 59.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 123.407 1.575 . . . . 0.0 109.101 174.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 t -43.58 153.19 0.12 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.844 2.458 . . . . 0.0 114.907 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.536 ' HE ' ' HG2' ' B' 1138 ' ' GLU . 0.0 OUTLIER -46.83 -34.31 5.22 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 -174.31 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.76 -27.73 36.66 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.35 -48.59 11.76 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.609 1.564 . . . . 0.0 113.473 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -63.53 -33.31 75.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.97 -17.31 63.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -75.61 -30.89 59.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.725 0.81 . . . . 0.0 112.085 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.3 -60.5 1.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.301 1.44 . . . . 0.0 111.803 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mt -81.37 -3.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.494 1.918 . . . . 0.0 112.974 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.79 8.33 68.19 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.155 -1.591 . . . . 0.0 115.028 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -80.39 -4.01 51.91 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.447 1.099 . . . . 0.0 112.637 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -71.66 145.78 48.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.562 1.145 . . . . 0.0 113.28 -175.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.18 15.73 39.28 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 125.584 1.564 . . . . 0.0 114.145 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.54 177.57 8.91 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.362 1.865 . . . . 0.0 113.544 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 41' ' ' GLY . 35.1 m -72.08 169.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 126.302 1.841 . . . . 0.0 115.27 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 35.1 m-20 -58.41 22.27 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.889 2.876 . . . . 0.0 115.425 174.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -141.81 10.79 2.62 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.52 71.62 2.31 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.931 2.366 . . . . 0.0 108.441 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.457 ' HB3' HD23 ' A' ' 59' ' ' LEU . 2.0 p90 -98.46 168.26 10.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.8 tp -138.48 153.26 48.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.804 2.442 . . . . 0.0 109.584 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.6 t -116.07 101.53 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.158 0.983 . . . . 0.0 108.739 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.19 28.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.546 1.938 . . . . 0.0 109.506 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 56' ' ' VAL . 8.2 pm0 -142.76 -154.16 0.51 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.697 0.761 . . . . 0.0 113.012 174.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -120.85 147.66 45.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 132.704 4.402 . . . . 0.0 108.277 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 7.51 46.17 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.573 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.35 -68.1 0.82 Allowed 'General case' 0 C--N 1.352 0.691 0 C-N-CA 130.184 3.394 . . . . 0.0 111.083 -174.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -78.85 116.79 62.59 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 122.997 2.635 . . . . 0.0 108.464 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.8 -15.96 51.15 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.758 2.306 . . . . 0.0 114.846 -168.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.64 13.98 9.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.632 2.373 . . . . 0.0 111.833 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.71 124.12 7.99 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 122.726 3.85 . . . . 0.0 122.726 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.528 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 60.0 m-85 -144.0 84.08 1.76 Allowed 'General case' 0 CA--C 1.564 1.505 1 C-N-CA 132.455 4.302 . . . . 0.0 110.595 174.315 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -98.24 144.11 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 119.817 -1.802 . . . . 0.0 113.299 -174.366 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 122.83 42.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 101.017 -3.698 . . . . 0.0 101.017 171.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 p -116.3 105.28 12.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 43' ' ' PHE . 1.5 mt -97.91 158.32 15.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -172.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.56 125.83 51.79 Favored 'General case' 0 CA--C 1.497 -1.079 1 N-CA-C 96.508 -5.367 . . . . 0.0 96.508 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.619 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.359 0.0 OUTLIER -112.7 -146.34 0.41 Allowed 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.881 1.363 . . . . 0.0 111.521 -171.348 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.619 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.271 14.6 tp -95.79 -7.09 38.07 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.173 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.275 5.4 pt20 -151.03 -17.9 0.21 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -150.4 -160.37 1.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.681 0.792 . . . . 0.0 111.792 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.96 141.79 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.746 1.218 . . . . 0.0 109.376 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -138.05 150.3 46.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.705 0.802 . . . . 0.0 111.363 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.19 144.24 43.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.178 0.991 . . . . 0.0 113.572 -173.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.91 69.42 1.27 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.5 tm? -142.16 123.04 14.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 115.584 -2.15 . . . . 0.0 111.925 174.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' B' 1141 ' ' ASN 0.255 38.7 mt -139.53 -41.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 122.843 2.565 . . . . 0.0 112.921 173.258 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.3 148.88 71.62 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 120.351 1.432 . . . . 0.0 114.162 -175.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -81.35 179.57 5.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.172 3.248 . . . . 0.0 111.387 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.07 139.52 56.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.93 -167.59 1.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.132 1.773 . . . . 0.0 111.369 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.33 -7.97 27.95 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -122.66 20.59 10.21 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.808 1.643 . . . . 0.0 112.845 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.07 -171.48 39.92 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.345 1.926 . . . . 0.0 111.381 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -121.73 -137.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 108.109 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.43 123.22 6.28 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.338 1.426 . . . . 0.0 107.725 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.89 137.26 36.86 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -146.09 130.79 17.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.489 1.916 . . . . 0.0 111.733 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 m -141.61 0.99 1.5 Allowed 'General case' 0 N--CA 1.492 1.672 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 -173.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.507 ' HB3' HG12 ' B' 1140 ' ' VAL . 5.5 ptt? -29.91 156.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 174.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.9 -31.0 16.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.53 2.21 13.78 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.615 1.166 . . . . 0.0 114.112 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.78 105.38 0.41 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.224 1.393 . . . . 0.0 114.757 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 54.1 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.014 1.726 . . . . 0.0 109.535 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.499 68.9 p -77.77 12.83 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 121.569 3.915 . . . . 0.0 121.569 -172.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -39.47 35.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 131.629 3.972 . . . . 0.0 121.049 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.77 174.57 9.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.281 2.632 . . . . 0.0 109.281 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -68.93 155.23 40.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.711 -1.243 . . . . 0.0 111.368 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.8 -41.13 65.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.582 -0.699 . . . . 0.0 112.653 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.03 -40.53 96.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.71 -33.91 60.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.943 0.497 . . . . 0.0 112.218 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -73.86 -34.03 64.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.534 1.134 . . . . 0.0 112.347 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.744 1.217 . . . . 0.0 112.646 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.4 -37.88 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.679 0.792 . . . . 0.0 111.812 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -80.4 -34.77 36.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.789 1.235 . . . . 0.0 112.691 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -80.63 -15.27 57.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.69 -48.83 63.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.585 1.154 . . . . 0.0 113.752 -174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -81.93 -44.62 16.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.673 1.189 . . . . 0.0 113.267 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.43 88.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.945 1.698 . . . . 0.0 110.747 -175.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -69.56 172.58 7.12 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.975 0.91 . . . . 0.0 110.328 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -101.31 4.81 41.99 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.779 1.632 . . . . 0.0 112.32 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.17 -141.78 0.52 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 128.0 2.714 . . . . 0.0 115.067 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.431 HG21 ' HB2' ' A' ' 61' ' ' HIS . 8.0 tp -107.93 161.37 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.231 1.812 . . . . 0.0 109.245 174.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -31.33 -45.68 0.32 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 119.007 2.966 . . . . 0.0 119.007 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -75.36 -157.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.581 2.854 . . . . 0.0 116.829 -173.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 92.4 m -45.8 -59.21 2.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.639 3.176 . . . . 0.0 118.186 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.99 156.34 19.81 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.84 1.2 . . . . 0.0 111.91 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -14.89 3.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -108.54 141.19 40.81 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.77 1.623 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -93.69 169.57 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 86.4 m -136.36 -154.78 0.58 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.65 2.38 . . . . 0.0 109.307 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.0 m -121.06 123.37 42.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.587 1.155 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 t -103.61 168.52 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.7 1.2 . . . . 0.0 112.74 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 124.44 1.096 . . . . 0.0 112.24 175.675 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 CA--C 1.539 0.762 0 N-CA-C 111.497 -0.232 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B 1138 ' ' GLU . . . . . 0.536 ' HG2' ' HE ' ' A' ' 26' ' ' ARG . 8.3 tt0 . . . . . 0 CA--C 1.546 0.789 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.805 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1140 ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 83' ' ' MET 0.319 95.2 t . . . . . 0 N--CA 1.504 2.262 0 N-CA-C 119.852 3.278 . . . . 0.0 119.852 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B 1141 ' ' ASN . . . . . 0.579 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.2 m-80 -67.15 -17.91 65.06 Favored 'General case' 0 CA--C 1.579 2.087 1 N-CA-C 99.14 -4.393 . . . . 0.0 99.14 165.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1142 ' ' GLN . . . . . 0.414 ' N ' ' C ' ' B' 1140 ' ' VAL . 49.6 mm-40 -132.44 4.43 0.04 OUTLIER Pre-proline 0 C--N 1.384 2.078 1 N-CA-C 125.509 5.374 . . . . 0.0 125.509 173.425 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo 6.16 58.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.892 1.728 . . . . 0.0 113.567 -126.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B 1144 ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' B' 1142 ' ' GLN . 34.7 t70 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 133.05 4.54 . . . . 0.0 116.993 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 . . . . . 0 CA--C 1.544 0.725 0 CA-C-O 121.372 0.606 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -141.07 150.23 42.66 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -141.03 148.23 39.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 128.398 2.679 . . . . 0.0 108.912 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.36 41.28 1.3 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 123.15 2.705 . . . . 0.0 112.532 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -142.58 31.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.004 1.383 . . . . 0.0 110.721 174.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.09 79.67 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.67 1.188 . . . . 0.0 108.141 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 m -52.58 154.57 2.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.678 1.591 . . . . 0.0 112.325 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -47.15 -39.35 13.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.48 -34.61 74.6 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.916 1.286 . . . . 0.0 112.779 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -81.75 -43.98 17.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.275 1.03 . . . . 0.0 111.598 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 t -62.15 -36.45 81.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.521 1.128 . . . . 0.0 112.361 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.9 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttp-105 -79.12 -35.64 41.89 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.914 0.779 . . . . 0.0 111.54 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -83.39 -45.27 13.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.251 1.42 . . . . 0.0 112.574 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.26 -7.5 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.923 0.889 . . . . 0.0 111.236 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.37 -0.97 59.36 Favored Glycine 0 N--CA 1.471 0.997 0 O-C-N 119.966 -1.709 . . . . 0.0 116.46 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.48 -3.78 58.96 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.93 1.365 . . . . 0.0 111.219 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.56 152.78 29.93 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.92 1.688 . . . . 0.0 111.743 174.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.6 22.42 3.17 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.667 1.127 . . . . 0.0 115.086 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.13 -170.5 2.76 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.398 1.479 . . . . 0.0 112.032 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -54.87 156.92 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.951 1.3 . . . . 0.0 111.392 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 6.9 m-20 -46.54 -24.3 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.58 ' HA2' ' CD2' ' A' ' 113' ' ' HIS . . . -99.63 43.46 1.81 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 119.804 2.682 . . . . 0.0 119.804 -173.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.87 75.43 0.96 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.461 ' CD2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -98.26 171.65 8.07 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 117.278 2.325 . . . . 0.0 117.278 -172.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -141.47 142.69 33.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 0.0 110.107 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.53 93.51 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.07 161.77 24.88 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.36 1.464 . . . . 0.0 110.039 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' HA ' HG13 ' A' ' 56' ' ' VAL . 4.4 pm0 -141.56 -158.62 0.88 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -140.48 163.39 32.96 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 123.475 1.607 . . . . 0.0 109.862 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.26 1.3 pp0? -96.11 11.97 32.34 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.836 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -97.49 -73.85 0.59 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 131.632 3.973 . . . . 0.0 108.321 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.89 120.58 47.63 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 121.399 1.909 . . . . 0.0 109.588 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.29 -13.87 23.05 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.919 2.413 . . . . 0.0 113.976 -168.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -125.59 30.88 5.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.278 2.231 . . . . 0.0 110.467 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.48 132.32 10.93 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 122.505 3.762 . . . . 0.0 122.505 -172.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.408 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 38.2 m-85 -144.02 76.29 1.5 Allowed 'General case' 0 CA--C 1.559 1.303 1 C-N-CA 131.786 4.034 . . . . 0.0 109.019 174.06 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.44 154.79 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.129 2.172 . . . . 0.0 113.046 -174.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' A' ' 43' ' ' PHE . 1.2 mt -111.36 131.45 55.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 172.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.5 p -113.74 113.52 25.08 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -97.2 153.27 18.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.45 ' HA ' HG12 ' A' ' 65' ' ' VAL . 41.8 t -115.03 63.31 0.68 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.5 ' CG ' ' H ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -66.8 -170.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.706 -173.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.5 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.504 0.3 OUTLIER -97.01 7.83 45.8 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 119.696 3.221 . . . . 0.0 119.696 -173.582 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -142.29 -28.57 0.6 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.034 1.459 . . . . 0.0 112.554 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.8 179.75 7.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.943 0.897 . . . . 0.0 111.243 174.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 60' ' ' CYS . 5.0 m -116.48 116.69 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -128.93 160.08 33.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.807 1.643 . . . . 0.0 112.705 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.496 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 91.3 m-70 -101.31 165.24 11.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.522 1.529 . . . . 0.0 113.689 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -133.63 47.6 2.44 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.523 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.7 tm? -142.47 135.48 28.48 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.513 -1.992 . . . . 0.0 113.993 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' B' 1141 ' ' ASN . 52.4 mt -140.36 -43.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.245 0.929 . . . . 0.0 111.05 171.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.98 155.3 68.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -83.32 -176.12 2.65 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.754 3.636 . . . . 0.0 111.877 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -54.03 141.13 29.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.478 1.111 . . . . 0.0 113.861 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -123.56 -170.82 2.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.882 1.273 . . . . 0.0 111.714 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.16 -13.86 20.68 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.015 1.326 . . . . 0.0 112.3 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -99.1 5.58 46.88 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.618 1.567 . . . . 0.0 113.517 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -170.1 -157.7 12.8 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.107 1.337 . . . . 0.0 113.478 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -106.93 -137.14 0.36 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.844 1.258 . . . . 0.0 108.79 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.69 123.22 16.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.87 132.11 37.82 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.413 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 6.6 m-85 -150.17 161.65 41.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.178 1.791 . . . . 0.0 114.698 174.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' B' 1141 ' ' ASN 0.253 1.5 m -145.31 -160.54 1.15 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.905 1.282 . . . . 0.0 108.746 173.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.46 ' HA ' ' CG1' ' B' 1140 ' ' VAL . 9.0 ttm -155.65 -179.93 8.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 129.398 3.079 . . . . 0.0 107.952 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.62 -30.56 70.17 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.12 -0.988 . . . . 0.0 110.13 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.31 40.19 1.91 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.914 1.286 . . . . 0.0 112.669 174.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 179.48 19.56 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 63.83 1.42 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.173 2.189 . . . . 0.0 111.919 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.545 24.6 p -78.4 2.44 18.74 Favored 'General case' 0 N--CA 1.487 1.377 1 N-CA-C 123.352 4.575 . . . . 0.0 123.352 -172.795 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.413 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 27.5 ptt180 -40.36 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 1 C-N-CA 132.377 4.271 . . . . 0.0 119.872 172.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.86 159.79 35.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.499 1.919 . . . . 0.0 112.69 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 m -61.36 136.61 58.1 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.092 1.357 . . . . 0.0 112.715 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.19 -30.16 68.3 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.67 -41.28 99.0 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.903 0.774 . . . . 0.0 112.412 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.4 -39.52 74.44 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.756 -0.59 . . . . 0.0 111.085 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -64.19 -30.56 71.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.437 1.095 . . . . 0.0 112.748 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -76.43 -45.23 32.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.417 1.087 . . . . 0.0 111.94 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.9 -57.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.726 0.694 . . . . 0.0 111.853 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -82.77 -51.03 8.06 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.309 54.3 m-85 -79.85 7.04 9.53 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -173.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -54.72 -29.51 53.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 121.408 1.913 . . . . 0.0 112.941 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.51 -26.59 51.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.692 1.997 . . . . 0.0 114.572 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.6 mt -147.02 71.92 1.24 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.06 2.544 . . . . 0.0 106.773 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.09 159.85 16.49 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 59.59 3.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.93 2.092 . . . . 0.0 111.548 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.27 -154.02 2.04 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 125.54 1.543 . . . . 0.0 113.687 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 tp -79.5 -179.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.836 1.654 . . . . 0.0 111.987 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.4 mt -40.1 139.23 1.03 Allowed Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.769 -1.586 . . . . 0.0 110.586 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -56.17 71.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 125.025 3.817 . . . . 0.0 119.894 -159.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.6 m -103.54 -128.98 0.24 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 129.069 2.948 . . . . 0.0 107.592 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.55 73.5 8.59 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.619 -1.3 . . . . 0.0 108.909 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -2.81 6.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -84.42 56.05 3.64 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.803 1.241 . . . . 0.0 111.103 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.58 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -60.97 141.43 57.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.768 1.627 . . . . 0.0 114.26 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.98 -171.33 2.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 129.402 3.081 . . . . 0.0 109.282 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.79 140.12 33.45 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.1 t -99.85 175.99 5.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.109 1.764 . . . . 0.0 111.865 174.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 . . . . . 0 N--CA 1.476 0.827 0 C-N-CA 125.487 1.515 . . . . 0.0 112.647 -174.757 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 CA--C 1.54 0.792 0 CA-C-O 120.767 0.236 . . . . 0.0 112.653 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 . . . . . 0 CA--C 1.542 0.661 0 C-N-CA 124.992 1.317 . . . . 0.0 112.427 -179.483 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B 1140 ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 83' ' ' MET . 26.7 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 116.079 -1.915 . . . . 0.0 114.7 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1141 ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -60.15 -28.5 67.95 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 169.081 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.352 3.7 mp0 -154.25 158.42 32.39 Favored Pre-proline 0 N--CA 1.435 -1.212 1 C-N-CA 137.216 6.206 . . . . 0.0 104.348 169.775 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 60.26 2.06 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 CA-C-N 121.585 1.602 . . . . 0.0 110.261 152.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.1 t0 . . . . . 0 C--O 1.254 1.322 1 C-N-CA 134.446 5.098 . . . . 0.0 115.652 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -117.75 138.09 52.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -141.92 177.84 7.92 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.598 2.759 . . . . 0.0 108.607 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.16 -130.3 3.81 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 121.913 2.142 . . . . 0.0 112.773 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 61.3 ttp85 -51.03 122.49 7.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.315 2.057 . . . . 0.0 115.929 -172.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.87 78.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 1 N-CA-C 99.146 -4.39 . . . . 0.0 99.146 173.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -30.91 121.18 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.977 2.511 . . . . 0.0 115.051 -171.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -24.93 63.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.45 1.9 . . . . 0.0 113.65 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -80.98 -39.2 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.166 1.386 . . . . 0.0 112.805 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.88 -40.62 22.13 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.105 1.362 . . . . 0.0 113.695 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -56.01 -32.65 64.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.193 1.397 . . . . 0.0 113.781 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.463 ' HA ' ' CG2' ' A' ' 65' ' ' VAL 0.266 1.5 pt20 -64.14 -15.84 60.61 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 174.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -80.61 -28.38 37.04 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.117 0.967 . . . . 0.0 112.038 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.13 -59.02 1.81 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.502 1.521 . . . . 0.0 112.588 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.15 -6.47 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 126.431 1.892 . . . . 0.0 111.63 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.53 7.06 65.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 119.965 -1.709 . . . . 0.0 114.348 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -7.78 59.11 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.021 0.911 . . . . 0.0 110.126 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 142.63 50.19 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.256 1.422 . . . . 0.0 110.355 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.73 27.76 5.37 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.709 1.147 . . . . 0.0 115.586 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.57 179.58 7.68 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.343 1.071 . . . . 0.0 112.357 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.25 149.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.422 0.689 . . . . 0.0 111.68 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.16 2.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.37 15.76 22.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.439 2.447 . . . . 0.0 116.911 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.64 71.16 4.23 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.196 2.498 . . . . 0.0 105.147 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.39 174.24 6.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -140.52 162.27 35.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.33 2.652 . . . . 0.0 109.033 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.28 107.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.299 1.04 . . . . 0.0 109.31 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' HH11 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.54 164.92 28.91 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.624 1.97 . . . . 0.0 107.899 -177.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.889 ' HA ' HG13 ' A' ' 56' ' ' VAL . 15.4 pt-20 -141.05 -172.53 3.5 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.2 t -98.37 138.55 35.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.429 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.427 ' H ' ' HB2' ' A' ' 23' ' ' ARG 0.358 0.0 OUTLIER -98.2 5.53 48.37 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.661 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -113.47 -43.37 3.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 128.46 2.704 . . . . 0.0 113.999 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -76.37 127.22 85.18 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 120.558 1.526 . . . . 0.0 111.733 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -69.67 -25.5 28.96 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.989 2.459 . . . . 0.0 116.664 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -110.39 23.97 13.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.929 . . . . 0.0 111.171 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.595 ' HA3' HD22 ' A' ' 69' ' ' LEU . . . -98.91 129.75 10.0 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 122.16 3.624 . . . . 0.0 122.16 -172.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -144.32 121.54 11.53 Favored 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.899 4.879 . . . . 0.0 102.181 173.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.889 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.325 0.9 OUTLIER -125.11 138.94 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 123.552 2.887 . . . . 0.0 112.787 -174.954 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 tt -98.6 126.11 44.07 Favored 'General case' 0 CA--C 1.536 0.438 1 N-CA-C 99.546 -4.242 . . . . 0.0 99.546 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 p -125.64 112.05 15.69 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.873 1.215 . . . . 0.0 108.243 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.31 167.16 11.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.607 1.163 . . . . 0.0 111.502 -173.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.493 ' HA ' HG12 ' A' ' 65' ' ' VAL . 49.7 t -126.33 94.97 4.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.561 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.326 0.0 OUTLIER -90.72 -161.84 0.84 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.008 -173.077 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.532 0.3 OUTLIER -96.88 13.07 30.0 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 -174.287 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -147.4 -36.24 0.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.107 -1.861 . . . . 0.0 112.16 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -151.1 -177.55 6.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 60' ' ' CYS . 5.0 m -100.03 127.41 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 173.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -128.96 146.4 50.98 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.206 1.402 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -117.66 159.93 22.13 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -172.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.429 ' CZ ' HG11 ' B' 1140 ' ' VAL . 8.6 m-85 -131.87 84.05 2.14 Favored 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.596 1.558 . . . . 0.0 115.196 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.595 HD22 ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -136.3 19.51 3.16 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 121.745 3.98 . . . . 0.0 121.745 -174.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 mt -93.07 4.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 118.949 -2.344 . . . . 0.0 116.534 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.4 mt -135.78 138.95 29.31 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.749 1.159 . . . . 0.0 111.85 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -84.93 -176.95 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.297 3.331 . . . . 0.0 111.195 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 m -62.56 147.01 50.41 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.707 -1.246 . . . . 0.0 112.331 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -125.03 -176.67 3.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.336 1.054 . . . . 0.0 111.963 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -97.54 -8.72 28.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.75 0.82 . . . . 0.0 112.786 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -99.39 0.18 42.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.075 1.35 . . . . 0.0 112.552 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -162.4 -155.8 8.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.261 1.41 . . . . 0.0 114.233 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.64 -135.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.921 1.688 . . . . 0.0 108.794 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.98 117.33 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -84.12 126.45 33.1 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.507 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 25.9 m-85 -143.04 157.23 44.73 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.9 p -148.73 -159.2 1.0 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.839 2.056 . . . . 0.0 110.751 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.662 ' HA ' HG12 ' B' 1140 ' ' VAL . 46.9 mtt -155.54 -169.08 3.01 Favored 'General case' 0 C--N 1.314 -0.97 1 C-N-CA 137.309 6.244 . . . . 0.0 107.335 -172.36 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.21 -34.75 78.16 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.457 ' H ' HD21 ' A' ' 107' ' ' LEU . 25.3 t0 -141.18 60.76 1.5 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.937 1.695 . . . . 0.0 110.367 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.14 172.41 22.08 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -141.24 42.84 1.78 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.142 1.777 . . . . 0.0 114.01 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 2.3 p -70.95 -1.45 11.99 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 120.632 3.568 . . . . 0.0 120.632 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.507 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 2.5 ptm180 -43.21 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 1 C-N-CA 131.868 4.067 . . . . 0.0 119.817 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.81 166.35 24.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.805 2.442 . . . . 0.0 110.466 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -66.17 132.99 49.75 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.05 -1.031 . . . . 0.0 109.667 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.98 -46.2 24.81 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.75 -40.0 82.6 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.69 -28.28 68.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.58 0.752 . . . . 0.0 112.562 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -88.01 -20.63 25.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 112.329 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 tt -69.21 -55.29 11.03 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.92 -1.112 . . . . 0.0 111.192 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.76 -60.11 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.856 0.753 . . . . 0.0 112.297 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -82.28 -64.0 1.27 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.265 99.6 m-85 -69.94 -5.55 26.92 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -172.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -53.32 -29.48 34.01 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 123.452 2.842 . . . . 0.0 113.608 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -64.38 -32.06 73.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.132 1.773 . . . . 0.0 114.139 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -151.44 74.71 1.14 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.105 2.162 . . . . 0.0 106.532 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -107.3 -167.23 1.24 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.92 1.288 . . . . 0.0 114.12 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -104.03 76.6 1.37 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.676 1.99 . . . . 0.0 108.861 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.99 -157.94 1.04 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.797 1.189 . . . . 0.0 113.362 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.654 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -61.76 158.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.659 1.184 . . . . 0.0 113.816 -174.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.654 ' H ' HD13 ' A' ' 106' ' ' ILE . 12.5 mt -28.73 -64.16 0.18 Allowed Pre-proline 0 CA--C 1.566 1.585 0 CA-C-O 115.281 -2.295 . . . . 0.0 115.764 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 107' ' ' LEU . 11.8 Cg_endo -119.59 -21.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.637 0 CA-C-N 124.252 2.554 . . . . 0.0 117.308 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.2 m -86.22 -145.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.18 1.792 . . . . 0.0 114.145 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.86 141.89 47.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.468 1.107 . . . . 0.0 113.261 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -104.89 -9.43 17.99 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -174.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -106.32 146.89 29.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.509 1.124 . . . . 0.0 112.478 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -111.51 153.26 26.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.255 1.422 . . . . 0.0 114.169 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.06 -179.92 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.065 2.146 . . . . 0.0 110.843 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 95.3 m -98.96 124.04 43.66 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.895 -1.128 . . . . 0.0 113.094 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t -102.69 -177.44 3.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.039 1.736 . . . . 0.0 114.413 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 123.942 0.897 . . . . 0.0 110.85 175.575 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 CA--C 1.547 1.142 0 CA-C-O 120.743 0.226 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.55 -174.899 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B 1140 ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 83' ' ' MET 0.281 77.6 t . . . . . 0 N--CA 1.509 2.518 0 N-CA-C 117.988 2.588 . . . . 0.0 117.988 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.33 -28.45 65.07 Favored 'General case' 0 CA--C 1.583 2.221 1 N-CA-C 99.696 -4.187 . . . . 0.0 99.696 167.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1142 ' ' GLN . . . . . 0.458 ' C ' ' H ' ' B' 1144 ' ' ASP . 4.4 mp0 -146.79 169.48 9.38 Favored Pre-proline 0 C--N 1.369 1.45 0 C-N-CA 130.103 3.361 . . . . 0.0 113.272 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.24 41.22 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.647 0 C-N-CA 124.466 3.444 . . . . 0.0 113.947 146.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B 1144 ' ' ASP . . . . . 0.458 ' H ' ' C ' ' B' 1142 ' ' GLN . 42.1 t0 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 132.564 4.345 . . . . 0.0 115.396 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.9 m95 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.85 143.78 31.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 -173.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -141.36 149.78 41.58 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.766 3.226 . . . . 0.0 107.839 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.91 39.87 1.41 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-N 123.532 2.878 . . . . 0.0 114.912 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -146.29 30.93 1.02 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.928 0.891 . . . . 0.0 112.352 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 tp -128.19 75.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.479 1.112 . . . . 0.0 109.954 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -45.32 150.16 0.47 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.008 1.723 . . . . 0.0 113.756 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -52.24 -31.57 32.9 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -174.235 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.0 -33.16 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -81.49 -49.97 9.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.027 1.331 . . . . 0.0 112.37 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 p -66.47 -29.05 69.09 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.401 -0.812 . . . . 0.0 112.514 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.14 -14.57 63.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.488 1.495 . . . . 0.0 113.723 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -79.86 -34.26 39.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.292 1.037 . . . . 0.0 111.335 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mp -86.98 -42.77 12.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.438 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.23 -10.74 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 111.168 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.59 -1.41 58.96 Favored Glycine 0 N--CA 1.469 0.879 0 O-C-N 120.436 -1.415 . . . . 0.0 116.112 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -88.02 -0.14 56.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.771 1.285 . . . . 0.0 111.868 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.76 158.99 19.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.083 1.753 . . . . 0.0 111.308 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.15 25.51 2.64 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.405 1.002 . . . . 0.0 114.995 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.5 -170.73 2.93 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.458 1.103 . . . . 0.0 111.644 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.3 m -54.72 154.99 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.759 0.823 . . . . 0.0 110.542 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 17.8 m-20 -55.66 -10.4 0.69 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.54 13.03 63.01 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.14 2.781 . . . . 0.0 116.445 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.41 78.92 4.4 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 122.193 2.997 . . . . 0.0 105.843 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.17 170.65 8.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.6 tp -133.97 153.23 51.91 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.768 2.027 . . . . 0.0 109.768 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.41 102.55 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.33 163.91 31.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.825 1.25 . . . . 0.0 109.252 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' HG13 ' A' ' 56' ' ' VAL . 4.6 pm0 -143.06 -159.26 0.95 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.579 1.181 . . . . 0.0 112.797 174.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -120.53 150.85 40.2 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 130.781 3.633 . . . . 0.0 108.021 174.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.85 5.82 48.57 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -98.99 -64.33 1.05 Allowed 'General case' 0 C--N 1.357 0.896 0 C-N-CA 131.411 3.884 . . . . 0.0 113.756 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -58.38 123.9 68.54 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 122.478 2.399 . . . . 0.0 111.459 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.86 -21.13 38.37 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.308 2.672 . . . . 0.0 113.89 -170.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -111.14 21.46 16.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.826 2.45 . . . . 0.0 112.182 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA3' HD22 ' A' ' 69' ' ' LEU . . . -95.96 123.32 7.64 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 120.718 3.047 . . . . 0.0 120.718 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -143.48 103.93 4.16 Favored 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 132.69 4.396 . . . . 0.0 102.606 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.568 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.311 0.8 OUTLIER -110.79 138.9 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 121.346 1.884 . . . . 0.0 114.177 -173.834 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.21 128.03 45.28 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.9 p -127.11 113.73 16.8 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.859 1.209 . . . . 0.0 109.005 -173.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.96 153.45 17.76 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.212 1.005 . . . . 0.0 112.382 -172.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.491 ' HA ' HG12 ' A' ' 65' ' ' VAL . 48.5 t -113.64 75.7 0.94 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.474 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.323 2.5 t60 -82.81 -172.35 4.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.266 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.474 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.559 0.2 OUTLIER -98.5 22.3 10.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -173.763 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -149.96 -39.36 0.14 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.748 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 175.83 10.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.045 0.938 . . . . 0.0 110.512 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 60' ' ' CYS . 6.0 m -118.16 112.53 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -110.86 158.07 19.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.95 1.7 . . . . 0.0 112.87 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 22.4 m-70 -120.76 160.06 24.13 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.465 1.506 . . . . 0.0 114.517 -173.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -131.24 87.2 2.44 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.55 HD22 ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -140.89 23.36 2.25 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' B' 1144 ' ' ASP . 5.8 mt -92.07 -3.26 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 118.326 -2.733 . . . . 0.0 118.065 -168.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -136.77 136.46 21.58 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 120.913 1.688 . . . . 0.0 113.214 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.38 170.24 16.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.952 3.101 . . . . 0.0 112.495 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -57.48 141.06 48.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.659 1.184 . . . . 0.0 113.658 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -131.34 178.82 6.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.647 1.179 . . . . 0.0 112.795 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -99.08 -7.18 27.11 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.91 1.284 . . . . 0.0 111.441 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -106.99 45.1 1.0 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.947 2.499 . . . . 0.0 107.295 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 148.32 -160.53 28.38 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.121 2.772 . . . . 0.0 109.09 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -124.18 -123.33 0.26 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.22 116.8 5.3 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.59 136.05 40.52 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -146.88 154.57 41.46 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 m -146.47 -172.93 4.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.245 2.618 . . . . 0.0 109.226 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.541 ' HA ' HG12 ' B' 1140 ' ' VAL . 15.2 mtp -154.48 176.92 11.77 Favored 'General case' 0 C--N 1.311 -1.085 1 C-N-CA 138.95 6.9 . . . . 0.0 107.175 -172.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.45 -25.52 65.94 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.329 -0.857 . . . . 0.0 111.235 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.45 36.52 2.05 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.344 1.058 . . . . 0.0 112.833 174.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 170.12 24.84 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -141.37 60.24 1.5 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.639 1.976 . . . . 0.0 112.418 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.507 41.3 p -76.97 9.75 2.75 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -173.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -38.14 31.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 2 C-N-CA 133.482 4.713 . . . . 0.0 122.756 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -113.81 169.63 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.629 1.571 . . . . 0.0 110.795 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -56.26 140.21 45.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.481 1.113 . . . . 0.0 111.915 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.16 -47.1 30.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.449 0.7 . . . . 0.0 112.75 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.6 -38.79 87.72 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.809 -0.557 . . . . 0.0 111.842 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.28 -37.05 86.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.866 0.466 . . . . 0.0 111.408 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -68.66 -41.68 79.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.458 -0.777 . . . . 0.0 112.121 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 tt -65.82 -39.65 91.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.508 0.595 . . . . 0.0 111.912 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.32 -69.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.756 -0.59 . . . . 0.0 111.204 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.15 -41.26 20.66 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.51 -27.83 34.29 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 121.294 1.861 . . . . 0.0 115.348 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -39.3 -42.42 1.02 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -21.11 58.91 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -146.47 56.96 1.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.013 2.125 . . . . 0.0 110.913 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -91.18 -154.78 0.37 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.116 0.966 . . . . 0.0 112.187 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.89 -4.48 27.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.304 1.842 . . . . 0.0 113.601 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 44.71 -145.27 2.12 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.523 2.011 . . . . 0.0 116.543 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -79.56 159.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.999 1.719 . . . . 0.0 111.199 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.41 ' CB ' ' HD3' ' A' ' 108' ' ' PRO . 2.8 mt -35.17 -54.22 1.12 Allowed Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 116.318 -1.801 . . . . 0.0 115.525 174.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 107' ' ' LEU . 56.9 Cg_endo -118.73 -33.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 -172.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.31 -131.95 0.13 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 126.591 1.956 . . . . 0.0 115.31 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.49 137.68 52.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.9 1.28 . . . . 0.0 113.559 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.446 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -91.51 -13.49 32.04 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.489 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -99.81 161.73 13.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.927 1.291 . . . . 0.0 112.373 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -132.21 154.32 49.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 113.314 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 168.11 20.54 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.882 2.473 . . . . 0.0 108.742 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.2 m -98.09 130.0 44.89 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 119.922 -1.736 . . . . 0.0 112.673 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -99.22 178.16 4.99 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.577 1.151 . . . . 0.0 112.441 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 . . . . . 0 N--CA 1.478 0.939 0 C-N-CA 124.478 1.111 . . . . 0.0 112.791 -179.773 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.538 0.704 0 CA-C-O 120.911 0.296 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 116.214 -1.85 . . . . 0.0 113.922 174.539 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B 1140 ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 83' ' ' MET 0.326 78.2 t . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1141 ' ' ASN . . . . . 0.403 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.3 m-80 -59.57 -29.86 68.24 Favored 'General case' 0 CA--C 1.581 2.168 1 N-CA-C 99.048 -4.427 . . . . 0.0 99.048 167.228 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.263 1.9 mp0 -151.72 172.53 5.33 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 130.657 3.583 . . . . 0.0 114.037 171.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.02 59.1 0.3 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.396 2.064 . . . . 0.0 110.93 141.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B 1144 ' ' ASP . . . . . 0.477 ' HA ' HD13 ' A' ' 70' ' ' ILE 0.255 30.0 t70 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 131.472 3.909 . . . . 0.0 117.448 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 m -134.88 150.96 74.71 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.39 1.476 . . . . 0.0 112.09 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.47 156.4 61.58 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.384 2.723 . . . . 0.0 112.792 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.44 158.06 43.84 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.381 1.472 . . . . 0.0 112.208 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -94.51 151.26 19.49 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.563 1.145 . . . . 0.0 112.233 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.5 -6.92 88.15 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.593 1.092 . . . . 0.0 115.636 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -62.85 140.77 58.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.438 1.495 . . . . 0.0 112.425 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.2 p -130.29 162.71 28.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.965 1.706 . . . . 0.0 112.44 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.2 tp -141.83 142.31 33.15 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.118 1.367 . . . . 0.0 111.519 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -97.24 10.11 40.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.866 1.666 . . . . 0.0 114.81 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.8 160.78 27.58 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.167 1.387 . . . . 0.0 114.018 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 174.19 3.65 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.364 1.466 . . . . 0.0 113.484 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.3 mm -69.94 -42.36 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.332 -0.855 . . . . 0.0 111.582 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -79.71 57.36 2.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.53 1.532 . . . . 0.0 112.724 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -116.61 -2.54 11.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.0 p -141.67 175.96 9.28 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 128.226 2.611 . . . . 0.0 110.134 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.07 9.85 0.65 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -57.15 -22.65 41.74 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -124.15 22.53 8.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.335 1.854 . . . . 0.0 112.854 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.91 126.47 41.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.172 1.389 . . . . 0.0 111.885 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -141.11 156.55 45.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.036 2.135 . . . . 0.0 108.904 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.86 32.76 2.1 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 123.412 2.823 . . . . 0.0 113.841 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -145.86 47.62 1.25 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.712 1.244 . . . . 0.0 110.522 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.252 7.0 tt -139.5 62.62 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 122.97 1.367 . . . . 0.0 108.357 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -47.89 153.37 0.64 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.619 1.967 . . . . 0.0 112.73 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -35.73 0.71 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -174.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.25 -33.7 61.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.66 -46.61 14.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.482 1.113 . . . . 0.0 112.322 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 p -63.99 -31.32 72.46 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.929 -1.107 . . . . 0.0 112.353 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -71.08 -16.41 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.734 1.152 . . . . 0.0 113.675 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -80.21 -35.15 36.66 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.03 0.932 . . . . 0.0 111.586 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.1 mp -88.95 -45.23 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.497 1.119 . . . . 0.0 112.649 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.06 -9.1 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.159 0.984 . . . . 0.0 111.533 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.35 -0.27 61.37 Favored Glycine 0 N--CA 1.472 1.086 0 O-C-N 120.019 -1.676 . . . . 0.0 115.62 -174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -80.75 -14.25 58.27 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.155 0.978 . . . . 0.0 109.354 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.03 157.27 22.97 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.732 2.013 . . . . 0.0 111.966 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.69 33.4 2.05 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 124.769 1.176 . . . . 0.0 114.718 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.45 -179.29 7.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.705 1.202 . . . . 0.0 112.875 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 m -51.27 149.32 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.105 0.962 . . . . 0.0 111.819 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 1.2 m-20 -40.22 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 129.683 3.193 . . . . 0.0 116.717 -174.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.84 19.4 53.5 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 120.129 2.811 . . . . 0.0 120.129 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.4 78.43 4.42 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 123.509 3.654 . . . . 0.0 105.596 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.506 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -100.41 170.29 8.51 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -172.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 tp -140.46 156.11 46.46 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.289 3.036 . . . . 0.0 108.821 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.06 79.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 122.872 1.32 . . . . 0.0 108.681 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.459 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -115.78 168.82 9.71 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.249 1.42 . . . . 0.0 110.806 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HA ' HG13 ' A' ' 56' ' ' VAL . 8.6 pt-20 -142.75 -156.33 0.67 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.547 0.689 . . . . 0.0 110.394 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.5 p -134.52 154.3 51.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.923 2.089 . . . . 0.0 109.077 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.285 1.4 pp0? -99.53 6.05 45.92 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.625 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -99.78 -61.67 1.34 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 131.246 3.819 . . . . 0.0 113.038 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -64.14 125.15 87.52 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 123.786 2.994 . . . . 0.0 107.584 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.83 -6.84 19.58 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.143 2.562 . . . . 0.0 114.101 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -129.03 26.87 5.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.649 2.379 . . . . 0.0 111.737 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA2' ' HG ' ' A' ' 69' ' ' LEU . . . -96.17 127.01 9.01 Favored Glycine 0 C--N 1.356 1.692 0 N-CA-C 121.992 3.557 . . . . 0.0 121.992 -172.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.486 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 33.3 m-85 -145.12 77.69 1.53 Allowed 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 133.602 4.761 . . . . 0.0 109.465 174.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.516 HG11 ' HE1' ' B' 1139 ' ' PTR . 0.5 OUTLIER -98.73 145.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.509 -1.995 . . . . 0.0 115.233 -173.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.95 128.38 48.39 Favored 'General case' 0 CA--C 1.542 0.672 1 N-CA-C 99.187 -4.375 . . . . 0.0 99.187 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 p -126.87 113.14 16.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.115 -1.615 . . . . 0.0 109.135 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 43' ' ' PHE . 11.2 mt -98.78 153.0 19.08 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.249 1.02 . . . . 0.0 111.421 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.417 ' HA ' HG12 ' A' ' 65' ' ' VAL . 53.6 t -124.94 114.63 19.41 Favored 'General case' 0 CA--C 1.496 -1.109 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 40' ' ' ASP 0.267 0.0 OUTLIER -113.41 -165.88 1.04 Allowed 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.024 1.453 . . . . 0.0 112.489 -173.054 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.542 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.462 0.3 OUTLIER -96.65 8.11 44.99 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 118.561 2.8 . . . . 0.0 118.561 -173.795 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -146.44 -27.02 0.42 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 125.202 1.564 . . . . 0.0 112.777 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -150.07 -177.96 6.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.953 0.901 . . . . 0.0 112.312 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 60' ' ' CYS . 4.1 m -131.26 135.24 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.639 1.176 . . . . 0.0 109.43 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -140.96 158.25 44.2 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.774 0.83 . . . . 0.0 112.63 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.459 ' CG ' HH21 ' A' ' 46' ' ' ARG . 88.2 m-70 -111.57 149.03 32.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.197 1.399 . . . . 0.0 110.854 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 65.27 1.12 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.862 1.265 . . . . 0.0 113.252 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.4 tm? -141.81 129.85 22.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.355 1.462 . . . . 0.0 112.348 174.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' B' 1141 ' ' ASN . 12.1 mt -140.66 -42.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.714 1.143 . . . . 0.0 110.964 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 80' ' ' TYR . 13.1 mt -120.99 147.41 46.32 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.92 -173.31 1.72 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.294 3.329 . . . . 0.0 110.945 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -57.76 130.0 44.47 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.308 -0.87 . . . . 0.0 112.95 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -110.96 179.14 4.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.695 1.198 . . . . 0.0 112.246 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.03 -11.52 21.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.398 1.079 . . . . 0.0 112.305 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.1 32.93 4.07 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.061 2.144 . . . . 0.0 111.52 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.29 -150.07 21.43 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.782 2.61 . . . . 0.0 110.323 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -128.22 -130.77 0.22 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.233 1.413 . . . . 0.0 107.247 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -57.38 122.82 13.48 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.787 1.63 . . . . 0.0 107.819 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -84.47 138.83 32.58 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -174.114 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.534 ' H ' ' HB3' ' A' ' 89' ' ' ARG . 5.3 m-85 -145.34 137.1 25.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.174 2.19 . . . . 0.0 112.349 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -140.44 1.48 1.77 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.5 ttp -29.81 144.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.55 2.432 . . . . 0.0 113.813 173.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.21 -31.89 34.01 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -112.25 4.13 17.57 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.778 1.231 . . . . 0.0 113.266 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.93 88.73 0.18 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.584 1.564 . . . . 0.0 113.286 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -97.44 53.24 1.14 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.785 1.234 . . . . 0.0 108.85 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.469 68.5 p -79.25 20.03 0.54 Allowed 'General case' 0 N--CA 1.47 0.546 1 N-CA-C 122.566 4.284 . . . . 0.0 122.566 -172.605 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.534 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -39.64 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 121.609 3.929 . . . . 0.0 121.609 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -140.24 174.37 10.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 129.836 3.254 . . . . 0.0 107.708 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 m -62.4 116.4 5.04 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.317 -1.489 . . . . 0.0 109.831 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.2 -32.72 74.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.272 0.629 . . . . 0.0 112.336 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.36 -33.23 75.08 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.5 -37.38 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 111.373 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -28.68 62.92 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.844 0.858 . . . . 0.0 113.257 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.53 -34.0 68.68 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.215 1.406 . . . . 0.0 112.152 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.7 -39.7 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.061 0.944 . . . . 0.0 111.766 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -80.59 -47.19 14.51 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.48 1.112 . . . . 0.0 111.954 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.29 -18.83 65.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -40.03 -49.96 2.55 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.601 1.96 . . . . 0.0 115.167 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -81.18 -47.73 13.04 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.277 1.031 . . . . 0.0 113.534 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.23 92.71 3.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.73 1.612 . . . . 0.0 109.223 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -70.77 176.93 3.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.699 1.2 . . . . 0.0 113.049 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -90.13 -5.18 56.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.58 -166.62 1.16 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.028 1.299 . . . . 0.0 115.261 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.5 tt -90.24 -174.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.294 1.437 . . . . 0.0 107.512 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.74 110.21 2.59 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 121.583 1.992 . . . . 0.0 108.652 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -102.96 157.47 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 N-CA-C 118.98 2.646 . . . . 0.0 118.98 -129.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.33 -43.5 1.16 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 130.735 3.614 . . . . 0.0 106.372 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.5 158.37 41.07 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.955 3.302 . . . . 0.0 107.368 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.268 0.0 OUTLIER -121.4 -22.54 5.93 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.411 2.745 . . . . 0.0 118.411 -174.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.65 142.02 33.12 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.838 1.654 . . . . 0.0 112.13 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -97.85 152.6 19.02 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.195 0.998 . . . . 0.0 112.764 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 170.11 16.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.03 2.532 . . . . 0.0 108.991 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 62.5 m -98.0 132.76 43.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.388 -1.445 . . . . 0.0 113.217 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.5 t -111.1 162.04 15.3 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -68.94 146.25 52.93 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.36 1.464 . . . . 0.0 112.297 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -87.02 -37.83 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.621 0.769 . . . . 0.0 111.528 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.88 166.04 22.07 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.743 1.217 . . . . 0.0 113.297 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.376 1.47 . . . . 0.0 110.86 174.827 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 CA--C 1.542 0.886 0 N-CA-C 114.429 0.896 . . . . 0.0 114.429 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -150.84 156.61 35.87 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.284 1.434 . . . . 0.0 111.717 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.52 161.71 94.05 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.708 0.931 . . . . 0.0 112.77 -5.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.93 -92.62 0.06 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1139 ' ' PTR . . . . . 0.516 ' HE1' HG11 ' A' ' 56' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 57.9 t -144.52 141.22 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 130.954 3.702 . . . . 0.0 101.706 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1141 ' ' ASN . . . . . 0.412 ' HB2' HD12 ' A' ' 70' ' ' ILE 0.357 69.4 m-20 122.66 -27.8 0.01 OUTLIER 'General case' 0 CA--C 1.59 2.506 4 C-N-CA 139.289 7.036 . . . . 0.0 92.801 -169.258 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.282 1.6 mp0 -130.69 -136.87 0.0 OUTLIER Pre-proline 0 C--N 1.381 1.962 0 C-N-CA 130.75 3.62 . . . . 0.0 115.154 168.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -91.68 122.04 0.66 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 123.046 2.123 . . . . 0.0 113.406 75.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -172.319 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -68.22 150.32 97.77 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.463 1.105 . . . . 0.0 113.022 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.98 157.0 63.59 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.406 2.737 . . . . 0.0 112.723 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.95 164.26 32.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.294 1.438 . . . . 0.0 112.44 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.1 p -140.25 162.6 34.9 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.813 1.645 . . . . 0.0 112.156 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.65 -148.14 46.32 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.803 0.716 . . . . 0.0 113.116 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -145.83 151.62 38.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.729 1.211 . . . . 0.0 112.378 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.9 p -89.53 -2.46 58.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.434 1.493 . . . . 0.0 113.586 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.2 tp -62.81 127.42 31.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.199 1.4 . . . . 0.0 111.586 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.7 p -91.48 -8.9 46.39 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.91 145.48 27.76 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.587 1.555 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.1 54.35 2.74 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.081 1.352 . . . . 0.0 112.547 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.5 mm -73.48 129.77 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.124 0.97 . . . . 0.0 110.706 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -98.49 159.03 15.22 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.499 1.519 . . . . 0.0 113.149 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -136.56 2.46 2.69 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 45.4 p -142.68 179.52 6.94 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.543 2.737 . . . . 0.0 110.527 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.19 18.73 0.08 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.381 1.472 . . . . 0.0 113.984 174.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.21 0.45 0.07 Allowed 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 118.753 2.871 . . . . 0.0 118.753 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -97.93 -8.68 27.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.879 1.272 . . . . 0.0 112.115 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -75.74 127.79 33.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.1 1.36 . . . . 0.0 112.065 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -141.35 147.77 38.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.941 1.696 . . . . 0.0 110.364 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.46 40.71 1.3 Allowed Glycine 0 C--O 1.219 -0.789 0 CA-C-N 122.746 2.521 . . . . 0.0 110.805 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 47.13 1.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.808 1.289 . . . . 0.0 109.832 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tt -150.42 81.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.507 1.123 . . . . 0.0 109.303 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.3 t -61.74 164.17 6.49 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.685 1.594 . . . . 0.0 113.884 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.65 -27.64 18.1 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.44 -44.43 19.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.156 0.982 . . . . 0.0 112.467 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.45 -32.02 32.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.667 1.187 . . . . 0.0 113.808 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 p -66.8 -35.52 80.26 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.219 -0.926 . . . . 0.0 112.101 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.273 6.1 pt20 -69.81 -13.71 62.41 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -77.43 -30.59 53.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.709 0.803 . . . . 0.0 111.257 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 mp -92.16 -62.28 1.44 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.795 1.238 . . . . 0.0 111.957 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 mt -70.45 -10.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 125.14 1.376 . . . . 0.0 111.938 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.15 -6.67 57.69 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 121.078 -1.014 . . . . 0.0 115.557 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -102.39 20.78 16.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.6 1.16 . . . . 0.0 110.656 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -105.12 141.84 35.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.642 3.177 . . . . 0.0 111.361 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.48 20.62 48.94 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.2 170.21 16.74 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.969 1.384 . . . . 0.0 112.923 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.46 158.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.915 0.886 . . . . 0.0 111.119 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.15 -7.02 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.694 2.398 . . . . 0.0 116.45 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.06 1.54 44.28 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.866 -1.515 . . . . 0.0 116.456 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.17 84.51 4.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.058 2.429 . . . . 0.0 104.495 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.13 174.6 6.24 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.19 136.1 33.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.357 1.863 . . . . 0.0 110.82 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -101.12 99.78 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.525 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -141.06 167.37 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.428 1.891 . . . . 0.0 110.068 -174.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -142.87 -149.73 0.28 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 t -140.72 164.62 29.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.84 1.305 . . . . 0.0 109.134 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.06 8.42 44.55 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.49 1.916 . . . . 0.0 106.827 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -98.58 -70.46 0.72 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 131.172 3.789 . . . . 0.0 109.251 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -63.87 123.25 81.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 122.028 2.194 . . . . 0.0 109.941 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -74.8 -14.64 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.071 2.514 . . . . 0.0 113.726 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.42 33.59 5.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.479 2.312 . . . . 0.0 110.284 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.63 124.89 8.31 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 120.803 3.081 . . . . 0.0 120.803 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 62.1 m-85 -144.2 77.46 1.55 Allowed 'General case' 0 CA--C 1.56 1.331 1 C-N-CA 131.835 4.054 . . . . 0.0 110.418 174.374 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -98.12 152.83 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.252 1.821 . . . . 0.0 113.863 -174.263 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.58 134.96 54.41 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 102.215 -3.254 . . . . 0.0 102.215 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 p -134.79 122.81 22.62 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.313 1.869 . . . . 0.0 109.391 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.07 159.93 14.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.432 0.693 . . . . 0.0 112.653 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 49.9 t -119.17 69.27 0.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.554 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.302 0.6 OUTLIER -81.07 -173.94 4.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.309 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.554 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.489 0.6 OUTLIER -97.96 8.27 45.02 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -174.088 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -145.94 -27.99 0.43 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 124.757 1.286 . . . . 0.0 112.765 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 171.39 16.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.714 0.806 . . . . 0.0 111.992 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.78 96.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.152 0.981 . . . . 0.0 108.475 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -99.4 160.39 14.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.675 1.59 . . . . 0.0 110.328 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.525 ' CG ' HH21 ' A' ' 46' ' ' ARG . 61.9 m-70 -119.2 137.87 53.34 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 124.455 1.102 . . . . 0.0 113.617 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.47 59.85 1.57 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 120.072 -1.643 . . . . 0.0 113.447 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -143.04 128.67 19.18 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.666 HD12 ' HB2' ' B' 1141 ' ' ASN . 20.4 mt -140.71 -29.39 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 120.085 1.311 . . . . 0.0 112.269 171.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.04 159.49 71.86 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -87.85 -159.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 125.183 3.922 . . . . 0.0 111.838 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -65.41 143.63 57.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.004 -1.06 . . . . 0.0 113.452 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -130.75 -176.39 3.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.757 1.223 . . . . 0.0 112.392 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.51 -15.38 19.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.645 1.178 . . . . 0.0 113.662 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -102.13 31.84 3.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.816 1.646 . . . . 0.0 111.204 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 163.28 -159.0 31.52 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.023 2.249 . . . . 0.0 110.435 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -118.88 -125.66 0.28 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.11 110.88 1.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.16 112.41 18.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.613 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.377 32.3 p90 -151.21 171.76 16.9 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 119.393 3.108 . . . . 0.0 119.393 174.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 88' ' ' THR . 65.8 p -150.88 -141.45 0.11 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.443 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.431 ' C ' HG12 ' B' 1140 ' ' VAL . 10.1 tmm? -154.71 -164.92 1.93 Allowed 'General case' 0 CA--C 1.547 0.849 1 C-N-CA 131.863 4.065 . . . . 0.0 104.422 -173.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -78.1 -24.19 47.65 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.612 1.551 . . . . 0.0 110.01 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -140.54 57.39 1.58 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.196 1.798 . . . . 0.0 111.613 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 177.34 20.79 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 116.507 1.363 . . . . 0.0 116.507 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.52 49.15 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.501 1.92 . . . . 0.0 113.202 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.427 ' H ' ' HA ' ' A' ' 82' ' ' SER 0.495 70.5 p -79.1 6.25 9.99 Favored 'General case' 0 N--CA 1.487 1.395 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -173.362 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.613 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 16.7 ptt180 -39.73 16.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 2 C-N-CA 132.881 4.473 . . . . 0.0 122.088 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -107.9 176.78 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.959 1.704 . . . . 0.0 109.528 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -63.81 151.18 42.95 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.15 -1.594 . . . . 0.0 111.128 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -76.19 -36.97 58.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.0 tp -67.27 -46.95 72.14 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.652 0.66 . . . . 0.0 112.434 -174.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.5 -34.75 77.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.402 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -67.23 -43.63 81.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 111.851 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.27 -33.45 73.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.704 0.801 . . . . 0.0 111.993 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.8 t -79.12 -51.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.098 0.959 . . . . 0.0 112.231 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -71.46 -40.29 70.39 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.41 -1.431 . . . . 0.0 113.681 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -83.2 5.55 22.46 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -57.27 -34.13 68.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.439 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -81.52 -35.42 30.38 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.553 1.541 . . . . 0.0 113.262 -176.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.7 mt -142.57 90.83 2.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.562 1.945 . . . . 0.0 109.372 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.66 -171.11 3.32 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.065 0.946 . . . . 0.0 113.348 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -100.13 -20.35 16.03 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 49.32 -165.76 0.34 Allowed Glycine 0 N--CA 1.476 1.319 0 C-N-CA 126.494 1.997 . . . . 0.0 116.382 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.8 tt -84.35 161.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.588 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -29.62 -59.1 0.27 Allowed Pre-proline 0 CA--C 1.564 1.515 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -123.61 -15.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 N-CA-C 117.668 2.141 . . . . 0.0 117.668 -165.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.9 m -103.28 -140.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 126.607 1.963 . . . . 0.0 113.111 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.48 133.81 45.96 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.304 1.411 . . . . 0.0 111.837 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.504 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -95.54 -17.47 21.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -86.09 163.67 17.75 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.221 -0.924 . . . . 0.0 111.649 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -136.43 148.96 48.02 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 173.2 11.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.173 2.589 . . . . 0.0 109.635 175.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 79.7 m -98.26 132.55 43.67 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.531 -1.356 . . . . 0.0 112.096 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -107.6 172.85 6.6 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -117.63 145.52 44.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.188 2.195 . . . . 0.0 109.315 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.3 m -76.46 -177.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.388 1.075 . . . . 0.0 111.801 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.67 34.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.045 1.338 . . . . 0.0 114.255 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 C--O 1.252 1.214 0 C-N-CA 127.855 2.462 . . . . 0.0 110.939 179.386 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 N--CA 1.483 0.892 0 N-CA-C 113.953 0.713 . . . . 0.0 113.953 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -75.76 149.37 83.19 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.777 0.831 . . . . 0.0 112.602 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.97 145.06 35.2 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.971 2.448 . . . . 0.0 111.654 173.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -94.0 -95.16 0.16 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.386 1.074 . . . . 0.0 111.351 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1139 ' ' PTR . . . . . 0.439 ' HE1' HG11 ' A' ' 56' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1140 ' ' VAL . . . . . 0.431 HG12 ' C ' ' A' ' 83' ' ' MET . 0.2 OUTLIER -165.67 118.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 131.273 3.829 . . . . 0.0 106.771 173.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1141 ' ' ASN . . . . . 0.666 ' HB2' HD12 ' A' ' 70' ' ' ILE . 2.3 m-80 158.86 -47.94 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.776 3 C-N-CA 144.495 9.118 . . . . 0.0 92.216 -173.146 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.342 2.6 mp0 -140.85 157.86 66.55 Favored Pre-proline 0 N--CA 1.43 -1.43 1 C-N-CA 134.025 4.93 . . . . 0.0 105.808 170.196 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.62 58.58 3.2 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 CA-C-N 122.206 1.824 . . . . 0.0 110.123 150.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B 1144 ' ' ASP . . . . . . . . . . . . 0.256 27.6 t70 . . . . . 0 C--O 1.253 1.276 1 C-N-CA 135.922 5.689 . . . . 0.0 117.377 -173.715 . . . . . . . . 2 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 112.255 -0.338 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 p -146.99 154.64 47.05 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.469 1.508 . . . . 0.0 112.358 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.92 159.39 52.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.309 2.673 . . . . 0.0 112.682 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.37 153.62 43.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.965 0.906 . . . . 0.0 112.855 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.1 p -84.1 -7.21 59.44 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.89 164.29 51.63 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.759 1.171 . . . . 0.0 114.59 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -73.6 -8.49 56.17 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 m -75.09 -7.43 53.71 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.1 tp -72.86 143.19 47.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.069 1.348 . . . . 0.0 111.327 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.8 m -64.12 -13.18 46.12 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.75 -10.75 55.36 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.817 1.647 . . . . 0.0 113.895 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.42 -13.82 61.15 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.5 mm -80.32 143.98 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.459 1.504 . . . . 0.0 109.894 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -66.67 148.91 51.26 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -138.74 5.17 2.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.1 p -142.43 -175.13 4.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 129.171 2.988 . . . . 0.0 109.476 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 15.12 0.12 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.911 1.285 . . . . 0.0 114.12 174.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.256 2.2 pp -61.46 -9.68 6.14 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -114.82 17.87 16.8 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.197 1.799 . . . . 0.0 112.155 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -132.84 136.73 46.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.982 1.313 . . . . 0.0 114.502 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -142.61 155.25 44.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.06 2.144 . . . . 0.0 109.76 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.75 33.01 2.08 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 122.927 2.603 . . . . 0.0 112.78 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 tpt85 -137.99 7.66 2.7 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 118.904 1.352 . . . . 0.0 114.387 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.313 7.1 tp -104.48 67.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 122.752 1.263 . . . . 0.0 110.182 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 m -46.45 152.18 0.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.651 1.981 . . . . 0.0 112.538 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -32.42 3.77 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.74 -30.9 40.99 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.691 0.996 . . . . 0.0 113.691 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -81.73 -43.36 18.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.486 1.114 . . . . 0.0 113.136 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -65.61 -32.53 74.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.16 -0.962 . . . . 0.0 112.621 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -67.68 -21.33 65.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -74.39 -28.69 61.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.718 0.807 . . . . 0.0 111.905 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.56 -51.83 4.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.106 1.362 . . . . 0.0 112.312 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.14 -12.72 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.614 1.566 . . . . 0.0 111.566 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.67 8.81 66.25 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.491 -1.381 . . . . 0.0 113.867 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -77.66 -10.56 59.59 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.773 1.229 . . . . 0.0 112.073 174.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.347 0.0 OUTLIER -140.45 136.52 33.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.407 1.483 . . . . 0.0 113.552 176.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.66 67.32 0.23 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.544 1.545 . . . . 0.0 114.983 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.06 -176.51 5.56 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.808 0.843 . . . . 0.0 110.827 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.26 142.12 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.461 -1.399 . . . . 0.0 108.425 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -45.91 -21.97 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 113' ' ' HIS . . . -94.8 21.22 44.72 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.495 -1.229 . . . . 0.0 115.293 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 42' ' ' LEU . 3.9 mm? -98.67 62.06 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 171.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -96.63 163.16 13.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 -170.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -122.61 150.27 42.87 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.452 1.901 . . . . 0.0 109.519 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.04 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.28 167.31 22.45 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 125.068 1.347 . . . . 0.0 109.011 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -142.89 -158.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -131.29 159.79 36.83 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 122.709 1.243 . . . . 0.0 108.747 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 113.475 -1.693 . . . . 0.0 107.861 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -98.25 -63.81 1.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 129.292 3.037 . . . . 0.0 108.133 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -60.66 121.04 58.11 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 120.606 1.548 . . . . 0.0 110.047 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.85 -15.18 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.773 2.316 . . . . 0.0 113.104 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -125.7 32.72 5.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.163 2.185 . . . . 0.0 110.895 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.28 128.17 9.46 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 58.6 m-85 -143.88 78.24 1.58 Allowed 'General case' 0 CA--C 1.558 1.288 1 C-N-CA 131.738 4.015 . . . . 0.0 110.492 174.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG11 ' HE1' ' B' 1139 ' ' PTR . 0.5 OUTLIER -98.45 142.73 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 126.291 1.836 . . . . 0.0 113.049 -174.146 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.6 130.53 45.84 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 p -127.33 120.25 28.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.186 1.357 . . . . 0.0 109.152 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -96.04 151.13 19.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.203 1.001 . . . . 0.0 112.565 -172.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.8 t -117.03 65.55 0.72 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.472 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.257 24.7 t60 -81.33 178.82 8.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.304 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.472 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.423 3.1 pp -99.03 27.31 5.12 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.624 2.77 . . . . 0.0 117.843 -173.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -150.54 -43.72 0.12 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 112.06 -2.336 . . . . 0.0 111.649 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 179.71 7.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.496 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.02 122.61 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -129.93 167.36 18.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.64 1.176 . . . . 0.0 112.662 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -126.39 139.91 52.9 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -173.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -107.53 65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.275 1.83 . . . . 0.0 113.703 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.9 tm? -144.74 134.44 23.52 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.13 -1.606 . . . . 0.0 114.748 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' B' 1141 ' ' ASN . 7.9 mt -141.42 -36.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 120.53 1.514 . . . . 0.0 112.948 170.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 160.12 61.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -77.39 -177.98 4.25 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.408 3.405 . . . . 0.0 111.752 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 p -61.15 144.76 53.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -129.84 -175.36 3.58 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.247 1.419 . . . . 0.0 110.808 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.56 -3.37 33.5 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -99.31 10.23 41.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.247 1.419 . . . . 0.0 111.702 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.68 -161.87 28.07 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 128.046 2.736 . . . . 0.0 109.66 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -115.1 -122.58 0.29 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 116.419 -1.753 . . . . 0.0 106.469 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -58.65 113.85 2.22 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -82.26 120.2 25.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.481 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.46 12.9 p90 -151.33 162.63 40.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 118.638 2.829 . . . . 0.0 118.638 173.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -150.98 -146.34 0.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 0.0 112.093 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.461 ' HA ' HG12 ' B' 1140 ' ' VAL . 32.1 mtt -155.38 -171.41 3.78 Favored 'General case' 0 C--N 1.316 -0.865 1 C-N-CA 134.049 4.939 . . . . 0.0 106.653 -173.164 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.37 -30.63 68.67 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -140.65 61.23 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.277 1.431 . . . . 0.0 111.373 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.68 174.76 22.46 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -141.92 47.52 1.63 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.07 1.748 . . . . 0.0 113.11 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.51 9.4 p -75.25 -2.08 26.4 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 121.466 3.876 . . . . 0.0 121.466 -173.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.481 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 40.9 ptt180 -44.61 36.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 1 C-N-CA 133.534 4.733 . . . . 0.0 120.832 173.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -125.36 160.58 29.0 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.919 -1.738 . . . . 0.0 111.761 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.8 m -56.5 135.82 54.32 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.979 0.911 . . . . 0.0 111.623 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.17 -39.77 89.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.0 -42.34 98.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.937 0.335 . . . . 0.0 111.792 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.08 -41.99 81.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.28 0.632 . . . . 0.0 111.31 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -68.08 -33.05 73.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.37 -43.76 20.54 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.684 0.675 . . . . 0.0 112.23 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.2 t -69.91 -63.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 119.255 0.934 . . . . 0.0 110.324 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -83.45 -57.65 3.16 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.321 44.0 m-85 -81.47 22.23 0.72 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -79.54 -42.74 24.47 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 121.496 1.953 . . . . 0.0 113.705 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -18.92 60.36 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt -140.14 56.97 1.61 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.316 1.847 . . . . 0.0 110.178 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.04 -156.82 0.15 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.835 0.854 . . . . 0.0 110.454 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.46 4.42 9.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.704 1.602 . . . . 0.0 112.54 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.88 -141.72 0.69 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.437 2.446 . . . . 0.0 115.786 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.55 153.77 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 111.716 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mt -34.88 -56.12 0.89 Allowed Pre-proline 0 CA--C 1.563 1.467 0 CA-C-O 116.272 -1.823 . . . . 0.0 115.841 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -115.17 -33.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.37 0 N-CA-C 117.589 2.111 . . . . 0.0 117.589 -169.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.9 m -91.17 -125.89 0.08 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.042 1.737 . . . . 0.0 114.413 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.93 155.66 19.36 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.637 1.575 . . . . 0.0 111.82 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -8.51 10.24 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -115.87 148.24 40.19 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.874 1.67 . . . . 0.0 113.513 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 7.6 m-70 -101.08 150.31 23.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.378 1.071 . . . . 0.0 111.26 174.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 76.9 m -130.38 -61.49 0.96 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 5.1 t -141.64 -158.48 0.87 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 111.232 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.2 m -134.19 135.85 43.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.866 2.467 . . . . 0.0 110.902 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -132.77 138.02 47.02 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.193 0.997 . . . . 0.0 111.057 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.6 m -144.34 161.53 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.34 1.856 . . . . 0.0 111.42 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.87 156.39 39.34 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.546 0.738 . . . . 0.0 112.592 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.298 1.839 . . . . 0.0 111.722 179.134 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo . . . . . 0 N--CA 1.483 0.895 0 N-CA-C 113.948 0.711 . . . . 0.0 113.948 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -74.19 146.39 84.43 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.77 0.828 . . . . 0.0 112.606 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.22 141.0 35.03 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.278 2.652 . . . . 0.0 111.54 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1138 ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' B' 1143 ' ' PRO . 15.7 pt-20 -145.66 123.14 11.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.049 1.339 . . . . 0.0 111.667 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1139 ' ' PTR . . . . . 0.461 ' HE1' HG11 ' A' ' 56' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B 1140 ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 83' ' ' MET . 2.2 t -147.09 -15.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 115.777 -2.059 . . . . 0.0 115.588 -174.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1141 ' ' ASN . . . . . 0.593 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.5 m-80 -54.89 -30.24 57.71 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 169.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1142 ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' 1140 ' ' VAL 0.342 4.1 mp0 -150.52 156.93 36.79 Favored Pre-proline 0 N--CA 1.424 -1.757 1 C-N-CA 136.69 5.996 . . . . 0.0 104.486 169.723 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' B' B 1143 ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' B' 1138 ' ' GLU . 56.7 Cg_endo -71.23 60.84 2.54 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 CA-C-N 120.95 1.375 . . . . 0.0 109.638 152.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 C--O 1.253 1.284 1 C-N-CA 134.719 5.207 . . . . 0.0 116.001 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -72.68 146.79 88.73 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 121.463 -1.022 . . . . 0.0 112.359 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -83.35 -10.18 44.7 Favored 'Cis proline' 0 CA--C 1.543 0.927 0 N-CA-C 114.983 1.109 . . . . 0.0 114.983 4.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.54 -16.28 23.87 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.0 p -62.32 -22.8 66.35 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.441 1.897 . . . . 0.0 113.061 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.05 2.69 0.14 Allowed Glycine 0 CA--C 1.536 1.368 0 N-CA-C 116.841 1.496 . . . . 0.0 116.841 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -108.99 2.18 21.13 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 119.453 1.627 . . . . 0.0 114.59 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.3 m -58.61 147.57 32.02 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.253 1.021 . . . . 0.0 112.891 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.91 153.74 39.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.278 1.031 . . . . 0.0 112.096 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.0 m -68.56 152.3 45.56 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.721 1.208 . . . . 0.0 113.346 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.91 160.66 39.75 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.555 1.542 . . . . 0.0 111.809 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.78 147.27 49.13 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.781 0.832 . . . . 0.0 113.047 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.6 -22.69 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.578 1.151 . . . . 0.0 112.851 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -124.36 160.34 28.32 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.03 2.132 . . . . 0.0 112.918 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -132.49 -1.52 3.5 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -142.79 178.53 7.58 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 129.066 2.947 . . . . 0.0 110.449 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 13.14 1.21 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.106 1.362 . . . . 0.0 114.358 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -52.8 149.84 5.88 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 -99.8 26.44 6.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.641 1.576 . . . . 0.0 113.801 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -137.09 128.48 28.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.237 1.018 . . . . 0.0 112.33 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -140.11 138.18 35.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.453 2.701 . . . . 0.0 106.968 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.62 46.58 1.03 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-N 123.073 2.67 . . . . 0.0 114.06 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.22 48.3 1.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.48 1.609 . . . . 0.0 108.912 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.1 tp -150.67 68.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.126 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -50.61 157.2 0.78 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.733 1.613 . . . . 0.0 113.259 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -45.03 -37.37 4.05 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -77.35 -25.62 51.22 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.404 1.081 . . . . 0.0 113.859 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -81.55 -48.72 11.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.083 1.753 . . . . 0.0 111.66 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -68.56 -26.88 65.63 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.045 0.938 . . . . 0.0 112.895 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.41 -19.32 65.44 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.716 1.144 . . . . 0.0 113.555 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -77.79 -29.22 50.73 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.029 0.831 . . . . 0.0 111.735 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.54 -48.56 7.23 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 111.964 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.28 -9.42 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.973 0.909 . . . . 0.0 111.368 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.31 -0.05 59.84 Favored Glycine 0 N--CA 1.472 1.084 0 O-C-N 120.085 -1.635 . . . . 0.0 115.013 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.94 -13.36 58.97 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 117.833 0.817 . . . . 0.0 110.021 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.75 154.78 23.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.244 1.818 . . . . 0.0 112.094 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.41 26.36 2.56 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.75 1.167 . . . . 0.0 114.716 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.45 -166.95 1.29 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.163 1.385 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 m -53.91 151.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.026 0.93 . . . . 0.0 110.447 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 5.3 m-20 -50.7 -18.7 0.76 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.75 28.02 16.28 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.67 2.081 . . . . 0.0 116.526 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.59 74.21 3.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.294 2.047 . . . . 0.0 106.471 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.468 ' CD2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.1 tp -141.01 145.24 35.67 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.824 1.65 . . . . 0.0 111.348 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -98.23 68.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 119.891 1.223 . . . . 0.0 110.393 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -99.67 158.35 15.83 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 124.032 0.933 . . . . 0.0 111.465 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.6 pm0 -141.64 -160.46 1.09 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.2 t -140.15 158.49 43.96 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 122.352 1.072 . . . . 0.0 109.658 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 1.5 pp0? -97.34 8.44 44.58 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.64 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -98.55 -68.29 0.81 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 129.07 2.948 . . . . 0.0 110.439 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.59 119.38 46.64 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 122.756 2.526 . . . . 0.0 109.419 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.49 -12.41 18.67 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.008 2.472 . . . . 0.0 114.866 -159.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' O ' HD21 ' A' ' 69' ' ' LEU . 94.4 mt-30 -120.44 36.17 4.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.961 2.504 . . . . 0.0 109.203 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' HG ' ' A' ' 69' ' ' LEU . . . -98.46 123.23 7.8 Favored Glycine 0 C--N 1.349 1.293 1 N-CA-C 124.568 4.587 . . . . 0.0 124.568 -172.456 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.462 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 20.3 m-85 -144.49 77.57 1.54 Allowed 'General case' 0 CA--C 1.558 1.262 1 C-N-CA 132.665 4.386 . . . . 0.0 109.749 174.011 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.601 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.42 153.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 127.164 2.186 . . . . 0.0 112.724 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.468 HD22 ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -113.25 129.58 56.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.25 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 p -111.55 118.09 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.3 mt -96.53 147.47 23.83 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.423 0.689 . . . . 0.0 111.865 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.461 ' HA ' HG12 ' A' ' 65' ' ' VAL . 33.8 t -114.76 66.03 0.68 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.28 0.4 OUTLIER -70.06 -168.18 0.2 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 112.852 -1.977 . . . . 0.0 112.394 -173.603 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.512 0.3 OUTLIER -96.85 4.39 51.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.836 3.273 . . . . 0.0 119.836 -173.507 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.329 7.1 pt20 -149.75 -16.14 0.27 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 118.361 -1.336 . . . . 0.0 114.372 169.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -150.57 173.11 14.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.518 1.127 . . . . 0.0 110.737 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 60' ' ' CYS . 16.5 m -123.35 110.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -120.47 161.77 20.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.72 1.608 . . . . 0.0 112.03 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 90.9 m-70 -106.23 163.57 12.7 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.013 1.325 . . . . 0.0 112.783 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -117.48 13.44 14.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 118.259 2.688 . . . . 0.0 118.259 -172.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 69' ' ' LEU . 2.3 tm? -113.27 133.65 54.99 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -173.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.1 mt -141.72 -42.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.695 0.798 . . . . 0.0 110.849 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -119.77 151.37 52.11 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -92.01 -174.31 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.901 3.734 . . . . 0.0 112.003 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 m -60.24 145.06 48.71 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.486 -0.759 . . . . 0.0 112.191 174.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -120.7 -170.06 1.93 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.276 1.43 . . . . 0.0 111.935 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.83 -14.47 19.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.115 0.966 . . . . 0.0 112.832 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -110.97 8.76 22.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.676 1.59 . . . . 0.0 113.659 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.42 168.74 38.82 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.778 1.656 . . . . 0.0 112.847 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -83.76 -145.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.948 1.299 . . . . 0.0 110.789 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -52.06 116.44 2.19 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.348 0.976 . . . . 0.0 109.16 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 134.95 36.12 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.436 ' H ' ' HB3' ' A' ' 89' ' ' ARG 0.293 28.9 m-85 -142.0 134.02 27.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.115 1.766 . . . . 0.0 113.602 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -140.45 20.7 2.38 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.0 ttp -26.98 149.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -52.63 -23.11 5.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -126.19 19.26 7.62 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.256 1.422 . . . . 0.0 112.61 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.06 162.34 26.77 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.511 1.529 . . . . 0.0 115.591 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -141.03 50.99 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.194 1.798 . . . . 0.0 108.506 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.563 10.5 p -76.38 10.97 1.74 Allowed 'General case' 0 N--CA 1.477 0.876 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -172.329 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 6.4 ptt180 -38.76 49.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 130.643 3.577 . . . . 0.0 120.609 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -137.29 165.12 26.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.213 2.605 . . . . 0.0 109.899 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -57.41 141.71 46.35 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.57 -33.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.86 -32.13 72.45 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -79.61 -33.94 41.12 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.745 0.702 . . . . 0.0 111.918 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.44 -35.35 60.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.552 2.341 . . . . 0.0 111.882 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.22 -40.11 67.34 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.775 2.03 . . . . 0.0 112.376 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.81 -50.26 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.877 0.871 . . . . 0.0 110.485 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.84 -88.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.012 1.325 . . . . 0.0 112.87 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -47.91 0.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 121.396 3.85 . . . . 0.0 121.396 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -56.08 -37.11 68.89 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 121.891 2.132 . . . . 0.0 113.392 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -15.77 61.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.63 39.86 1.86 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.206 1.403 . . . . 0.0 112.575 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -75.56 -161.8 0.17 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 125.34 1.456 . . . . 0.0 113.449 -174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -90.9 -0.38 57.71 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.883 1.673 . . . . 0.0 113.712 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 54.64 -152.2 12.91 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.87 1.7 . . . . 0.0 115.229 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.75 175.28 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.048 1.339 . . . . 0.0 111.686 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -41.56 -59.65 2.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -109.93 -46.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 122.613 1.969 . . . . 0.0 116.682 -166.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 74.3 m -94.68 -127.68 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -48.07 134.91 13.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.645 1.978 . . . . 0.0 115.082 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.447 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -87.94 -8.69 55.36 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -177.131 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -116.86 148.59 41.14 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.216 -0.927 . . . . 0.0 113.072 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -113.68 165.09 12.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.636 1.974 . . . . 0.0 110.499 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 5.9 m -136.87 -170.41 2.69 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.755 1.622 . . . . 0.0 112.066 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 82.8 m -99.13 135.61 40.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.28 1.032 . . . . 0.0 110.086 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -125.75 171.29 10.76 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.88 1.272 . . . . 0.0 113.054 -173.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 -63.4 144.22 57.15 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 110.575 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 m -69.64 161.26 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.558 1.143 . . . . 0.0 111.851 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.27 34.63 0.31 Allowed 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.1 tp . . . . . 0 C--O 1.255 1.363 0 C-N-CA 126.004 1.722 . . . . 0.0 113.24 -175.291 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 CA--C 1.541 0.863 0 N-CA-C 113.996 0.729 . . . . 0.0 113.996 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -76.83 -46.46 2.98 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-O 117.45 -1.262 . . . . 0.0 114.367 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.45 125.41 7.65 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.078 1.852 . . . . 0.0 111.99 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.91 -114.11 0.31 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.876 1.67 . . . . 0.0 110.543 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1139 ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B 1140 ' ' VAL . . . . . 0.413 ' C ' ' N ' ' B' 1142 ' ' GLN . 2.7 t -140.48 -28.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -177.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.278 11.8 m-80 -56.41 -27.95 57.92 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B 1142 ' ' GLN . . . . . 0.413 ' N ' ' C ' ' B' 1140 ' ' VAL 0.314 4.3 mp0 -158.62 157.86 28.94 Favored Pre-proline 0 N--CA 1.433 -1.304 1 C-N-CA 135.932 5.693 . . . . 0.0 104.962 168.554 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.67 60.67 2.18 Favored 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 121.891 1.711 . . . . 0.0 109.392 149.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.254 1.33 1 C-N-CA 134.044 4.938 . . . . 0.0 115.896 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.2 -0.36 . . . . 0.0 112.2 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.6 p -146.59 155.78 48.94 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.372 1.469 . . . . 0.0 112.502 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.54 157.84 98.74 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 CA-C-N 119.468 0.846 . . . . 0.0 112.896 -5.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.11 -25.03 64.21 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 m -90.49 14.87 11.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.843 1.657 . . . . 0.0 113.766 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.28 -16.84 75.57 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 124.389 0.995 . . . . 0.0 115.505 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.0 p -86.95 154.45 20.79 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.152 1.381 . . . . 0.0 112.598 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 82.1 p -147.92 161.57 41.05 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.774 1.23 . . . . 0.0 113.15 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.4 tp -145.79 147.4 31.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.946 1.698 . . . . 0.0 110.696 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.6 m -138.88 155.78 47.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.839 1.256 . . . . 0.0 112.394 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.64 158.06 43.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.449 1.499 . . . . 0.0 111.889 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.23 151.88 46.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.1 0.96 . . . . 0.0 112.505 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 tp -75.99 -21.72 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -78.54 47.44 0.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.384 1.874 . . . . 0.0 113.105 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -123.32 -10.19 8.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 p -142.62 175.77 9.54 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 129.518 3.127 . . . . 0.0 110.531 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.62 60.62 0.68 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.603 1.561 . . . . 0.0 112.208 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.41 37.18 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 130.833 3.653 . . . . 0.0 120.292 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -97.89 53.26 1.09 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 119.69 -1.881 . . . . 0.0 110.049 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -150.56 112.92 4.65 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.162 1.385 . . . . 0.0 111.508 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -140.97 155.62 46.2 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.636 1.974 . . . . 0.0 109.962 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.8 0.65 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 122.261 2.3 . . . . 0.0 111.949 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.255 32.9 tpt85 -148.63 42.06 0.97 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.008 1.385 . . . . 0.0 111.096 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.78 63.77 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.563 1.145 . . . . 0.0 110.071 -174.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 t -55.38 151.03 10.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -48.31 -30.79 5.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.029 2.531 . . . . 0.0 116.756 -173.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -79.79 -35.43 38.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.147 0.979 . . . . 0.0 112.713 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.71 -40.36 22.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.034 . . . . 0.0 112.376 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.04 -37.37 71.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.484 1.114 . . . . 0.0 112.319 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.22 -16.77 64.28 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -80.12 -27.59 39.11 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.239 1.016 . . . . 0.0 111.557 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.5 -49.75 5.28 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.582 1.553 . . . . 0.0 112.135 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.12 -12.46 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 124.309 1.044 . . . . 0.0 111.657 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.23 1.18 60.51 Favored Glycine 0 N--CA 1.474 1.172 0 O-C-N 120.45 -1.406 . . . . 0.0 114.948 -174.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -79.65 -13.9 59.17 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 117.973 0.887 . . . . 0.0 109.629 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.53 164.19 19.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.929 2.091 . . . . 0.0 112.291 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.64 30.2 3.83 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.306 1.431 . . . . 0.0 114.148 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.24 -172.45 3.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.896 1.678 . . . . 0.0 113.596 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.19 155.61 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.166 1.387 . . . . 0.0 111.28 174.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -49.3 -16.04 0.16 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.917 1.687 . . . . 0.0 115.283 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.75 7.19 70.62 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 127.02 2.248 . . . . 0.0 114.473 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.68 57.52 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.507 ' CG ' HD21 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -98.57 172.61 7.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.5 tp -138.74 139.5 38.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.802 2.041 . . . . 0.0 109.84 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.39 107.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' C ' ' HD2' ' A' ' 46' ' ' ARG . 5.3 ppt_? -141.3 176.18 9.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.08 2.152 . . . . 0.0 110.621 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -145.99 -146.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -141.72 168.77 18.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 125.338 1.455 . . . . 0.0 110.259 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.57 10.87 40.02 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.667 172.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -99.06 -82.25 0.44 Allowed 'General case' 0 N--CA 1.481 1.109 1 C-N-CA 133.94 4.896 . . . . 0.0 108.756 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -54.62 118.13 15.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 121.216 1.825 . . . . 0.0 111.034 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.99 -12.33 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.99 2.46 . . . . 0.0 113.26 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -116.52 33.0 5.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.801 2.44 . . . . 0.0 110.16 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.8 128.62 9.61 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 121.773 3.469 . . . . 0.0 121.773 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.473 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 46.9 m-85 -142.64 66.93 1.32 Allowed 'General case' 0 CA--C 1.56 1.356 1 C-N-CA 132.139 4.175 . . . . 0.0 110.759 174.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.453 HG11 ' HE1' ' B' 1139 ' ' PTR . 0.5 OUTLIER -97.41 146.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.799 1.761 . . . . 0.0 114.109 -174.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.507 HD21 ' CG ' ' A' ' 43' ' ' PHE . 1.9 tt -105.01 121.15 43.16 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 172.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p -108.91 118.19 36.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.0 160.42 14.47 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -171.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.5 t -122.57 53.39 1.26 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.43 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.299 2.5 t-80 -66.11 178.81 1.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -172.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.467 0.5 OUTLIER -97.9 12.34 34.41 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -172.832 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -147.07 -27.32 0.39 Allowed 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 125.211 1.569 . . . . 0.0 112.112 170.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 173.88 13.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.68 93.23 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.54 1.162 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.34 170.07 8.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.515 1.526 . . . . 0.0 112.154 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.457 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 87.0 m-70 -117.19 163.13 16.76 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.491 1.516 . . . . 0.0 112.336 -173.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.31 14.92 14.83 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -172.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -114.13 140.63 48.35 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.064 -2.273 . . . . 0.0 116.032 -173.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mm -141.38 -44.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.994 0.918 . . . . 0.0 110.059 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -121.32 158.91 52.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -89.71 -148.08 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.873 3.715 . . . . 0.0 110.225 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -66.55 152.44 45.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.789 1.236 . . . . 0.0 112.682 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -139.89 -177.36 4.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.241 1.416 . . . . 0.0 111.74 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.68 -18.15 18.2 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -108.88 18.5 20.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.862 1.265 . . . . 0.0 112.666 174.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.06 -161.34 23.92 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.483 2.468 . . . . 0.0 110.096 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -116.87 -127.27 0.29 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.3 112.99 1.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 89' ' ' ARG . 2.3 t80 -76.97 132.39 38.99 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -173.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . 0.252 25.0 m-85 -142.9 141.4 31.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.142 2.177 . . . . 0.0 112.553 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 p -149.66 21.59 0.91 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -27.82 152.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -28.02 3.3 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 119.19 3.033 . . . . 0.0 119.19 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.99 18.48 14.66 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.323 1.42 . . . . 0.0 113.628 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.24 172.81 23.64 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.304 1.681 . . . . 0.0 117.304 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.81 55.2 1.58 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 128.722 2.809 . . . . 0.0 107.207 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.487 16.1 p -71.89 2.1 6.06 Favored 'General case' 0 N--CA 1.474 0.767 1 N-CA-C 122.933 4.42 . . . . 0.0 122.933 -171.969 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.417 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 32.2 ptt180 -38.74 29.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 2 N-CA-C 122.96 4.429 . . . . 0.0 122.96 173.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.71 161.68 26.75 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.845 2.058 . . . . 0.0 110.154 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -62.03 140.41 58.37 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.07 -34.12 71.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.639 0.776 . . . . 0.0 112.479 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.84 -27.5 69.38 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.46 -35.61 63.32 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.606 0.762 . . . . 0.0 111.502 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -75.6 -37.95 59.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 111.436 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.5 tt -51.35 -42.3 61.22 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.95 1.7 . . . . 0.0 113.1 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.48 -42.35 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.602 0.761 . . . . 0.0 111.599 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -80.37 -32.91 37.58 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.051 1.34 . . . . 0.0 113.006 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -80.34 -13.14 59.41 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -58.47 -42.57 87.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.916 1.689 . . . . 0.0 113.757 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -82.14 -39.97 22.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.703 1.201 . . . . 0.0 113.346 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.5 mt -145.33 83.5 1.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.592 1.557 . . . . 0.0 111.614 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -70.71 133.57 46.73 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -73.24 -3.43 26.76 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 49.99 -157.87 1.71 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.641 2.067 . . . . 0.0 114.82 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.444 HG13 ' H ' ' A' ' 107' ' ' LEU . 4.0 tp -80.73 -175.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.473 0.709 . . . . 0.0 112.216 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.444 ' H ' HG13 ' A' ' 106' ' ' ILE . 15.7 mt -42.15 136.02 2.3 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.472 1.509 . . . . 0.0 110.839 173.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -80.16 51.53 3.95 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 N-CA-C 118.431 2.435 . . . . 0.0 118.431 -130.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 85.5 m -68.5 -55.77 10.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -179.53 5.93 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 129.418 3.087 . . . . 0.0 108.306 174.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.305 0.0 OUTLIER -139.03 -51.85 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.705 2.483 . . . . 0.0 117.705 -174.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -68.46 144.18 54.76 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.347 1.43 . . . . 0.0 113.323 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -107.58 165.78 11.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.217 1.407 . . . . 0.0 113.992 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 84.5 m -140.62 -157.23 0.75 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 128.029 2.532 . . . . 0.0 109.798 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.17 134.27 53.81 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.985 1.314 . . . . 0.0 109.782 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -109.62 170.09 8.29 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -86.93 125.38 34.0 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.713 1.205 . . . . 0.0 110.647 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.0 t -93.83 -37.84 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.957 0.903 . . . . 0.0 111.886 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.95 162.48 27.54 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.601 1.161 . . . . 0.0 113.63 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.365 1.866 . . . . 0.0 111.807 175.789 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo . . . . . 0 CA--C 1.542 0.88 0 N-CA-C 113.956 0.714 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -71.5 147.48 92.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.949 0.899 . . . . 0.0 112.352 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.27 158.61 48.44 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.232 2.621 . . . . 0.0 111.692 172.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -133.22 -112.86 0.22 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 109.71 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1139 ' ' PTR . . . . . 0.455 ' HD1' ' H ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 3.1 t -140.3 -25.88 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 118.425 2.75 . . . . 0.0 118.425 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.348 9.9 m-80 -61.75 -25.85 67.71 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.314 3.9 mp0 -155.76 154.38 27.83 Favored Pre-proline 0 N--CA 1.424 -1.762 1 C-N-CA 134.918 5.287 . . . . 0.0 105.196 168.381 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.81 58.51 2.67 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 CA-C-N 121.861 1.7 . . . . 0.0 109.256 151.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.3 t0 . . . . . 0 C--O 1.254 1.317 1 C-N-CA 134.606 5.162 . . . . 0.0 115.984 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 CA-C-O 121.081 0.267 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.8 m -68.68 149.46 97.94 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 124.453 1.101 . . . . 0.0 112.898 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.71 -21.0 19.5 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.264 2.643 . . . . 0.0 113.588 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.66 41.99 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.972 1.709 . . . . 0.0 111.433 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.9 m -75.54 -17.47 60.07 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.53 -173.31 44.39 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.071 1.32 . . . . 0.0 113.437 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.0 p -131.8 156.21 46.41 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.85 1.66 . . . . 0.0 111.845 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.7 p -76.06 146.67 39.24 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.163 0.985 . . . . 0.0 112.842 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.3 tp -150.24 148.58 29.06 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.41 1.484 . . . . 0.0 111.08 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 t -72.43 165.28 24.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.837 0.855 . . . . 0.0 112.568 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.63 156.93 37.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.742 0.817 . . . . 0.0 112.898 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.51 160.4 38.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.504 1.522 . . . . 0.0 111.948 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.0 pt -70.02 155.44 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.836 0.854 . . . . 0.0 112.81 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -64.88 142.97 58.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.226 1.41 . . . . 0.0 112.415 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -102.7 -3.85 25.92 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.8 p -142.34 -173.43 3.84 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 129.28 3.032 . . . . 0.0 108.437 174.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.51 8.19 8.3 Favored 'General case' 0 CA--C 1.552 1.048 0 O-C-N 120.572 -1.33 . . . . 0.0 113.875 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -54.36 -23.76 16.79 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 117.73 2.492 . . . . 0.0 117.73 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -127.38 6.3 6.34 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.597 1.559 . . . . 0.0 114.19 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -150.81 124.98 9.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -141.5 146.58 36.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.977 2.511 . . . . 0.0 109.128 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.7 24.96 4.04 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 123.427 2.831 . . . . 0.0 113.856 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -137.92 15.77 2.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.358 1.063 . . . . 0.0 113.122 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -100.84 70.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -46.28 151.73 0.49 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 112.995 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.283 0.0 OUTLIER -44.19 -40.3 4.97 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -73.83 -28.42 61.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.462 1.105 . . . . 0.0 113.237 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -81.04 -46.89 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.785 1.234 . . . . 0.0 111.396 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -68.11 -33.06 73.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 118.44 -0.791 . . . . 0.0 112.419 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.295 2.0 pt20 -68.77 -11.23 60.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 -80.94 -37.43 29.52 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.63 1.172 . . . . 0.0 110.704 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.3 mp -88.6 -45.06 10.18 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.779 1.632 . . . . 0.0 112.643 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.25 -12.64 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.399 1.079 . . . . 0.0 110.832 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.96 2.07 61.51 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.429 -1.419 . . . . 0.0 114.869 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 -12.81 59.34 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.783 0.833 . . . . 0.0 110.709 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.66 151.96 28.71 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.59 1.556 . . . . 0.0 112.873 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.15 20.19 4.52 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.127 1.346 . . . . 0.0 115.454 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.43 -173.04 3.85 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.21 150.96 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.165 0.986 . . . . 0.0 111.607 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 9.1 m-20 -49.11 -19.7 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -174.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 113' ' ' HIS . . . -97.65 22.65 39.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 127.502 2.477 . . . . 0.0 116.852 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.12 77.81 4.05 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 121.743 2.771 . . . . 0.0 106.689 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.79 165.48 11.93 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -173.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.5 tp -126.77 148.84 49.89 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.315 2.646 . . . . 0.0 109.178 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.02 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.19 165.84 26.42 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 125.714 1.606 . . . . 0.0 108.662 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.682 ' HA ' HG13 ' A' ' 56' ' ' VAL 0.265 5.3 pt-20 -141.56 -164.32 1.75 Allowed 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.486 -0.758 . . . . 0.0 110.422 173.432 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.12 148.09 52.46 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.266 1.2 pp0? -95.47 15.12 20.51 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.703 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -98.16 -72.7 0.64 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 131.959 4.104 . . . . 0.0 111.224 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -57.87 141.05 81.04 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-N 121.248 1.84 . . . . 0.0 113.605 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -85.54 -17.55 4.25 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.9 3.066 . . . . 0.0 115.121 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -118.34 26.41 9.63 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.997 2.119 . . . . 0.0 110.308 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.19 126.07 8.76 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 121.825 3.49 . . . . 0.0 121.825 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -143.58 94.19 2.57 Favored 'General case' 0 CA--C 1.545 0.777 1 C-N-CA 132.044 4.138 . . . . 0.0 103.384 173.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.682 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.283 1.3 m -99.0 138.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 121.261 1.846 . . . . 0.0 114.233 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.02 121.2 40.66 Favored 'General case' 0 CA--C 1.539 0.535 1 N-CA-C 99.901 -4.111 . . . . 0.0 99.901 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.3 p -119.33 122.13 41.14 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -95.28 177.53 5.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.433 ' HA ' HG12 ' A' ' 65' ' ' VAL . 32.2 t -129.57 66.07 1.47 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.51 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.265 0.4 OUTLIER -71.81 -171.64 0.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.16 -173.985 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.51 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.487 0.3 OUTLIER -97.03 6.65 48.22 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -173.521 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -146.08 -26.13 0.44 Allowed 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 124.961 1.413 . . . . 0.0 113.259 170.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -150.52 -178.03 6.31 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.834 0.854 . . . . 0.0 111.417 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 60' ' ' CYS . 16.5 m -125.32 114.08 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.97 0.89 . . . . 0.0 109.749 173.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -110.98 162.51 14.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.707 2.403 . . . . 0.0 111.816 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.81 159.26 32.9 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.431 ' CZ ' HG11 ' B' 1140 ' ' VAL . 12.8 m-85 -130.97 86.22 2.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.948 -1.72 . . . . 0.0 112.852 -174.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.584 ' HG ' ' CE1' ' B' 1139 ' ' PTR . 0.0 OUTLIER -141.75 28.63 1.76 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 122.216 4.154 . . . . 0.0 122.216 -173.733 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.35 -14.23 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 -170.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 mt -127.73 144.85 52.69 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.45 -170.61 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 125.014 3.81 . . . . 0.0 111.718 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -72.03 147.82 46.46 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.473 -1.392 . . . . 0.0 112.9 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -130.92 -177.38 4.35 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.943 0.897 . . . . 0.0 112.552 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.71 -5.09 32.17 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 111.903 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -99.51 15.81 25.32 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.3 1.84 . . . . 0.0 111.664 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.47 -156.72 25.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 127.153 2.311 . . . . 0.0 109.707 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -115.64 -126.16 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -59.87 115.25 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.75 131.2 39.66 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.486 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 16.3 m-85 -143.82 155.55 44.17 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 175.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -145.88 -164.24 1.91 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.261 2.224 . . . . 0.0 109.894 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.707 ' HA ' HG12 ' B' 1140 ' ' VAL . 67.1 mtm -156.73 -173.67 4.58 Favored 'General case' 0 C--N 1.314 -0.95 1 C-N-CA 136.424 5.89 . . . . 0.0 109.089 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.94 -29.5 65.54 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.49 44.62 1.85 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.48 1.112 . . . . 0.0 112.846 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.36 171.87 24.09 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.956 1.543 . . . . 0.0 116.956 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 56.7 1.48 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.801 2.041 . . . . 0.0 112.301 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 32.2 p -76.98 5.31 8.22 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 121.766 3.987 . . . . 0.0 121.766 -173.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.486 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 37.8 ptt180 -38.91 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 2 C-N-CA 132.875 4.47 . . . . 0.0 122.423 173.345 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -126.5 159.89 32.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.325 1.85 . . . . 0.0 111.182 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 m -64.23 137.64 58.04 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.441 -0.787 . . . . 0.0 110.665 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.56 -47.49 47.67 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -64.32 -33.72 76.49 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.93 -32.59 69.55 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.342 0.657 . . . . 0.0 112.289 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.75 -28.81 36.37 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.975 1.31 . . . . 0.0 112.296 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.88 -29.04 69.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.359 1.064 . . . . 0.0 113.29 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.6 t -70.11 -76.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.28 0.946 . . . . 0.0 110.832 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -81.9 -44.5 16.73 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.82 -0.84 49.89 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -66.1 -42.65 89.0 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 122.788 2.54 . . . . 0.0 113.81 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -80.16 -11.79 59.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.32 1.448 . . . . 0.0 114.361 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 65.08 1.34 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.536 1.534 . . . . 0.0 109.689 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -101.71 -163.56 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.311 1.444 . . . . 0.0 111.871 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -96.63 -1.6 46.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.569 1.548 . . . . 0.0 111.23 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 52.24 -146.29 15.45 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 126.631 2.062 . . . . 0.0 114.298 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.24 179.17 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.737 1.615 . . . . 0.0 112.023 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 mt -40.32 -55.9 3.85 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.395 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 109' ' ' CYS . 68.4 Cg_endo -122.44 -41.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 N-CA-C 118.191 2.343 . . . . 0.0 118.191 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.405 ' H ' ' HD2' ' A' ' 108' ' ' PRO . 71.6 m -90.39 -127.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.507 1.923 . . . . 0.0 115.967 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.56 142.19 23.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.833 1.653 . . . . 0.0 114.649 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.445 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -93.72 -6.88 45.18 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -174.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -110.95 152.67 26.51 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.522 1.129 . . . . 0.0 112.55 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 64.6 m-70 -125.06 160.14 29.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.417 1.487 . . . . 0.0 111.706 175.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 28.0 m -141.06 -162.82 1.43 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 130.025 3.33 . . . . 0.0 108.135 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.2 m -125.75 133.54 52.05 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.879 -1.138 . . . . 0.0 112.121 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -99.28 176.11 5.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.149 0.98 . . . . 0.0 111.678 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -123.64 165.0 17.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.754 1.622 . . . . 0.0 113.329 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.62 156.29 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.93 1.692 . . . . 0.0 112.093 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.24 150.83 44.88 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.703 0.801 . . . . 0.0 112.366 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.3 tp . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.083 1.753 . . . . 0.0 111.888 -179.441 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo . . . . . 0 N--CA 1.484 0.939 0 N-CA-C 114.058 0.753 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -133.9 151.99 77.83 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.516 1.526 . . . . 0.0 111.327 177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.03 164.74 32.72 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.754 2.97 . . . . 0.0 112.929 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -81.45 -106.21 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.849 1.26 . . . . 0.0 112.597 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1139 ' ' PTR . . . . . 0.584 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1140 ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 83' ' ' MET . 54.1 t -140.69 -32.88 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.56 -29.5 51.33 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 102.193 -3.262 . . . . 0.0 102.193 169.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1142 ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' 1140 ' ' VAL 0.317 1.0 OUTLIER -161.44 157.34 21.47 Favored Pre-proline 0 N--CA 1.427 -1.621 1 C-N-CA 135.165 5.386 . . . . 0.0 105.574 168.443 . . . . . . . . 5 4 . 1 . 006 nuclear build full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.79 52.65 0.72 Allowed 'Trans proline' 0 CA--C 1.554 1.502 0 C-N-CA 122.6 2.2 . . . . 0.0 111.381 152.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--O 1.255 1.364 1 C-N-CA 134.873 5.269 . . . . 0.0 114.793 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.846 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.0 p -77.31 159.84 76.81 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.635 1.174 . . . . 0.0 113.103 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -59.53 151.13 71.38 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.387 2.725 . . . . 0.0 114.238 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.39 -22.69 51.25 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -150.21 160.88 43.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.827 1.651 . . . . 0.0 111.185 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.08 18.1 79.64 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.166 0.889 . . . . 0.0 115.07 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.7 p -63.74 -20.48 65.78 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.615 1.208 . . . . 0.0 114.128 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 m -72.83 -7.09 49.16 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.6 mt -98.67 -2.51 38.15 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.623 1.569 . . . . 0.0 113.786 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.3 m -66.74 141.41 57.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.516 1.126 . . . . 0.0 112.911 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.81 165.33 20.97 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.67 1.188 . . . . 0.0 113.188 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.27 158.48 34.91 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.124 0.969 . . . . 0.0 112.652 174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.0 mt -73.69 140.9 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.996 0.918 . . . . 0.0 109.66 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -74.97 41.46 0.16 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.477 1.911 . . . . 0.0 115.044 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -134.69 14.24 3.69 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 127.435 2.294 . . . . 0.0 114.329 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 p -102.57 -74.33 0.63 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.032 2.133 . . . . 0.0 112.753 -173.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -79.48 -12.15 59.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.607 0.763 . . . . 0.0 111.424 174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.26 -14.24 60.13 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 -123.55 44.78 2.61 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.666 1.987 . . . . 0.0 110.494 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -143.29 134.45 25.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.196 1.398 . . . . 0.0 112.531 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -142.0 157.6 44.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.357 1.863 . . . . 0.0 109.694 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.96 23.4 2.61 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 121.956 2.162 . . . . 0.0 114.145 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -147.13 52.92 1.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.61 1.205 . . . . 0.0 110.952 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.261 7.4 tt -140.63 59.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 123.407 1.575 . . . . 0.0 109.101 174.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 t -43.58 153.19 0.12 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.844 2.458 . . . . 0.0 114.907 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.536 ' HE ' ' HG2' ' B' 1138 ' ' GLU . 0.0 OUTLIER -46.83 -34.31 5.22 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 -174.31 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.76 -27.73 36.66 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.35 -48.59 11.76 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.609 1.564 . . . . 0.0 113.473 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -63.53 -33.31 75.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.97 -17.31 63.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -75.61 -30.89 59.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.725 0.81 . . . . 0.0 112.085 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.3 -60.5 1.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.301 1.44 . . . . 0.0 111.803 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mt -81.37 -3.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.494 1.918 . . . . 0.0 112.974 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.79 8.33 68.19 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.155 -1.591 . . . . 0.0 115.028 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -80.39 -4.01 51.91 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.447 1.099 . . . . 0.0 112.637 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -71.66 145.78 48.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.562 1.145 . . . . 0.0 113.28 -175.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.18 15.73 39.28 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 125.584 1.564 . . . . 0.0 114.145 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.54 177.57 8.91 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.362 1.865 . . . . 0.0 113.544 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 41' ' ' GLY . 35.1 m -72.08 169.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 126.302 1.841 . . . . 0.0 115.27 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 35.1 m-20 -58.41 22.27 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.889 2.876 . . . . 0.0 115.425 174.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -141.81 10.79 2.62 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.52 71.62 2.31 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.931 2.366 . . . . 0.0 108.441 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.457 ' HB3' HD23 ' A' ' 59' ' ' LEU . 2.0 p90 -98.46 168.26 10.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.8 tp -138.48 153.26 48.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.804 2.442 . . . . 0.0 109.584 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.6 t -116.07 101.53 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.158 0.983 . . . . 0.0 108.739 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.19 28.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.546 1.938 . . . . 0.0 109.506 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 56' ' ' VAL . 8.2 pm0 -142.76 -154.16 0.51 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.697 0.761 . . . . 0.0 113.012 174.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -120.85 147.66 45.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 132.704 4.402 . . . . 0.0 108.277 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 7.51 46.17 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.573 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.35 -68.1 0.82 Allowed 'General case' 0 C--N 1.352 0.691 0 C-N-CA 130.184 3.394 . . . . 0.0 111.083 -174.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -78.85 116.79 62.59 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 122.997 2.635 . . . . 0.0 108.464 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.8 -15.96 51.15 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.758 2.306 . . . . 0.0 114.846 -168.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.64 13.98 9.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.632 2.373 . . . . 0.0 111.833 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.71 124.12 7.99 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 122.726 3.85 . . . . 0.0 122.726 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.528 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 60.0 m-85 -144.0 84.08 1.76 Allowed 'General case' 0 CA--C 1.564 1.505 1 C-N-CA 132.455 4.302 . . . . 0.0 110.595 174.315 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.459 HG11 ' HE1' ' B' 1139 ' ' PTR . 0.5 OUTLIER -98.24 144.11 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 119.817 -1.802 . . . . 0.0 113.299 -174.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 122.83 42.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 101.017 -3.698 . . . . 0.0 101.017 171.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 p -116.3 105.28 12.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 43' ' ' PHE . 1.5 mt -97.91 158.32 15.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -172.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.56 125.83 51.79 Favored 'General case' 0 CA--C 1.497 -1.079 1 N-CA-C 96.508 -5.367 . . . . 0.0 96.508 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.619 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.359 0.0 OUTLIER -112.7 -146.34 0.41 Allowed 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.881 1.363 . . . . 0.0 111.521 -171.348 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.619 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.271 14.6 tp -95.79 -7.09 38.07 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.275 5.4 pt20 -151.03 -17.9 0.21 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -150.4 -160.37 1.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.681 0.792 . . . . 0.0 111.792 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.96 141.79 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.746 1.218 . . . . 0.0 109.376 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -138.05 150.3 46.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.705 0.802 . . . . 0.0 111.363 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.19 144.24 43.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.178 0.991 . . . . 0.0 113.572 -173.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.91 69.42 1.27 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.5 tm? -142.16 123.04 14.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 115.584 -2.15 . . . . 0.0 111.925 174.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' B' 1141 ' ' ASN 0.255 38.7 mt -139.53 -41.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 122.843 2.565 . . . . 0.0 112.921 173.258 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.3 148.88 71.62 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 120.351 1.432 . . . . 0.0 114.162 -175.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -81.35 179.57 5.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.172 3.248 . . . . 0.0 111.387 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.07 139.52 56.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.93 -167.59 1.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.132 1.773 . . . . 0.0 111.369 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.33 -7.97 27.95 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -122.66 20.59 10.21 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.808 1.643 . . . . 0.0 112.845 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.07 -171.48 39.92 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.345 1.926 . . . . 0.0 111.381 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -121.73 -137.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 108.109 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.43 123.22 6.28 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.338 1.426 . . . . 0.0 107.725 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.89 137.26 36.86 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -146.09 130.79 17.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.489 1.916 . . . . 0.0 111.733 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 m -141.61 0.99 1.5 Allowed 'General case' 0 N--CA 1.492 1.672 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 -173.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.507 ' HB3' HG12 ' B' 1140 ' ' VAL . 5.5 ptt? -29.91 156.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 174.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.9 -31.0 16.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.53 2.21 13.78 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.615 1.166 . . . . 0.0 114.112 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.78 105.38 0.41 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.224 1.393 . . . . 0.0 114.757 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 54.1 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.014 1.726 . . . . 0.0 109.535 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.499 68.9 p -77.77 12.83 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 121.569 3.915 . . . . 0.0 121.569 -172.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -39.47 35.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 131.629 3.972 . . . . 0.0 121.049 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.77 174.57 9.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.281 2.632 . . . . 0.0 109.281 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -68.93 155.23 40.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.711 -1.243 . . . . 0.0 111.368 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.8 -41.13 65.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.582 -0.699 . . . . 0.0 112.653 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.03 -40.53 96.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.71 -33.91 60.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.943 0.497 . . . . 0.0 112.218 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -73.86 -34.03 64.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.534 1.134 . . . . 0.0 112.347 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.744 1.217 . . . . 0.0 112.646 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.4 -37.88 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.679 0.792 . . . . 0.0 111.812 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -80.4 -34.77 36.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.789 1.235 . . . . 0.0 112.691 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -80.63 -15.27 57.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.69 -48.83 63.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.585 1.154 . . . . 0.0 113.752 -174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -81.93 -44.62 16.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.673 1.189 . . . . 0.0 113.267 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.43 88.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.945 1.698 . . . . 0.0 110.747 -175.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -69.56 172.58 7.12 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.975 0.91 . . . . 0.0 110.328 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -101.31 4.81 41.99 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.779 1.632 . . . . 0.0 112.32 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.17 -141.78 0.52 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 128.0 2.714 . . . . 0.0 115.067 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.431 HG21 ' HB2' ' A' ' 61' ' ' HIS . 8.0 tp -107.93 161.37 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.231 1.812 . . . . 0.0 109.245 174.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -31.33 -45.68 0.32 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 119.007 2.966 . . . . 0.0 119.007 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -75.36 -157.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.581 2.854 . . . . 0.0 116.829 -173.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 92.4 m -45.8 -59.21 2.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.639 3.176 . . . . 0.0 118.186 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.99 156.34 19.81 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.84 1.2 . . . . 0.0 111.91 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -14.89 3.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -108.54 141.19 40.81 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.77 1.623 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -93.69 169.57 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 86.4 m -136.36 -154.78 0.58 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.65 2.38 . . . . 0.0 109.307 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.0 m -121.06 123.37 42.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.587 1.155 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 t -103.61 168.52 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.7 1.2 . . . . 0.0 112.74 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -87.61 155.91 19.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.44 1.096 . . . . 0.0 112.24 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.97 -39.02 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.595 1.158 . . . . 0.0 112.535 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.0 154.07 40.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.749 0.82 . . . . 0.0 112.506 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 tm? . . . . . 0 C--O 1.254 1.317 0 C-N-CA 126.06 1.744 . . . . 0.0 110.685 -179.673 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo . . . . . 0 N--CA 1.482 0.844 0 N-CA-C 114.406 0.887 . . . . 0.0 114.406 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -75.36 -54.53 2.39 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.639 -1.172 . . . . 0.0 113.055 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.05 160.84 42.19 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.432 2.088 . . . . 0.0 111.497 169.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1138 ' ' GLU . . . . . 0.536 ' HG2' ' HE ' ' A' ' 26' ' ' ARG . 8.3 tt0 -136.74 -72.4 0.44 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.805 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B 1139 ' ' PTR . . . . . 0.551 ' C ' HD11 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1140 ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 83' ' ' MET 0.319 95.2 t -81.48 -0.5 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 1 C-N-CA 132.207 4.203 . . . . 0.0 119.852 -172.165 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' B' B 1141 ' ' ASN . . . . . 0.579 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.2 m-80 -67.15 -17.91 65.06 Favored 'General case' 0 CA--C 1.579 2.087 1 N-CA-C 99.14 -4.393 . . . . 0.0 99.14 165.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1142 ' ' GLN . . . . . 0.414 ' N ' ' C ' ' B' 1140 ' ' VAL . 49.6 mm-40 -132.44 4.43 0.04 OUTLIER Pre-proline 0 C--N 1.384 2.078 1 N-CA-C 125.509 5.374 . . . . 0.0 125.509 173.425 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo 6.16 58.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.892 1.728 . . . . 0.0 113.567 -126.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B 1144 ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' B' 1142 ' ' GLN . 34.7 t70 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 133.05 4.54 . . . . 0.0 116.993 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.864 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 m -69.69 147.39 96.4 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.445 1.098 . . . . 0.0 112.579 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.97 -16.9 46.06 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.459 2.773 . . . . 0.0 114.402 -173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.99 0.37 27.9 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.839 1.256 . . . . 0.0 114.125 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -64.15 140.8 58.91 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.269 1.028 . . . . 0.0 112.878 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.03 163.25 53.17 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.313 0.959 . . . . 0.0 113.932 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -89.25 137.23 32.51 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.958 1.303 . . . . 0.0 112.229 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.8 m -106.51 -3.65 20.62 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.2 tp -82.08 136.12 35.24 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.729 1.211 . . . . 0.0 111.517 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.7 t -95.48 137.29 34.75 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.204 1.001 . . . . 0.0 112.288 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.06 -3.18 35.34 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.166 1.387 . . . . 0.0 113.383 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.13 -1.62 58.12 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.7 pt -68.83 153.21 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.504 1.121 . . . . 0.0 112.931 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -74.32 152.65 39.58 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.504 1.122 . . . . 0.0 112.72 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -133.12 0.94 3.48 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.4 p -142.04 -176.0 4.63 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 128.613 2.765 . . . . 0.0 109.691 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -78.78 16.09 0.94 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.932 1.293 . . . . 0.0 113.963 174.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -57.52 147.4 26.87 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -131.88 38.11 3.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.926 1.29 . . . . 0.0 112.301 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -141.07 150.23 42.66 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -141.03 148.23 39.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 128.398 2.679 . . . . 0.0 108.912 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.36 41.28 1.3 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 123.15 2.705 . . . . 0.0 112.532 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -142.58 31.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.004 1.383 . . . . 0.0 110.721 174.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.09 79.67 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.67 1.188 . . . . 0.0 108.141 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 m -52.58 154.57 2.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.678 1.591 . . . . 0.0 112.325 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -47.15 -39.35 13.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.48 -34.61 74.6 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.916 1.286 . . . . 0.0 112.779 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -81.75 -43.98 17.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.275 1.03 . . . . 0.0 111.598 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 t -62.15 -36.45 81.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.521 1.128 . . . . 0.0 112.361 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.9 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttp-105 -79.12 -35.64 41.89 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.914 0.779 . . . . 0.0 111.54 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -83.39 -45.27 13.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.251 1.42 . . . . 0.0 112.574 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.26 -7.5 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.923 0.889 . . . . 0.0 111.236 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.37 -0.97 59.36 Favored Glycine 0 N--CA 1.471 0.997 0 O-C-N 119.966 -1.709 . . . . 0.0 116.46 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.48 -3.78 58.96 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.93 1.365 . . . . 0.0 111.219 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.56 152.78 29.93 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.92 1.688 . . . . 0.0 111.743 174.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.6 22.42 3.17 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.667 1.127 . . . . 0.0 115.086 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.13 -170.5 2.76 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.398 1.479 . . . . 0.0 112.032 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -54.87 156.92 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.951 1.3 . . . . 0.0 111.392 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 6.9 m-20 -46.54 -24.3 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.58 ' HA2' ' CD2' ' A' ' 113' ' ' HIS . . . -99.63 43.46 1.81 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 119.804 2.682 . . . . 0.0 119.804 -173.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.87 75.43 0.96 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.461 ' CD2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -98.26 171.65 8.07 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 117.278 2.325 . . . . 0.0 117.278 -172.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -141.47 142.69 33.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 0.0 110.107 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.53 93.51 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.4 HH22 ' P ' ' B' 1139 ' ' PTR . 0.0 OUTLIER -124.07 161.77 24.88 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.36 1.464 . . . . 0.0 110.039 174.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' HA ' HG13 ' A' ' 56' ' ' VAL . 4.4 pm0 -141.56 -158.62 0.88 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -140.48 163.39 32.96 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 123.475 1.607 . . . . 0.0 109.862 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.26 1.3 pp0? -96.11 11.97 32.34 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.836 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -97.49 -73.85 0.59 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 131.632 3.973 . . . . 0.0 108.321 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.89 120.58 47.63 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 121.399 1.909 . . . . 0.0 109.588 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.29 -13.87 23.05 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.919 2.413 . . . . 0.0 113.976 -168.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -125.59 30.88 5.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.278 2.231 . . . . 0.0 110.467 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.48 132.32 10.93 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 122.505 3.762 . . . . 0.0 122.505 -172.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.408 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 38.2 m-85 -144.02 76.29 1.5 Allowed 'General case' 0 CA--C 1.559 1.303 1 C-N-CA 131.786 4.034 . . . . 0.0 109.019 174.06 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.44 154.79 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.129 2.172 . . . . 0.0 113.046 -174.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' A' ' 43' ' ' PHE . 1.2 mt -111.36 131.45 55.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 172.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.5 p -113.74 113.52 25.08 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -97.2 153.27 18.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.45 ' HA ' HG12 ' A' ' 65' ' ' VAL . 41.8 t -115.03 63.31 0.68 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.5 ' CG ' ' H ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -66.8 -170.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.706 -173.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.5 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.504 0.3 OUTLIER -97.01 7.83 45.8 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 119.696 3.221 . . . . 0.0 119.696 -173.582 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -142.29 -28.57 0.6 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.034 1.459 . . . . 0.0 112.554 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.8 179.75 7.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.943 0.897 . . . . 0.0 111.243 174.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 60' ' ' CYS . 5.0 m -116.48 116.69 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -128.93 160.08 33.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.807 1.643 . . . . 0.0 112.705 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.496 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 91.3 m-70 -101.31 165.24 11.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.522 1.529 . . . . 0.0 113.689 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -133.63 47.6 2.44 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.523 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.7 tm? -142.47 135.48 28.48 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.513 -1.992 . . . . 0.0 113.993 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' B' 1141 ' ' ASN . 52.4 mt -140.36 -43.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.245 0.929 . . . . 0.0 111.05 171.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.98 155.3 68.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -83.32 -176.12 2.65 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.754 3.636 . . . . 0.0 111.877 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -54.03 141.13 29.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.478 1.111 . . . . 0.0 113.861 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -123.56 -170.82 2.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.882 1.273 . . . . 0.0 111.714 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.16 -13.86 20.68 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.015 1.326 . . . . 0.0 112.3 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -99.1 5.58 46.88 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.618 1.567 . . . . 0.0 113.517 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -170.1 -157.7 12.8 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.107 1.337 . . . . 0.0 113.478 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -106.93 -137.14 0.36 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.844 1.258 . . . . 0.0 108.79 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.69 123.22 16.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.87 132.11 37.82 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.413 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 6.6 m-85 -150.17 161.65 41.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.178 1.791 . . . . 0.0 114.698 174.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' B' 1141 ' ' ASN 0.253 1.5 m -145.31 -160.54 1.15 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.905 1.282 . . . . 0.0 108.746 173.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.46 ' HA ' ' CG1' ' B' 1140 ' ' VAL . 9.0 ttm -155.65 -179.93 8.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 129.398 3.079 . . . . 0.0 107.952 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.62 -30.56 70.17 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.12 -0.988 . . . . 0.0 110.13 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.31 40.19 1.91 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.914 1.286 . . . . 0.0 112.669 174.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 179.48 19.56 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 63.83 1.42 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.173 2.189 . . . . 0.0 111.919 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.545 24.6 p -78.4 2.44 18.74 Favored 'General case' 0 N--CA 1.487 1.377 1 N-CA-C 123.352 4.575 . . . . 0.0 123.352 -172.795 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.413 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 27.5 ptt180 -40.36 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 1 C-N-CA 132.377 4.271 . . . . 0.0 119.872 172.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.86 159.79 35.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.499 1.919 . . . . 0.0 112.69 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 m -61.36 136.61 58.1 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.092 1.357 . . . . 0.0 112.715 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.19 -30.16 68.3 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.67 -41.28 99.0 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.903 0.774 . . . . 0.0 112.412 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.4 -39.52 74.44 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.756 -0.59 . . . . 0.0 111.085 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -64.19 -30.56 71.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.437 1.095 . . . . 0.0 112.748 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -76.43 -45.23 32.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.417 1.087 . . . . 0.0 111.94 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.9 -57.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.726 0.694 . . . . 0.0 111.853 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -82.77 -51.03 8.06 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.309 54.3 m-85 -79.85 7.04 9.53 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -173.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -54.72 -29.51 53.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 121.408 1.913 . . . . 0.0 112.941 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.51 -26.59 51.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.692 1.997 . . . . 0.0 114.572 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.6 mt -147.02 71.92 1.24 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.06 2.544 . . . . 0.0 106.773 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.09 159.85 16.49 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 59.59 3.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.93 2.092 . . . . 0.0 111.548 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.27 -154.02 2.04 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 125.54 1.543 . . . . 0.0 113.687 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 tp -79.5 -179.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.836 1.654 . . . . 0.0 111.987 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.4 mt -40.1 139.23 1.03 Allowed Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.769 -1.586 . . . . 0.0 110.586 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -56.17 71.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 125.025 3.817 . . . . 0.0 119.894 -159.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.6 m -103.54 -128.98 0.24 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 129.069 2.948 . . . . 0.0 107.592 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.55 73.5 8.59 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.619 -1.3 . . . . 0.0 108.909 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -2.81 6.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -84.42 56.05 3.64 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.803 1.241 . . . . 0.0 111.103 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.58 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -60.97 141.43 57.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.768 1.627 . . . . 0.0 114.26 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.98 -171.33 2.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 129.402 3.081 . . . . 0.0 109.282 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.79 140.12 33.45 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.1 t -99.85 175.99 5.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.109 1.764 . . . . 0.0 111.865 174.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -68.83 147.8 51.2 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.487 1.515 . . . . 0.0 112.647 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -118.1 153.47 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.865 1.666 . . . . 0.0 112.25 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.08 152.6 32.82 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.96 0.904 . . . . 0.0 112.427 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.9 tp . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.552 1.941 . . . . 0.0 111.391 177.705 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo . . . . . 0 CA--C 1.54 0.79 0 N-CA-C 114.843 1.055 . . . . 0.0 114.843 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -82.32 159.88 63.68 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.628 1.571 . . . . 0.0 112.905 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.12 142.77 63.36 Favored 'Cis proline' 0 C--N 1.354 0.843 0 CA-C-N 119.597 0.892 . . . . 0.0 112.653 -3.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -108.79 -105.98 0.35 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.992 1.317 . . . . 0.0 112.427 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1139 ' ' PTR . . . . . 0.461 ' HE1' HG11 ' A' ' 56' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1140 ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 83' ' ' MET . 26.7 t -143.17 -16.89 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 C-N-CA 126.653 1.981 . . . . 0.0 114.7 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B 1141 ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -60.15 -28.5 67.95 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 169.081 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.352 3.7 mp0 -154.25 158.42 32.39 Favored Pre-proline 0 N--CA 1.435 -1.212 1 C-N-CA 137.216 6.206 . . . . 0.0 104.348 169.775 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 60.26 2.06 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 CA-C-N 121.585 1.602 . . . . 0.0 110.261 152.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.1 t0 . . . . . 0 C--O 1.254 1.322 1 C-N-CA 134.446 5.098 . . . . 0.0 115.652 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 m -68.4 148.39 98.18 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 124.373 1.069 . . . . 0.0 112.936 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.74 156.21 61.21 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.517 2.811 . . . . 0.0 112.705 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.93 154.46 38.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.086 0.954 . . . . 0.0 112.606 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 m -69.35 142.68 53.93 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.211 1.005 . . . . 0.0 112.458 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.02 172.11 55.12 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.139 0.876 . . . . 0.0 113.958 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -81.13 -18.75 45.32 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.348 1.059 . . . . 0.0 113.38 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 p -81.33 158.66 24.63 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.491 1.517 . . . . 0.0 113.03 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -130.08 161.76 30.3 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.999 1.72 . . . . 0.0 111.281 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 m -61.32 132.71 54.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.127 0.971 . . . . 0.0 112.247 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.1 160.74 17.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.422 1.089 . . . . 0.0 113.424 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.3 145.29 38.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.655 1.582 . . . . 0.0 110.771 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 pt -79.26 -22.09 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -76.98 59.64 1.68 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.252 1.821 . . . . 0.0 113.899 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -121.48 -0.15 9.84 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.6 p -142.1 -180.0 6.57 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 128.772 2.829 . . . . 0.0 109.852 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -76.37 15.46 0.59 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.876 1.27 . . . . 0.0 114.244 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -62.25 -15.41 47.01 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -174.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -101.05 7.38 43.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.08 1.752 . . . . 0.0 112.989 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -117.75 138.09 52.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -141.92 177.84 7.92 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.598 2.759 . . . . 0.0 108.607 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.16 -130.3 3.81 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 121.913 2.142 . . . . 0.0 112.773 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 61.3 ttp85 -51.03 122.49 7.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.315 2.057 . . . . 0.0 115.929 -172.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.87 78.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 1 N-CA-C 99.146 -4.39 . . . . 0.0 99.146 173.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -30.91 121.18 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.977 2.511 . . . . 0.0 115.051 -171.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -24.93 63.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.45 1.9 . . . . 0.0 113.65 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -80.98 -39.2 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.166 1.386 . . . . 0.0 112.805 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.88 -40.62 22.13 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.105 1.362 . . . . 0.0 113.695 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -56.01 -32.65 64.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.193 1.397 . . . . 0.0 113.781 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.463 ' HA ' ' CG2' ' A' ' 65' ' ' VAL 0.266 1.5 pt20 -64.14 -15.84 60.61 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 174.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -80.61 -28.38 37.04 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.117 0.967 . . . . 0.0 112.038 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.13 -59.02 1.81 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.502 1.521 . . . . 0.0 112.588 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.15 -6.47 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 126.431 1.892 . . . . 0.0 111.63 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.53 7.06 65.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 119.965 -1.709 . . . . 0.0 114.348 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -7.78 59.11 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.021 0.911 . . . . 0.0 110.126 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 142.63 50.19 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.256 1.422 . . . . 0.0 110.355 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.73 27.76 5.37 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.709 1.147 . . . . 0.0 115.586 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.57 179.58 7.68 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.343 1.071 . . . . 0.0 112.357 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.25 149.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.422 0.689 . . . . 0.0 111.68 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.16 2.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.37 15.76 22.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.439 2.447 . . . . 0.0 116.911 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.64 71.16 4.23 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.196 2.498 . . . . 0.0 105.147 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.39 174.24 6.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -140.52 162.27 35.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.33 2.652 . . . . 0.0 109.033 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.28 107.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.299 1.04 . . . . 0.0 109.31 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' HH11 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.54 164.92 28.91 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.624 1.97 . . . . 0.0 107.899 -177.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.889 ' HA ' HG13 ' A' ' 56' ' ' VAL . 15.4 pt-20 -141.05 -172.53 3.5 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.2 t -98.37 138.55 35.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.429 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.427 ' H ' ' HB2' ' A' ' 23' ' ' ARG 0.358 0.0 OUTLIER -98.2 5.53 48.37 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.661 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -113.47 -43.37 3.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 128.46 2.704 . . . . 0.0 113.999 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -76.37 127.22 85.18 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 120.558 1.526 . . . . 0.0 111.733 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -69.67 -25.5 28.96 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.989 2.459 . . . . 0.0 116.664 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -110.39 23.97 13.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.929 . . . . 0.0 111.171 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.595 ' HA3' HD22 ' A' ' 69' ' ' LEU . . . -98.91 129.75 10.0 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 122.16 3.624 . . . . 0.0 122.16 -172.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -144.32 121.54 11.53 Favored 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.899 4.879 . . . . 0.0 102.181 173.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.889 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.325 0.9 OUTLIER -125.11 138.94 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 123.552 2.887 . . . . 0.0 112.787 -174.954 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 tt -98.6 126.11 44.07 Favored 'General case' 0 CA--C 1.536 0.438 1 N-CA-C 99.546 -4.242 . . . . 0.0 99.546 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 p -125.64 112.05 15.69 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.873 1.215 . . . . 0.0 108.243 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.31 167.16 11.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.607 1.163 . . . . 0.0 111.502 -173.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.493 ' HA ' HG12 ' A' ' 65' ' ' VAL . 49.7 t -126.33 94.97 4.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.561 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.326 0.0 OUTLIER -90.72 -161.84 0.84 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.008 -173.077 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.532 0.3 OUTLIER -96.88 13.07 30.0 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 -174.287 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -147.4 -36.24 0.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.107 -1.861 . . . . 0.0 112.16 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -151.1 -177.55 6.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 60' ' ' CYS . 5.0 m -100.03 127.41 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 173.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -128.96 146.4 50.98 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.206 1.402 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -117.66 159.93 22.13 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -172.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.429 ' CZ ' HG11 ' B' 1140 ' ' VAL . 8.6 m-85 -131.87 84.05 2.14 Favored 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.596 1.558 . . . . 0.0 115.196 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.595 HD22 ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -136.3 19.51 3.16 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 121.745 3.98 . . . . 0.0 121.745 -174.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 mt -93.07 4.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 118.949 -2.344 . . . . 0.0 116.534 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.4 mt -135.78 138.95 29.31 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.749 1.159 . . . . 0.0 111.85 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -84.93 -176.95 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.297 3.331 . . . . 0.0 111.195 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 m -62.56 147.01 50.41 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.707 -1.246 . . . . 0.0 112.331 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -125.03 -176.67 3.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.336 1.054 . . . . 0.0 111.963 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -97.54 -8.72 28.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.75 0.82 . . . . 0.0 112.786 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -99.39 0.18 42.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.075 1.35 . . . . 0.0 112.552 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -162.4 -155.8 8.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.261 1.41 . . . . 0.0 114.233 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.64 -135.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.921 1.688 . . . . 0.0 108.794 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.98 117.33 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -84.12 126.45 33.1 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.507 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 25.9 m-85 -143.04 157.23 44.73 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.9 p -148.73 -159.2 1.0 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.839 2.056 . . . . 0.0 110.751 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.662 ' HA ' HG12 ' B' 1140 ' ' VAL . 46.9 mtt -155.54 -169.08 3.01 Favored 'General case' 0 C--N 1.314 -0.97 1 C-N-CA 137.309 6.244 . . . . 0.0 107.335 -172.36 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.21 -34.75 78.16 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.457 ' H ' HD21 ' A' ' 107' ' ' LEU . 25.3 t0 -141.18 60.76 1.5 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.937 1.695 . . . . 0.0 110.367 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.14 172.41 22.08 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -141.24 42.84 1.78 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.142 1.777 . . . . 0.0 114.01 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 2.3 p -70.95 -1.45 11.99 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 120.632 3.568 . . . . 0.0 120.632 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.507 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 2.5 ptm180 -43.21 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 1 C-N-CA 131.868 4.067 . . . . 0.0 119.817 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.81 166.35 24.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.805 2.442 . . . . 0.0 110.466 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -66.17 132.99 49.75 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.05 -1.031 . . . . 0.0 109.667 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.98 -46.2 24.81 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.75 -40.0 82.6 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.69 -28.28 68.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.58 0.752 . . . . 0.0 112.562 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -88.01 -20.63 25.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 112.329 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 tt -69.21 -55.29 11.03 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.92 -1.112 . . . . 0.0 111.192 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.76 -60.11 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.856 0.753 . . . . 0.0 112.297 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -82.28 -64.0 1.27 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.265 99.6 m-85 -69.94 -5.55 26.92 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -172.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -53.32 -29.48 34.01 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 123.452 2.842 . . . . 0.0 113.608 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -64.38 -32.06 73.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.132 1.773 . . . . 0.0 114.139 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -151.44 74.71 1.14 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.105 2.162 . . . . 0.0 106.532 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -107.3 -167.23 1.24 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.92 1.288 . . . . 0.0 114.12 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -104.03 76.6 1.37 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.676 1.99 . . . . 0.0 108.861 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.99 -157.94 1.04 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.797 1.189 . . . . 0.0 113.362 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.654 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -61.76 158.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.659 1.184 . . . . 0.0 113.816 -174.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.654 ' H ' HD13 ' A' ' 106' ' ' ILE . 12.5 mt -28.73 -64.16 0.18 Allowed Pre-proline 0 CA--C 1.566 1.585 0 CA-C-O 115.281 -2.295 . . . . 0.0 115.764 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 107' ' ' LEU . 11.8 Cg_endo -119.59 -21.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.637 0 CA-C-N 124.252 2.554 . . . . 0.0 117.308 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.2 m -86.22 -145.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.18 1.792 . . . . 0.0 114.145 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.86 141.89 47.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.468 1.107 . . . . 0.0 113.261 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -104.89 -9.43 17.99 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -174.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -106.32 146.89 29.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.509 1.124 . . . . 0.0 112.478 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -111.51 153.26 26.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.255 1.422 . . . . 0.0 114.169 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.06 -179.92 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.065 2.146 . . . . 0.0 110.843 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 95.3 m -98.96 124.04 43.66 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.895 -1.128 . . . . 0.0 113.094 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t -102.69 -177.44 3.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.039 1.736 . . . . 0.0 114.413 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -64.4 128.75 37.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.942 0.897 . . . . 0.0 110.85 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.9 157.63 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.864 0.866 . . . . 0.0 113.005 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.12 0.5 31.86 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.255 1.381 0 C-N-CA 126.119 1.768 . . . . 0.0 112.773 -179.894 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 CA--C 1.539 0.762 0 N-CA-C 113.575 0.567 . . . . 0.0 113.575 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 36.11 92.74 0.05 OUTLIER Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 128.159 2.584 . . . . 0.0 116.781 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -78.54 -171.03 9.31 Favored 'Cis proline' 0 CA--C 1.547 1.142 0 CA-C-N 119.963 1.022 . . . . 0.0 112.162 -6.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -137.76 -71.2 0.43 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.55 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1139 ' ' PTR . . . . . 0.513 ' CD1' ' HG ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1140 ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 83' ' ' MET 0.281 77.6 t 46.39 -23.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.518 1 C-N-CA 139.6 7.16 . . . . 0.0 117.988 174.61 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.33 -28.45 65.07 Favored 'General case' 0 CA--C 1.583 2.221 1 N-CA-C 99.696 -4.187 . . . . 0.0 99.696 167.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1142 ' ' GLN . . . . . 0.458 ' C ' ' H ' ' B' 1144 ' ' ASP . 4.4 mp0 -146.79 169.48 9.38 Favored Pre-proline 0 C--N 1.369 1.45 0 C-N-CA 130.103 3.361 . . . . 0.0 113.272 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.24 41.22 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.647 0 C-N-CA 124.466 3.444 . . . . 0.0 113.947 146.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B 1144 ' ' ASP . . . . . 0.458 ' H ' ' C ' ' B' 1142 ' ' GLN . 42.1 t0 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 132.564 4.345 . . . . 0.0 115.396 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 CA-C-O 121.114 0.285 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.0 p -76.92 160.66 75.96 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.723 1.209 . . . . 0.0 113.095 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.79 151.48 76.7 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.357 2.705 . . . . 0.0 114.318 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.51 162.71 28.08 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.338 1.055 . . . . 0.0 113.041 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -136.83 156.06 48.99 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.541 1.536 . . . . 0.0 112.472 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.18 155.77 47.97 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.356 0.979 . . . . 0.0 114.44 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -71.41 145.45 49.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.784 1.234 . . . . 0.0 111.427 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.4 t -132.6 150.27 52.18 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.092 1.357 . . . . 0.0 112.203 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -117.08 11.97 14.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.073 1.749 . . . . 0.0 113.698 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 t -66.15 151.89 45.97 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.306 1.042 . . . . 0.0 112.776 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.11 165.69 26.84 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.515 1.526 . . . . 0.0 112.68 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.34 -0.22 35.84 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.05 150.37 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.824 1.25 . . . . 0.0 112.264 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -64.78 145.58 56.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.497 1.119 . . . . 0.0 112.547 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -130.65 2.48 4.5 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 p -142.04 -173.9 3.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 128.337 2.655 . . . . 0.0 109.616 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.27 9.35 1.7 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -61.06 149.03 38.29 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -114.29 15.19 18.11 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.457 1.503 . . . . 0.0 113.373 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.85 143.78 31.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 -173.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -141.36 149.78 41.58 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.766 3.226 . . . . 0.0 107.839 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.91 39.87 1.41 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-N 123.532 2.878 . . . . 0.0 114.912 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -146.29 30.93 1.02 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.928 0.891 . . . . 0.0 112.352 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 tp -128.19 75.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.479 1.112 . . . . 0.0 109.954 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -45.32 150.16 0.47 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.008 1.723 . . . . 0.0 113.756 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HD2' ' O3P' ' B' 1139 ' ' PTR . 0.2 OUTLIER -52.24 -31.57 32.9 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -174.235 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.0 -33.16 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -81.49 -49.97 9.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.027 1.331 . . . . 0.0 112.37 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 p -66.47 -29.05 69.09 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.401 -0.812 . . . . 0.0 112.514 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.14 -14.57 63.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.488 1.495 . . . . 0.0 113.723 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -79.86 -34.26 39.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.292 1.037 . . . . 0.0 111.335 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mp -86.98 -42.77 12.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.438 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.23 -10.74 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 111.168 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.59 -1.41 58.96 Favored Glycine 0 N--CA 1.469 0.879 0 O-C-N 120.436 -1.415 . . . . 0.0 116.112 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -88.02 -0.14 56.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.771 1.285 . . . . 0.0 111.868 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.76 158.99 19.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.083 1.753 . . . . 0.0 111.308 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.15 25.51 2.64 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.405 1.002 . . . . 0.0 114.995 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.5 -170.73 2.93 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.458 1.103 . . . . 0.0 111.644 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.3 m -54.72 154.99 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.759 0.823 . . . . 0.0 110.542 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 17.8 m-20 -55.66 -10.4 0.69 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.54 13.03 63.01 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.14 2.781 . . . . 0.0 116.445 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.41 78.92 4.4 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 122.193 2.997 . . . . 0.0 105.843 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.17 170.65 8.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.6 tp -133.97 153.23 51.91 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.768 2.027 . . . . 0.0 109.768 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.41 102.55 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.33 163.91 31.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.825 1.25 . . . . 0.0 109.252 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' HG13 ' A' ' 56' ' ' VAL . 4.6 pm0 -143.06 -159.26 0.95 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.579 1.181 . . . . 0.0 112.797 174.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -120.53 150.85 40.2 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 130.781 3.633 . . . . 0.0 108.021 174.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.85 5.82 48.57 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -98.99 -64.33 1.05 Allowed 'General case' 0 C--N 1.357 0.896 0 C-N-CA 131.411 3.884 . . . . 0.0 113.756 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -58.38 123.9 68.54 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 122.478 2.399 . . . . 0.0 111.459 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.86 -21.13 38.37 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.308 2.672 . . . . 0.0 113.89 -170.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -111.14 21.46 16.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.826 2.45 . . . . 0.0 112.182 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA3' HD22 ' A' ' 69' ' ' LEU . . . -95.96 123.32 7.64 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 120.718 3.047 . . . . 0.0 120.718 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -143.48 103.93 4.16 Favored 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 132.69 4.396 . . . . 0.0 102.606 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.568 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.311 0.8 OUTLIER -110.79 138.9 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 121.346 1.884 . . . . 0.0 114.177 -173.834 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.21 128.03 45.28 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.9 p -127.11 113.73 16.8 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.859 1.209 . . . . 0.0 109.005 -173.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.96 153.45 17.76 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.212 1.005 . . . . 0.0 112.382 -172.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.491 ' HA ' HG12 ' A' ' 65' ' ' VAL . 48.5 t -113.64 75.7 0.94 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.474 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.323 2.5 t60 -82.81 -172.35 4.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.266 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.559 0.2 OUTLIER -98.5 22.3 10.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -173.763 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -149.96 -39.36 0.14 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.748 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 175.83 10.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.045 0.938 . . . . 0.0 110.512 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 60' ' ' CYS . 6.0 m -118.16 112.53 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -110.86 158.07 19.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.95 1.7 . . . . 0.0 112.87 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 22.4 m-70 -120.76 160.06 24.13 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.465 1.506 . . . . 0.0 114.517 -173.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -131.24 87.2 2.44 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD22 ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -140.89 23.36 2.25 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' B' 1144 ' ' ASP . 5.8 mt -92.07 -3.26 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 118.326 -2.733 . . . . 0.0 118.065 -168.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -136.77 136.46 21.58 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 120.913 1.688 . . . . 0.0 113.214 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.38 170.24 16.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.952 3.101 . . . . 0.0 112.495 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -57.48 141.06 48.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.659 1.184 . . . . 0.0 113.658 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -131.34 178.82 6.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.647 1.179 . . . . 0.0 112.795 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -99.08 -7.18 27.11 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.91 1.284 . . . . 0.0 111.441 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -106.99 45.1 1.0 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.947 2.499 . . . . 0.0 107.295 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 148.32 -160.53 28.38 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.121 2.772 . . . . 0.0 109.09 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -124.18 -123.33 0.26 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.22 116.8 5.3 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.59 136.05 40.52 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -146.88 154.57 41.46 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 m -146.47 -172.93 4.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.245 2.618 . . . . 0.0 109.226 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.541 ' HA ' HG12 ' B' 1140 ' ' VAL . 15.2 mtp -154.48 176.92 11.77 Favored 'General case' 0 C--N 1.311 -1.085 1 C-N-CA 138.95 6.9 . . . . 0.0 107.175 -172.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.45 -25.52 65.94 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.329 -0.857 . . . . 0.0 111.235 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.45 36.52 2.05 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.344 1.058 . . . . 0.0 112.833 174.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 170.12 24.84 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -141.37 60.24 1.5 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.639 1.976 . . . . 0.0 112.418 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.507 41.3 p -76.97 9.75 2.75 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -173.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -38.14 31.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 2 C-N-CA 133.482 4.713 . . . . 0.0 122.756 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -113.81 169.63 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.629 1.571 . . . . 0.0 110.795 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -56.26 140.21 45.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.481 1.113 . . . . 0.0 111.915 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.16 -47.1 30.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.449 0.7 . . . . 0.0 112.75 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.6 -38.79 87.72 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.809 -0.557 . . . . 0.0 111.842 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.28 -37.05 86.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.866 0.466 . . . . 0.0 111.408 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -68.66 -41.68 79.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.458 -0.777 . . . . 0.0 112.121 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 tt -65.82 -39.65 91.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.508 0.595 . . . . 0.0 111.912 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.32 -69.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.756 -0.59 . . . . 0.0 111.204 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.15 -41.26 20.66 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.51 -27.83 34.29 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 121.294 1.861 . . . . 0.0 115.348 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -39.3 -42.42 1.02 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -21.11 58.91 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -146.47 56.96 1.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.013 2.125 . . . . 0.0 110.913 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -91.18 -154.78 0.37 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.116 0.966 . . . . 0.0 112.187 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.89 -4.48 27.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.304 1.842 . . . . 0.0 113.601 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 44.71 -145.27 2.12 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.523 2.011 . . . . 0.0 116.543 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -79.56 159.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.999 1.719 . . . . 0.0 111.199 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.41 ' CB ' ' HD3' ' A' ' 108' ' ' PRO . 2.8 mt -35.17 -54.22 1.12 Allowed Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 116.318 -1.801 . . . . 0.0 115.525 174.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 107' ' ' LEU . 56.9 Cg_endo -118.73 -33.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 -172.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.31 -131.95 0.13 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 126.591 1.956 . . . . 0.0 115.31 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.49 137.68 52.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.9 1.28 . . . . 0.0 113.559 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.446 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -91.51 -13.49 32.04 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -99.81 161.73 13.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.927 1.291 . . . . 0.0 112.373 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -132.21 154.32 49.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 113.314 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 168.11 20.54 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.882 2.473 . . . . 0.0 108.742 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.2 m -98.09 130.0 44.89 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 119.922 -1.736 . . . . 0.0 112.673 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -99.22 178.16 4.99 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.577 1.151 . . . . 0.0 112.441 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -62.78 152.33 36.18 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.478 1.111 . . . . 0.0 112.791 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.8 m -79.61 164.93 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.942 1.297 . . . . 0.0 112.68 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.96 163.45 27.84 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.381 0.672 . . . . 0.0 112.776 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 C--O 1.255 1.345 0 C-N-CA 126.314 1.846 . . . . 0.0 112.166 -178.184 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 113.981 0.724 . . . . 0.0 113.981 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -135.15 150.29 72.46 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.644 1.578 . . . . 0.0 111.063 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.47 152.32 78.82 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.526 2.817 . . . . 0.0 112.524 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -143.64 -60.05 0.4 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 116.214 -1.85 . . . . 0.0 113.922 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1139 ' ' PTR . . . . . 0.533 ' CD1' ' HG ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1140 ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 83' ' ' MET 0.326 78.2 t 46.42 -22.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.269 1 C-N-CA 139.215 7.006 . . . . 0.0 118.21 174.184 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' B' B 1141 ' ' ASN . . . . . 0.403 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.3 m-80 -59.57 -29.86 68.24 Favored 'General case' 0 CA--C 1.581 2.168 1 N-CA-C 99.048 -4.427 . . . . 0.0 99.048 167.228 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.263 1.9 mp0 -151.72 172.53 5.33 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 130.657 3.583 . . . . 0.0 114.037 171.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.02 59.1 0.3 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.396 2.064 . . . . 0.0 110.93 141.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B 1144 ' ' ASP . . . . . 0.477 ' HA ' HD13 ' A' ' 70' ' ' ILE 0.255 30.0 t70 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 131.472 3.909 . . . . 0.0 117.448 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.4 m95 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 112.854 0.686 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.91 126.47 41.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.172 1.389 . . . . 0.0 111.885 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -141.11 156.55 45.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.036 2.135 . . . . 0.0 108.904 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.86 32.76 2.1 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 123.412 2.823 . . . . 0.0 113.841 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -145.86 47.62 1.25 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.712 1.244 . . . . 0.0 110.522 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.252 7.0 tt -139.5 62.62 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 122.97 1.367 . . . . 0.0 108.357 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -47.89 153.37 0.64 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.619 1.967 . . . . 0.0 112.73 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -35.73 0.71 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -174.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.25 -33.7 61.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.66 -46.61 14.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.482 1.113 . . . . 0.0 112.322 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 p -63.99 -31.32 72.46 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.929 -1.107 . . . . 0.0 112.353 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -71.08 -16.41 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.734 1.152 . . . . 0.0 113.675 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -80.21 -35.15 36.66 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.03 0.932 . . . . 0.0 111.586 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.1 mp -88.95 -45.23 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.497 1.119 . . . . 0.0 112.649 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.06 -9.1 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.159 0.984 . . . . 0.0 111.533 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.35 -0.27 61.37 Favored Glycine 0 N--CA 1.472 1.086 0 O-C-N 120.019 -1.676 . . . . 0.0 115.62 -174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -80.75 -14.25 58.27 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.155 0.978 . . . . 0.0 109.354 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.03 157.27 22.97 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.732 2.013 . . . . 0.0 111.966 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.69 33.4 2.05 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 124.769 1.176 . . . . 0.0 114.718 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.45 -179.29 7.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.705 1.202 . . . . 0.0 112.875 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 m -51.27 149.32 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.105 0.962 . . . . 0.0 111.819 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 1.2 m-20 -40.22 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 129.683 3.193 . . . . 0.0 116.717 -174.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.84 19.4 53.5 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 120.129 2.811 . . . . 0.0 120.129 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.4 78.43 4.42 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 123.509 3.654 . . . . 0.0 105.596 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.506 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -100.41 170.29 8.51 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -172.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 tp -140.46 156.11 46.46 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.289 3.036 . . . . 0.0 108.821 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.06 79.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 122.872 1.32 . . . . 0.0 108.681 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.459 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -115.78 168.82 9.71 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.249 1.42 . . . . 0.0 110.806 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HA ' HG13 ' A' ' 56' ' ' VAL . 8.6 pt-20 -142.75 -156.33 0.67 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.547 0.689 . . . . 0.0 110.394 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.5 p -134.52 154.3 51.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.923 2.089 . . . . 0.0 109.077 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.285 1.4 pp0? -99.53 6.05 45.92 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.625 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -99.78 -61.67 1.34 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 131.246 3.819 . . . . 0.0 113.038 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -64.14 125.15 87.52 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 123.786 2.994 . . . . 0.0 107.584 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.83 -6.84 19.58 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.143 2.562 . . . . 0.0 114.101 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -129.03 26.87 5.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.649 2.379 . . . . 0.0 111.737 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA2' ' HG ' ' A' ' 69' ' ' LEU . . . -96.17 127.01 9.01 Favored Glycine 0 C--N 1.356 1.692 0 N-CA-C 121.992 3.557 . . . . 0.0 121.992 -172.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.486 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 33.3 m-85 -145.12 77.69 1.53 Allowed 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 133.602 4.761 . . . . 0.0 109.465 174.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -98.73 145.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.509 -1.995 . . . . 0.0 115.233 -173.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.95 128.38 48.39 Favored 'General case' 0 CA--C 1.542 0.672 1 N-CA-C 99.187 -4.375 . . . . 0.0 99.187 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 p -126.87 113.14 16.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.115 -1.615 . . . . 0.0 109.135 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 43' ' ' PHE . 11.2 mt -98.78 153.0 19.08 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.249 1.02 . . . . 0.0 111.421 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.417 ' HA ' HG12 ' A' ' 65' ' ' VAL . 53.6 t -124.94 114.63 19.41 Favored 'General case' 0 CA--C 1.496 -1.109 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 40' ' ' ASP 0.267 0.0 OUTLIER -113.41 -165.88 1.04 Allowed 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.024 1.453 . . . . 0.0 112.489 -173.054 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.542 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.462 0.3 OUTLIER -96.65 8.11 44.99 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 118.561 2.8 . . . . 0.0 118.561 -173.795 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -146.44 -27.02 0.42 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 125.202 1.564 . . . . 0.0 112.777 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -150.07 -177.96 6.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.953 0.901 . . . . 0.0 112.312 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 60' ' ' CYS . 4.1 m -131.26 135.24 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.639 1.176 . . . . 0.0 109.43 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -140.96 158.25 44.2 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.774 0.83 . . . . 0.0 112.63 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.459 ' CG ' HH21 ' A' ' 46' ' ' ARG . 88.2 m-70 -111.57 149.03 32.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.197 1.399 . . . . 0.0 110.854 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 65.27 1.12 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.862 1.265 . . . . 0.0 113.252 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.4 tm? -141.81 129.85 22.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.355 1.462 . . . . 0.0 112.348 174.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' B' 1141 ' ' ASN . 12.1 mt -140.66 -42.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.714 1.143 . . . . 0.0 110.964 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 80' ' ' TYR . 13.1 mt -120.99 147.41 46.32 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.92 -173.31 1.72 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.294 3.329 . . . . 0.0 110.945 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -57.76 130.0 44.47 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.308 -0.87 . . . . 0.0 112.95 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -110.96 179.14 4.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.695 1.198 . . . . 0.0 112.246 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.03 -11.52 21.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.398 1.079 . . . . 0.0 112.305 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.1 32.93 4.07 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.061 2.144 . . . . 0.0 111.52 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.29 -150.07 21.43 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.782 2.61 . . . . 0.0 110.323 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -128.22 -130.77 0.22 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.233 1.413 . . . . 0.0 107.247 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -57.38 122.82 13.48 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.787 1.63 . . . . 0.0 107.819 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -84.47 138.83 32.58 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -174.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.534 ' H ' ' HB3' ' A' ' 89' ' ' ARG . 5.3 m-85 -145.34 137.1 25.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.174 2.19 . . . . 0.0 112.349 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -140.44 1.48 1.77 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.5 ttp -29.81 144.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.55 2.432 . . . . 0.0 113.813 173.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.21 -31.89 34.01 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -112.25 4.13 17.57 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.778 1.231 . . . . 0.0 113.266 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.93 88.73 0.18 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.584 1.564 . . . . 0.0 113.286 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -97.44 53.24 1.14 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.785 1.234 . . . . 0.0 108.85 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.469 68.5 p -79.25 20.03 0.54 Allowed 'General case' 0 N--CA 1.47 0.546 1 N-CA-C 122.566 4.284 . . . . 0.0 122.566 -172.605 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.534 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -39.64 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 121.609 3.929 . . . . 0.0 121.609 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -140.24 174.37 10.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 129.836 3.254 . . . . 0.0 107.708 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 m -62.4 116.4 5.04 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.317 -1.489 . . . . 0.0 109.831 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.2 -32.72 74.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.272 0.629 . . . . 0.0 112.336 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.36 -33.23 75.08 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.5 -37.38 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 111.373 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -28.68 62.92 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.844 0.858 . . . . 0.0 113.257 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.53 -34.0 68.68 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.215 1.406 . . . . 0.0 112.152 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.7 -39.7 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.061 0.944 . . . . 0.0 111.766 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -80.59 -47.19 14.51 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.48 1.112 . . . . 0.0 111.954 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.29 -18.83 65.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -40.03 -49.96 2.55 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.601 1.96 . . . . 0.0 115.167 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -81.18 -47.73 13.04 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.277 1.031 . . . . 0.0 113.534 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.23 92.71 3.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.73 1.612 . . . . 0.0 109.223 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -70.77 176.93 3.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.699 1.2 . . . . 0.0 113.049 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -90.13 -5.18 56.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.58 -166.62 1.16 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.028 1.299 . . . . 0.0 115.261 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.5 tt -90.24 -174.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.294 1.437 . . . . 0.0 107.512 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.74 110.21 2.59 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 121.583 1.992 . . . . 0.0 108.652 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -102.96 157.47 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 N-CA-C 118.98 2.646 . . . . 0.0 118.98 -129.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.33 -43.5 1.16 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 130.735 3.614 . . . . 0.0 106.372 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.5 158.37 41.07 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.955 3.302 . . . . 0.0 107.368 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.268 0.0 OUTLIER -121.4 -22.54 5.93 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.411 2.745 . . . . 0.0 118.411 -174.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.65 142.02 33.12 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.838 1.654 . . . . 0.0 112.13 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -97.85 152.6 19.02 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.195 0.998 . . . . 0.0 112.764 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 170.11 16.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.03 2.532 . . . . 0.0 108.991 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 62.5 m -98.0 132.76 43.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.388 -1.445 . . . . 0.0 113.217 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.5 t -111.1 162.04 15.3 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 . . . . . 0 N--CA 1.478 0.942 0 C-N-CA 125.36 1.464 . . . . 0.0 112.297 178.564 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 CA--C 1.539 0.76 0 N-CA-C 112.77 0.258 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.052 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B 1141 ' ' ASN . . . . . 0.412 ' HB2' HD12 ' A' ' 70' ' ' ILE 0.357 69.4 m-20 122.66 -27.8 0.01 OUTLIER 'General case' 0 CA--C 1.59 2.506 4 C-N-CA 139.289 7.036 . . . . 0.0 92.801 -169.258 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.282 1.6 mp0 -130.69 -136.87 0.0 OUTLIER Pre-proline 0 C--N 1.381 1.962 0 C-N-CA 130.75 3.62 . . . . 0.0 115.154 168.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -91.68 122.04 0.66 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 123.046 2.123 . . . . 0.0 113.406 75.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -172.319 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m95 . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -75.74 127.79 33.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.1 1.36 . . . . 0.0 112.065 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -141.35 147.77 38.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.941 1.696 . . . . 0.0 110.364 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.46 40.71 1.3 Allowed Glycine 0 C--O 1.219 -0.789 0 CA-C-N 122.746 2.521 . . . . 0.0 110.805 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 47.13 1.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.808 1.289 . . . . 0.0 109.832 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tt -150.42 81.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.507 1.123 . . . . 0.0 109.303 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.3 t -61.74 164.17 6.49 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.685 1.594 . . . . 0.0 113.884 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.65 -27.64 18.1 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.44 -44.43 19.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.156 0.982 . . . . 0.0 112.467 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.45 -32.02 32.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.667 1.187 . . . . 0.0 113.808 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 p -66.8 -35.52 80.26 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.219 -0.926 . . . . 0.0 112.101 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.273 6.1 pt20 -69.81 -13.71 62.41 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -77.43 -30.59 53.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.709 0.803 . . . . 0.0 111.257 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 mp -92.16 -62.28 1.44 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.795 1.238 . . . . 0.0 111.957 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 mt -70.45 -10.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 125.14 1.376 . . . . 0.0 111.938 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.15 -6.67 57.69 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 121.078 -1.014 . . . . 0.0 115.557 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -102.39 20.78 16.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.6 1.16 . . . . 0.0 110.656 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -105.12 141.84 35.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.642 3.177 . . . . 0.0 111.361 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.48 20.62 48.94 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.2 170.21 16.74 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.969 1.384 . . . . 0.0 112.923 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.46 158.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.915 0.886 . . . . 0.0 111.119 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.15 -7.02 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.694 2.398 . . . . 0.0 116.45 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.06 1.54 44.28 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.866 -1.515 . . . . 0.0 116.456 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.17 84.51 4.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.058 2.429 . . . . 0.0 104.495 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.13 174.6 6.24 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.19 136.1 33.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.357 1.863 . . . . 0.0 110.82 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -101.12 99.78 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.525 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -141.06 167.37 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.428 1.891 . . . . 0.0 110.068 -174.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -142.87 -149.73 0.28 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 t -140.72 164.62 29.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.84 1.305 . . . . 0.0 109.134 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.06 8.42 44.55 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.49 1.916 . . . . 0.0 106.827 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -98.58 -70.46 0.72 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 131.172 3.789 . . . . 0.0 109.251 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -63.87 123.25 81.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 122.028 2.194 . . . . 0.0 109.941 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -74.8 -14.64 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.071 2.514 . . . . 0.0 113.726 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.42 33.59 5.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.479 2.312 . . . . 0.0 110.284 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.63 124.89 8.31 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 120.803 3.081 . . . . 0.0 120.803 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 62.1 m-85 -144.2 77.46 1.55 Allowed 'General case' 0 CA--C 1.56 1.331 1 C-N-CA 131.835 4.054 . . . . 0.0 110.418 174.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -98.12 152.83 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.252 1.821 . . . . 0.0 113.863 -174.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.58 134.96 54.41 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 102.215 -3.254 . . . . 0.0 102.215 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 p -134.79 122.81 22.62 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.313 1.869 . . . . 0.0 109.391 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.07 159.93 14.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.432 0.693 . . . . 0.0 112.653 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 49.9 t -119.17 69.27 0.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.554 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.302 0.6 OUTLIER -81.07 -173.94 4.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.309 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.554 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.489 0.6 OUTLIER -97.96 8.27 45.02 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -174.088 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -145.94 -27.99 0.43 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 124.757 1.286 . . . . 0.0 112.765 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 171.39 16.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.714 0.806 . . . . 0.0 111.992 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.78 96.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.152 0.981 . . . . 0.0 108.475 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -99.4 160.39 14.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.675 1.59 . . . . 0.0 110.328 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.525 ' CG ' HH21 ' A' ' 46' ' ' ARG . 61.9 m-70 -119.2 137.87 53.34 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 124.455 1.102 . . . . 0.0 113.617 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.47 59.85 1.57 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 120.072 -1.643 . . . . 0.0 113.447 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -143.04 128.67 19.18 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.666 HD12 ' HB2' ' B' 1141 ' ' ASN . 20.4 mt -140.71 -29.39 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 120.085 1.311 . . . . 0.0 112.269 171.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.04 159.49 71.86 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -87.85 -159.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 125.183 3.922 . . . . 0.0 111.838 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -65.41 143.63 57.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.004 -1.06 . . . . 0.0 113.452 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -130.75 -176.39 3.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.757 1.223 . . . . 0.0 112.392 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.51 -15.38 19.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.645 1.178 . . . . 0.0 113.662 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -102.13 31.84 3.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.816 1.646 . . . . 0.0 111.204 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 163.28 -159.0 31.52 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.023 2.249 . . . . 0.0 110.435 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -118.88 -125.66 0.28 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.11 110.88 1.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.16 112.41 18.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.613 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.377 32.3 p90 -151.21 171.76 16.9 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 119.393 3.108 . . . . 0.0 119.393 174.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 88' ' ' THR . 65.8 p -150.88 -141.45 0.11 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.443 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.431 ' C ' HG12 ' B' 1140 ' ' VAL . 10.1 tmm? -154.71 -164.92 1.93 Allowed 'General case' 0 CA--C 1.547 0.849 1 C-N-CA 131.863 4.065 . . . . 0.0 104.422 -173.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -78.1 -24.19 47.65 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.612 1.551 . . . . 0.0 110.01 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -140.54 57.39 1.58 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.196 1.798 . . . . 0.0 111.613 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 177.34 20.79 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 116.507 1.363 . . . . 0.0 116.507 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.52 49.15 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.501 1.92 . . . . 0.0 113.202 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.427 ' H ' ' HA ' ' A' ' 82' ' ' SER 0.495 70.5 p -79.1 6.25 9.99 Favored 'General case' 0 N--CA 1.487 1.395 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -173.362 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.613 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 16.7 ptt180 -39.73 16.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 2 C-N-CA 132.881 4.473 . . . . 0.0 122.088 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -107.9 176.78 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.959 1.704 . . . . 0.0 109.528 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -63.81 151.18 42.95 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.15 -1.594 . . . . 0.0 111.128 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -76.19 -36.97 58.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.0 tp -67.27 -46.95 72.14 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.652 0.66 . . . . 0.0 112.434 -174.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.5 -34.75 77.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.402 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -67.23 -43.63 81.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 111.851 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.27 -33.45 73.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.704 0.801 . . . . 0.0 111.993 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.8 t -79.12 -51.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.098 0.959 . . . . 0.0 112.231 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -71.46 -40.29 70.39 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.41 -1.431 . . . . 0.0 113.681 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -83.2 5.55 22.46 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -57.27 -34.13 68.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.439 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -81.52 -35.42 30.38 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.553 1.541 . . . . 0.0 113.262 -176.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.7 mt -142.57 90.83 2.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.562 1.945 . . . . 0.0 109.372 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.66 -171.11 3.32 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.065 0.946 . . . . 0.0 113.348 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -100.13 -20.35 16.03 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 49.32 -165.76 0.34 Allowed Glycine 0 N--CA 1.476 1.319 0 C-N-CA 126.494 1.997 . . . . 0.0 116.382 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.8 tt -84.35 161.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.588 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -29.62 -59.1 0.27 Allowed Pre-proline 0 CA--C 1.564 1.515 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -123.61 -15.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 N-CA-C 117.668 2.141 . . . . 0.0 117.668 -165.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.9 m -103.28 -140.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 126.607 1.963 . . . . 0.0 113.111 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.48 133.81 45.96 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.304 1.411 . . . . 0.0 111.837 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.504 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -95.54 -17.47 21.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -86.09 163.67 17.75 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.221 -0.924 . . . . 0.0 111.649 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -136.43 148.96 48.02 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 173.2 11.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.173 2.589 . . . . 0.0 109.635 175.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 79.7 m -98.26 132.55 43.67 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.531 -1.356 . . . . 0.0 112.096 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -107.6 172.85 6.6 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 127.188 2.195 . . . . 0.0 109.315 174.49 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 CA--C 1.539 0.767 0 CA-C-O 120.85 0.271 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 124.386 1.074 . . . . 0.0 111.351 174.83 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B 1140 ' ' VAL . . . . . 0.431 HG12 ' C ' ' A' ' 83' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 125.949 2.785 . . . . 0.0 106.771 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B 1141 ' ' ASN . . . . . 0.666 ' HB2' HD12 ' A' ' 70' ' ' ILE . 2.3 m-80 158.86 -47.94 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.776 3 C-N-CA 144.495 9.118 . . . . 0.0 92.216 -173.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.342 2.6 mp0 -140.85 157.86 66.55 Favored Pre-proline 0 N--CA 1.43 -1.43 1 C-N-CA 134.025 4.93 . . . . 0.0 105.808 170.196 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.62 58.58 3.2 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 CA-C-N 122.206 1.824 . . . . 0.0 110.123 150.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B 1144 ' ' ASP . . . . . . . . . . . . 0.256 27.6 t70 . . . . . 0 C--O 1.253 1.276 1 C-N-CA 135.922 5.689 . . . . 0.0 117.377 -173.715 . . . . . . . . 2 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.4 m0 . . . . . 0 CA--C 1.552 1.047 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -132.84 136.73 46.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.982 1.313 . . . . 0.0 114.502 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -142.61 155.25 44.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.06 2.144 . . . . 0.0 109.76 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.75 33.01 2.08 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 122.927 2.603 . . . . 0.0 112.78 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 tpt85 -137.99 7.66 2.7 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 118.904 1.352 . . . . 0.0 114.387 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.313 7.1 tp -104.48 67.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 122.752 1.263 . . . . 0.0 110.182 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 m -46.45 152.18 0.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.651 1.981 . . . . 0.0 112.538 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -32.42 3.77 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.74 -30.9 40.99 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.691 0.996 . . . . 0.0 113.691 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -81.73 -43.36 18.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.486 1.114 . . . . 0.0 113.136 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -65.61 -32.53 74.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.16 -0.962 . . . . 0.0 112.621 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -67.68 -21.33 65.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -74.39 -28.69 61.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.718 0.807 . . . . 0.0 111.905 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.56 -51.83 4.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.106 1.362 . . . . 0.0 112.312 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.14 -12.72 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.614 1.566 . . . . 0.0 111.566 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.67 8.81 66.25 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.491 -1.381 . . . . 0.0 113.867 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -77.66 -10.56 59.59 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.773 1.229 . . . . 0.0 112.073 174.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.347 0.0 OUTLIER -140.45 136.52 33.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.407 1.483 . . . . 0.0 113.552 176.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.66 67.32 0.23 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.544 1.545 . . . . 0.0 114.983 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.06 -176.51 5.56 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.808 0.843 . . . . 0.0 110.827 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.26 142.12 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.461 -1.399 . . . . 0.0 108.425 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -45.91 -21.97 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 113' ' ' HIS . . . -94.8 21.22 44.72 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.495 -1.229 . . . . 0.0 115.293 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 42' ' ' LEU . 3.9 mm? -98.67 62.06 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 171.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -96.63 163.16 13.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 -170.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -122.61 150.27 42.87 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.452 1.901 . . . . 0.0 109.519 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.04 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.28 167.31 22.45 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 125.068 1.347 . . . . 0.0 109.011 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -142.89 -158.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -131.29 159.79 36.83 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 122.709 1.243 . . . . 0.0 108.747 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 113.475 -1.693 . . . . 0.0 107.861 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -98.25 -63.81 1.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 129.292 3.037 . . . . 0.0 108.133 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -60.66 121.04 58.11 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 120.606 1.548 . . . . 0.0 110.047 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.85 -15.18 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.773 2.316 . . . . 0.0 113.104 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -125.7 32.72 5.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.163 2.185 . . . . 0.0 110.895 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.28 128.17 9.46 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 58.6 m-85 -143.88 78.24 1.58 Allowed 'General case' 0 CA--C 1.558 1.288 1 C-N-CA 131.738 4.015 . . . . 0.0 110.492 174.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.45 142.73 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 126.291 1.836 . . . . 0.0 113.049 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.6 130.53 45.84 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 p -127.33 120.25 28.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.186 1.357 . . . . 0.0 109.152 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -96.04 151.13 19.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.203 1.001 . . . . 0.0 112.565 -172.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.8 t -117.03 65.55 0.72 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.472 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.257 24.7 t60 -81.33 178.82 8.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.472 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.423 3.1 pp -99.03 27.31 5.12 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.624 2.77 . . . . 0.0 117.843 -173.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -150.54 -43.72 0.12 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 112.06 -2.336 . . . . 0.0 111.649 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 179.71 7.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.496 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.02 122.61 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -129.93 167.36 18.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.64 1.176 . . . . 0.0 112.662 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -126.39 139.91 52.9 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -173.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -107.53 65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.275 1.83 . . . . 0.0 113.703 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.9 tm? -144.74 134.44 23.52 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.13 -1.606 . . . . 0.0 114.748 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' B' 1141 ' ' ASN . 7.9 mt -141.42 -36.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 120.53 1.514 . . . . 0.0 112.948 170.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 160.12 61.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -77.39 -177.98 4.25 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.408 3.405 . . . . 0.0 111.752 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 p -61.15 144.76 53.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -129.84 -175.36 3.58 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.247 1.419 . . . . 0.0 110.808 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.56 -3.37 33.5 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -99.31 10.23 41.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.247 1.419 . . . . 0.0 111.702 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.68 -161.87 28.07 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 128.046 2.736 . . . . 0.0 109.66 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -115.1 -122.58 0.29 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 116.419 -1.753 . . . . 0.0 106.469 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -58.65 113.85 2.22 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -82.26 120.2 25.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.481 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.46 12.9 p90 -151.33 162.63 40.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 118.638 2.829 . . . . 0.0 118.638 173.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -150.98 -146.34 0.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 0.0 112.093 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.461 ' HA ' HG12 ' B' 1140 ' ' VAL . 32.1 mtt -155.38 -171.41 3.78 Favored 'General case' 0 C--N 1.316 -0.865 1 C-N-CA 134.049 4.939 . . . . 0.0 106.653 -173.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.37 -30.63 68.67 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -140.65 61.23 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.277 1.431 . . . . 0.0 111.373 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.68 174.76 22.46 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -141.92 47.52 1.63 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.07 1.748 . . . . 0.0 113.11 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.51 9.4 p -75.25 -2.08 26.4 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 121.466 3.876 . . . . 0.0 121.466 -173.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.481 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 40.9 ptt180 -44.61 36.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 1 C-N-CA 133.534 4.733 . . . . 0.0 120.832 173.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -125.36 160.58 29.0 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.919 -1.738 . . . . 0.0 111.761 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.8 m -56.5 135.82 54.32 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.979 0.911 . . . . 0.0 111.623 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.17 -39.77 89.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.0 -42.34 98.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.937 0.335 . . . . 0.0 111.792 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.08 -41.99 81.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.28 0.632 . . . . 0.0 111.31 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -68.08 -33.05 73.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.37 -43.76 20.54 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.684 0.675 . . . . 0.0 112.23 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.2 t -69.91 -63.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 119.255 0.934 . . . . 0.0 110.324 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -83.45 -57.65 3.16 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.321 44.0 m-85 -81.47 22.23 0.72 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -79.54 -42.74 24.47 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 121.496 1.953 . . . . 0.0 113.705 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -18.92 60.36 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt -140.14 56.97 1.61 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.316 1.847 . . . . 0.0 110.178 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.04 -156.82 0.15 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.835 0.854 . . . . 0.0 110.454 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.46 4.42 9.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.704 1.602 . . . . 0.0 112.54 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.88 -141.72 0.69 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.437 2.446 . . . . 0.0 115.786 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.55 153.77 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 111.716 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mt -34.88 -56.12 0.89 Allowed Pre-proline 0 CA--C 1.563 1.467 0 CA-C-O 116.272 -1.823 . . . . 0.0 115.841 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -115.17 -33.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.37 0 N-CA-C 117.589 2.111 . . . . 0.0 117.589 -169.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.9 m -91.17 -125.89 0.08 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.042 1.737 . . . . 0.0 114.413 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.93 155.66 19.36 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.637 1.575 . . . . 0.0 111.82 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -8.51 10.24 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -115.87 148.24 40.19 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.874 1.67 . . . . 0.0 113.513 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 7.6 m-70 -101.08 150.31 23.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.378 1.071 . . . . 0.0 111.26 174.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 76.9 m -130.38 -61.49 0.96 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 5.1 t -141.64 -158.48 0.87 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 111.232 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.2 m -134.19 135.85 43.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.866 2.467 . . . . 0.0 110.902 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 . . . . . 0 N--CA 1.478 0.955 0 C-N-CA 124.193 0.997 . . . . 0.0 111.057 174.401 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 CA--C 1.54 0.791 0 CA-C-O 120.974 0.323 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B 1138 ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' B' 1143 ' ' PRO . 15.7 pt-20 . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.049 1.339 . . . . 0.0 111.667 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1140 ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 83' ' ' MET . 2.2 t . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 115.777 -2.059 . . . . 0.0 115.588 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B 1141 ' ' ASN . . . . . 0.593 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.5 m-80 -54.89 -30.24 57.71 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 169.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1142 ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' 1140 ' ' VAL 0.342 4.1 mp0 -150.52 156.93 36.79 Favored Pre-proline 0 N--CA 1.424 -1.757 1 C-N-CA 136.69 5.996 . . . . 0.0 104.486 169.723 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' B' B 1143 ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' B' 1138 ' ' GLU . 56.7 Cg_endo -71.23 60.84 2.54 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 CA-C-N 120.95 1.375 . . . . 0.0 109.638 152.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 C--O 1.253 1.284 1 C-N-CA 134.719 5.207 . . . . 0.0 116.001 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -137.09 128.48 28.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.237 1.018 . . . . 0.0 112.33 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -140.11 138.18 35.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.453 2.701 . . . . 0.0 106.968 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.62 46.58 1.03 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-N 123.073 2.67 . . . . 0.0 114.06 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.22 48.3 1.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.48 1.609 . . . . 0.0 108.912 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.1 tp -150.67 68.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.126 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -50.61 157.2 0.78 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.733 1.613 . . . . 0.0 113.259 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -45.03 -37.37 4.05 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -77.35 -25.62 51.22 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.404 1.081 . . . . 0.0 113.859 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -81.55 -48.72 11.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.083 1.753 . . . . 0.0 111.66 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -68.56 -26.88 65.63 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.045 0.938 . . . . 0.0 112.895 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.41 -19.32 65.44 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.716 1.144 . . . . 0.0 113.555 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -77.79 -29.22 50.73 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.029 0.831 . . . . 0.0 111.735 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.54 -48.56 7.23 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 111.964 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.28 -9.42 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.973 0.909 . . . . 0.0 111.368 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.31 -0.05 59.84 Favored Glycine 0 N--CA 1.472 1.084 0 O-C-N 120.085 -1.635 . . . . 0.0 115.013 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.94 -13.36 58.97 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 117.833 0.817 . . . . 0.0 110.021 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.75 154.78 23.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.244 1.818 . . . . 0.0 112.094 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.41 26.36 2.56 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.75 1.167 . . . . 0.0 114.716 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.45 -166.95 1.29 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.163 1.385 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 m -53.91 151.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.026 0.93 . . . . 0.0 110.447 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 5.3 m-20 -50.7 -18.7 0.76 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.75 28.02 16.28 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.67 2.081 . . . . 0.0 116.526 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.59 74.21 3.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.294 2.047 . . . . 0.0 106.471 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.468 ' CD2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.1 tp -141.01 145.24 35.67 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.824 1.65 . . . . 0.0 111.348 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -98.23 68.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 119.891 1.223 . . . . 0.0 110.393 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -99.67 158.35 15.83 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 124.032 0.933 . . . . 0.0 111.465 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.6 pm0 -141.64 -160.46 1.09 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.2 t -140.15 158.49 43.96 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 122.352 1.072 . . . . 0.0 109.658 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 1.5 pp0? -97.34 8.44 44.58 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.64 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -98.55 -68.29 0.81 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 129.07 2.948 . . . . 0.0 110.439 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.59 119.38 46.64 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 122.756 2.526 . . . . 0.0 109.419 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.49 -12.41 18.67 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.008 2.472 . . . . 0.0 114.866 -159.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' O ' HD21 ' A' ' 69' ' ' LEU . 94.4 mt-30 -120.44 36.17 4.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.961 2.504 . . . . 0.0 109.203 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' HG ' ' A' ' 69' ' ' LEU . . . -98.46 123.23 7.8 Favored Glycine 0 C--N 1.349 1.293 1 N-CA-C 124.568 4.587 . . . . 0.0 124.568 -172.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.462 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 20.3 m-85 -144.49 77.57 1.54 Allowed 'General case' 0 CA--C 1.558 1.262 1 C-N-CA 132.665 4.386 . . . . 0.0 109.749 174.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.601 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.42 153.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 127.164 2.186 . . . . 0.0 112.724 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.468 HD22 ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -113.25 129.58 56.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 p -111.55 118.09 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.3 mt -96.53 147.47 23.83 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.423 0.689 . . . . 0.0 111.865 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.461 ' HA ' HG12 ' A' ' 65' ' ' VAL . 33.8 t -114.76 66.03 0.68 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.28 0.4 OUTLIER -70.06 -168.18 0.2 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 112.852 -1.977 . . . . 0.0 112.394 -173.603 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.512 0.3 OUTLIER -96.85 4.39 51.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.836 3.273 . . . . 0.0 119.836 -173.507 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.329 7.1 pt20 -149.75 -16.14 0.27 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 118.361 -1.336 . . . . 0.0 114.372 169.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -150.57 173.11 14.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.518 1.127 . . . . 0.0 110.737 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 60' ' ' CYS . 16.5 m -123.35 110.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -120.47 161.77 20.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.72 1.608 . . . . 0.0 112.03 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 90.9 m-70 -106.23 163.57 12.7 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.013 1.325 . . . . 0.0 112.783 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -117.48 13.44 14.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 118.259 2.688 . . . . 0.0 118.259 -172.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 69' ' ' LEU . 2.3 tm? -113.27 133.65 54.99 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -173.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.1 mt -141.72 -42.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.695 0.798 . . . . 0.0 110.849 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -119.77 151.37 52.11 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -92.01 -174.31 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.901 3.734 . . . . 0.0 112.003 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 m -60.24 145.06 48.71 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.486 -0.759 . . . . 0.0 112.191 174.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -120.7 -170.06 1.93 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.276 1.43 . . . . 0.0 111.935 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.83 -14.47 19.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.115 0.966 . . . . 0.0 112.832 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -110.97 8.76 22.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.676 1.59 . . . . 0.0 113.659 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.42 168.74 38.82 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.778 1.656 . . . . 0.0 112.847 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -83.76 -145.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.948 1.299 . . . . 0.0 110.789 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -52.06 116.44 2.19 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.348 0.976 . . . . 0.0 109.16 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 134.95 36.12 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.436 ' H ' ' HB3' ' A' ' 89' ' ' ARG 0.293 28.9 m-85 -142.0 134.02 27.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.115 1.766 . . . . 0.0 113.602 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -140.45 20.7 2.38 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.0 ttp -26.98 149.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -52.63 -23.11 5.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -126.19 19.26 7.62 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.256 1.422 . . . . 0.0 112.61 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.06 162.34 26.77 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.511 1.529 . . . . 0.0 115.591 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -141.03 50.99 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.194 1.798 . . . . 0.0 108.506 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.563 10.5 p -76.38 10.97 1.74 Allowed 'General case' 0 N--CA 1.477 0.876 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -172.329 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 6.4 ptt180 -38.76 49.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 130.643 3.577 . . . . 0.0 120.609 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -137.29 165.12 26.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.213 2.605 . . . . 0.0 109.899 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -57.41 141.71 46.35 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.57 -33.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.86 -32.13 72.45 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -79.61 -33.94 41.12 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.745 0.702 . . . . 0.0 111.918 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.44 -35.35 60.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.552 2.341 . . . . 0.0 111.882 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.22 -40.11 67.34 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.775 2.03 . . . . 0.0 112.376 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.81 -50.26 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.877 0.871 . . . . 0.0 110.485 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.84 -88.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.012 1.325 . . . . 0.0 112.87 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -47.91 0.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 121.396 3.85 . . . . 0.0 121.396 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -56.08 -37.11 68.89 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 121.891 2.132 . . . . 0.0 113.392 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -15.77 61.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.63 39.86 1.86 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.206 1.403 . . . . 0.0 112.575 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -75.56 -161.8 0.17 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 125.34 1.456 . . . . 0.0 113.449 -174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -90.9 -0.38 57.71 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.883 1.673 . . . . 0.0 113.712 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 54.64 -152.2 12.91 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.87 1.7 . . . . 0.0 115.229 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.75 175.28 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.048 1.339 . . . . 0.0 111.686 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -41.56 -59.65 2.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -109.93 -46.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 122.613 1.969 . . . . 0.0 116.682 -166.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 74.3 m -94.68 -127.68 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -48.07 134.91 13.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.645 1.978 . . . . 0.0 115.082 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.447 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -87.94 -8.69 55.36 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -177.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -116.86 148.59 41.14 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.216 -0.927 . . . . 0.0 113.072 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -113.68 165.09 12.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.636 1.974 . . . . 0.0 110.499 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 5.9 m -136.87 -170.41 2.69 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.755 1.622 . . . . 0.0 112.066 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 82.8 m -99.13 135.61 40.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.28 1.032 . . . . 0.0 110.086 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -125.75 171.29 10.76 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.88 1.272 . . . . 0.0 113.054 -173.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 . . . . . 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 110.575 174.559 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.54 0.81 0 CA-C-O 120.82 0.258 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 CA--C 1.554 1.098 0 C-N-CA 125.876 1.67 . . . . 0.0 110.543 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B 1140 ' ' VAL . . . . . 0.413 ' C ' ' N ' ' B' 1142 ' ' GLN . 2.7 t . . . . . 0 N--CA 1.507 2.414 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.278 11.8 m-80 -56.41 -27.95 57.92 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B 1142 ' ' GLN . . . . . 0.413 ' N ' ' C ' ' B' 1140 ' ' VAL 0.314 4.3 mp0 -158.62 157.86 28.94 Favored Pre-proline 0 N--CA 1.433 -1.304 1 C-N-CA 135.932 5.693 . . . . 0.0 104.962 168.554 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.67 60.67 2.18 Favored 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 121.891 1.711 . . . . 0.0 109.392 149.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.254 1.33 1 C-N-CA 134.044 4.938 . . . . 0.0 115.896 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 121.827 0.823 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -150.56 112.92 4.65 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.162 1.385 . . . . 0.0 111.508 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -140.97 155.62 46.2 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.636 1.974 . . . . 0.0 109.962 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.8 0.65 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 122.261 2.3 . . . . 0.0 111.949 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.255 32.9 tpt85 -148.63 42.06 0.97 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.008 1.385 . . . . 0.0 111.096 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.78 63.77 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.563 1.145 . . . . 0.0 110.071 -174.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 t -55.38 151.03 10.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -48.31 -30.79 5.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.029 2.531 . . . . 0.0 116.756 -173.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -79.79 -35.43 38.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.147 0.979 . . . . 0.0 112.713 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.71 -40.36 22.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.034 . . . . 0.0 112.376 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.04 -37.37 71.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.484 1.114 . . . . 0.0 112.319 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.22 -16.77 64.28 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -80.12 -27.59 39.11 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.239 1.016 . . . . 0.0 111.557 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.5 -49.75 5.28 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.582 1.553 . . . . 0.0 112.135 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.12 -12.46 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 124.309 1.044 . . . . 0.0 111.657 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.23 1.18 60.51 Favored Glycine 0 N--CA 1.474 1.172 0 O-C-N 120.45 -1.406 . . . . 0.0 114.948 -174.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -79.65 -13.9 59.17 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 117.973 0.887 . . . . 0.0 109.629 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.53 164.19 19.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.929 2.091 . . . . 0.0 112.291 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.64 30.2 3.83 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.306 1.431 . . . . 0.0 114.148 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.24 -172.45 3.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.896 1.678 . . . . 0.0 113.596 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.19 155.61 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.166 1.387 . . . . 0.0 111.28 174.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -49.3 -16.04 0.16 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.917 1.687 . . . . 0.0 115.283 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.75 7.19 70.62 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 127.02 2.248 . . . . 0.0 114.473 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.68 57.52 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.507 ' CG ' HD21 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -98.57 172.61 7.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.5 tp -138.74 139.5 38.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.802 2.041 . . . . 0.0 109.84 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.39 107.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.539 ' C ' ' HD2' ' A' ' 46' ' ' ARG . 5.3 ppt_? -141.3 176.18 9.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.08 2.152 . . . . 0.0 110.621 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -145.99 -146.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -141.72 168.77 18.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 125.338 1.455 . . . . 0.0 110.259 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.57 10.87 40.02 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.667 172.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -99.06 -82.25 0.44 Allowed 'General case' 0 N--CA 1.481 1.109 1 C-N-CA 133.94 4.896 . . . . 0.0 108.756 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -54.62 118.13 15.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 121.216 1.825 . . . . 0.0 111.034 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.99 -12.33 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.99 2.46 . . . . 0.0 113.26 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -116.52 33.0 5.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.801 2.44 . . . . 0.0 110.16 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.8 128.62 9.61 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 121.773 3.469 . . . . 0.0 121.773 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.473 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 46.9 m-85 -142.64 66.93 1.32 Allowed 'General case' 0 CA--C 1.56 1.356 1 C-N-CA 132.139 4.175 . . . . 0.0 110.759 174.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.41 146.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.799 1.761 . . . . 0.0 114.109 -174.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.507 HD21 ' CG ' ' A' ' 43' ' ' PHE . 1.9 tt -105.01 121.15 43.16 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 172.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p -108.91 118.19 36.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.0 160.42 14.47 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -171.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.5 t -122.57 53.39 1.26 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.43 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.299 2.5 t-80 -66.11 178.81 1.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -172.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.467 0.5 OUTLIER -97.9 12.34 34.41 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -172.832 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -147.07 -27.32 0.39 Allowed 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 125.211 1.569 . . . . 0.0 112.112 170.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 173.88 13.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.68 93.23 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.54 1.162 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.34 170.07 8.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.515 1.526 . . . . 0.0 112.154 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.457 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 87.0 m-70 -117.19 163.13 16.76 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.491 1.516 . . . . 0.0 112.336 -173.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.31 14.92 14.83 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -172.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -114.13 140.63 48.35 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.064 -2.273 . . . . 0.0 116.032 -173.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mm -141.38 -44.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.994 0.918 . . . . 0.0 110.059 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -121.32 158.91 52.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -89.71 -148.08 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.873 3.715 . . . . 0.0 110.225 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -66.55 152.44 45.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.789 1.236 . . . . 0.0 112.682 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -139.89 -177.36 4.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.241 1.416 . . . . 0.0 111.74 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.68 -18.15 18.2 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -108.88 18.5 20.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.862 1.265 . . . . 0.0 112.666 174.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.06 -161.34 23.92 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.483 2.468 . . . . 0.0 110.096 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -116.87 -127.27 0.29 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.3 112.99 1.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 89' ' ' ARG . 2.3 t80 -76.97 132.39 38.99 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -173.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . 0.252 25.0 m-85 -142.9 141.4 31.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.142 2.177 . . . . 0.0 112.553 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 p -149.66 21.59 0.91 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -27.82 152.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -28.02 3.3 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 119.19 3.033 . . . . 0.0 119.19 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.99 18.48 14.66 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.323 1.42 . . . . 0.0 113.628 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.24 172.81 23.64 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.304 1.681 . . . . 0.0 117.304 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.81 55.2 1.58 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 128.722 2.809 . . . . 0.0 107.207 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.487 16.1 p -71.89 2.1 6.06 Favored 'General case' 0 N--CA 1.474 0.767 1 N-CA-C 122.933 4.42 . . . . 0.0 122.933 -171.969 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.417 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 32.2 ptt180 -38.74 29.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 2 N-CA-C 122.96 4.429 . . . . 0.0 122.96 173.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.71 161.68 26.75 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.845 2.058 . . . . 0.0 110.154 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -62.03 140.41 58.37 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.07 -34.12 71.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.639 0.776 . . . . 0.0 112.479 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.84 -27.5 69.38 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.46 -35.61 63.32 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.606 0.762 . . . . 0.0 111.502 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -75.6 -37.95 59.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 111.436 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.5 tt -51.35 -42.3 61.22 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.95 1.7 . . . . 0.0 113.1 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.48 -42.35 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.602 0.761 . . . . 0.0 111.599 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -80.37 -32.91 37.58 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.051 1.34 . . . . 0.0 113.006 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -80.34 -13.14 59.41 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -58.47 -42.57 87.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.916 1.689 . . . . 0.0 113.757 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -82.14 -39.97 22.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.703 1.201 . . . . 0.0 113.346 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.5 mt -145.33 83.5 1.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.592 1.557 . . . . 0.0 111.614 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -70.71 133.57 46.73 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -73.24 -3.43 26.76 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 49.99 -157.87 1.71 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.641 2.067 . . . . 0.0 114.82 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.444 HG13 ' H ' ' A' ' 107' ' ' LEU . 4.0 tp -80.73 -175.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.473 0.709 . . . . 0.0 112.216 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.444 ' H ' HG13 ' A' ' 106' ' ' ILE . 15.7 mt -42.15 136.02 2.3 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.472 1.509 . . . . 0.0 110.839 173.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -80.16 51.53 3.95 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 N-CA-C 118.431 2.435 . . . . 0.0 118.431 -130.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 85.5 m -68.5 -55.77 10.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -179.53 5.93 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 129.418 3.087 . . . . 0.0 108.306 174.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.305 0.0 OUTLIER -139.03 -51.85 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.705 2.483 . . . . 0.0 117.705 -174.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -68.46 144.18 54.76 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.347 1.43 . . . . 0.0 113.323 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -107.58 165.78 11.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.217 1.407 . . . . 0.0 113.992 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 84.5 m -140.62 -157.23 0.75 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 128.029 2.532 . . . . 0.0 109.798 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.17 134.27 53.81 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.985 1.314 . . . . 0.0 109.782 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -109.62 170.09 8.29 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 . . . . . 0 N--CA 1.474 0.767 0 C-N-CA 124.713 1.205 . . . . 0.0 110.647 176.155 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 CA--C 1.539 0.767 0 CA-C-O 121.191 0.413 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 109.71 176.885 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.507 2.41 0 N-CA-C 118.425 2.75 . . . . 0.0 118.425 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.348 9.9 m-80 -61.75 -25.85 67.71 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.314 3.9 mp0 -155.76 154.38 27.83 Favored Pre-proline 0 N--CA 1.424 -1.762 1 C-N-CA 134.918 5.287 . . . . 0.0 105.196 168.381 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.81 58.51 2.67 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 CA-C-N 121.861 1.7 . . . . 0.0 109.256 151.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.3 t0 . . . . . 0 C--O 1.254 1.317 1 C-N-CA 134.606 5.162 . . . . 0.0 115.984 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.2 m0 . . . . . 0 CA--C 1.543 0.673 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -150.81 124.98 9.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -141.5 146.58 36.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.977 2.511 . . . . 0.0 109.128 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.7 24.96 4.04 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 123.427 2.831 . . . . 0.0 113.856 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -137.92 15.77 2.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.358 1.063 . . . . 0.0 113.122 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -100.84 70.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -46.28 151.73 0.49 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 112.995 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.283 0.0 OUTLIER -44.19 -40.3 4.97 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -73.83 -28.42 61.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.462 1.105 . . . . 0.0 113.237 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -81.04 -46.89 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.785 1.234 . . . . 0.0 111.396 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -68.11 -33.06 73.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 118.44 -0.791 . . . . 0.0 112.419 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.295 2.0 pt20 -68.77 -11.23 60.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 -80.94 -37.43 29.52 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.63 1.172 . . . . 0.0 110.704 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.3 mp -88.6 -45.06 10.18 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.779 1.632 . . . . 0.0 112.643 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.25 -12.64 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.399 1.079 . . . . 0.0 110.832 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.96 2.07 61.51 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.429 -1.419 . . . . 0.0 114.869 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 -12.81 59.34 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.783 0.833 . . . . 0.0 110.709 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.66 151.96 28.71 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.59 1.556 . . . . 0.0 112.873 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.15 20.19 4.52 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.127 1.346 . . . . 0.0 115.454 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.43 -173.04 3.85 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.21 150.96 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.165 0.986 . . . . 0.0 111.607 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 9.1 m-20 -49.11 -19.7 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -174.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 113' ' ' HIS . . . -97.65 22.65 39.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 127.502 2.477 . . . . 0.0 116.852 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.12 77.81 4.05 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 121.743 2.771 . . . . 0.0 106.689 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.79 165.48 11.93 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -173.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.5 tp -126.77 148.84 49.89 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.315 2.646 . . . . 0.0 109.178 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.02 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.19 165.84 26.42 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 125.714 1.606 . . . . 0.0 108.662 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.682 ' HA ' HG13 ' A' ' 56' ' ' VAL 0.265 5.3 pt-20 -141.56 -164.32 1.75 Allowed 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.486 -0.758 . . . . 0.0 110.422 173.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.12 148.09 52.46 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.266 1.2 pp0? -95.47 15.12 20.51 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.703 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -98.16 -72.7 0.64 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 131.959 4.104 . . . . 0.0 111.224 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -57.87 141.05 81.04 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-N 121.248 1.84 . . . . 0.0 113.605 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -85.54 -17.55 4.25 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.9 3.066 . . . . 0.0 115.121 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -118.34 26.41 9.63 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.997 2.119 . . . . 0.0 110.308 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.19 126.07 8.76 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 121.825 3.49 . . . . 0.0 121.825 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -143.58 94.19 2.57 Favored 'General case' 0 CA--C 1.545 0.777 1 C-N-CA 132.044 4.138 . . . . 0.0 103.384 173.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.682 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.283 1.3 m -99.0 138.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 121.261 1.846 . . . . 0.0 114.233 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.02 121.2 40.66 Favored 'General case' 0 CA--C 1.539 0.535 1 N-CA-C 99.901 -4.111 . . . . 0.0 99.901 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.3 p -119.33 122.13 41.14 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -95.28 177.53 5.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.433 ' HA ' HG12 ' A' ' 65' ' ' VAL . 32.2 t -129.57 66.07 1.47 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.51 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.265 0.4 OUTLIER -71.81 -171.64 0.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.16 -173.985 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.51 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.487 0.3 OUTLIER -97.03 6.65 48.22 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -173.521 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -146.08 -26.13 0.44 Allowed 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 124.961 1.413 . . . . 0.0 113.259 170.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -150.52 -178.03 6.31 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.834 0.854 . . . . 0.0 111.417 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 60' ' ' CYS . 16.5 m -125.32 114.08 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.97 0.89 . . . . 0.0 109.749 173.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -110.98 162.51 14.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.707 2.403 . . . . 0.0 111.816 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.81 159.26 32.9 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.431 ' CZ ' HG11 ' B' 1140 ' ' VAL . 12.8 m-85 -130.97 86.22 2.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.948 -1.72 . . . . 0.0 112.852 -174.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -141.75 28.63 1.76 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 122.216 4.154 . . . . 0.0 122.216 -173.733 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.35 -14.23 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 -170.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 mt -127.73 144.85 52.69 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.45 -170.61 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 125.014 3.81 . . . . 0.0 111.718 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -72.03 147.82 46.46 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.473 -1.392 . . . . 0.0 112.9 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -130.92 -177.38 4.35 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.943 0.897 . . . . 0.0 112.552 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.71 -5.09 32.17 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 111.903 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -99.51 15.81 25.32 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.3 1.84 . . . . 0.0 111.664 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.47 -156.72 25.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 127.153 2.311 . . . . 0.0 109.707 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -115.64 -126.16 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -59.87 115.25 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.75 131.2 39.66 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.486 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 16.3 m-85 -143.82 155.55 44.17 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 175.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -145.88 -164.24 1.91 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.261 2.224 . . . . 0.0 109.894 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.707 ' HA ' HG12 ' B' 1140 ' ' VAL . 67.1 mtm -156.73 -173.67 4.58 Favored 'General case' 0 C--N 1.314 -0.95 1 C-N-CA 136.424 5.89 . . . . 0.0 109.089 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.94 -29.5 65.54 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.49 44.62 1.85 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.48 1.112 . . . . 0.0 112.846 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.36 171.87 24.09 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.956 1.543 . . . . 0.0 116.956 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 56.7 1.48 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.801 2.041 . . . . 0.0 112.301 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 32.2 p -76.98 5.31 8.22 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 121.766 3.987 . . . . 0.0 121.766 -173.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.486 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 37.8 ptt180 -38.91 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 2 C-N-CA 132.875 4.47 . . . . 0.0 122.423 173.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -126.5 159.89 32.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.325 1.85 . . . . 0.0 111.182 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 m -64.23 137.64 58.04 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.441 -0.787 . . . . 0.0 110.665 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.56 -47.49 47.67 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -64.32 -33.72 76.49 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.93 -32.59 69.55 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.342 0.657 . . . . 0.0 112.289 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.75 -28.81 36.37 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.975 1.31 . . . . 0.0 112.296 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.88 -29.04 69.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.359 1.064 . . . . 0.0 113.29 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.6 t -70.11 -76.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.28 0.946 . . . . 0.0 110.832 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -81.9 -44.5 16.73 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.82 -0.84 49.89 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -66.1 -42.65 89.0 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 122.788 2.54 . . . . 0.0 113.81 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -80.16 -11.79 59.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.32 1.448 . . . . 0.0 114.361 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 65.08 1.34 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.536 1.534 . . . . 0.0 109.689 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -101.71 -163.56 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.311 1.444 . . . . 0.0 111.871 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -96.63 -1.6 46.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.569 1.548 . . . . 0.0 111.23 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 52.24 -146.29 15.45 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 126.631 2.062 . . . . 0.0 114.298 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.24 179.17 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.737 1.615 . . . . 0.0 112.023 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 mt -40.32 -55.9 3.85 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.395 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 109' ' ' CYS . 68.4 Cg_endo -122.44 -41.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 N-CA-C 118.191 2.343 . . . . 0.0 118.191 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.405 ' H ' ' HD2' ' A' ' 108' ' ' PRO . 71.6 m -90.39 -127.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.507 1.923 . . . . 0.0 115.967 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.56 142.19 23.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.833 1.653 . . . . 0.0 114.649 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.445 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -93.72 -6.88 45.18 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -174.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -110.95 152.67 26.51 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.522 1.129 . . . . 0.0 112.55 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 64.6 m-70 -125.06 160.14 29.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.417 1.487 . . . . 0.0 111.706 175.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 28.0 m -141.06 -162.82 1.43 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 130.025 3.33 . . . . 0.0 108.135 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.2 m -125.75 133.54 52.05 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.879 -1.138 . . . . 0.0 112.121 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -99.28 176.11 5.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.149 0.98 . . . . 0.0 111.678 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 125.754 1.622 . . . . 0.0 113.329 -175.651 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 CA--C 1.539 0.737 0 CA-C-O 121.291 0.455 . . . . 0.0 112.929 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 42.6 mp0 . . . . . 0 CA--C 1.551 0.992 0 C-N-CA 124.849 1.26 . . . . 0.0 112.597 178.147 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B 1140 ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 83' ' ' MET . 54.1 t . . . . . 0 N--CA 1.499 2.001 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.56 -29.5 51.33 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 102.193 -3.262 . . . . 0.0 102.193 169.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1142 ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' 1140 ' ' VAL 0.317 1.0 OUTLIER -161.44 157.34 21.47 Favored Pre-proline 0 N--CA 1.427 -1.621 1 C-N-CA 135.165 5.386 . . . . 0.0 105.574 168.443 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.79 52.65 0.72 Allowed 'Trans proline' 0 CA--C 1.554 1.502 0 C-N-CA 122.6 2.2 . . . . 0.0 111.381 152.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--O 1.255 1.364 1 C-N-CA 134.873 5.269 . . . . 0.0 114.793 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.886 0.85 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -143.29 134.45 25.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.196 1.398 . . . . 0.0 112.531 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -142.0 157.6 44.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.357 1.863 . . . . 0.0 109.694 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.96 23.4 2.61 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 121.956 2.162 . . . . 0.0 114.145 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -147.13 52.92 1.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.61 1.205 . . . . 0.0 110.952 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.261 7.4 tt -140.63 59.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 123.407 1.575 . . . . 0.0 109.101 174.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 t -43.58 153.19 0.12 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.844 2.458 . . . . 0.0 114.907 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.536 ' HE ' ' HG2' ' B' 1138 ' ' GLU . 0.0 OUTLIER -46.83 -34.31 5.22 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 -174.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.76 -27.73 36.66 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.35 -48.59 11.76 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.609 1.564 . . . . 0.0 113.473 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -63.53 -33.31 75.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.97 -17.31 63.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -75.61 -30.89 59.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.725 0.81 . . . . 0.0 112.085 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.3 -60.5 1.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.301 1.44 . . . . 0.0 111.803 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mt -81.37 -3.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.494 1.918 . . . . 0.0 112.974 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.79 8.33 68.19 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.155 -1.591 . . . . 0.0 115.028 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -80.39 -4.01 51.91 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.447 1.099 . . . . 0.0 112.637 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -71.66 145.78 48.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.562 1.145 . . . . 0.0 113.28 -175.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.18 15.73 39.28 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 125.584 1.564 . . . . 0.0 114.145 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.54 177.57 8.91 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.362 1.865 . . . . 0.0 113.544 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 41' ' ' GLY . 35.1 m -72.08 169.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 126.302 1.841 . . . . 0.0 115.27 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 35.1 m-20 -58.41 22.27 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.889 2.876 . . . . 0.0 115.425 174.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -141.81 10.79 2.62 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.52 71.62 2.31 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.931 2.366 . . . . 0.0 108.441 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.457 ' HB3' HD23 ' A' ' 59' ' ' LEU . 2.0 p90 -98.46 168.26 10.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.8 tp -138.48 153.26 48.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.804 2.442 . . . . 0.0 109.584 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.6 t -116.07 101.53 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.158 0.983 . . . . 0.0 108.739 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.19 28.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.546 1.938 . . . . 0.0 109.506 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 56' ' ' VAL . 8.2 pm0 -142.76 -154.16 0.51 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.697 0.761 . . . . 0.0 113.012 174.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -120.85 147.66 45.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 132.704 4.402 . . . . 0.0 108.277 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 7.51 46.17 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.573 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.35 -68.1 0.82 Allowed 'General case' 0 C--N 1.352 0.691 0 C-N-CA 130.184 3.394 . . . . 0.0 111.083 -174.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -78.85 116.79 62.59 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 122.997 2.635 . . . . 0.0 108.464 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.8 -15.96 51.15 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.758 2.306 . . . . 0.0 114.846 -168.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.64 13.98 9.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.632 2.373 . . . . 0.0 111.833 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.71 124.12 7.99 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 122.726 3.85 . . . . 0.0 122.726 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.528 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 60.0 m-85 -144.0 84.08 1.76 Allowed 'General case' 0 CA--C 1.564 1.505 1 C-N-CA 132.455 4.302 . . . . 0.0 110.595 174.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -98.24 144.11 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 119.817 -1.802 . . . . 0.0 113.299 -174.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 122.83 42.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 101.017 -3.698 . . . . 0.0 101.017 171.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 p -116.3 105.28 12.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 43' ' ' PHE . 1.5 mt -97.91 158.32 15.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -172.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.56 125.83 51.79 Favored 'General case' 0 CA--C 1.497 -1.079 1 N-CA-C 96.508 -5.367 . . . . 0.0 96.508 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.619 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.359 0.0 OUTLIER -112.7 -146.34 0.41 Allowed 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.881 1.363 . . . . 0.0 111.521 -171.348 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.619 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.271 14.6 tp -95.79 -7.09 38.07 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.275 5.4 pt20 -151.03 -17.9 0.21 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -150.4 -160.37 1.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.681 0.792 . . . . 0.0 111.792 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.96 141.79 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.746 1.218 . . . . 0.0 109.376 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -138.05 150.3 46.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.705 0.802 . . . . 0.0 111.363 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.19 144.24 43.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.178 0.991 . . . . 0.0 113.572 -173.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.91 69.42 1.27 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.5 tm? -142.16 123.04 14.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 115.584 -2.15 . . . . 0.0 111.925 174.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' B' 1141 ' ' ASN 0.255 38.7 mt -139.53 -41.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 122.843 2.565 . . . . 0.0 112.921 173.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.3 148.88 71.62 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 120.351 1.432 . . . . 0.0 114.162 -175.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -81.35 179.57 5.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.172 3.248 . . . . 0.0 111.387 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.07 139.52 56.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.93 -167.59 1.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.132 1.773 . . . . 0.0 111.369 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.33 -7.97 27.95 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -122.66 20.59 10.21 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.808 1.643 . . . . 0.0 112.845 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.07 -171.48 39.92 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.345 1.926 . . . . 0.0 111.381 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -121.73 -137.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 108.109 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.43 123.22 6.28 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.338 1.426 . . . . 0.0 107.725 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.89 137.26 36.86 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -146.09 130.79 17.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.489 1.916 . . . . 0.0 111.733 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 m -141.61 0.99 1.5 Allowed 'General case' 0 N--CA 1.492 1.672 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 -173.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.507 ' HB3' HG12 ' B' 1140 ' ' VAL . 5.5 ptt? -29.91 156.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 174.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.9 -31.0 16.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.53 2.21 13.78 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.615 1.166 . . . . 0.0 114.112 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.78 105.38 0.41 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.224 1.393 . . . . 0.0 114.757 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 54.1 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.014 1.726 . . . . 0.0 109.535 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.499 68.9 p -77.77 12.83 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 121.569 3.915 . . . . 0.0 121.569 -172.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -39.47 35.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 131.629 3.972 . . . . 0.0 121.049 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.77 174.57 9.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.281 2.632 . . . . 0.0 109.281 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -68.93 155.23 40.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.711 -1.243 . . . . 0.0 111.368 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.8 -41.13 65.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.582 -0.699 . . . . 0.0 112.653 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.03 -40.53 96.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.71 -33.91 60.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.943 0.497 . . . . 0.0 112.218 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -73.86 -34.03 64.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.534 1.134 . . . . 0.0 112.347 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.744 1.217 . . . . 0.0 112.646 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.4 -37.88 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.679 0.792 . . . . 0.0 111.812 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -80.4 -34.77 36.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.789 1.235 . . . . 0.0 112.691 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -80.63 -15.27 57.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.69 -48.83 63.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.585 1.154 . . . . 0.0 113.752 -174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -81.93 -44.62 16.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.673 1.189 . . . . 0.0 113.267 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.43 88.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.945 1.698 . . . . 0.0 110.747 -175.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -69.56 172.58 7.12 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.975 0.91 . . . . 0.0 110.328 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -101.31 4.81 41.99 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.779 1.632 . . . . 0.0 112.32 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.17 -141.78 0.52 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 128.0 2.714 . . . . 0.0 115.067 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.431 HG21 ' HB2' ' A' ' 61' ' ' HIS . 8.0 tp -107.93 161.37 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.231 1.812 . . . . 0.0 109.245 174.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -31.33 -45.68 0.32 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 119.007 2.966 . . . . 0.0 119.007 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -75.36 -157.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.581 2.854 . . . . 0.0 116.829 -173.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 92.4 m -45.8 -59.21 2.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.639 3.176 . . . . 0.0 118.186 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.99 156.34 19.81 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.84 1.2 . . . . 0.0 111.91 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -14.89 3.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -108.54 141.19 40.81 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.77 1.623 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -93.69 169.57 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 86.4 m -136.36 -154.78 0.58 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.65 2.38 . . . . 0.0 109.307 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.0 m -121.06 123.37 42.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.587 1.155 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 t -103.61 168.52 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.7 1.2 . . . . 0.0 112.74 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 124.44 1.096 . . . . 0.0 112.24 175.675 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 CA--C 1.539 0.762 0 N-CA-C 111.497 -0.232 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B 1138 ' ' GLU . . . . . 0.536 ' HG2' ' HE ' ' A' ' 26' ' ' ARG . 8.3 tt0 . . . . . 0 CA--C 1.546 0.789 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.805 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1140 ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 83' ' ' MET 0.319 95.2 t . . . . . 0 N--CA 1.504 2.262 0 N-CA-C 119.852 3.278 . . . . 0.0 119.852 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B 1141 ' ' ASN . . . . . 0.579 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.2 m-80 -67.15 -17.91 65.06 Favored 'General case' 0 CA--C 1.579 2.087 1 N-CA-C 99.14 -4.393 . . . . 0.0 99.14 165.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1142 ' ' GLN . . . . . 0.414 ' N ' ' C ' ' B' 1140 ' ' VAL . 49.6 mm-40 -132.44 4.43 0.04 OUTLIER Pre-proline 0 C--N 1.384 2.078 1 N-CA-C 125.509 5.374 . . . . 0.0 125.509 173.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo 6.16 58.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.892 1.728 . . . . 0.0 113.567 -126.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B 1144 ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' B' 1142 ' ' GLN . 34.7 t70 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 133.05 4.54 . . . . 0.0 116.993 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 . . . . . 0 CA--C 1.544 0.725 0 CA-C-O 121.372 0.606 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -141.07 150.23 42.66 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -141.03 148.23 39.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 128.398 2.679 . . . . 0.0 108.912 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.36 41.28 1.3 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 123.15 2.705 . . . . 0.0 112.532 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -142.58 31.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.004 1.383 . . . . 0.0 110.721 174.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.09 79.67 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.67 1.188 . . . . 0.0 108.141 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 m -52.58 154.57 2.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.678 1.591 . . . . 0.0 112.325 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -47.15 -39.35 13.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.48 -34.61 74.6 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.916 1.286 . . . . 0.0 112.779 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -81.75 -43.98 17.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.275 1.03 . . . . 0.0 111.598 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 t -62.15 -36.45 81.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.521 1.128 . . . . 0.0 112.361 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.9 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttp-105 -79.12 -35.64 41.89 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.914 0.779 . . . . 0.0 111.54 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -83.39 -45.27 13.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.251 1.42 . . . . 0.0 112.574 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.26 -7.5 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.923 0.889 . . . . 0.0 111.236 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.37 -0.97 59.36 Favored Glycine 0 N--CA 1.471 0.997 0 O-C-N 119.966 -1.709 . . . . 0.0 116.46 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.48 -3.78 58.96 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.93 1.365 . . . . 0.0 111.219 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.56 152.78 29.93 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.92 1.688 . . . . 0.0 111.743 174.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.6 22.42 3.17 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.667 1.127 . . . . 0.0 115.086 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.13 -170.5 2.76 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.398 1.479 . . . . 0.0 112.032 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -54.87 156.92 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.951 1.3 . . . . 0.0 111.392 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 6.9 m-20 -46.54 -24.3 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.58 ' HA2' ' CD2' ' A' ' 113' ' ' HIS . . . -99.63 43.46 1.81 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 119.804 2.682 . . . . 0.0 119.804 -173.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.87 75.43 0.96 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.461 ' CD2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -98.26 171.65 8.07 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 117.278 2.325 . . . . 0.0 117.278 -172.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -141.47 142.69 33.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 0.0 110.107 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.53 93.51 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.07 161.77 24.88 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.36 1.464 . . . . 0.0 110.039 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' HA ' HG13 ' A' ' 56' ' ' VAL . 4.4 pm0 -141.56 -158.62 0.88 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -140.48 163.39 32.96 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 123.475 1.607 . . . . 0.0 109.862 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.26 1.3 pp0? -96.11 11.97 32.34 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.836 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -97.49 -73.85 0.59 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 131.632 3.973 . . . . 0.0 108.321 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.89 120.58 47.63 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 121.399 1.909 . . . . 0.0 109.588 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.29 -13.87 23.05 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.919 2.413 . . . . 0.0 113.976 -168.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -125.59 30.88 5.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.278 2.231 . . . . 0.0 110.467 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.48 132.32 10.93 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 122.505 3.762 . . . . 0.0 122.505 -172.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.408 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 38.2 m-85 -144.02 76.29 1.5 Allowed 'General case' 0 CA--C 1.559 1.303 1 C-N-CA 131.786 4.034 . . . . 0.0 109.019 174.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.44 154.79 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.129 2.172 . . . . 0.0 113.046 -174.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' A' ' 43' ' ' PHE . 1.2 mt -111.36 131.45 55.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 172.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.5 p -113.74 113.52 25.08 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -97.2 153.27 18.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.45 ' HA ' HG12 ' A' ' 65' ' ' VAL . 41.8 t -115.03 63.31 0.68 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.5 ' CG ' ' H ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -66.8 -170.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.706 -173.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.5 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.504 0.3 OUTLIER -97.01 7.83 45.8 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 119.696 3.221 . . . . 0.0 119.696 -173.582 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -142.29 -28.57 0.6 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.034 1.459 . . . . 0.0 112.554 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.8 179.75 7.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.943 0.897 . . . . 0.0 111.243 174.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 60' ' ' CYS . 5.0 m -116.48 116.69 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -128.93 160.08 33.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.807 1.643 . . . . 0.0 112.705 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.496 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 91.3 m-70 -101.31 165.24 11.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.522 1.529 . . . . 0.0 113.689 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -133.63 47.6 2.44 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.523 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.7 tm? -142.47 135.48 28.48 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.513 -1.992 . . . . 0.0 113.993 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' B' 1141 ' ' ASN . 52.4 mt -140.36 -43.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.245 0.929 . . . . 0.0 111.05 171.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.98 155.3 68.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -83.32 -176.12 2.65 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.754 3.636 . . . . 0.0 111.877 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -54.03 141.13 29.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.478 1.111 . . . . 0.0 113.861 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -123.56 -170.82 2.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.882 1.273 . . . . 0.0 111.714 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.16 -13.86 20.68 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.015 1.326 . . . . 0.0 112.3 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -99.1 5.58 46.88 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.618 1.567 . . . . 0.0 113.517 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -170.1 -157.7 12.8 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.107 1.337 . . . . 0.0 113.478 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -106.93 -137.14 0.36 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.844 1.258 . . . . 0.0 108.79 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.69 123.22 16.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.87 132.11 37.82 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.413 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 6.6 m-85 -150.17 161.65 41.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.178 1.791 . . . . 0.0 114.698 174.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' B' 1141 ' ' ASN 0.253 1.5 m -145.31 -160.54 1.15 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.905 1.282 . . . . 0.0 108.746 173.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.46 ' HA ' ' CG1' ' B' 1140 ' ' VAL . 9.0 ttm -155.65 -179.93 8.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 129.398 3.079 . . . . 0.0 107.952 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.62 -30.56 70.17 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.12 -0.988 . . . . 0.0 110.13 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.31 40.19 1.91 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.914 1.286 . . . . 0.0 112.669 174.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 179.48 19.56 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 63.83 1.42 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.173 2.189 . . . . 0.0 111.919 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.545 24.6 p -78.4 2.44 18.74 Favored 'General case' 0 N--CA 1.487 1.377 1 N-CA-C 123.352 4.575 . . . . 0.0 123.352 -172.795 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.413 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 27.5 ptt180 -40.36 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 1 C-N-CA 132.377 4.271 . . . . 0.0 119.872 172.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.86 159.79 35.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.499 1.919 . . . . 0.0 112.69 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 m -61.36 136.61 58.1 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.092 1.357 . . . . 0.0 112.715 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.19 -30.16 68.3 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.67 -41.28 99.0 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.903 0.774 . . . . 0.0 112.412 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.4 -39.52 74.44 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.756 -0.59 . . . . 0.0 111.085 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -64.19 -30.56 71.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.437 1.095 . . . . 0.0 112.748 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -76.43 -45.23 32.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.417 1.087 . . . . 0.0 111.94 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.9 -57.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.726 0.694 . . . . 0.0 111.853 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -82.77 -51.03 8.06 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.309 54.3 m-85 -79.85 7.04 9.53 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -173.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -54.72 -29.51 53.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 121.408 1.913 . . . . 0.0 112.941 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.51 -26.59 51.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.692 1.997 . . . . 0.0 114.572 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.6 mt -147.02 71.92 1.24 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.06 2.544 . . . . 0.0 106.773 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.09 159.85 16.49 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 59.59 3.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.93 2.092 . . . . 0.0 111.548 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.27 -154.02 2.04 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 125.54 1.543 . . . . 0.0 113.687 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 tp -79.5 -179.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.836 1.654 . . . . 0.0 111.987 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.4 mt -40.1 139.23 1.03 Allowed Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.769 -1.586 . . . . 0.0 110.586 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -56.17 71.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 125.025 3.817 . . . . 0.0 119.894 -159.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.6 m -103.54 -128.98 0.24 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 129.069 2.948 . . . . 0.0 107.592 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.55 73.5 8.59 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.619 -1.3 . . . . 0.0 108.909 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -2.81 6.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -84.42 56.05 3.64 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.803 1.241 . . . . 0.0 111.103 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.58 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -60.97 141.43 57.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.768 1.627 . . . . 0.0 114.26 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.98 -171.33 2.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 129.402 3.081 . . . . 0.0 109.282 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.79 140.12 33.45 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.1 t -99.85 175.99 5.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.109 1.764 . . . . 0.0 111.865 174.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 . . . . . 0 N--CA 1.476 0.827 0 C-N-CA 125.487 1.515 . . . . 0.0 112.647 -174.757 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 CA--C 1.54 0.792 0 CA-C-O 120.767 0.236 . . . . 0.0 112.653 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 . . . . . 0 CA--C 1.542 0.661 0 C-N-CA 124.992 1.317 . . . . 0.0 112.427 -179.483 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B 1140 ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 83' ' ' MET . 26.7 t . . . . . 0 N--CA 1.501 2.104 0 CA-C-O 116.079 -1.915 . . . . 0.0 114.7 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1141 ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -60.15 -28.5 67.95 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 169.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.352 3.7 mp0 -154.25 158.42 32.39 Favored Pre-proline 0 N--CA 1.435 -1.212 1 C-N-CA 137.216 6.206 . . . . 0.0 104.348 169.775 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 60.26 2.06 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 CA-C-N 121.585 1.602 . . . . 0.0 110.261 152.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.1 t0 . . . . . 0 C--O 1.254 1.322 1 C-N-CA 134.446 5.098 . . . . 0.0 115.652 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -117.75 138.09 52.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -141.92 177.84 7.92 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.598 2.759 . . . . 0.0 108.607 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.16 -130.3 3.81 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 121.913 2.142 . . . . 0.0 112.773 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 61.3 ttp85 -51.03 122.49 7.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.315 2.057 . . . . 0.0 115.929 -172.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.87 78.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 1 N-CA-C 99.146 -4.39 . . . . 0.0 99.146 173.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -30.91 121.18 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.977 2.511 . . . . 0.0 115.051 -171.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -24.93 63.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.45 1.9 . . . . 0.0 113.65 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -80.98 -39.2 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.166 1.386 . . . . 0.0 112.805 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.88 -40.62 22.13 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.105 1.362 . . . . 0.0 113.695 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -56.01 -32.65 64.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.193 1.397 . . . . 0.0 113.781 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.463 ' HA ' ' CG2' ' A' ' 65' ' ' VAL 0.266 1.5 pt20 -64.14 -15.84 60.61 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 174.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -80.61 -28.38 37.04 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.117 0.967 . . . . 0.0 112.038 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.13 -59.02 1.81 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.502 1.521 . . . . 0.0 112.588 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.15 -6.47 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 126.431 1.892 . . . . 0.0 111.63 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.53 7.06 65.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 119.965 -1.709 . . . . 0.0 114.348 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -7.78 59.11 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.021 0.911 . . . . 0.0 110.126 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 142.63 50.19 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.256 1.422 . . . . 0.0 110.355 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.73 27.76 5.37 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.709 1.147 . . . . 0.0 115.586 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.57 179.58 7.68 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.343 1.071 . . . . 0.0 112.357 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.25 149.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.422 0.689 . . . . 0.0 111.68 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.16 2.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.37 15.76 22.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.439 2.447 . . . . 0.0 116.911 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.64 71.16 4.23 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.196 2.498 . . . . 0.0 105.147 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.39 174.24 6.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -140.52 162.27 35.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.33 2.652 . . . . 0.0 109.033 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.28 107.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.299 1.04 . . . . 0.0 109.31 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' HH11 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.54 164.92 28.91 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.624 1.97 . . . . 0.0 107.899 -177.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.889 ' HA ' HG13 ' A' ' 56' ' ' VAL . 15.4 pt-20 -141.05 -172.53 3.5 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.2 t -98.37 138.55 35.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.429 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.427 ' H ' ' HB2' ' A' ' 23' ' ' ARG 0.358 0.0 OUTLIER -98.2 5.53 48.37 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.661 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -113.47 -43.37 3.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 128.46 2.704 . . . . 0.0 113.999 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -76.37 127.22 85.18 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 120.558 1.526 . . . . 0.0 111.733 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -69.67 -25.5 28.96 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.989 2.459 . . . . 0.0 116.664 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -110.39 23.97 13.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.929 . . . . 0.0 111.171 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.595 ' HA3' HD22 ' A' ' 69' ' ' LEU . . . -98.91 129.75 10.0 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 122.16 3.624 . . . . 0.0 122.16 -172.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -144.32 121.54 11.53 Favored 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.899 4.879 . . . . 0.0 102.181 173.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.889 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.325 0.9 OUTLIER -125.11 138.94 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 123.552 2.887 . . . . 0.0 112.787 -174.954 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 tt -98.6 126.11 44.07 Favored 'General case' 0 CA--C 1.536 0.438 1 N-CA-C 99.546 -4.242 . . . . 0.0 99.546 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 p -125.64 112.05 15.69 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.873 1.215 . . . . 0.0 108.243 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.31 167.16 11.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.607 1.163 . . . . 0.0 111.502 -173.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.493 ' HA ' HG12 ' A' ' 65' ' ' VAL . 49.7 t -126.33 94.97 4.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.561 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.326 0.0 OUTLIER -90.72 -161.84 0.84 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.008 -173.077 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.532 0.3 OUTLIER -96.88 13.07 30.0 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 -174.287 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -147.4 -36.24 0.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.107 -1.861 . . . . 0.0 112.16 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -151.1 -177.55 6.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 60' ' ' CYS . 5.0 m -100.03 127.41 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 173.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -128.96 146.4 50.98 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.206 1.402 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -117.66 159.93 22.13 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -172.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.429 ' CZ ' HG11 ' B' 1140 ' ' VAL . 8.6 m-85 -131.87 84.05 2.14 Favored 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.596 1.558 . . . . 0.0 115.196 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.595 HD22 ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -136.3 19.51 3.16 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 121.745 3.98 . . . . 0.0 121.745 -174.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 mt -93.07 4.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 118.949 -2.344 . . . . 0.0 116.534 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.4 mt -135.78 138.95 29.31 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.749 1.159 . . . . 0.0 111.85 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -84.93 -176.95 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.297 3.331 . . . . 0.0 111.195 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 m -62.56 147.01 50.41 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.707 -1.246 . . . . 0.0 112.331 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -125.03 -176.67 3.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.336 1.054 . . . . 0.0 111.963 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -97.54 -8.72 28.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.75 0.82 . . . . 0.0 112.786 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -99.39 0.18 42.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.075 1.35 . . . . 0.0 112.552 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -162.4 -155.8 8.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.261 1.41 . . . . 0.0 114.233 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.64 -135.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.921 1.688 . . . . 0.0 108.794 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.98 117.33 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -84.12 126.45 33.1 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.507 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 25.9 m-85 -143.04 157.23 44.73 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.9 p -148.73 -159.2 1.0 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.839 2.056 . . . . 0.0 110.751 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.662 ' HA ' HG12 ' B' 1140 ' ' VAL . 46.9 mtt -155.54 -169.08 3.01 Favored 'General case' 0 C--N 1.314 -0.97 1 C-N-CA 137.309 6.244 . . . . 0.0 107.335 -172.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.21 -34.75 78.16 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.457 ' H ' HD21 ' A' ' 107' ' ' LEU . 25.3 t0 -141.18 60.76 1.5 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.937 1.695 . . . . 0.0 110.367 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.14 172.41 22.08 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -141.24 42.84 1.78 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.142 1.777 . . . . 0.0 114.01 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 2.3 p -70.95 -1.45 11.99 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 120.632 3.568 . . . . 0.0 120.632 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.507 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 2.5 ptm180 -43.21 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 1 C-N-CA 131.868 4.067 . . . . 0.0 119.817 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.81 166.35 24.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.805 2.442 . . . . 0.0 110.466 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -66.17 132.99 49.75 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.05 -1.031 . . . . 0.0 109.667 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.98 -46.2 24.81 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.75 -40.0 82.6 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.69 -28.28 68.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.58 0.752 . . . . 0.0 112.562 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -88.01 -20.63 25.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 112.329 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 tt -69.21 -55.29 11.03 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.92 -1.112 . . . . 0.0 111.192 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.76 -60.11 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.856 0.753 . . . . 0.0 112.297 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -82.28 -64.0 1.27 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.265 99.6 m-85 -69.94 -5.55 26.92 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -172.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -53.32 -29.48 34.01 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 123.452 2.842 . . . . 0.0 113.608 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -64.38 -32.06 73.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.132 1.773 . . . . 0.0 114.139 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -151.44 74.71 1.14 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.105 2.162 . . . . 0.0 106.532 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -107.3 -167.23 1.24 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.92 1.288 . . . . 0.0 114.12 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -104.03 76.6 1.37 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.676 1.99 . . . . 0.0 108.861 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.99 -157.94 1.04 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.797 1.189 . . . . 0.0 113.362 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.654 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -61.76 158.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.659 1.184 . . . . 0.0 113.816 -174.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.654 ' H ' HD13 ' A' ' 106' ' ' ILE . 12.5 mt -28.73 -64.16 0.18 Allowed Pre-proline 0 CA--C 1.566 1.585 0 CA-C-O 115.281 -2.295 . . . . 0.0 115.764 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 107' ' ' LEU . 11.8 Cg_endo -119.59 -21.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.637 0 CA-C-N 124.252 2.554 . . . . 0.0 117.308 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.2 m -86.22 -145.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.18 1.792 . . . . 0.0 114.145 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.86 141.89 47.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.468 1.107 . . . . 0.0 113.261 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -104.89 -9.43 17.99 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -174.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -106.32 146.89 29.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.509 1.124 . . . . 0.0 112.478 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -111.51 153.26 26.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.255 1.422 . . . . 0.0 114.169 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.06 -179.92 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.065 2.146 . . . . 0.0 110.843 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 95.3 m -98.96 124.04 43.66 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.895 -1.128 . . . . 0.0 113.094 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t -102.69 -177.44 3.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.039 1.736 . . . . 0.0 114.413 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 123.942 0.897 . . . . 0.0 110.85 175.575 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 CA--C 1.547 1.142 0 CA-C-O 120.743 0.226 . . . . 0.0 112.162 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 CA--C 1.541 0.626 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.55 -174.899 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B 1140 ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 83' ' ' MET 0.281 77.6 t . . . . . 0 N--CA 1.509 2.518 0 N-CA-C 117.988 2.588 . . . . 0.0 117.988 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.33 -28.45 65.07 Favored 'General case' 0 CA--C 1.583 2.221 1 N-CA-C 99.696 -4.187 . . . . 0.0 99.696 167.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1142 ' ' GLN . . . . . 0.458 ' C ' ' H ' ' B' 1144 ' ' ASP . 4.4 mp0 -146.79 169.48 9.38 Favored Pre-proline 0 C--N 1.369 1.45 0 C-N-CA 130.103 3.361 . . . . 0.0 113.272 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.24 41.22 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.647 0 C-N-CA 124.466 3.444 . . . . 0.0 113.947 146.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B 1144 ' ' ASP . . . . . 0.458 ' H ' ' C ' ' B' 1142 ' ' GLN . 42.1 t0 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 132.564 4.345 . . . . 0.0 115.396 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.9 m95 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.85 143.78 31.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 -173.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -141.36 149.78 41.58 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.766 3.226 . . . . 0.0 107.839 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.91 39.87 1.41 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-N 123.532 2.878 . . . . 0.0 114.912 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -146.29 30.93 1.02 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.928 0.891 . . . . 0.0 112.352 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 tp -128.19 75.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.479 1.112 . . . . 0.0 109.954 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -45.32 150.16 0.47 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.008 1.723 . . . . 0.0 113.756 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -52.24 -31.57 32.9 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -174.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.0 -33.16 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -81.49 -49.97 9.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.027 1.331 . . . . 0.0 112.37 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 p -66.47 -29.05 69.09 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.401 -0.812 . . . . 0.0 112.514 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.14 -14.57 63.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.488 1.495 . . . . 0.0 113.723 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -79.86 -34.26 39.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.292 1.037 . . . . 0.0 111.335 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mp -86.98 -42.77 12.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.438 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.23 -10.74 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 111.168 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.59 -1.41 58.96 Favored Glycine 0 N--CA 1.469 0.879 0 O-C-N 120.436 -1.415 . . . . 0.0 116.112 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -88.02 -0.14 56.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.771 1.285 . . . . 0.0 111.868 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.76 158.99 19.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.083 1.753 . . . . 0.0 111.308 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.15 25.51 2.64 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.405 1.002 . . . . 0.0 114.995 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.5 -170.73 2.93 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.458 1.103 . . . . 0.0 111.644 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.3 m -54.72 154.99 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.759 0.823 . . . . 0.0 110.542 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 17.8 m-20 -55.66 -10.4 0.69 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.54 13.03 63.01 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.14 2.781 . . . . 0.0 116.445 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.41 78.92 4.4 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 122.193 2.997 . . . . 0.0 105.843 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.17 170.65 8.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.6 tp -133.97 153.23 51.91 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.768 2.027 . . . . 0.0 109.768 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.41 102.55 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.33 163.91 31.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.825 1.25 . . . . 0.0 109.252 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' HG13 ' A' ' 56' ' ' VAL . 4.6 pm0 -143.06 -159.26 0.95 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.579 1.181 . . . . 0.0 112.797 174.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -120.53 150.85 40.2 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 130.781 3.633 . . . . 0.0 108.021 174.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.85 5.82 48.57 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -98.99 -64.33 1.05 Allowed 'General case' 0 C--N 1.357 0.896 0 C-N-CA 131.411 3.884 . . . . 0.0 113.756 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -58.38 123.9 68.54 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 122.478 2.399 . . . . 0.0 111.459 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.86 -21.13 38.37 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.308 2.672 . . . . 0.0 113.89 -170.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -111.14 21.46 16.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.826 2.45 . . . . 0.0 112.182 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA3' HD22 ' A' ' 69' ' ' LEU . . . -95.96 123.32 7.64 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 120.718 3.047 . . . . 0.0 120.718 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -143.48 103.93 4.16 Favored 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 132.69 4.396 . . . . 0.0 102.606 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.568 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.311 0.8 OUTLIER -110.79 138.9 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 121.346 1.884 . . . . 0.0 114.177 -173.834 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.21 128.03 45.28 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.9 p -127.11 113.73 16.8 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.859 1.209 . . . . 0.0 109.005 -173.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.96 153.45 17.76 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.212 1.005 . . . . 0.0 112.382 -172.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.491 ' HA ' HG12 ' A' ' 65' ' ' VAL . 48.5 t -113.64 75.7 0.94 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.474 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.323 2.5 t60 -82.81 -172.35 4.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.266 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.474 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.559 0.2 OUTLIER -98.5 22.3 10.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -173.763 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -149.96 -39.36 0.14 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.748 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 175.83 10.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.045 0.938 . . . . 0.0 110.512 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 60' ' ' CYS . 6.0 m -118.16 112.53 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -110.86 158.07 19.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.95 1.7 . . . . 0.0 112.87 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 22.4 m-70 -120.76 160.06 24.13 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.465 1.506 . . . . 0.0 114.517 -173.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -131.24 87.2 2.44 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.55 HD22 ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -140.89 23.36 2.25 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' B' 1144 ' ' ASP . 5.8 mt -92.07 -3.26 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 118.326 -2.733 . . . . 0.0 118.065 -168.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -136.77 136.46 21.58 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 120.913 1.688 . . . . 0.0 113.214 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.38 170.24 16.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.952 3.101 . . . . 0.0 112.495 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -57.48 141.06 48.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.659 1.184 . . . . 0.0 113.658 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -131.34 178.82 6.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.647 1.179 . . . . 0.0 112.795 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -99.08 -7.18 27.11 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.91 1.284 . . . . 0.0 111.441 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -106.99 45.1 1.0 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.947 2.499 . . . . 0.0 107.295 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 148.32 -160.53 28.38 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.121 2.772 . . . . 0.0 109.09 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -124.18 -123.33 0.26 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.22 116.8 5.3 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.59 136.05 40.52 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -146.88 154.57 41.46 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 m -146.47 -172.93 4.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.245 2.618 . . . . 0.0 109.226 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.541 ' HA ' HG12 ' B' 1140 ' ' VAL . 15.2 mtp -154.48 176.92 11.77 Favored 'General case' 0 C--N 1.311 -1.085 1 C-N-CA 138.95 6.9 . . . . 0.0 107.175 -172.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.45 -25.52 65.94 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.329 -0.857 . . . . 0.0 111.235 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.45 36.52 2.05 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.344 1.058 . . . . 0.0 112.833 174.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 170.12 24.84 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -141.37 60.24 1.5 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.639 1.976 . . . . 0.0 112.418 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.507 41.3 p -76.97 9.75 2.75 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -173.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -38.14 31.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 2 C-N-CA 133.482 4.713 . . . . 0.0 122.756 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -113.81 169.63 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.629 1.571 . . . . 0.0 110.795 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -56.26 140.21 45.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.481 1.113 . . . . 0.0 111.915 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.16 -47.1 30.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.449 0.7 . . . . 0.0 112.75 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.6 -38.79 87.72 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.809 -0.557 . . . . 0.0 111.842 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.28 -37.05 86.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.866 0.466 . . . . 0.0 111.408 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -68.66 -41.68 79.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.458 -0.777 . . . . 0.0 112.121 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 tt -65.82 -39.65 91.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.508 0.595 . . . . 0.0 111.912 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.32 -69.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.756 -0.59 . . . . 0.0 111.204 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.15 -41.26 20.66 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.51 -27.83 34.29 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 121.294 1.861 . . . . 0.0 115.348 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -39.3 -42.42 1.02 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -21.11 58.91 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -146.47 56.96 1.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.013 2.125 . . . . 0.0 110.913 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -91.18 -154.78 0.37 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.116 0.966 . . . . 0.0 112.187 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.89 -4.48 27.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.304 1.842 . . . . 0.0 113.601 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 44.71 -145.27 2.12 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.523 2.011 . . . . 0.0 116.543 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -79.56 159.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.999 1.719 . . . . 0.0 111.199 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.41 ' CB ' ' HD3' ' A' ' 108' ' ' PRO . 2.8 mt -35.17 -54.22 1.12 Allowed Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 116.318 -1.801 . . . . 0.0 115.525 174.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 107' ' ' LEU . 56.9 Cg_endo -118.73 -33.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 -172.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.31 -131.95 0.13 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 126.591 1.956 . . . . 0.0 115.31 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.49 137.68 52.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.9 1.28 . . . . 0.0 113.559 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.446 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -91.51 -13.49 32.04 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -99.81 161.73 13.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.927 1.291 . . . . 0.0 112.373 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -132.21 154.32 49.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 113.314 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 168.11 20.54 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.882 2.473 . . . . 0.0 108.742 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.2 m -98.09 130.0 44.89 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 119.922 -1.736 . . . . 0.0 112.673 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -99.22 178.16 4.99 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.577 1.151 . . . . 0.0 112.441 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 . . . . . 0 N--CA 1.478 0.939 0 C-N-CA 124.478 1.111 . . . . 0.0 112.791 -179.773 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.538 0.704 0 CA-C-O 120.911 0.296 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 116.214 -1.85 . . . . 0.0 113.922 174.539 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B 1140 ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 83' ' ' MET 0.326 78.2 t . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1141 ' ' ASN . . . . . 0.403 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.3 m-80 -59.57 -29.86 68.24 Favored 'General case' 0 CA--C 1.581 2.168 1 N-CA-C 99.048 -4.427 . . . . 0.0 99.048 167.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.263 1.9 mp0 -151.72 172.53 5.33 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 130.657 3.583 . . . . 0.0 114.037 171.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.02 59.1 0.3 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.396 2.064 . . . . 0.0 110.93 141.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B 1144 ' ' ASP . . . . . 0.477 ' HA ' HD13 ' A' ' 70' ' ' ILE 0.255 30.0 t70 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 131.472 3.909 . . . . 0.0 117.448 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 m -134.88 150.96 74.71 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 125.39 1.476 . . . . 0.0 112.09 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.47 156.4 61.58 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.384 2.723 . . . . 0.0 112.792 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.44 158.06 43.84 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.381 1.472 . . . . 0.0 112.208 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -94.51 151.26 19.49 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.563 1.145 . . . . 0.0 112.233 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.5 -6.92 88.15 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.593 1.092 . . . . 0.0 115.636 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -62.85 140.77 58.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.438 1.495 . . . . 0.0 112.425 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 86.2 p -130.29 162.71 28.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.965 1.706 . . . . 0.0 112.44 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.2 tp -141.83 142.31 33.15 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.118 1.367 . . . . 0.0 111.519 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.5 p -97.24 10.11 40.4 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.866 1.666 . . . . 0.0 114.81 -175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.8 160.78 27.58 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.167 1.387 . . . . 0.0 114.018 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 174.19 3.65 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.364 1.466 . . . . 0.0 113.484 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 47.3 mm -69.94 -42.36 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.332 -0.855 . . . . 0.0 111.582 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -79.71 57.36 2.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.53 1.532 . . . . 0.0 112.724 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -116.61 -2.54 11.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.0 p -141.67 175.96 9.28 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 128.226 2.611 . . . . 0.0 110.134 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.07 9.85 0.65 Allowed 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -57.15 -22.65 41.74 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 117.908 2.559 . . . . 0.0 117.908 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -124.15 22.53 8.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.335 1.854 . . . . 0.0 112.854 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -127.91 126.47 41.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.172 1.389 . . . . 0.0 111.885 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -141.11 156.55 45.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.036 2.135 . . . . 0.0 108.904 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.86 32.76 2.1 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 123.412 2.823 . . . . 0.0 113.841 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -145.86 47.62 1.25 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.712 1.244 . . . . 0.0 110.522 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.252 7.0 tt -139.5 62.62 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 122.97 1.367 . . . . 0.0 108.357 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -47.89 153.37 0.64 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.619 1.967 . . . . 0.0 112.73 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -35.73 0.71 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -174.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.25 -33.7 61.33 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.66 -46.61 14.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.482 1.113 . . . . 0.0 112.322 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.8 p -63.99 -31.32 72.46 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.929 -1.107 . . . . 0.0 112.353 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -71.08 -16.41 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.734 1.152 . . . . 0.0 113.675 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -80.21 -35.15 36.66 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.03 0.932 . . . . 0.0 111.586 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.1 mp -88.95 -45.23 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.497 1.119 . . . . 0.0 112.649 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.06 -9.1 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.159 0.984 . . . . 0.0 111.533 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.35 -0.27 61.37 Favored Glycine 0 N--CA 1.472 1.086 0 O-C-N 120.019 -1.676 . . . . 0.0 115.62 -174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -80.75 -14.25 58.27 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.155 0.978 . . . . 0.0 109.354 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.03 157.27 22.97 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.732 2.013 . . . . 0.0 111.966 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.69 33.4 2.05 Favored Glycine 0 N--CA 1.478 1.479 0 C-N-CA 124.769 1.176 . . . . 0.0 114.718 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.45 -179.29 7.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.705 1.202 . . . . 0.0 112.875 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 m -51.27 149.32 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 124.105 0.962 . . . . 0.0 111.819 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 1.2 m-20 -40.22 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 129.683 3.193 . . . . 0.0 116.717 -174.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.84 19.4 53.5 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 120.129 2.811 . . . . 0.0 120.129 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.4 78.43 4.42 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 123.509 3.654 . . . . 0.0 105.596 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.506 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -100.41 170.29 8.51 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 119.385 3.106 . . . . 0.0 119.385 -172.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.2 tp -140.46 156.11 46.46 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.289 3.036 . . . . 0.0 108.821 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.06 79.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 122.872 1.32 . . . . 0.0 108.681 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.459 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -115.78 168.82 9.71 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.249 1.42 . . . . 0.0 110.806 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HA ' HG13 ' A' ' 56' ' ' VAL . 8.6 pt-20 -142.75 -156.33 0.67 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.547 0.689 . . . . 0.0 110.394 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.5 p -134.52 154.3 51.51 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 126.923 2.089 . . . . 0.0 109.077 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.285 1.4 pp0? -99.53 6.05 45.92 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.625 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -99.78 -61.67 1.34 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 131.246 3.819 . . . . 0.0 113.038 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -64.14 125.15 87.52 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 123.786 2.994 . . . . 0.0 107.584 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.83 -6.84 19.58 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.143 2.562 . . . . 0.0 114.101 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -129.03 26.87 5.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.649 2.379 . . . . 0.0 111.737 -174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA2' ' HG ' ' A' ' 69' ' ' LEU . . . -96.17 127.01 9.01 Favored Glycine 0 C--N 1.356 1.692 0 N-CA-C 121.992 3.557 . . . . 0.0 121.992 -172.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.486 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 33.3 m-85 -145.12 77.69 1.53 Allowed 'General case' 0 CA--C 1.566 1.559 1 C-N-CA 133.602 4.761 . . . . 0.0 109.465 174.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.516 HG11 ' HE1' ' B' 1139 ' ' PTR . 0.5 OUTLIER -98.73 145.89 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 119.509 -1.995 . . . . 0.0 115.233 -173.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.95 128.38 48.39 Favored 'General case' 0 CA--C 1.542 0.672 1 N-CA-C 99.187 -4.375 . . . . 0.0 99.187 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 p -126.87 113.14 16.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.115 -1.615 . . . . 0.0 109.135 -172.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 43' ' ' PHE . 11.2 mt -98.78 153.0 19.08 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.249 1.02 . . . . 0.0 111.421 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.417 ' HA ' HG12 ' A' ' 65' ' ' VAL . 53.6 t -124.94 114.63 19.41 Favored 'General case' 0 CA--C 1.496 -1.109 1 N-CA-C 100.11 -4.033 . . . . 0.0 100.11 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 40' ' ' ASP 0.267 0.0 OUTLIER -113.41 -165.88 1.04 Allowed 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.024 1.453 . . . . 0.0 112.489 -173.054 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.542 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.462 0.3 OUTLIER -96.65 8.11 44.99 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 118.561 2.8 . . . . 0.0 118.561 -173.795 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -146.44 -27.02 0.42 Allowed 'General case' 0 N--CA 1.438 -1.043 0 O-C-N 125.202 1.564 . . . . 0.0 112.777 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -150.07 -177.96 6.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.953 0.901 . . . . 0.0 112.312 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 60' ' ' CYS . 4.1 m -131.26 135.24 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.639 1.176 . . . . 0.0 109.43 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -140.96 158.25 44.2 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.774 0.83 . . . . 0.0 112.63 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.459 ' CG ' HH21 ' A' ' 46' ' ' ARG . 88.2 m-70 -111.57 149.03 32.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.197 1.399 . . . . 0.0 110.854 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.02 65.27 1.12 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.862 1.265 . . . . 0.0 113.252 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.4 tm? -141.81 129.85 22.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.355 1.462 . . . . 0.0 112.348 174.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' B' 1141 ' ' ASN . 12.1 mt -140.66 -42.74 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 119.714 1.143 . . . . 0.0 110.964 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 80' ' ' TYR . 13.1 mt -120.99 147.41 46.32 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -81.92 -173.31 1.72 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.294 3.329 . . . . 0.0 110.945 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -57.76 130.0 44.47 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.308 -0.87 . . . . 0.0 112.95 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -110.96 179.14 4.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.695 1.198 . . . . 0.0 112.246 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -99.03 -11.52 21.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.398 1.079 . . . . 0.0 112.305 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.1 32.93 4.07 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.061 2.144 . . . . 0.0 111.52 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.29 -150.07 21.43 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.782 2.61 . . . . 0.0 110.323 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -128.22 -130.77 0.22 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.233 1.413 . . . . 0.0 107.247 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -57.38 122.82 13.48 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.787 1.63 . . . . 0.0 107.819 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' HB3' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -84.47 138.83 32.58 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -174.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.534 ' H ' ' HB3' ' A' ' 89' ' ' ARG . 5.3 m-85 -145.34 137.1 25.42 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.174 2.19 . . . . 0.0 112.349 175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.8 m -140.44 1.48 1.77 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.5 ttp -29.81 144.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 122.55 2.432 . . . . 0.0 113.813 173.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -52.21 -31.89 34.01 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -112.25 4.13 17.57 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.778 1.231 . . . . 0.0 113.266 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.93 88.73 0.18 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.584 1.564 . . . . 0.0 113.286 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -97.44 53.24 1.14 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.785 1.234 . . . . 0.0 108.85 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.469 68.5 p -79.25 20.03 0.54 Allowed 'General case' 0 N--CA 1.47 0.546 1 N-CA-C 122.566 4.284 . . . . 0.0 122.566 -172.605 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.534 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -39.64 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 121.609 3.929 . . . . 0.0 121.609 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -140.24 174.37 10.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 129.836 3.254 . . . . 0.0 107.708 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.5 m -62.4 116.4 5.04 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.317 -1.489 . . . . 0.0 109.831 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -66.2 -32.72 74.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.272 0.629 . . . . 0.0 112.336 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.36 -33.23 75.08 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.5 -37.38 63.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 111.373 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.61 -28.68 62.92 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.844 0.858 . . . . 0.0 113.257 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 tt -57.53 -34.0 68.68 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.215 1.406 . . . . 0.0 112.152 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.7 -39.7 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.061 0.944 . . . . 0.0 111.766 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -80.59 -47.19 14.51 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.48 1.112 . . . . 0.0 111.954 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -65.29 -18.83 65.62 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -40.03 -49.96 2.55 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.601 1.96 . . . . 0.0 115.167 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -81.18 -47.73 13.04 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.277 1.031 . . . . 0.0 113.534 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.23 92.71 3.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.73 1.612 . . . . 0.0 109.223 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -70.77 176.93 3.86 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.699 1.2 . . . . 0.0 113.049 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -90.13 -5.18 56.78 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 52.58 -166.62 1.16 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.028 1.299 . . . . 0.0 115.261 -174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.5 tt -90.24 -174.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.294 1.437 . . . . 0.0 107.512 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.74 110.21 2.59 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 121.583 1.992 . . . . 0.0 108.652 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -102.96 157.47 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 N-CA-C 118.98 2.646 . . . . 0.0 118.98 -129.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -130.33 -43.5 1.16 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 130.735 3.614 . . . . 0.0 106.372 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -131.5 158.37 41.07 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.955 3.302 . . . . 0.0 107.368 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.268 0.0 OUTLIER -121.4 -22.54 5.93 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 118.411 2.745 . . . . 0.0 118.411 -174.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -81.65 142.02 33.12 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.838 1.654 . . . . 0.0 112.13 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -97.85 152.6 19.02 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.195 0.998 . . . . 0.0 112.764 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 170.11 16.36 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.03 2.532 . . . . 0.0 108.991 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 62.5 m -98.0 132.76 43.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.388 -1.445 . . . . 0.0 113.217 -173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.5 t -111.1 162.04 15.3 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -68.94 146.25 52.93 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.36 1.464 . . . . 0.0 112.297 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -87.02 -37.83 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.621 0.769 . . . . 0.0 111.528 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.88 166.04 22.07 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.743 1.217 . . . . 0.0 113.297 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 C--O 1.255 1.356 0 C-N-CA 125.376 1.47 . . . . 0.0 110.86 174.827 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 CA--C 1.542 0.886 0 N-CA-C 114.429 0.896 . . . . 0.0 114.429 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -150.84 156.61 35.87 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.284 1.434 . . . . 0.0 111.717 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.52 161.71 94.05 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.708 0.931 . . . . 0.0 112.77 -5.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.93 -92.62 0.06 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1139 ' ' PTR . . . . . 0.516 ' HE1' HG11 ' A' ' 56' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 57.9 t -144.52 141.22 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 130.954 3.702 . . . . 0.0 101.706 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1141 ' ' ASN . . . . . 0.412 ' HB2' HD12 ' A' ' 70' ' ' ILE 0.357 69.4 m-20 122.66 -27.8 0.01 OUTLIER 'General case' 0 CA--C 1.59 2.506 4 C-N-CA 139.289 7.036 . . . . 0.0 92.801 -169.258 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.282 1.6 mp0 -130.69 -136.87 0.0 OUTLIER Pre-proline 0 C--N 1.381 1.962 0 C-N-CA 130.75 3.62 . . . . 0.0 115.154 168.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -91.68 122.04 0.66 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 123.046 2.123 . . . . 0.0 113.406 75.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -172.319 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -68.22 150.32 97.77 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.463 1.105 . . . . 0.0 113.022 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.98 157.0 63.59 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.406 2.737 . . . . 0.0 112.723 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.95 164.26 32.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.294 1.438 . . . . 0.0 112.44 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.1 p -140.25 162.6 34.9 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.813 1.645 . . . . 0.0 112.156 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.65 -148.14 46.32 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.803 0.716 . . . . 0.0 113.116 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -145.83 151.62 38.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.729 1.211 . . . . 0.0 112.378 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.9 p -89.53 -2.46 58.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.434 1.493 . . . . 0.0 113.586 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.2 tp -62.81 127.42 31.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.199 1.4 . . . . 0.0 111.586 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.7 p -91.48 -8.9 46.39 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.91 145.48 27.76 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.587 1.555 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.1 54.35 2.74 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.081 1.352 . . . . 0.0 112.547 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.5 mm -73.48 129.77 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.124 0.97 . . . . 0.0 110.706 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -98.49 159.03 15.22 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.499 1.519 . . . . 0.0 113.149 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -136.56 2.46 2.69 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 45.4 p -142.68 179.52 6.94 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 128.543 2.737 . . . . 0.0 110.527 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.19 18.73 0.08 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.381 1.472 . . . . 0.0 113.984 174.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.21 0.45 0.07 Allowed 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 118.753 2.871 . . . . 0.0 118.753 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -97.93 -8.68 27.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.879 1.272 . . . . 0.0 112.115 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -75.74 127.79 33.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.1 1.36 . . . . 0.0 112.065 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -141.35 147.77 38.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.941 1.696 . . . . 0.0 110.364 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.46 40.71 1.3 Allowed Glycine 0 C--O 1.219 -0.789 0 CA-C-N 122.746 2.521 . . . . 0.0 110.805 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 47.13 1.3 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 122.808 1.289 . . . . 0.0 109.832 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tt -150.42 81.27 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.507 1.123 . . . . 0.0 109.303 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.3 t -61.74 164.17 6.49 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.685 1.594 . . . . 0.0 113.884 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.65 -27.64 18.1 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.44 -44.43 19.27 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.156 0.982 . . . . 0.0 112.467 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -81.45 -32.02 32.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.667 1.187 . . . . 0.0 113.808 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 p -66.8 -35.52 80.26 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.219 -0.926 . . . . 0.0 112.101 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.273 6.1 pt20 -69.81 -13.71 62.41 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 176.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.4 ttp85 -77.43 -30.59 53.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.709 0.803 . . . . 0.0 111.257 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 mp -92.16 -62.28 1.44 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.795 1.238 . . . . 0.0 111.957 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 mt -70.45 -10.58 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 125.14 1.376 . . . . 0.0 111.938 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.15 -6.67 57.69 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 121.078 -1.014 . . . . 0.0 115.557 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -102.39 20.78 16.29 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.6 1.16 . . . . 0.0 110.656 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -105.12 141.84 35.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 129.642 3.177 . . . . 0.0 111.361 -174.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -99.48 20.62 48.94 Favored Glycine 0 N--CA 1.479 1.54 0 N-CA-C 118.303 2.081 . . . . 0.0 118.303 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.2 170.21 16.74 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 118.969 1.384 . . . . 0.0 112.923 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.46 158.71 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.915 0.886 . . . . 0.0 111.119 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.15 -7.02 0.17 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.694 2.398 . . . . 0.0 116.45 -174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.06 1.54 44.28 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 113.866 -1.515 . . . . 0.0 116.456 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.17 84.51 4.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.058 2.429 . . . . 0.0 104.495 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -99.13 174.6 6.24 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.19 136.1 33.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.357 1.863 . . . . 0.0 110.82 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -101.12 99.78 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.525 HH21 ' CG ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -141.06 167.37 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.428 1.891 . . . . 0.0 110.068 -174.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -142.87 -149.73 0.28 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.2 t -140.72 164.62 29.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.84 1.305 . . . . 0.0 109.134 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.06 8.42 44.55 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.49 1.916 . . . . 0.0 106.827 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -98.58 -70.46 0.72 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 131.172 3.789 . . . . 0.0 109.251 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -63.87 123.25 81.1 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-N 122.028 2.194 . . . . 0.0 109.941 173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -74.8 -14.64 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.071 2.514 . . . . 0.0 113.726 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.42 33.59 5.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.479 2.312 . . . . 0.0 110.284 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.63 124.89 8.31 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 120.803 3.081 . . . . 0.0 120.803 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 62.1 m-85 -144.2 77.46 1.55 Allowed 'General case' 0 CA--C 1.56 1.331 1 C-N-CA 131.835 4.054 . . . . 0.0 110.418 174.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -98.12 152.83 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.252 1.821 . . . . 0.0 113.863 -174.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.58 134.96 54.41 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 102.215 -3.254 . . . . 0.0 102.215 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 67.4 p -134.79 122.81 22.62 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.313 1.869 . . . . 0.0 109.391 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mt -97.07 159.93 14.63 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.432 0.693 . . . . 0.0 112.653 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 49.9 t -119.17 69.27 0.81 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.554 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.302 0.6 OUTLIER -81.07 -173.94 4.58 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.309 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.554 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.489 0.6 OUTLIER -97.96 8.27 45.02 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -174.088 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -145.94 -27.99 0.43 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 124.757 1.286 . . . . 0.0 112.765 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 171.39 16.93 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.714 0.806 . . . . 0.0 111.992 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.78 96.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.152 0.981 . . . . 0.0 108.475 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -99.4 160.39 14.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.675 1.59 . . . . 0.0 110.328 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.525 ' CG ' HH21 ' A' ' 46' ' ' ARG . 61.9 m-70 -119.2 137.87 53.34 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 124.455 1.102 . . . . 0.0 113.617 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -97.47 59.85 1.57 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 120.072 -1.643 . . . . 0.0 113.447 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -143.04 128.67 19.18 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.666 HD12 ' HB2' ' B' 1141 ' ' ASN . 20.4 mt -140.71 -29.39 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 120.085 1.311 . . . . 0.0 112.269 171.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.04 159.49 71.86 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -87.85 -159.35 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 125.183 3.922 . . . . 0.0 111.838 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -65.41 143.63 57.59 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.004 -1.06 . . . . 0.0 113.452 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -130.75 -176.39 3.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.757 1.223 . . . . 0.0 112.392 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.51 -15.38 19.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.645 1.178 . . . . 0.0 113.662 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -102.13 31.84 3.77 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.816 1.646 . . . . 0.0 111.204 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 163.28 -159.0 31.52 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 127.023 2.249 . . . . 0.0 110.435 -175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -118.88 -125.66 0.28 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.0 mt -60.11 110.88 1.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -81.16 112.41 18.48 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.613 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.377 32.3 p90 -151.21 171.76 16.9 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 119.393 3.108 . . . . 0.0 119.393 174.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 88' ' ' THR . 65.8 p -150.88 -141.45 0.11 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.443 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.431 ' C ' HG12 ' B' 1140 ' ' VAL . 10.1 tmm? -154.71 -164.92 1.93 Allowed 'General case' 0 CA--C 1.547 0.849 1 C-N-CA 131.863 4.065 . . . . 0.0 104.422 -173.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -78.1 -24.19 47.65 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.612 1.551 . . . . 0.0 110.01 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -140.54 57.39 1.58 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.196 1.798 . . . . 0.0 111.613 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 177.34 20.79 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 116.507 1.363 . . . . 0.0 116.507 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.52 49.15 1.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.501 1.92 . . . . 0.0 113.202 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.427 ' H ' ' HA ' ' A' ' 82' ' ' SER 0.495 70.5 p -79.1 6.25 9.99 Favored 'General case' 0 N--CA 1.487 1.395 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -173.362 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.613 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 16.7 ptt180 -39.73 16.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 2 C-N-CA 132.881 4.473 . . . . 0.0 122.088 173.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -107.9 176.78 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.959 1.704 . . . . 0.0 109.528 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -63.81 151.18 42.95 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 120.15 -1.594 . . . . 0.0 111.128 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -76.19 -36.97 58.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.0 tp -67.27 -46.95 72.14 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.652 0.66 . . . . 0.0 112.434 -174.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.5 -34.75 77.77 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.402 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -67.23 -43.63 81.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.822 0.849 . . . . 0.0 111.851 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.27 -33.45 73.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.704 0.801 . . . . 0.0 111.993 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.8 t -79.12 -51.74 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.098 0.959 . . . . 0.0 112.231 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -71.46 -40.29 70.39 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.41 -1.431 . . . . 0.0 113.681 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -83.2 5.55 22.46 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -57.27 -34.13 68.34 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.439 ' H ' ' CD ' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -81.52 -35.42 30.38 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.553 1.541 . . . . 0.0 113.262 -176.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.7 mt -142.57 90.83 2.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.562 1.945 . . . . 0.0 109.372 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.66 -171.11 3.32 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.065 0.946 . . . . 0.0 113.348 -174.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -100.13 -20.35 16.03 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 49.32 -165.76 0.34 Allowed Glycine 0 N--CA 1.476 1.319 0 C-N-CA 126.494 1.997 . . . . 0.0 116.382 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.8 tt -84.35 161.73 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.588 173.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -29.62 -59.1 0.27 Allowed Pre-proline 0 CA--C 1.564 1.515 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -123.61 -15.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 N-CA-C 117.668 2.141 . . . . 0.0 117.668 -165.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.9 m -103.28 -140.63 0.36 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 126.607 1.963 . . . . 0.0 113.111 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.48 133.81 45.96 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.304 1.411 . . . . 0.0 111.837 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.504 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -95.54 -17.47 21.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -86.09 163.67 17.75 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.221 -0.924 . . . . 0.0 111.649 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -136.43 148.96 48.02 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.26 173.2 11.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.173 2.589 . . . . 0.0 109.635 175.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 79.7 m -98.26 132.55 43.67 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.531 -1.356 . . . . 0.0 112.096 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -107.6 172.85 6.6 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -117.63 145.52 44.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.188 2.195 . . . . 0.0 109.315 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.3 m -76.46 -177.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.388 1.075 . . . . 0.0 111.801 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.67 34.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.045 1.338 . . . . 0.0 114.255 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 C--O 1.252 1.214 0 C-N-CA 127.855 2.462 . . . . 0.0 110.939 179.386 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 N--CA 1.483 0.892 0 N-CA-C 113.953 0.713 . . . . 0.0 113.953 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -75.76 149.37 83.19 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.777 0.831 . . . . 0.0 112.602 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.97 145.06 35.2 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.971 2.448 . . . . 0.0 111.654 173.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -94.0 -95.16 0.16 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.386 1.074 . . . . 0.0 111.351 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1139 ' ' PTR . . . . . 0.439 ' HE1' HG11 ' A' ' 56' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1140 ' ' VAL . . . . . 0.431 HG12 ' C ' ' A' ' 83' ' ' MET . 0.2 OUTLIER -165.67 118.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 131.273 3.829 . . . . 0.0 106.771 173.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1141 ' ' ASN . . . . . 0.666 ' HB2' HD12 ' A' ' 70' ' ' ILE . 2.3 m-80 158.86 -47.94 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.776 3 C-N-CA 144.495 9.118 . . . . 0.0 92.216 -173.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.342 2.6 mp0 -140.85 157.86 66.55 Favored Pre-proline 0 N--CA 1.43 -1.43 1 C-N-CA 134.025 4.93 . . . . 0.0 105.808 170.196 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -72.62 58.58 3.2 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 CA-C-N 122.206 1.824 . . . . 0.0 110.123 150.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B 1144 ' ' ASP . . . . . . . . . . . . 0.256 27.6 t70 . . . . . 0 C--O 1.253 1.276 1 C-N-CA 135.922 5.689 . . . . 0.0 117.377 -173.715 . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 112.255 -0.338 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 p -146.99 154.64 47.05 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.469 1.508 . . . . 0.0 112.358 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.92 159.39 52.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.309 2.673 . . . . 0.0 112.682 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.37 153.62 43.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.965 0.906 . . . . 0.0 112.855 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.1 p -84.1 -7.21 59.44 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.89 164.29 51.63 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.759 1.171 . . . . 0.0 114.59 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -73.6 -8.49 56.17 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 m -75.09 -7.43 53.71 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.1 tp -72.86 143.19 47.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.069 1.348 . . . . 0.0 111.327 176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 17.8 m -64.12 -13.18 46.12 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.75 -10.75 55.36 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.817 1.647 . . . . 0.0 113.895 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.42 -13.82 61.15 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.5 mm -80.32 143.98 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.459 1.504 . . . . 0.0 109.894 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -66.67 148.91 51.26 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -138.74 5.17 2.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.1 p -142.43 -175.13 4.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 129.171 2.988 . . . . 0.0 109.476 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 15.12 0.12 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.911 1.285 . . . . 0.0 114.12 174.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . 0.256 2.2 pp -61.46 -9.68 6.14 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -114.82 17.87 16.8 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.197 1.799 . . . . 0.0 112.155 174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -132.84 136.73 46.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.982 1.313 . . . . 0.0 114.502 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -142.61 155.25 44.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.06 2.144 . . . . 0.0 109.76 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.75 33.01 2.08 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 122.927 2.603 . . . . 0.0 112.78 174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 tpt85 -137.99 7.66 2.7 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 118.904 1.352 . . . . 0.0 114.387 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.313 7.1 tp -104.48 67.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 122.752 1.263 . . . . 0.0 110.182 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 m -46.45 152.18 0.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.651 1.981 . . . . 0.0 112.538 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.88 -32.42 3.77 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.74 -30.9 40.99 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.691 0.996 . . . . 0.0 113.691 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -81.73 -43.36 18.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.486 1.114 . . . . 0.0 113.136 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -65.61 -32.53 74.16 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.16 -0.962 . . . . 0.0 112.621 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -67.68 -21.33 65.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -74.39 -28.69 61.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.718 0.807 . . . . 0.0 111.905 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.56 -51.83 4.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.106 1.362 . . . . 0.0 112.312 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.14 -12.72 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.614 1.566 . . . . 0.0 111.566 -176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.67 8.81 66.25 Favored Glycine 0 N--CA 1.476 1.346 0 O-C-N 120.491 -1.381 . . . . 0.0 113.867 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -77.66 -10.56 59.59 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.773 1.229 . . . . 0.0 112.073 174.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.347 0.0 OUTLIER -140.45 136.52 33.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.407 1.483 . . . . 0.0 113.552 176.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.66 67.32 0.23 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.544 1.545 . . . . 0.0 114.983 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.06 -176.51 5.56 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.808 0.843 . . . . 0.0 110.827 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -64.26 142.12 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.461 -1.399 . . . . 0.0 108.425 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -45.91 -21.97 0.17 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 113' ' ' HIS . . . -94.8 21.22 44.72 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.495 -1.229 . . . . 0.0 115.293 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 42' ' ' LEU . 3.9 mm? -98.67 62.06 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 171.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -96.63 163.16 13.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 119.045 2.98 . . . . 0.0 119.045 -170.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -122.61 150.27 42.87 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.452 1.901 . . . . 0.0 109.519 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.0 t -115.04 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.28 167.31 22.45 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 125.068 1.347 . . . . 0.0 109.011 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -142.89 -158.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -131.29 159.79 36.83 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 122.709 1.243 . . . . 0.0 108.747 174.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -95.71 9.72 39.39 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 113.475 -1.693 . . . . 0.0 107.861 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -98.25 -63.81 1.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 129.292 3.037 . . . . 0.0 108.133 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -60.66 121.04 58.11 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 120.606 1.548 . . . . 0.0 110.047 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.85 -15.18 21.28 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.773 2.316 . . . . 0.0 113.104 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -125.7 32.72 5.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.163 2.185 . . . . 0.0 110.895 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.28 128.17 9.46 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 58.6 m-85 -143.88 78.24 1.58 Allowed 'General case' 0 CA--C 1.558 1.288 1 C-N-CA 131.738 4.015 . . . . 0.0 110.492 174.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG11 ' HE1' ' B' 1139 ' ' PTR . 0.5 OUTLIER -98.45 142.73 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 126.291 1.836 . . . . 0.0 113.049 -174.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 tt -99.6 130.53 45.84 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 101.66 -3.459 . . . . 0.0 101.66 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 p -127.33 120.25 28.14 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.186 1.357 . . . . 0.0 109.152 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -96.04 151.13 19.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.203 1.001 . . . . 0.0 112.565 -172.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 43.8 t -117.03 65.55 0.72 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.472 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.257 24.7 t60 -81.33 178.82 8.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -172.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.472 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.423 3.1 pp -99.03 27.31 5.12 Favored 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.624 2.77 . . . . 0.0 117.843 -173.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -150.54 -43.72 0.12 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 112.06 -2.336 . . . . 0.0 111.649 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.87 179.71 7.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.496 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.02 122.61 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -129.93 167.36 18.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.64 1.176 . . . . 0.0 112.662 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -126.39 139.91 52.9 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -173.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -107.53 65.64 0.65 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.275 1.83 . . . . 0.0 113.703 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.9 tm? -144.74 134.44 23.52 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.13 -1.606 . . . . 0.0 114.748 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' B' 1141 ' ' ASN . 7.9 mt -141.42 -36.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 120.53 1.514 . . . . 0.0 112.948 170.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 160.12 61.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -77.39 -177.98 4.25 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 124.408 3.405 . . . . 0.0 111.752 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.4 p -61.15 144.76 53.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -129.84 -175.36 3.58 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.247 1.419 . . . . 0.0 110.808 -175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.56 -3.37 33.5 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -99.31 10.23 41.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.247 1.419 . . . . 0.0 111.702 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.68 -161.87 28.07 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 128.046 2.736 . . . . 0.0 109.66 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -115.1 -122.58 0.29 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 116.419 -1.753 . . . . 0.0 106.469 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.8 mt -58.65 113.85 2.22 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -82.26 120.2 25.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.481 ' H ' ' HA ' ' A' ' 89' ' ' ARG 0.46 12.9 p90 -151.33 162.63 40.58 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 118.638 2.829 . . . . 0.0 118.638 173.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -150.98 -146.34 0.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 123.143 1.449 . . . . 0.0 112.093 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.461 ' HA ' HG12 ' B' 1140 ' ' VAL . 32.1 mtt -155.38 -171.41 3.78 Favored 'General case' 0 C--N 1.316 -0.865 1 C-N-CA 134.049 4.939 . . . . 0.0 106.653 -173.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.37 -30.63 68.67 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -140.65 61.23 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.277 1.431 . . . . 0.0 111.373 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.68 174.76 22.46 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -141.92 47.52 1.63 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.07 1.748 . . . . 0.0 113.11 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.51 9.4 p -75.25 -2.08 26.4 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 121.466 3.876 . . . . 0.0 121.466 -173.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.481 ' HA ' ' H ' ' A' ' 81' ' ' PHE . 40.9 ptt180 -44.61 36.15 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 1 C-N-CA 133.534 4.733 . . . . 0.0 120.832 173.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -125.36 160.58 29.0 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.919 -1.738 . . . . 0.0 111.761 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.8 m -56.5 135.82 54.32 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.979 0.911 . . . . 0.0 111.623 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.17 -39.77 89.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.8 tp -61.0 -42.34 98.26 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.937 0.335 . . . . 0.0 111.792 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.08 -41.99 81.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.28 0.632 . . . . 0.0 111.31 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -68.08 -33.05 73.81 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -80.37 -43.76 20.54 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.684 0.675 . . . . 0.0 112.23 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.2 t -69.91 -63.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 119.255 0.934 . . . . 0.0 110.324 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -83.45 -57.65 3.16 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.321 44.0 m-85 -81.47 22.23 0.72 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -172.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -79.54 -42.74 24.47 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 121.496 1.953 . . . . 0.0 113.705 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -18.92 60.36 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -174.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt -140.14 56.97 1.61 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.316 1.847 . . . . 0.0 110.178 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.04 -156.82 0.15 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.835 0.854 . . . . 0.0 110.454 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.46 4.42 9.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.704 1.602 . . . . 0.0 112.54 174.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.88 -141.72 0.69 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.437 2.446 . . . . 0.0 115.786 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.55 153.77 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 111.716 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mt -34.88 -56.12 0.89 Allowed Pre-proline 0 CA--C 1.563 1.467 0 CA-C-O 116.272 -1.823 . . . . 0.0 115.841 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -115.17 -33.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.37 0 N-CA-C 117.589 2.111 . . . . 0.0 117.589 -169.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.9 m -91.17 -125.89 0.08 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.042 1.737 . . . . 0.0 114.413 -174.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.93 155.66 19.36 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.637 1.575 . . . . 0.0 111.82 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -8.51 10.24 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -115.87 148.24 40.19 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.874 1.67 . . . . 0.0 113.513 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 7.6 m-70 -101.08 150.31 23.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.378 1.071 . . . . 0.0 111.26 174.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 76.9 m -130.38 -61.49 0.96 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 5.1 t -141.64 -158.48 0.87 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 111.232 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.2 m -134.19 135.85 43.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.866 2.467 . . . . 0.0 110.902 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -132.77 138.02 47.02 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.193 0.997 . . . . 0.0 111.057 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.6 m -144.34 161.53 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.34 1.856 . . . . 0.0 111.42 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.87 156.39 39.34 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.546 0.738 . . . . 0.0 112.592 174.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.298 1.839 . . . . 0.0 111.722 179.134 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo . . . . . 0 N--CA 1.483 0.895 0 N-CA-C 113.948 0.711 . . . . 0.0 113.948 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -74.19 146.39 84.43 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.77 0.828 . . . . 0.0 112.606 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.22 141.0 35.03 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.278 2.652 . . . . 0.0 111.54 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1138 ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' B' 1143 ' ' PRO . 15.7 pt-20 -145.66 123.14 11.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.049 1.339 . . . . 0.0 111.667 -175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1139 ' ' PTR . . . . . 0.461 ' HE1' HG11 ' A' ' 56' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B 1140 ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 83' ' ' MET . 2.2 t -147.09 -15.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 115.777 -2.059 . . . . 0.0 115.588 -174.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1141 ' ' ASN . . . . . 0.593 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.5 m-80 -54.89 -30.24 57.71 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 169.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1142 ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' 1140 ' ' VAL 0.342 4.1 mp0 -150.52 156.93 36.79 Favored Pre-proline 0 N--CA 1.424 -1.757 1 C-N-CA 136.69 5.996 . . . . 0.0 104.486 169.723 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' B' B 1143 ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' B' 1138 ' ' GLU . 56.7 Cg_endo -71.23 60.84 2.54 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 CA-C-N 120.95 1.375 . . . . 0.0 109.638 152.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 C--O 1.253 1.284 1 C-N-CA 134.719 5.207 . . . . 0.0 116.001 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m -72.68 146.79 88.73 Favored Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 121.463 -1.022 . . . . 0.0 112.359 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -83.35 -10.18 44.7 Favored 'Cis proline' 0 CA--C 1.543 0.927 0 N-CA-C 114.983 1.109 . . . . 0.0 114.983 4.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.54 -16.28 23.87 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.0 p -62.32 -22.8 66.35 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.441 1.897 . . . . 0.0 113.061 174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.05 2.69 0.14 Allowed Glycine 0 CA--C 1.536 1.368 0 N-CA-C 116.841 1.496 . . . . 0.0 116.841 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -108.99 2.18 21.13 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 119.453 1.627 . . . . 0.0 114.59 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.3 m -58.61 147.57 32.02 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.253 1.021 . . . . 0.0 112.891 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.91 153.74 39.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.278 1.031 . . . . 0.0 112.096 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.0 m -68.56 152.3 45.56 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.721 1.208 . . . . 0.0 113.346 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.91 160.66 39.75 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.555 1.542 . . . . 0.0 111.809 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.78 147.27 49.13 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.781 0.832 . . . . 0.0 113.047 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.6 -22.69 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.578 1.151 . . . . 0.0 112.851 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -124.36 160.34 28.32 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.03 2.132 . . . . 0.0 112.918 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -132.49 -1.52 3.5 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -142.79 178.53 7.58 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 129.066 2.947 . . . . 0.0 110.449 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 13.14 1.21 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.106 1.362 . . . . 0.0 114.358 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -52.8 149.84 5.88 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -173.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 -99.8 26.44 6.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.641 1.576 . . . . 0.0 113.801 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -137.09 128.48 28.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.237 1.018 . . . . 0.0 112.33 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -140.11 138.18 35.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 128.453 2.701 . . . . 0.0 106.968 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.62 46.58 1.03 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-N 123.073 2.67 . . . . 0.0 114.06 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.22 48.3 1.13 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 123.48 1.609 . . . . 0.0 108.912 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.1 tp -150.67 68.63 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.126 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -50.61 157.2 0.78 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.733 1.613 . . . . 0.0 113.259 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -45.03 -37.37 4.05 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -174.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -77.35 -25.62 51.22 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.404 1.081 . . . . 0.0 113.859 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -81.55 -48.72 11.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.083 1.753 . . . . 0.0 111.66 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -68.56 -26.88 65.63 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.045 0.938 . . . . 0.0 112.895 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -64.41 -19.32 65.44 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.716 1.144 . . . . 0.0 113.555 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -77.79 -29.22 50.73 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.029 0.831 . . . . 0.0 111.735 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.54 -48.56 7.23 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 111.964 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.28 -9.42 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.973 0.909 . . . . 0.0 111.368 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.31 -0.05 59.84 Favored Glycine 0 N--CA 1.472 1.084 0 O-C-N 120.085 -1.635 . . . . 0.0 115.013 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -80.94 -13.36 58.97 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 117.833 0.817 . . . . 0.0 110.021 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.75 154.78 23.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.244 1.818 . . . . 0.0 112.094 177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.41 26.36 2.56 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.75 1.167 . . . . 0.0 114.716 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.45 -166.95 1.29 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.163 1.385 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 m -53.91 151.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.026 0.93 . . . . 0.0 110.447 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 5.3 m-20 -50.7 -18.7 0.76 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.75 28.02 16.28 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.67 2.081 . . . . 0.0 116.526 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.59 74.21 3.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 120.294 2.047 . . . . 0.0 106.471 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.468 ' CD2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -99.45 165.79 11.48 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -173.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.1 tp -141.01 145.24 35.67 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.824 1.65 . . . . 0.0 111.348 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -98.23 68.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 119.891 1.223 . . . . 0.0 110.393 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -99.67 158.35 15.83 Favored 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 124.032 0.933 . . . . 0.0 111.465 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.601 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.6 pm0 -141.64 -160.46 1.09 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.2 t -140.15 158.49 43.96 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 122.352 1.072 . . . . 0.0 109.658 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 1.5 pp0? -97.34 8.44 44.58 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.64 174.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -98.55 -68.29 0.81 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 129.07 2.948 . . . . 0.0 110.439 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -61.59 119.38 46.64 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 122.756 2.526 . . . . 0.0 109.419 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.49 -12.41 18.67 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.008 2.472 . . . . 0.0 114.866 -159.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' O ' HD21 ' A' ' 69' ' ' LEU . 94.4 mt-30 -120.44 36.17 4.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.961 2.504 . . . . 0.0 109.203 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' HG ' ' A' ' 69' ' ' LEU . . . -98.46 123.23 7.8 Favored Glycine 0 C--N 1.349 1.293 1 N-CA-C 124.568 4.587 . . . . 0.0 124.568 -172.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.462 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 20.3 m-85 -144.49 77.57 1.54 Allowed 'General case' 0 CA--C 1.558 1.262 1 C-N-CA 132.665 4.386 . . . . 0.0 109.749 174.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.601 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.42 153.97 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 127.164 2.186 . . . . 0.0 112.724 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.468 HD22 ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -113.25 129.58 56.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 p -111.55 118.09 34.78 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.3 mt -96.53 147.47 23.83 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.423 0.689 . . . . 0.0 111.865 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.461 ' HA ' HG12 ' A' ' 65' ' ' VAL . 33.8 t -114.76 66.03 0.68 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.28 0.4 OUTLIER -70.06 -168.18 0.2 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 112.852 -1.977 . . . . 0.0 112.394 -173.603 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.512 0.3 OUTLIER -96.85 4.39 51.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 119.836 3.273 . . . . 0.0 119.836 -173.507 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.329 7.1 pt20 -149.75 -16.14 0.27 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 118.361 -1.336 . . . . 0.0 114.372 169.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -150.57 173.11 14.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.518 1.127 . . . . 0.0 110.737 174.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 60' ' ' CYS . 16.5 m -123.35 110.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -120.47 161.77 20.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.72 1.608 . . . . 0.0 112.03 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 90.9 m-70 -106.23 163.57 12.7 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.013 1.325 . . . . 0.0 112.783 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -117.48 13.44 14.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 118.259 2.688 . . . . 0.0 118.259 -172.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 69' ' ' LEU . 2.3 tm? -113.27 133.65 54.99 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -173.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.1 mt -141.72 -42.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.695 0.798 . . . . 0.0 110.849 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -119.77 151.37 52.11 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -92.01 -174.31 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.901 3.734 . . . . 0.0 112.003 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 m -60.24 145.06 48.71 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.486 -0.759 . . . . 0.0 112.191 174.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -120.7 -170.06 1.93 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.276 1.43 . . . . 0.0 111.935 -174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.83 -14.47 19.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.115 0.966 . . . . 0.0 112.832 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -110.97 8.76 22.13 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.676 1.59 . . . . 0.0 113.659 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.42 168.74 38.82 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.778 1.656 . . . . 0.0 112.847 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -83.76 -145.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.948 1.299 . . . . 0.0 110.789 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -52.06 116.44 2.19 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.348 0.976 . . . . 0.0 109.16 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.32 134.95 36.12 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.436 ' H ' ' HB3' ' A' ' 89' ' ' ARG 0.293 28.9 m-85 -142.0 134.02 27.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.115 1.766 . . . . 0.0 113.602 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.0 m -140.45 20.7 2.38 Favored 'General case' 0 CA--C 1.557 1.228 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.0 ttp -26.98 149.25 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 172.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -52.63 -23.11 5.9 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -126.19 19.26 7.62 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.256 1.422 . . . . 0.0 112.61 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.06 162.34 26.77 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.511 1.529 . . . . 0.0 115.591 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -141.03 50.99 1.62 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.194 1.798 . . . . 0.0 108.506 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.563 10.5 p -76.38 10.97 1.74 Allowed 'General case' 0 N--CA 1.477 0.876 1 N-CA-C 122.58 4.289 . . . . 0.0 122.58 -172.329 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 6.4 ptt180 -38.76 49.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 130.643 3.577 . . . . 0.0 120.609 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -137.29 165.12 26.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.213 2.605 . . . . 0.0 109.899 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 m -57.41 141.71 46.35 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.202 -0.936 . . . . 0.0 110.189 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.57 -33.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 45.2 tp -61.86 -32.13 72.45 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -79.61 -33.94 41.12 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.745 0.702 . . . . 0.0 111.918 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -75.44 -35.35 60.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.552 2.341 . . . . 0.0 111.882 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 tt -54.22 -40.11 67.34 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.775 2.03 . . . . 0.0 112.376 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.4 t -49.81 -50.26 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.877 0.871 . . . . 0.0 110.485 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.84 -88.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.012 1.325 . . . . 0.0 112.87 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -47.91 0.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 121.396 3.85 . . . . 0.0 121.396 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -56.08 -37.11 68.89 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 121.891 2.132 . . . . 0.0 113.392 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -15.77 61.97 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -140.63 39.86 1.86 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.206 1.403 . . . . 0.0 112.575 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -75.56 -161.8 0.17 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 125.34 1.456 . . . . 0.0 113.449 -174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -90.9 -0.38 57.71 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.883 1.673 . . . . 0.0 113.712 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 54.64 -152.2 12.91 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.87 1.7 . . . . 0.0 115.229 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.75 175.28 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.048 1.339 . . . . 0.0 111.686 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -41.56 -59.65 2.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -109.93 -46.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 CA-C-N 122.613 1.969 . . . . 0.0 116.682 -166.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 74.3 m -94.68 -127.68 0.13 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -48.07 134.91 13.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.645 1.978 . . . . 0.0 115.082 -174.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.447 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -87.94 -8.69 55.36 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -177.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -116.86 148.59 41.14 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.216 -0.927 . . . . 0.0 113.072 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -113.68 165.09 12.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.636 1.974 . . . . 0.0 110.499 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 5.9 m -136.87 -170.41 2.69 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.755 1.622 . . . . 0.0 112.066 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 82.8 m -99.13 135.61 40.28 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.28 1.032 . . . . 0.0 110.086 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 m -125.75 171.29 10.76 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.88 1.272 . . . . 0.0 113.054 -173.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.1 ttt-85 -63.4 144.22 57.15 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.262 1.025 . . . . 0.0 110.575 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.4 m -69.64 161.26 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.558 1.143 . . . . 0.0 111.851 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.27 34.63 0.31 Allowed 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.1 tp . . . . . 0 C--O 1.255 1.363 0 C-N-CA 126.004 1.722 . . . . 0.0 113.24 -175.291 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 CA--C 1.541 0.863 0 N-CA-C 113.996 0.729 . . . . 0.0 113.996 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -76.83 -46.46 2.98 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-O 117.45 -1.262 . . . . 0.0 114.367 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.45 125.41 7.65 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.078 1.852 . . . . 0.0 111.99 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -121.91 -114.11 0.31 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.876 1.67 . . . . 0.0 110.543 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1139 ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B 1140 ' ' VAL . . . . . 0.413 ' C ' ' N ' ' B' 1142 ' ' GLN . 2.7 t -140.48 -28.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -177.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.278 11.8 m-80 -56.41 -27.95 57.92 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B 1142 ' ' GLN . . . . . 0.413 ' N ' ' C ' ' B' 1140 ' ' VAL 0.314 4.3 mp0 -158.62 157.86 28.94 Favored Pre-proline 0 N--CA 1.433 -1.304 1 C-N-CA 135.932 5.693 . . . . 0.0 104.962 168.554 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.67 60.67 2.18 Favored 'Trans proline' 0 CA--C 1.556 1.599 0 CA-C-N 121.891 1.711 . . . . 0.0 109.392 149.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 C--O 1.254 1.33 1 C-N-CA 134.044 4.938 . . . . 0.0 115.896 -173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.2 -0.36 . . . . 0.0 112.2 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.6 p -146.59 155.78 48.94 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.372 1.469 . . . . 0.0 112.502 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.54 157.84 98.74 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 CA-C-N 119.468 0.846 . . . . 0.0 112.896 -5.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.11 -25.03 64.21 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 m -90.49 14.87 11.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.843 1.657 . . . . 0.0 113.766 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.28 -16.84 75.57 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 124.389 0.995 . . . . 0.0 115.505 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.0 p -86.95 154.45 20.79 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.152 1.381 . . . . 0.0 112.598 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 82.1 p -147.92 161.57 41.05 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.774 1.23 . . . . 0.0 113.15 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.4 tp -145.79 147.4 31.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.946 1.698 . . . . 0.0 110.696 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.6 m -138.88 155.78 47.82 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.839 1.256 . . . . 0.0 112.394 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.64 158.06 43.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.449 1.499 . . . . 0.0 111.889 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.23 151.88 46.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.1 0.96 . . . . 0.0 112.505 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 tp -75.99 -21.72 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -78.54 47.44 0.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.384 1.874 . . . . 0.0 113.105 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -123.32 -10.19 8.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.4 p -142.62 175.77 9.54 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 129.518 3.127 . . . . 0.0 110.531 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.62 60.62 0.68 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.603 1.561 . . . . 0.0 112.208 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.41 37.18 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 130.833 3.653 . . . . 0.0 120.292 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -97.89 53.26 1.09 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 119.69 -1.881 . . . . 0.0 110.049 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -150.56 112.92 4.65 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.162 1.385 . . . . 0.0 111.508 175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -140.97 155.62 46.2 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.636 1.974 . . . . 0.0 109.962 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.09 53.8 0.65 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 122.261 2.3 . . . . 0.0 111.949 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.255 32.9 tpt85 -148.63 42.06 0.97 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.008 1.385 . . . . 0.0 111.096 174.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.78 63.77 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.563 1.145 . . . . 0.0 110.071 -174.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.1 t -55.38 151.03 10.61 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -48.31 -30.79 5.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.029 2.531 . . . . 0.0 116.756 -173.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -79.79 -35.43 38.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.147 0.979 . . . . 0.0 112.713 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -81.71 -40.36 22.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.034 . . . . 0.0 112.376 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.04 -37.37 71.69 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.484 1.114 . . . . 0.0 112.319 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.22 -16.77 64.28 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -80.12 -27.59 39.11 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.239 1.016 . . . . 0.0 111.557 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.5 -49.75 5.28 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.582 1.553 . . . . 0.0 112.135 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.12 -12.46 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 124.309 1.044 . . . . 0.0 111.657 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.23 1.18 60.51 Favored Glycine 0 N--CA 1.474 1.172 0 O-C-N 120.45 -1.406 . . . . 0.0 114.948 -174.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -79.65 -13.9 59.17 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 117.973 0.887 . . . . 0.0 109.629 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.53 164.19 19.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.929 2.091 . . . . 0.0 112.291 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.64 30.2 3.83 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.306 1.431 . . . . 0.0 114.148 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.24 -172.45 3.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 125.896 1.678 . . . . 0.0 113.596 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.19 155.61 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.166 1.387 . . . . 0.0 111.28 174.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -49.3 -16.04 0.16 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.917 1.687 . . . . 0.0 115.283 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.75 7.19 70.62 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 127.02 2.248 . . . . 0.0 114.473 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.68 57.52 1.59 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.507 ' CG ' HD21 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -98.57 172.61 7.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.5 tp -138.74 139.5 38.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.802 2.041 . . . . 0.0 109.84 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 t -99.39 107.42 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' C ' ' HD2' ' A' ' 46' ' ' ARG . 5.3 ppt_? -141.3 176.18 9.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.08 2.152 . . . . 0.0 110.621 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' HA ' HG13 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -145.99 -146.08 0.18 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -141.72 168.77 18.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 125.338 1.455 . . . . 0.0 110.259 174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.57 10.87 40.02 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.667 172.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -99.06 -82.25 0.44 Allowed 'General case' 0 N--CA 1.481 1.109 1 C-N-CA 133.94 4.896 . . . . 0.0 108.756 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -54.62 118.13 15.8 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 121.216 1.825 . . . . 0.0 111.034 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.99 -12.33 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.99 2.46 . . . . 0.0 113.26 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -116.52 33.0 5.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.801 2.44 . . . . 0.0 110.16 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.8 128.62 9.61 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 121.773 3.469 . . . . 0.0 121.773 -173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.473 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 46.9 m-85 -142.64 66.93 1.32 Allowed 'General case' 0 CA--C 1.56 1.356 1 C-N-CA 132.139 4.175 . . . . 0.0 110.759 174.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.453 HG11 ' HE1' ' B' 1139 ' ' PTR . 0.5 OUTLIER -97.41 146.16 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.799 1.761 . . . . 0.0 114.109 -174.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.507 HD21 ' CG ' ' A' ' 43' ' ' PHE . 1.9 tt -105.01 121.15 43.16 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 172.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p -108.91 118.19 36.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.3 mt -96.0 160.42 14.47 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -171.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.5 t -122.57 53.39 1.26 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.43 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.299 2.5 t-80 -66.11 178.81 1.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -172.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.43 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.467 0.5 OUTLIER -97.9 12.34 34.41 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -172.832 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -147.07 -27.32 0.39 Allowed 'General case' 0 N--CA 1.44 -0.966 0 O-C-N 125.211 1.569 . . . . 0.0 112.112 170.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 173.88 13.07 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.346 1.058 . . . . 0.0 110.975 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.68 93.23 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 122.54 1.162 . . . . 0.0 110.196 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -105.34 170.07 8.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.515 1.526 . . . . 0.0 112.154 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.457 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 87.0 m-70 -117.19 163.13 16.76 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.491 1.516 . . . . 0.0 112.336 -173.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.31 14.92 14.83 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 119.22 3.044 . . . . 0.0 119.22 -172.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 2.1 tm? -114.13 140.63 48.35 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 119.064 -2.273 . . . . 0.0 116.032 -173.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.5 mm -141.38 -44.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.994 0.918 . . . . 0.0 110.059 171.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 mt -121.32 158.91 52.06 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -89.71 -148.08 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.873 3.715 . . . . 0.0 110.225 172.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 p -66.55 152.44 45.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.789 1.236 . . . . 0.0 112.682 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -139.89 -177.36 4.95 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.241 1.416 . . . . 0.0 111.74 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.68 -18.15 18.2 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -108.88 18.5 20.65 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.862 1.265 . . . . 0.0 112.666 174.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.06 -161.34 23.92 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 127.483 2.468 . . . . 0.0 110.096 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -116.87 -127.27 0.29 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.3 mt -58.3 112.99 1.74 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 89' ' ' ARG . 2.3 t80 -76.97 132.39 38.99 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -173.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . 0.252 25.0 m-85 -142.9 141.4 31.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.142 2.177 . . . . 0.0 112.553 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.9 p -149.66 21.59 0.91 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -27.82 152.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -28.02 3.3 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 119.19 3.033 . . . . 0.0 119.19 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.99 18.48 14.66 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.323 1.42 . . . . 0.0 113.628 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.24 172.81 23.64 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.304 1.681 . . . . 0.0 117.304 -174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.81 55.2 1.58 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 128.722 2.809 . . . . 0.0 107.207 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.487 16.1 p -71.89 2.1 6.06 Favored 'General case' 0 N--CA 1.474 0.767 1 N-CA-C 122.933 4.42 . . . . 0.0 122.933 -171.969 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.417 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 32.2 ptt180 -38.74 29.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 2 N-CA-C 122.96 4.429 . . . . 0.0 122.96 173.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.71 161.68 26.75 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.845 2.058 . . . . 0.0 110.154 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -62.03 140.41 58.37 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.07 -34.12 71.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.639 0.776 . . . . 0.0 112.479 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.0 tp -62.84 -27.5 69.38 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.46 -35.61 63.32 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.606 0.762 . . . . 0.0 111.502 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -75.6 -37.95 59.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 111.436 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.5 tt -51.35 -42.3 61.22 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.95 1.7 . . . . 0.0 113.1 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.48 -42.35 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.602 0.761 . . . . 0.0 111.599 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -80.37 -32.91 37.58 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.051 1.34 . . . . 0.0 113.006 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -80.34 -13.14 59.41 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -58.47 -42.57 87.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.916 1.689 . . . . 0.0 113.757 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -82.14 -39.97 22.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.703 1.201 . . . . 0.0 113.346 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.5 mt -145.33 83.5 1.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.592 1.557 . . . . 0.0 111.614 -175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -70.71 133.57 46.73 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.356 -0.84 . . . . 0.0 109.339 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -73.24 -3.43 26.76 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 49.99 -157.87 1.71 Allowed Glycine 0 CA--C 1.54 1.644 0 C-N-CA 126.641 2.067 . . . . 0.0 114.82 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.444 HG13 ' H ' ' A' ' 107' ' ' LEU . 4.0 tp -80.73 -175.9 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.473 0.709 . . . . 0.0 112.216 174.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.444 ' H ' HG13 ' A' ' 106' ' ' ILE . 15.7 mt -42.15 136.02 2.3 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.472 1.509 . . . . 0.0 110.839 173.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -80.16 51.53 3.95 Favored 'Trans proline' 0 CA--C 1.549 1.264 0 N-CA-C 118.431 2.435 . . . . 0.0 118.431 -130.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 85.5 m -68.5 -55.77 10.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.913 1.685 . . . . 0.0 111.203 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.34 -179.53 5.93 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 129.418 3.087 . . . . 0.0 108.306 174.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.305 0.0 OUTLIER -139.03 -51.85 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.705 2.483 . . . . 0.0 117.705 -174.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -68.46 144.18 54.76 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.347 1.43 . . . . 0.0 113.323 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -107.58 165.78 11.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.217 1.407 . . . . 0.0 113.992 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 84.5 m -140.62 -157.23 0.75 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 128.029 2.532 . . . . 0.0 109.798 -176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.17 134.27 53.81 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.985 1.314 . . . . 0.0 109.782 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -109.62 170.09 8.29 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -86.93 125.38 34.0 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.713 1.205 . . . . 0.0 110.647 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.0 t -93.83 -37.84 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.957 0.903 . . . . 0.0 111.886 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.95 162.48 27.54 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.601 1.161 . . . . 0.0 113.63 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.365 1.866 . . . . 0.0 111.807 175.789 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo . . . . . 0 CA--C 1.542 0.88 0 N-CA-C 113.956 0.714 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -71.5 147.48 92.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.949 0.899 . . . . 0.0 112.352 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.27 158.61 48.44 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.232 2.621 . . . . 0.0 111.692 172.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -133.22 -112.86 0.22 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.274 1.43 . . . . 0.0 109.71 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1139 ' ' PTR . . . . . 0.455 ' HD1' ' H ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1140 ' ' VAL . . . . . . . . . . . . . 3.1 t -140.3 -25.88 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 N-CA-C 118.425 2.75 . . . . 0.0 118.425 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1141 ' ' ASN . . . . . . . . . . . . 0.348 9.9 m-80 -61.75 -25.85 67.71 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 170.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.314 3.9 mp0 -155.76 154.38 27.83 Favored Pre-proline 0 N--CA 1.424 -1.762 1 C-N-CA 134.918 5.287 . . . . 0.0 105.196 168.381 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.81 58.51 2.67 Favored 'Trans proline' 0 CA--C 1.554 1.512 0 CA-C-N 121.861 1.7 . . . . 0.0 109.256 151.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.3 t0 . . . . . 0 C--O 1.254 1.317 1 C-N-CA 134.606 5.162 . . . . 0.0 115.984 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 CA-C-O 121.081 0.267 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.8 m -68.68 149.46 97.94 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 124.453 1.101 . . . . 0.0 112.898 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.71 -21.0 19.5 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.264 2.643 . . . . 0.0 113.588 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.66 41.99 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.972 1.709 . . . . 0.0 111.433 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.9 m -75.54 -17.47 60.07 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.53 -173.31 44.39 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.071 1.32 . . . . 0.0 113.437 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.0 p -131.8 156.21 46.41 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.85 1.66 . . . . 0.0 111.845 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.7 p -76.06 146.67 39.24 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.163 0.985 . . . . 0.0 112.842 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.3 tp -150.24 148.58 29.06 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.41 1.484 . . . . 0.0 111.08 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 t -72.43 165.28 24.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.837 0.855 . . . . 0.0 112.568 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.63 156.93 37.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.742 0.817 . . . . 0.0 112.898 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.51 160.4 38.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.504 1.522 . . . . 0.0 111.948 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.0 pt -70.02 155.44 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.836 0.854 . . . . 0.0 112.81 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -64.88 142.97 58.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.226 1.41 . . . . 0.0 112.415 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -102.7 -3.85 25.92 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.8 p -142.34 -173.43 3.84 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 129.28 3.032 . . . . 0.0 108.437 174.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.51 8.19 8.3 Favored 'General case' 0 CA--C 1.552 1.048 0 O-C-N 120.572 -1.33 . . . . 0.0 113.875 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -54.36 -23.76 16.79 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 117.73 2.492 . . . . 0.0 117.73 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -127.38 6.3 6.34 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.597 1.559 . . . . 0.0 114.19 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -150.81 124.98 9.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -141.5 146.58 36.58 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.977 2.511 . . . . 0.0 109.128 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.7 24.96 4.04 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 123.427 2.831 . . . . 0.0 113.856 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -137.92 15.77 2.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.358 1.063 . . . . 0.0 113.122 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.6 tp -100.84 70.5 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -46.28 151.73 0.49 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 112.995 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.283 0.0 OUTLIER -44.19 -40.3 4.97 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -73.83 -28.42 61.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.462 1.105 . . . . 0.0 113.237 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -81.04 -46.89 14.33 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.785 1.234 . . . . 0.0 111.396 174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -68.11 -33.06 73.8 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 118.44 -0.791 . . . . 0.0 112.419 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.295 2.0 pt20 -68.77 -11.23 60.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 -80.94 -37.43 29.52 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.63 1.172 . . . . 0.0 110.704 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.3 mp -88.6 -45.06 10.18 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.779 1.632 . . . . 0.0 112.643 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.25 -12.64 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.399 1.079 . . . . 0.0 110.832 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.96 2.07 61.51 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.429 -1.419 . . . . 0.0 114.869 -175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -80.91 -12.81 59.34 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.783 0.833 . . . . 0.0 110.709 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.66 151.96 28.71 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.59 1.556 . . . . 0.0 112.873 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.15 20.19 4.52 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.127 1.346 . . . . 0.0 115.454 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.43 -173.04 3.85 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.796 1.638 . . . . 0.0 111.848 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -54.21 150.96 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.165 0.986 . . . . 0.0 111.607 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 9.1 m-20 -49.11 -19.7 0.47 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -174.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 113' ' ' HIS . . . -97.65 22.65 39.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 127.502 2.477 . . . . 0.0 116.852 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.12 77.81 4.05 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 121.743 2.771 . . . . 0.0 106.689 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.79 165.48 11.93 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -173.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.5 tp -126.77 148.84 49.89 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.315 2.646 . . . . 0.0 109.178 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.02 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.19 165.84 26.42 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 125.714 1.606 . . . . 0.0 108.662 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.682 ' HA ' HG13 ' A' ' 56' ' ' VAL 0.265 5.3 pt-20 -141.56 -164.32 1.75 Allowed 'General case' 0 C--N 1.316 -0.888 0 O-C-N 121.486 -0.758 . . . . 0.0 110.422 173.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.12 148.09 52.46 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.266 1.2 pp0? -95.47 15.12 20.51 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.703 174.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -98.16 -72.7 0.64 Allowed 'General case' 0 C--N 1.356 0.863 1 C-N-CA 131.959 4.104 . . . . 0.0 111.224 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -57.87 141.05 81.04 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-N 121.248 1.84 . . . . 0.0 113.605 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -85.54 -17.55 4.25 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.9 3.066 . . . . 0.0 115.121 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -118.34 26.41 9.63 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.997 2.119 . . . . 0.0 110.308 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.19 126.07 8.76 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 121.825 3.49 . . . . 0.0 121.825 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -143.58 94.19 2.57 Favored 'General case' 0 CA--C 1.545 0.777 1 C-N-CA 132.044 4.138 . . . . 0.0 103.384 173.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.682 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.283 1.3 m -99.0 138.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 121.261 1.846 . . . . 0.0 114.233 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tt -99.02 121.2 40.66 Favored 'General case' 0 CA--C 1.539 0.535 1 N-CA-C 99.901 -4.111 . . . . 0.0 99.901 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.3 p -119.33 122.13 41.14 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt -95.28 177.53 5.82 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -171.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.433 ' HA ' HG12 ' A' ' 65' ' ' VAL . 32.2 t -129.57 66.07 1.47 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.51 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.265 0.4 OUTLIER -71.81 -171.64 0.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.16 -173.985 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.51 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.487 0.3 OUTLIER -97.03 6.65 48.22 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 119.236 3.05 . . . . 0.0 119.236 -173.521 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -146.08 -26.13 0.44 Allowed 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 124.961 1.413 . . . . 0.0 113.259 170.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -150.52 -178.03 6.31 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.834 0.854 . . . . 0.0 111.417 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 60' ' ' CYS . 16.5 m -125.32 114.08 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.97 0.89 . . . . 0.0 109.749 173.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -110.98 162.51 14.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.707 2.403 . . . . 0.0 111.816 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -125.81 159.26 32.9 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.431 ' CZ ' HG11 ' B' 1140 ' ' VAL . 12.8 m-85 -130.97 86.22 2.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 119.948 -1.72 . . . . 0.0 112.852 -174.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.584 ' HG ' ' CE1' ' B' 1139 ' ' PTR . 0.0 OUTLIER -141.75 28.63 1.76 Allowed 'General case' 0 N--CA 1.51 2.551 1 N-CA-C 122.216 4.154 . . . . 0.0 122.216 -173.733 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.1 mt -96.35 -14.23 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 -170.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 mt -127.73 144.85 52.69 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -83.45 -170.61 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 125.014 3.81 . . . . 0.0 111.718 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.6 m -72.03 147.82 46.46 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.473 -1.392 . . . . 0.0 112.9 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -130.92 -177.38 4.35 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.943 0.897 . . . . 0.0 112.552 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.71 -5.09 32.17 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 111.903 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -99.51 15.81 25.32 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.3 1.84 . . . . 0.0 111.664 174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 172.47 -156.72 25.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 127.153 2.311 . . . . 0.0 109.707 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -115.64 -126.16 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -59.87 115.25 3.27 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.75 131.2 39.66 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.486 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 16.3 m-85 -143.82 155.55 44.17 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 175.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 98.9 p -145.88 -164.24 1.91 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.261 2.224 . . . . 0.0 109.894 173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.707 ' HA ' HG12 ' B' 1140 ' ' VAL . 67.1 mtm -156.73 -173.67 4.58 Favored 'General case' 0 C--N 1.314 -0.95 1 C-N-CA 136.424 5.89 . . . . 0.0 109.089 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.94 -29.5 65.54 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 172.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -140.49 44.62 1.85 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.48 1.112 . . . . 0.0 112.846 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.36 171.87 24.09 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.956 1.543 . . . . 0.0 116.956 -174.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.95 56.7 1.48 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.801 2.041 . . . . 0.0 112.301 -174.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 32.2 p -76.98 5.31 8.22 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 121.766 3.987 . . . . 0.0 121.766 -173.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.486 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 37.8 ptt180 -38.91 39.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 2 C-N-CA 132.875 4.47 . . . . 0.0 122.423 173.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -126.5 159.89 32.13 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.325 1.85 . . . . 0.0 111.182 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.8 m -64.23 137.64 58.04 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.441 -0.787 . . . . 0.0 110.665 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.56 -47.49 47.67 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -64.32 -33.72 76.49 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.93 -32.59 69.55 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.342 0.657 . . . . 0.0 112.289 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.75 -28.81 36.37 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.975 1.31 . . . . 0.0 112.296 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 tt -64.88 -29.04 69.97 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.359 1.064 . . . . 0.0 113.29 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.6 t -70.11 -76.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.28 0.946 . . . . 0.0 110.832 177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -81.9 -44.5 16.73 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -82.82 -0.84 49.89 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -66.1 -42.65 89.0 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 122.788 2.54 . . . . 0.0 113.81 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -80.16 -11.79 59.71 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.32 1.448 . . . . 0.0 114.361 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 65.08 1.34 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.536 1.534 . . . . 0.0 109.689 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -101.71 -163.56 1.02 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.311 1.444 . . . . 0.0 111.871 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -96.63 -1.6 46.47 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.569 1.548 . . . . 0.0 111.23 173.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 111' ' ' LEU . . . 52.24 -146.29 15.45 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 126.631 2.062 . . . . 0.0 114.298 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.24 179.17 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 125.737 1.615 . . . . 0.0 112.023 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 mt -40.32 -55.9 3.85 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.395 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 109' ' ' CYS . 68.4 Cg_endo -122.44 -41.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 N-CA-C 118.191 2.343 . . . . 0.0 118.191 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.405 ' H ' ' HD2' ' A' ' 108' ' ' PRO . 71.6 m -90.39 -127.33 0.08 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.507 1.923 . . . . 0.0 115.967 -173.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.56 142.19 23.31 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.833 1.653 . . . . 0.0 114.649 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.445 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -93.72 -6.88 45.18 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -174.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -110.95 152.67 26.51 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.522 1.129 . . . . 0.0 112.55 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 64.6 m-70 -125.06 160.14 29.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.417 1.487 . . . . 0.0 111.706 175.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 28.0 m -141.06 -162.82 1.43 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 130.025 3.33 . . . . 0.0 108.135 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.2 m -125.75 133.54 52.05 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.879 -1.138 . . . . 0.0 112.121 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 t -99.28 176.11 5.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.149 0.98 . . . . 0.0 111.678 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -123.64 165.0 17.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.754 1.622 . . . . 0.0 113.329 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.62 156.29 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.93 1.692 . . . . 0.0 112.093 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.24 150.83 44.88 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.703 0.801 . . . . 0.0 112.366 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.3 tp . . . . . 0 C--O 1.253 1.266 0 C-N-CA 126.083 1.753 . . . . 0.0 111.888 -179.441 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo . . . . . 0 N--CA 1.484 0.939 0 N-CA-C 114.058 0.753 . . . . 0.0 114.058 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -133.9 151.99 77.83 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.516 1.526 . . . . 0.0 111.327 177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.03 164.74 32.72 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.754 2.97 . . . . 0.0 112.929 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 42.6 mp0 -81.45 -106.21 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.849 1.26 . . . . 0.0 112.597 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1139 ' ' PTR . . . . . 0.584 ' CE1' ' HG ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1140 ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 83' ' ' MET . 54.1 t -140.69 -32.88 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.56 -29.5 51.33 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 102.193 -3.262 . . . . 0.0 102.193 169.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1142 ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' 1140 ' ' VAL 0.317 1.0 OUTLIER -161.44 157.34 21.47 Favored Pre-proline 0 N--CA 1.427 -1.621 1 C-N-CA 135.165 5.386 . . . . 0.0 105.574 168.443 . . . . . . . . 5 4 . 1 . 006 nuclear nobuild full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.79 52.65 0.72 Allowed 'Trans proline' 0 CA--C 1.554 1.502 0 C-N-CA 122.6 2.2 . . . . 0.0 111.381 152.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--O 1.255 1.364 1 C-N-CA 134.873 5.269 . . . . 0.0 114.793 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.846 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.0 p -77.31 159.84 76.81 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.635 1.174 . . . . 0.0 113.103 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -59.53 151.13 71.38 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.387 2.725 . . . . 0.0 114.238 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.39 -22.69 51.25 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -150.21 160.88 43.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.827 1.651 . . . . 0.0 111.185 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.08 18.1 79.64 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.166 0.889 . . . . 0.0 115.07 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.7 p -63.74 -20.48 65.78 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.615 1.208 . . . . 0.0 114.128 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 m -72.83 -7.09 49.16 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.6 mt -98.67 -2.51 38.15 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.623 1.569 . . . . 0.0 113.786 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 68.3 m -66.74 141.41 57.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.516 1.126 . . . . 0.0 112.911 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.81 165.33 20.97 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.67 1.188 . . . . 0.0 113.188 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.27 158.48 34.91 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.124 0.969 . . . . 0.0 112.652 174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.0 mt -73.69 140.9 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.996 0.918 . . . . 0.0 109.66 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -74.97 41.46 0.16 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.477 1.911 . . . . 0.0 115.044 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -134.69 14.24 3.69 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 127.435 2.294 . . . . 0.0 114.329 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 p -102.57 -74.33 0.63 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.032 2.133 . . . . 0.0 112.753 -173.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -79.48 -12.15 59.88 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.607 0.763 . . . . 0.0 111.424 174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.26 -14.24 60.13 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 -123.55 44.78 2.61 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.666 1.987 . . . . 0.0 110.494 174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -143.29 134.45 25.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.196 1.398 . . . . 0.0 112.531 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -142.0 157.6 44.74 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.357 1.863 . . . . 0.0 109.694 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.96 23.4 2.61 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 121.956 2.162 . . . . 0.0 114.145 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -147.13 52.92 1.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.61 1.205 . . . . 0.0 110.952 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.261 7.4 tt -140.63 59.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 123.407 1.575 . . . . 0.0 109.101 174.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.7 t -43.58 153.19 0.12 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.844 2.458 . . . . 0.0 114.907 -174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.536 ' HE ' ' HG2' ' B' 1138 ' ' GLU . 0.0 OUTLIER -46.83 -34.31 5.22 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 117.668 2.47 . . . . 0.0 117.668 -174.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -80.76 -27.73 36.66 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -81.35 -48.59 11.76 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.609 1.564 . . . . 0.0 113.473 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -63.53 -33.31 75.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.97 -17.31 63.92 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.4 ttm105 -75.61 -30.89 59.71 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.725 0.81 . . . . 0.0 112.085 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.3 -60.5 1.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.301 1.44 . . . . 0.0 111.803 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mt -81.37 -3.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.494 1.918 . . . . 0.0 112.974 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.79 8.33 68.19 Favored Glycine 0 N--CA 1.475 1.248 0 O-C-N 120.155 -1.591 . . . . 0.0 115.028 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -80.39 -4.01 51.91 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.447 1.099 . . . . 0.0 112.637 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -71.66 145.78 48.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.562 1.145 . . . . 0.0 113.28 -175.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.18 15.73 39.28 Favored Glycine 0 CA--C 1.542 1.722 0 C-N-CA 125.584 1.564 . . . . 0.0 114.145 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.54 177.57 8.91 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.362 1.865 . . . . 0.0 113.544 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 41' ' ' GLY . 35.1 m -72.08 169.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 126.302 1.841 . . . . 0.0 115.27 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 35.1 m-20 -58.41 22.27 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 128.889 2.876 . . . . 0.0 115.425 174.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 39' ' ' VAL . . . -141.81 10.79 2.62 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.52 71.62 2.31 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.931 2.366 . . . . 0.0 108.441 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.457 ' HB3' HD23 ' A' ' 59' ' ' LEU . 2.0 p90 -98.46 168.26 10.31 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.8 tp -138.48 153.26 48.8 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.804 2.442 . . . . 0.0 109.584 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.6 t -116.07 101.53 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.158 0.983 . . . . 0.0 108.739 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.19 28.15 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.546 1.938 . . . . 0.0 109.506 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 56' ' ' VAL . 8.2 pm0 -142.76 -154.16 0.51 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.697 0.761 . . . . 0.0 113.012 174.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -120.85 147.66 45.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 132.704 4.402 . . . . 0.0 108.277 174.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 7.51 46.17 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.573 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.35 -68.1 0.82 Allowed 'General case' 0 C--N 1.352 0.691 0 C-N-CA 130.184 3.394 . . . . 0.0 111.083 -174.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -78.85 116.79 62.59 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 122.997 2.635 . . . . 0.0 108.464 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.8 -15.96 51.15 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.758 2.306 . . . . 0.0 114.846 -168.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -87.64 13.98 9.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.632 2.373 . . . . 0.0 111.833 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.71 124.12 7.99 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 122.726 3.85 . . . . 0.0 122.726 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.528 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 60.0 m-85 -144.0 84.08 1.76 Allowed 'General case' 0 CA--C 1.564 1.505 1 C-N-CA 132.455 4.302 . . . . 0.0 110.595 174.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.459 HG11 ' HE1' ' B' 1139 ' ' PTR . 0.5 OUTLIER -98.24 144.11 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 119.817 -1.802 . . . . 0.0 113.299 -174.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 122.83 42.97 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 101.017 -3.698 . . . . 0.0 101.017 171.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 p -116.3 105.28 12.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 43' ' ' PHE . 1.5 mt -97.91 158.32 15.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -172.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.56 125.83 51.79 Favored 'General case' 0 CA--C 1.497 -1.079 1 N-CA-C 96.508 -5.367 . . . . 0.0 96.508 174.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.619 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.359 0.0 OUTLIER -112.7 -146.34 0.41 Allowed 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 124.881 1.363 . . . . 0.0 111.521 -171.348 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.619 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.271 14.6 tp -95.79 -7.09 38.07 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -175.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . 0.275 5.4 pt20 -151.03 -17.9 0.21 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 169.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -150.4 -160.37 1.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.681 0.792 . . . . 0.0 111.792 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -114.96 141.79 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.746 1.218 . . . . 0.0 109.376 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -138.05 150.3 46.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.705 0.802 . . . . 0.0 111.363 -174.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.19 144.24 43.02 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.178 0.991 . . . . 0.0 113.572 -173.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.91 69.42 1.27 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 55' ' ' PHE . 1.5 tm? -142.16 123.04 14.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 115.584 -2.15 . . . . 0.0 111.925 174.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' B' 1141 ' ' ASN 0.255 38.7 mt -139.53 -41.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-N 122.843 2.565 . . . . 0.0 112.921 173.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.3 148.88 71.62 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 120.351 1.432 . . . . 0.0 114.162 -175.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -81.35 179.57 5.74 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.172 3.248 . . . . 0.0 111.387 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.07 139.52 56.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -120.93 -167.59 1.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.132 1.773 . . . . 0.0 111.369 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -98.33 -7.97 27.95 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -122.66 20.59 10.21 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.808 1.643 . . . . 0.0 112.845 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.07 -171.48 39.92 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 126.345 1.926 . . . . 0.0 111.381 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -121.73 -137.98 0.32 Allowed 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 117.147 -1.406 . . . . 0.0 108.109 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.5 mp -48.43 123.22 6.28 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 120.338 1.426 . . . . 0.0 107.725 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.89 137.26 36.86 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -146.09 130.79 17.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.489 1.916 . . . . 0.0 111.733 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 m -141.61 0.99 1.5 Allowed 'General case' 0 N--CA 1.492 1.672 1 N-CA-C 121.817 4.006 . . . . 0.0 121.817 -173.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.507 ' HB3' HG12 ' B' 1140 ' ' VAL . 5.5 ptt? -29.91 156.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 174.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.9 -31.0 16.19 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.53 2.21 13.78 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.615 1.166 . . . . 0.0 114.112 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.78 105.38 0.41 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.224 1.393 . . . . 0.0 114.757 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 54.1 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.014 1.726 . . . . 0.0 109.535 174.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.499 68.9 p -77.77 12.83 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 121.569 3.915 . . . . 0.0 121.569 -172.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -39.47 35.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 131.629 3.972 . . . . 0.0 121.049 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.77 174.57 9.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.281 2.632 . . . . 0.0 109.281 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 t -68.93 155.23 40.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.711 -1.243 . . . . 0.0 111.368 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.8 -41.13 65.27 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.582 -0.699 . . . . 0.0 112.653 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -62.03 -40.53 96.02 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.71 -33.91 60.35 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.943 0.497 . . . . 0.0 112.218 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -73.86 -34.03 64.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.534 1.134 . . . . 0.0 112.347 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.06 -38.66 70.92 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.744 1.217 . . . . 0.0 112.646 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.9 t -61.4 -37.88 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.679 0.792 . . . . 0.0 111.812 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -80.4 -34.77 36.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.789 1.235 . . . . 0.0 112.691 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -80.63 -15.27 57.01 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -51.69 -48.83 63.34 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.585 1.154 . . . . 0.0 113.752 -174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -81.93 -44.62 16.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.673 1.189 . . . . 0.0 113.267 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.43 88.0 1.98 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.945 1.698 . . . . 0.0 110.747 -175.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -69.56 172.58 7.12 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.975 0.91 . . . . 0.0 110.328 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -101.31 4.81 41.99 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.779 1.632 . . . . 0.0 112.32 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 39.17 -141.78 0.52 Allowed Glycine 0 CA--C 1.537 1.458 0 C-N-CA 128.0 2.714 . . . . 0.0 115.067 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.431 HG21 ' HB2' ' A' ' 61' ' ' HIS . 8.0 tp -107.93 161.37 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 126.231 1.812 . . . . 0.0 109.245 174.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -31.33 -45.68 0.32 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 119.007 2.966 . . . . 0.0 119.007 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -75.36 -157.13 0.06 OUTLIER 'Trans proline' 0 CA--C 1.556 1.585 0 C-N-CA 123.581 2.854 . . . . 0.0 116.829 -173.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 92.4 m -45.8 -59.21 2.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.639 3.176 . . . . 0.0 118.186 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.99 156.34 19.81 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.84 1.2 . . . . 0.0 111.91 -174.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -14.89 3.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -108.54 141.19 40.81 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 120.77 1.623 . . . . 0.0 111.853 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -93.69 169.57 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 86.4 m -136.36 -154.78 0.58 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.65 2.38 . . . . 0.0 109.307 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 78.0 m -121.06 123.37 42.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.587 1.155 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 t -103.61 168.52 9.09 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.7 1.2 . . . . 0.0 112.74 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -87.61 155.91 19.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.44 1.096 . . . . 0.0 112.24 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.97 -39.02 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.595 1.158 . . . . 0.0 112.535 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.0 154.07 40.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.749 0.82 . . . . 0.0 112.506 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 tm? . . . . . 0 C--O 1.254 1.317 0 C-N-CA 126.06 1.744 . . . . 0.0 110.685 -179.673 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo . . . . . 0 N--CA 1.482 0.844 0 N-CA-C 114.406 0.887 . . . . 0.0 114.406 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 54.3 mm-40 -75.36 -54.53 2.39 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.639 -1.172 . . . . 0.0 113.055 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.05 160.84 42.19 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.432 2.088 . . . . 0.0 111.497 169.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1138 ' ' GLU . . . . . 0.536 ' HG2' ' HE ' ' A' ' 26' ' ' ARG . 8.3 tt0 -136.74 -72.4 0.44 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.805 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B 1139 ' ' PTR . . . . . 0.551 ' C ' HD11 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1140 ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 83' ' ' MET 0.319 95.2 t -81.48 -0.5 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 1 C-N-CA 132.207 4.203 . . . . 0.0 119.852 -172.165 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' B' B 1141 ' ' ASN . . . . . 0.579 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.2 m-80 -67.15 -17.91 65.06 Favored 'General case' 0 CA--C 1.579 2.087 1 N-CA-C 99.14 -4.393 . . . . 0.0 99.14 165.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1142 ' ' GLN . . . . . 0.414 ' N ' ' C ' ' B' 1140 ' ' VAL . 49.6 mm-40 -132.44 4.43 0.04 OUTLIER Pre-proline 0 C--N 1.384 2.078 1 N-CA-C 125.509 5.374 . . . . 0.0 125.509 173.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo 6.16 58.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.892 1.728 . . . . 0.0 113.567 -126.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B 1144 ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' B' 1142 ' ' GLN . 34.7 t70 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 133.05 4.54 . . . . 0.0 116.993 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.864 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 m -69.69 147.39 96.4 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.445 1.098 . . . . 0.0 112.579 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.97 -16.9 46.06 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.459 2.773 . . . . 0.0 114.402 -173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.99 0.37 27.9 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.839 1.256 . . . . 0.0 114.125 174.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -64.15 140.8 58.91 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.269 1.028 . . . . 0.0 112.878 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.03 163.25 53.17 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.313 0.959 . . . . 0.0 113.932 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.7 p -89.25 137.23 32.51 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.958 1.303 . . . . 0.0 112.229 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.8 m -106.51 -3.65 20.62 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.2 tp -82.08 136.12 35.24 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.729 1.211 . . . . 0.0 111.517 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.7 t -95.48 137.29 34.75 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.204 1.001 . . . . 0.0 112.288 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.06 -3.18 35.34 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.166 1.387 . . . . 0.0 113.383 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.13 -1.62 58.12 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.7 pt -68.83 153.21 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.504 1.121 . . . . 0.0 112.931 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -74.32 152.65 39.58 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.504 1.122 . . . . 0.0 112.72 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -133.12 0.94 3.48 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.4 p -142.04 -176.0 4.63 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 128.613 2.765 . . . . 0.0 109.691 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -78.78 16.09 0.94 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.932 1.293 . . . . 0.0 113.963 174.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -57.52 147.4 26.87 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -131.88 38.11 3.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.926 1.29 . . . . 0.0 112.301 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -141.07 150.23 42.66 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -141.03 148.23 39.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 128.398 2.679 . . . . 0.0 108.912 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.36 41.28 1.3 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 123.15 2.705 . . . . 0.0 112.532 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -142.58 31.69 1.47 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 123.004 1.383 . . . . 0.0 110.721 174.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.0 tp -131.09 79.67 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.67 1.188 . . . . 0.0 108.141 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.9 m -52.58 154.57 2.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.678 1.591 . . . . 0.0 112.325 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -47.15 -39.35 13.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -174.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.48 -34.61 74.6 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.916 1.286 . . . . 0.0 112.779 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -81.75 -43.98 17.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.275 1.03 . . . . 0.0 111.598 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 t -62.15 -36.45 81.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.521 1.128 . . . . 0.0 112.361 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.9 -16.41 64.3 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 ttp-105 -79.12 -35.64 41.89 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.914 0.779 . . . . 0.0 111.54 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -83.39 -45.27 13.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.251 1.42 . . . . 0.0 112.574 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.26 -7.5 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.923 0.889 . . . . 0.0 111.236 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.37 -0.97 59.36 Favored Glycine 0 N--CA 1.471 0.997 0 O-C-N 119.966 -1.709 . . . . 0.0 116.46 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.48 -3.78 58.96 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.93 1.365 . . . . 0.0 111.219 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.56 152.78 29.93 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.92 1.688 . . . . 0.0 111.743 174.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.6 22.42 3.17 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.667 1.127 . . . . 0.0 115.086 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.13 -170.5 2.76 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.398 1.479 . . . . 0.0 112.032 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 m -54.87 156.92 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.951 1.3 . . . . 0.0 111.392 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 6.9 m-20 -46.54 -24.3 0.51 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.58 ' HA2' ' CD2' ' A' ' 113' ' ' HIS . . . -99.63 43.46 1.81 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 119.804 2.682 . . . . 0.0 119.804 -173.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.87 75.43 0.96 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.461 ' CD2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -98.26 171.65 8.07 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 117.278 2.325 . . . . 0.0 117.278 -172.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -141.47 142.69 33.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 0.0 110.107 173.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -98.53 93.51 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.4 HH22 ' P ' ' B' 1139 ' ' PTR . 0.0 OUTLIER -124.07 161.77 24.88 Favored 'General case' 0 CA--C 1.497 -1.071 0 C-N-CA 125.36 1.464 . . . . 0.0 110.039 174.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' HA ' HG13 ' A' ' 56' ' ' VAL . 4.4 pm0 -141.56 -158.62 0.88 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -140.48 163.39 32.96 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 123.475 1.607 . . . . 0.0 109.862 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.26 1.3 pp0? -96.11 11.97 32.34 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.836 173.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -97.49 -73.85 0.59 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 131.632 3.973 . . . . 0.0 108.321 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.89 120.58 47.63 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 121.399 1.909 . . . . 0.0 109.588 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.29 -13.87 23.05 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.919 2.413 . . . . 0.0 113.976 -168.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -125.59 30.88 5.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.278 2.231 . . . . 0.0 110.467 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.48 132.32 10.93 Favored Glycine 0 C--N 1.351 1.414 0 N-CA-C 122.505 3.762 . . . . 0.0 122.505 -172.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.408 ' H ' ' CD2' ' A' ' 69' ' ' LEU . 38.2 m-85 -144.02 76.29 1.5 Allowed 'General case' 0 CA--C 1.559 1.303 1 C-N-CA 131.786 4.034 . . . . 0.0 109.019 174.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -97.44 154.79 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 127.129 2.172 . . . . 0.0 113.046 -174.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' A' ' 43' ' ' PHE . 1.2 mt -111.36 131.45 55.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 172.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.5 p -113.74 113.52 25.08 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mt -97.2 153.27 18.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.49 0.716 . . . . 0.0 112.567 -172.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.45 ' HA ' HG12 ' A' ' 65' ' ' VAL . 41.8 t -115.03 63.31 0.68 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 -178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.5 ' CG ' ' H ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -66.8 -170.95 0.12 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.706 -173.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.5 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.504 0.3 OUTLIER -97.01 7.83 45.8 Favored 'General case' 0 CA--C 1.492 -1.264 0 N-CA-C 119.696 3.221 . . . . 0.0 119.696 -173.582 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -142.29 -28.57 0.6 Allowed 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 125.034 1.459 . . . . 0.0 112.554 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.8 179.75 7.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.943 0.897 . . . . 0.0 111.243 174.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 60' ' ' CYS . 5.0 m -116.48 116.69 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 pttt -128.93 160.08 33.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.807 1.643 . . . . 0.0 112.705 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.496 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 91.3 m-70 -101.31 165.24 11.38 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.522 1.529 . . . . 0.0 113.689 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -133.63 47.6 2.44 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.523 HD13 ' C ' ' A' ' 69' ' ' LEU . 1.7 tm? -142.47 135.48 28.48 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.513 -1.992 . . . . 0.0 113.993 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' B' 1141 ' ' ASN . 52.4 mt -140.36 -43.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.245 0.929 . . . . 0.0 111.05 171.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.98 155.3 68.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -174.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -83.32 -176.12 2.65 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.754 3.636 . . . . 0.0 111.877 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -54.03 141.13 29.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.478 1.111 . . . . 0.0 113.861 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -123.56 -170.82 2.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.882 1.273 . . . . 0.0 111.714 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.16 -13.86 20.68 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.015 1.326 . . . . 0.0 112.3 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -99.1 5.58 46.88 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.618 1.567 . . . . 0.0 113.517 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -170.1 -157.7 12.8 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.107 1.337 . . . . 0.0 113.478 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -106.93 -137.14 0.36 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.844 1.258 . . . . 0.0 108.79 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.69 123.22 16.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -77.87 132.11 37.82 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.413 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 6.6 m-85 -150.17 161.65 41.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 126.178 1.791 . . . . 0.0 114.698 174.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' B' 1141 ' ' ASN 0.253 1.5 m -145.31 -160.54 1.15 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.905 1.282 . . . . 0.0 108.746 173.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.46 ' HA ' ' CG1' ' B' 1140 ' ' VAL . 9.0 ttm -155.65 -179.93 8.58 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 129.398 3.079 . . . . 0.0 107.952 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.62 -30.56 70.17 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.12 -0.988 . . . . 0.0 110.13 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -140.31 40.19 1.91 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.914 1.286 . . . . 0.0 112.669 174.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 179.48 19.56 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 116.391 1.316 . . . . 0.0 116.391 -174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 63.83 1.42 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.173 2.189 . . . . 0.0 111.919 -174.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.545 24.6 p -78.4 2.44 18.74 Favored 'General case' 0 N--CA 1.487 1.377 1 N-CA-C 123.352 4.575 . . . . 0.0 123.352 -172.795 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.413 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 27.5 ptt180 -40.36 48.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 1 C-N-CA 132.377 4.271 . . . . 0.0 119.872 172.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.86 159.79 35.51 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.499 1.919 . . . . 0.0 112.69 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 m -61.36 136.61 58.1 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.092 1.357 . . . . 0.0 112.715 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.19 -30.16 68.3 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 56.6 tp -62.67 -41.28 99.0 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.903 0.774 . . . . 0.0 112.412 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.4 -39.52 74.44 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.756 -0.59 . . . . 0.0 111.085 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -64.19 -30.56 71.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.437 1.095 . . . . 0.0 112.748 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 tt -76.43 -45.23 32.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.417 1.087 . . . . 0.0 111.94 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.5 t -74.9 -57.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.726 0.694 . . . . 0.0 111.853 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -82.77 -51.03 8.06 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.309 54.3 m-85 -79.85 7.04 9.53 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -173.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -54.72 -29.51 53.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 121.408 1.913 . . . . 0.0 112.941 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -77.51 -26.59 51.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.692 1.997 . . . . 0.0 114.572 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.6 mt -147.02 71.92 1.24 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 128.06 2.544 . . . . 0.0 106.773 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.09 159.85 16.49 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 59.59 3.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.93 2.092 . . . . 0.0 111.548 174.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -72.27 -154.02 2.04 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 125.54 1.543 . . . . 0.0 113.687 175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 tp -79.5 -179.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.836 1.654 . . . . 0.0 111.987 176.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 27.4 mt -40.1 139.23 1.03 Allowed Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 116.769 -1.586 . . . . 0.0 110.586 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -56.17 71.71 0.03 OUTLIER 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 125.025 3.817 . . . . 0.0 119.894 -159.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 73.6 m -103.54 -128.98 0.24 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 129.069 2.948 . . . . 0.0 107.592 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.55 73.5 8.59 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.619 -1.3 . . . . 0.0 108.909 174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -2.81 6.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -84.42 56.05 3.64 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.803 1.241 . . . . 0.0 111.103 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.58 ' CD2' ' HA2' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -60.97 141.43 57.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.768 1.627 . . . . 0.0 114.26 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.98 -171.33 2.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 129.402 3.081 . . . . 0.0 109.282 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.79 140.12 33.45 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.1 t -99.85 175.99 5.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.109 1.764 . . . . 0.0 111.865 174.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -68.83 147.8 51.2 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.487 1.515 . . . . 0.0 112.647 -174.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 m -118.1 153.47 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.865 1.666 . . . . 0.0 112.25 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.08 152.6 32.82 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.96 0.904 . . . . 0.0 112.427 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.9 tp . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.552 1.941 . . . . 0.0 111.391 177.705 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo . . . . . 0 CA--C 1.54 0.79 0 N-CA-C 114.843 1.055 . . . . 0.0 114.843 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -82.32 159.88 63.68 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.628 1.571 . . . . 0.0 112.905 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.12 142.77 63.36 Favored 'Cis proline' 0 C--N 1.354 0.843 0 CA-C-N 119.597 0.892 . . . . 0.0 112.653 -3.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -108.79 -105.98 0.35 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.992 1.317 . . . . 0.0 112.427 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1139 ' ' PTR . . . . . 0.461 ' HE1' HG11 ' A' ' 56' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1140 ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 83' ' ' MET . 26.7 t -143.17 -16.89 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 C-N-CA 126.653 1.981 . . . . 0.0 114.7 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B 1141 ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 82' ' ' SER . 0.0 OUTLIER -60.15 -28.5 67.95 Favored 'General case' 0 CA--C 1.58 2.119 0 N-CA-C 102.235 -3.246 . . . . 0.0 102.235 169.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.352 3.7 mp0 -154.25 158.42 32.39 Favored Pre-proline 0 N--CA 1.435 -1.212 1 C-N-CA 137.216 6.206 . . . . 0.0 104.348 169.775 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 60.26 2.06 Favored 'Trans proline' 0 CA--C 1.553 1.449 0 CA-C-N 121.585 1.602 . . . . 0.0 110.261 152.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B 1144 ' ' ASP . . . . . . . . . . . . . 22.1 t0 . . . . . 0 C--O 1.254 1.322 1 C-N-CA 134.446 5.098 . . . . 0.0 115.652 -173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 m -68.4 148.39 98.18 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 124.373 1.069 . . . . 0.0 112.936 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.74 156.21 61.21 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.517 2.811 . . . . 0.0 112.705 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.93 154.46 38.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.086 0.954 . . . . 0.0 112.606 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 m -69.35 142.68 53.93 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.211 1.005 . . . . 0.0 112.458 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.02 172.11 55.12 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.139 0.876 . . . . 0.0 113.958 174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.0 p -81.13 -18.75 45.32 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.348 1.059 . . . . 0.0 113.38 176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 p -81.33 158.66 24.63 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.491 1.517 . . . . 0.0 113.03 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.1 mt -130.08 161.76 30.3 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.999 1.72 . . . . 0.0 111.281 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.6 m -61.32 132.71 54.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.127 0.971 . . . . 0.0 112.247 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.1 160.74 17.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.422 1.089 . . . . 0.0 113.424 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.3 145.29 38.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.655 1.582 . . . . 0.0 110.771 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.4 pt -79.26 -22.09 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -76.98 59.64 1.68 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.252 1.821 . . . . 0.0 113.899 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -121.48 -0.15 9.84 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 76.6 p -142.1 -180.0 6.57 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 128.772 2.829 . . . . 0.0 109.852 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -76.37 15.46 0.59 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.876 1.27 . . . . 0.0 114.244 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -62.25 -15.41 47.01 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -174.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -101.05 7.38 43.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.08 1.752 . . . . 0.0 112.989 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -117.75 138.09 52.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -141.92 177.84 7.92 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.598 2.759 . . . . 0.0 108.607 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.16 -130.3 3.81 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 121.913 2.142 . . . . 0.0 112.773 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.427 ' HB2' ' H ' ' A' ' 49' ' ' GLN . 61.3 ttp85 -51.03 122.49 7.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.315 2.057 . . . . 0.0 115.929 -172.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 tt -154.87 78.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 1 N-CA-C 99.146 -4.39 . . . . 0.0 99.146 173.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.7 m -30.91 121.18 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.977 2.511 . . . . 0.0 115.051 -171.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.41 -24.93 63.89 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.45 1.9 . . . . 0.0 113.65 -174.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -80.98 -39.2 26.37 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.166 1.386 . . . . 0.0 112.805 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -81.88 -40.62 22.13 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.105 1.362 . . . . 0.0 113.695 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 p -56.01 -32.65 64.17 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.193 1.397 . . . . 0.0 113.781 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.463 ' HA ' ' CG2' ' A' ' 65' ' ' VAL 0.266 1.5 pt20 -64.14 -15.84 60.61 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 174.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -80.61 -28.38 37.04 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.117 0.967 . . . . 0.0 112.038 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.13 -59.02 1.81 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.502 1.521 . . . . 0.0 112.588 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.15 -6.47 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 126.431 1.892 . . . . 0.0 111.63 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -96.53 7.06 65.71 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 119.965 -1.709 . . . . 0.0 114.348 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -7.78 59.11 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.021 0.911 . . . . 0.0 110.126 173.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.48 142.63 50.19 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.256 1.422 . . . . 0.0 110.355 174.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -124.73 27.76 5.37 Favored Glycine 0 N--CA 1.477 1.368 0 C-N-CA 124.709 1.147 . . . . 0.0 115.586 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.57 179.58 7.68 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.343 1.071 . . . . 0.0 112.357 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.1 m -57.25 149.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.422 0.689 . . . . 0.0 111.68 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.16 2.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -174.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.37 15.76 22.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.439 2.447 . . . . 0.0 116.911 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -93.64 71.16 4.23 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 121.196 2.498 . . . . 0.0 105.147 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -99.39 174.24 6.37 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -172.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.7 tp -140.52 162.27 35.74 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.33 2.652 . . . . 0.0 109.033 174.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.3 t -118.28 107.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.299 1.04 . . . . 0.0 109.31 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HG2' HH11 ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.54 164.92 28.91 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.624 1.97 . . . . 0.0 107.899 -177.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.889 ' HA ' HG13 ' A' ' 56' ' ' VAL . 15.4 pt-20 -141.05 -172.53 3.5 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.2 t -98.37 138.55 35.44 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.429 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.427 ' H ' ' HB2' ' A' ' 23' ' ' ARG 0.358 0.0 OUTLIER -98.2 5.53 48.37 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 173.661 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -113.47 -43.37 3.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 128.46 2.704 . . . . 0.0 113.999 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -76.37 127.22 85.18 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-N 120.558 1.526 . . . . 0.0 111.733 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -69.67 -25.5 28.96 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.989 2.459 . . . . 0.0 116.664 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -110.39 23.97 13.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.929 . . . . 0.0 111.171 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.595 ' HA3' HD22 ' A' ' 69' ' ' LEU . . . -98.91 129.75 10.0 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 122.16 3.624 . . . . 0.0 122.16 -172.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -144.32 121.54 11.53 Favored 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.899 4.879 . . . . 0.0 102.181 173.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.889 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.325 0.9 OUTLIER -125.11 138.94 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-N 123.552 2.887 . . . . 0.0 112.787 -174.954 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 tt -98.6 126.11 44.07 Favored 'General case' 0 CA--C 1.536 0.438 1 N-CA-C 99.546 -4.242 . . . . 0.0 99.546 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 p -125.64 112.05 15.69 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 119.873 1.215 . . . . 0.0 108.243 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.31 167.16 11.51 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.607 1.163 . . . . 0.0 111.502 -173.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.493 ' HA ' HG12 ' A' ' 65' ' ' VAL . 49.7 t -126.33 94.97 4.22 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.561 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.326 0.0 OUTLIER -90.72 -161.84 0.84 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.974 -1.466 . . . . 0.0 112.008 -173.077 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.561 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.532 0.3 OUTLIER -96.88 13.07 30.0 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 -174.287 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -147.4 -36.24 0.22 Allowed 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 113.107 -1.861 . . . . 0.0 112.16 169.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -151.1 -177.55 6.09 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 60' ' ' CYS . 5.0 m -100.03 127.41 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 173.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -128.96 146.4 50.98 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.206 1.402 . . . . 0.0 111.07 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -117.66 159.93 22.13 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -172.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.429 ' CZ ' HG11 ' B' 1140 ' ' VAL . 8.6 m-85 -131.87 84.05 2.14 Favored 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.596 1.558 . . . . 0.0 115.196 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.595 HD22 ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -136.3 19.51 3.16 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 121.745 3.98 . . . . 0.0 121.745 -174.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 mt -93.07 4.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 118.949 -2.344 . . . . 0.0 116.534 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.4 mt -135.78 138.95 29.31 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 119.749 1.159 . . . . 0.0 111.85 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -84.93 -176.95 2.62 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.297 3.331 . . . . 0.0 111.195 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 m -62.56 147.01 50.41 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.707 -1.246 . . . . 0.0 112.331 174.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -125.03 -176.67 3.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.336 1.054 . . . . 0.0 111.963 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -97.54 -8.72 28.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.75 0.82 . . . . 0.0 112.786 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -99.39 0.18 42.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.075 1.35 . . . . 0.0 112.552 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -162.4 -155.8 8.17 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.261 1.41 . . . . 0.0 114.233 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -109.64 -135.51 0.36 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.921 1.688 . . . . 0.0 108.794 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.0 mt -57.98 117.33 4.21 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -84.12 126.45 33.1 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.507 ' H ' ' CA ' ' A' ' 89' ' ' ARG . 25.9 m-85 -143.04 157.23 44.73 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.9 p -148.73 -159.2 1.0 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.839 2.056 . . . . 0.0 110.751 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.662 ' HA ' HG12 ' B' 1140 ' ' VAL . 46.9 mtt -155.54 -169.08 3.01 Favored 'General case' 0 C--N 1.314 -0.97 1 C-N-CA 137.309 6.244 . . . . 0.0 107.335 -172.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.21 -34.75 78.16 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.457 ' H ' HD21 ' A' ' 107' ' ' LEU . 25.3 t0 -141.18 60.76 1.5 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.937 1.695 . . . . 0.0 110.367 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.14 172.41 22.08 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -141.24 42.84 1.78 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.142 1.777 . . . . 0.0 114.01 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.459 2.3 p -70.95 -1.45 11.99 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 120.632 3.568 . . . . 0.0 120.632 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.507 ' CA ' ' H ' ' A' ' 81' ' ' PHE . 2.5 ptm180 -43.21 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 1 C-N-CA 131.868 4.067 . . . . 0.0 119.817 172.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -141.81 166.35 24.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.805 2.442 . . . . 0.0 110.466 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.8 m -66.17 132.99 49.75 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 121.05 -1.031 . . . . 0.0 109.667 175.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -76.98 -46.2 24.81 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.75 -40.0 82.6 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.69 -28.28 68.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.58 0.752 . . . . 0.0 112.562 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -88.01 -20.63 25.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.66 1.584 . . . . 0.0 112.329 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 tt -69.21 -55.29 11.03 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.92 -1.112 . . . . 0.0 111.192 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.76 -60.11 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 118.856 0.753 . . . . 0.0 112.297 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -82.28 -64.0 1.27 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.265 99.6 m-85 -69.94 -5.55 26.92 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -172.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -53.32 -29.48 34.01 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 123.452 2.842 . . . . 0.0 113.608 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -64.38 -32.06 73.52 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.132 1.773 . . . . 0.0 114.139 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 tt -151.44 74.71 1.14 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.105 2.162 . . . . 0.0 106.532 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -107.3 -167.23 1.24 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.92 1.288 . . . . 0.0 114.12 -173.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -104.03 76.6 1.37 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.676 1.99 . . . . 0.0 108.861 173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.99 -157.94 1.04 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.797 1.189 . . . . 0.0 113.362 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.654 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -61.76 158.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.659 1.184 . . . . 0.0 113.816 -174.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.654 ' H ' HD13 ' A' ' 106' ' ' ILE . 12.5 mt -28.73 -64.16 0.18 Allowed Pre-proline 0 CA--C 1.566 1.585 0 CA-C-O 115.281 -2.295 . . . . 0.0 115.764 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 107' ' ' LEU . 11.8 Cg_endo -119.59 -21.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.637 0 CA-C-N 124.252 2.554 . . . . 0.0 117.308 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 84.2 m -86.22 -145.45 0.11 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.18 1.792 . . . . 0.0 114.145 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.86 141.89 47.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.468 1.107 . . . . 0.0 113.261 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -104.89 -9.43 17.99 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 -174.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -106.32 146.89 29.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.509 1.124 . . . . 0.0 112.478 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -111.51 153.26 26.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.255 1.422 . . . . 0.0 114.169 -174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.06 -179.92 6.36 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.065 2.146 . . . . 0.0 110.843 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 95.3 m -98.96 124.04 43.66 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.895 -1.128 . . . . 0.0 113.094 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 t -102.69 -177.44 3.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.039 1.736 . . . . 0.0 114.413 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.8 mtp85 -64.4 128.75 37.13 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.942 0.897 . . . . 0.0 110.85 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.9 157.63 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.864 0.866 . . . . 0.0 113.005 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.12 0.5 31.86 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.255 1.381 0 C-N-CA 126.119 1.768 . . . . 0.0 112.773 -179.894 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo . . . . . 0 CA--C 1.539 0.762 0 N-CA-C 113.575 0.567 . . . . 0.0 113.575 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 36.11 92.74 0.05 OUTLIER Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 128.159 2.584 . . . . 0.0 116.781 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -78.54 -171.03 9.31 Favored 'Cis proline' 0 CA--C 1.547 1.142 0 CA-C-N 119.963 1.022 . . . . 0.0 112.162 -6.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -137.76 -71.2 0.43 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.55 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1139 ' ' PTR . . . . . 0.513 ' CD1' ' HG ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1140 ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 83' ' ' MET 0.281 77.6 t 46.39 -23.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.518 1 C-N-CA 139.6 7.16 . . . . 0.0 117.988 174.61 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' B' B 1141 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.33 -28.45 65.07 Favored 'General case' 0 CA--C 1.583 2.221 1 N-CA-C 99.696 -4.187 . . . . 0.0 99.696 167.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1142 ' ' GLN . . . . . 0.458 ' C ' ' H ' ' B' 1144 ' ' ASP . 4.4 mp0 -146.79 169.48 9.38 Favored Pre-proline 0 C--N 1.369 1.45 0 C-N-CA 130.103 3.361 . . . . 0.0 113.272 170.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.24 41.22 0.08 OUTLIER 'Trans proline' 0 CA--C 1.557 1.647 0 C-N-CA 124.466 3.444 . . . . 0.0 113.947 146.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B 1144 ' ' ASP . . . . . 0.458 ' H ' ' C ' ' B' 1142 ' ' GLN . 42.1 t0 . . . . . 0 C--O 1.254 1.307 1 C-N-CA 132.564 4.345 . . . . 0.0 115.396 -174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 CA-C-O 121.114 0.285 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.0 p -76.92 160.66 75.96 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.723 1.209 . . . . 0.0 113.095 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.79 151.48 76.7 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.357 2.705 . . . . 0.0 114.318 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.51 162.71 28.08 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.338 1.055 . . . . 0.0 113.041 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -136.83 156.06 48.99 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.541 1.536 . . . . 0.0 112.472 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.18 155.77 47.97 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.356 0.979 . . . . 0.0 114.44 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -71.41 145.45 49.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.784 1.234 . . . . 0.0 111.427 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.4 t -132.6 150.27 52.18 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.092 1.357 . . . . 0.0 112.203 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -117.08 11.97 14.38 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.073 1.749 . . . . 0.0 113.698 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 t -66.15 151.89 45.97 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.306 1.042 . . . . 0.0 112.776 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.11 165.69 26.84 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.515 1.526 . . . . 0.0 112.68 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.34 -0.22 35.84 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.05 150.37 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.824 1.25 . . . . 0.0 112.264 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -64.78 145.58 56.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.497 1.119 . . . . 0.0 112.547 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -130.65 2.48 4.5 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.0 p -142.04 -173.9 3.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 128.337 2.655 . . . . 0.0 109.616 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.27 9.35 1.7 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 174.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -61.06 149.03 38.29 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -114.29 15.19 18.11 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.457 1.503 . . . . 0.0 113.373 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.85 143.78 31.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 -173.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -141.36 149.78 41.58 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.766 3.226 . . . . 0.0 107.839 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.91 39.87 1.41 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-N 123.532 2.878 . . . . 0.0 114.912 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -146.29 30.93 1.02 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.928 0.891 . . . . 0.0 112.352 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 tp -128.19 75.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.479 1.112 . . . . 0.0 109.954 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -45.32 150.16 0.47 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.008 1.723 . . . . 0.0 113.756 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HD2' ' O3P' ' B' 1139 ' ' PTR . 0.2 OUTLIER -52.24 -31.57 32.9 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -174.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.0 -33.16 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -81.49 -49.97 9.97 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.027 1.331 . . . . 0.0 112.37 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 p -66.47 -29.05 69.09 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.401 -0.812 . . . . 0.0 112.514 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.14 -14.57 63.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.488 1.495 . . . . 0.0 113.723 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -79.86 -34.26 39.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.292 1.037 . . . . 0.0 111.335 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mp -86.98 -42.77 12.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.438 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.23 -10.74 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 111.168 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.59 -1.41 58.96 Favored Glycine 0 N--CA 1.469 0.879 0 O-C-N 120.436 -1.415 . . . . 0.0 116.112 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -88.02 -0.14 56.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.771 1.285 . . . . 0.0 111.868 174.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.76 158.99 19.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.083 1.753 . . . . 0.0 111.308 174.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.15 25.51 2.64 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.405 1.002 . . . . 0.0 114.995 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.5 -170.73 2.93 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.458 1.103 . . . . 0.0 111.644 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.3 m -54.72 154.99 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.759 0.823 . . . . 0.0 110.542 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' HIS . 17.8 m-20 -55.66 -10.4 0.69 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.54 13.03 63.01 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.14 2.781 . . . . 0.0 116.445 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.41 78.92 4.4 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 122.193 2.997 . . . . 0.0 105.843 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -99.17 170.65 8.53 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.6 tp -133.97 153.23 51.91 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.768 2.027 . . . . 0.0 109.768 174.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.41 102.55 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -141.33 163.91 31.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.825 1.25 . . . . 0.0 109.252 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' HG13 ' A' ' 56' ' ' VAL . 4.6 pm0 -143.06 -159.26 0.95 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.579 1.181 . . . . 0.0 112.797 174.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -120.53 150.85 40.2 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 130.781 3.633 . . . . 0.0 108.021 174.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.85 5.82 48.57 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -98.99 -64.33 1.05 Allowed 'General case' 0 C--N 1.357 0.896 0 C-N-CA 131.411 3.884 . . . . 0.0 113.756 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -58.38 123.9 68.54 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 122.478 2.399 . . . . 0.0 111.459 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.86 -21.13 38.37 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.308 2.672 . . . . 0.0 113.89 -170.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -111.14 21.46 16.34 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.826 2.45 . . . . 0.0 112.182 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA3' HD22 ' A' ' 69' ' ' LEU . . . -95.96 123.32 7.64 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 120.718 3.047 . . . . 0.0 120.718 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -143.48 103.93 4.16 Favored 'General case' 0 CA--C 1.541 0.601 1 C-N-CA 132.69 4.396 . . . . 0.0 102.606 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.568 HG13 ' HA ' ' A' ' 47' ' ' GLU 0.311 0.8 OUTLIER -110.79 138.9 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 121.346 1.884 . . . . 0.0 114.177 -173.834 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 tt -99.21 128.03 45.28 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 101.489 -3.523 . . . . 0.0 101.489 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.9 p -127.11 113.73 16.8 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.859 1.209 . . . . 0.0 109.005 -173.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.96 153.45 17.76 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.212 1.005 . . . . 0.0 112.382 -172.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.491 ' HA ' HG12 ' A' ' 65' ' ' VAL . 48.5 t -113.64 75.7 0.94 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.474 ' CG ' ' H ' ' A' ' 62' ' ' LEU 0.323 2.5 t60 -82.81 -172.35 4.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.266 -173.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' H ' ' CG ' ' A' ' 61' ' ' HIS 0.559 0.2 OUTLIER -98.5 22.3 10.0 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -173.763 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -149.96 -39.36 0.14 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 112.782 -2.008 . . . . 0.0 111.748 170.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.49 175.83 10.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.045 0.938 . . . . 0.0 110.512 174.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 60' ' ' CYS . 6.0 m -118.16 112.53 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -110.86 158.07 19.13 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.95 1.7 . . . . 0.0 112.87 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 26' ' ' ARG . 22.4 m-70 -120.76 160.06 24.13 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.465 1.506 . . . . 0.0 114.517 -173.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -131.24 87.2 2.44 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD22 ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -140.89 23.36 2.25 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.88 3.659 . . . . 0.0 120.88 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' B' 1144 ' ' ASP . 5.8 mt -92.07 -3.26 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 118.326 -2.733 . . . . 0.0 118.065 -168.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -136.77 136.46 21.58 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 120.913 1.688 . . . . 0.0 113.214 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.38 170.24 16.29 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.952 3.101 . . . . 0.0 112.495 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -57.48 141.06 48.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.659 1.184 . . . . 0.0 113.658 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -131.34 178.82 6.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.647 1.179 . . . . 0.0 112.795 -174.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -99.08 -7.18 27.11 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.91 1.284 . . . . 0.0 111.441 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -106.99 45.1 1.0 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.947 2.499 . . . . 0.0 107.295 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 148.32 -160.53 28.38 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 128.121 2.772 . . . . 0.0 109.09 -174.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -124.18 -123.33 0.26 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 173.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.22 116.8 5.3 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -75.59 136.05 40.52 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -146.88 154.57 41.46 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 m -146.47 -172.93 4.07 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.245 2.618 . . . . 0.0 109.226 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.541 ' HA ' HG12 ' B' 1140 ' ' VAL . 15.2 mtp -154.48 176.92 11.77 Favored 'General case' 0 C--N 1.311 -1.085 1 C-N-CA 138.95 6.9 . . . . 0.0 107.175 -172.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -67.45 -25.52 65.94 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.329 -0.857 . . . . 0.0 111.235 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.45 36.52 2.05 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.344 1.058 . . . . 0.0 112.833 174.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.44 170.12 24.84 Favored Glycine 0 N--CA 1.478 1.445 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -141.37 60.24 1.5 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.639 1.976 . . . . 0.0 112.418 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.507 41.3 p -76.97 9.75 2.75 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 121.338 3.829 . . . . 0.0 121.338 -173.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.2 ptt85 -38.14 31.49 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 2 C-N-CA 133.482 4.713 . . . . 0.0 122.756 173.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -113.81 169.63 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.629 1.571 . . . . 0.0 110.795 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 30.0 m -56.26 140.21 45.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.481 1.113 . . . . 0.0 111.915 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.16 -47.1 30.08 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.449 0.7 . . . . 0.0 112.75 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 52.5 tp -66.6 -38.79 87.72 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.809 -0.557 . . . . 0.0 111.842 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.9 mt -64.28 -37.05 86.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.866 0.466 . . . . 0.0 111.408 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -68.66 -41.68 79.0 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.458 -0.777 . . . . 0.0 112.121 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 tt -65.82 -39.65 91.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.508 0.595 . . . . 0.0 111.912 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.7 t -75.32 -69.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.756 -0.59 . . . . 0.0 111.204 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.15 -41.26 20.66 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -81.51 -27.83 34.29 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 121.294 1.861 . . . . 0.0 115.348 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -39.3 -42.42 1.02 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -21.11 58.91 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -176.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.0 mt -146.47 56.96 1.17 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.013 2.125 . . . . 0.0 110.913 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -91.18 -154.78 0.37 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.116 0.966 . . . . 0.0 112.187 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.89 -4.48 27.7 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.304 1.842 . . . . 0.0 113.601 175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 44.71 -145.27 2.12 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.523 2.011 . . . . 0.0 116.543 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.7 tp -79.56 159.05 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.999 1.719 . . . . 0.0 111.199 174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.41 ' CB ' ' HD3' ' A' ' 108' ' ' PRO . 2.8 mt -35.17 -54.22 1.12 Allowed Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 116.318 -1.801 . . . . 0.0 115.525 174.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HD3' ' CB ' ' A' ' 107' ' ' LEU . 56.9 Cg_endo -118.73 -33.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 0 N-CA-C 117.51 2.081 . . . . 0.0 117.51 -172.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 75.0 m -92.31 -131.95 0.13 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 126.591 1.956 . . . . 0.0 115.31 -173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.49 137.68 52.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.9 1.28 . . . . 0.0 113.559 -174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.446 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -91.51 -13.49 32.04 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -99.81 161.73 13.43 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.927 1.291 . . . . 0.0 112.373 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -132.21 154.32 49.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.221 1.408 . . . . 0.0 113.314 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 168.11 20.54 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.882 2.473 . . . . 0.0 108.742 174.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 71.2 m -98.09 130.0 44.89 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 119.922 -1.736 . . . . 0.0 112.673 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 t -99.22 178.16 4.99 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.577 1.151 . . . . 0.0 112.441 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -62.78 152.33 36.18 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.478 1.111 . . . . 0.0 112.791 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.8 m -79.61 164.93 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.942 1.297 . . . . 0.0 112.68 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.96 163.45 27.84 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.381 0.672 . . . . 0.0 112.776 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 C--O 1.255 1.345 0 C-N-CA 126.314 1.846 . . . . 0.0 112.166 -178.184 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B 1135 ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 N--CA 1.483 0.896 0 N-CA-C 113.981 0.724 . . . . 0.0 113.981 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B 1136 ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -135.15 150.29 72.46 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.644 1.578 . . . . 0.0 111.063 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1137 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.47 152.32 78.82 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.526 2.817 . . . . 0.0 112.524 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1138 ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -143.64 -60.05 0.4 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 116.214 -1.85 . . . . 0.0 113.922 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1139 ' ' PTR . . . . . 0.533 ' CD1' ' HG ' ' A' ' 69' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1140 ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 83' ' ' MET 0.326 78.2 t 46.42 -22.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.269 1 C-N-CA 139.215 7.006 . . . . 0.0 118.21 174.184 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' B' B 1141 ' ' ASN . . . . . 0.403 ' HB2' HD12 ' A' ' 70' ' ' ILE . 1.3 m-80 -59.57 -29.86 68.24 Favored 'General case' 0 CA--C 1.581 2.168 1 N-CA-C 99.048 -4.427 . . . . 0.0 99.048 167.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B 1142 ' ' GLN . . . . . . . . . . . . 0.263 1.9 mp0 -151.72 172.53 5.33 Favored Pre-proline 0 N--CA 1.433 -1.309 0 C-N-CA 130.657 3.583 . . . . 0.0 114.037 171.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B 1143 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.02 59.1 0.3 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.396 2.064 . . . . 0.0 110.93 141.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B 1144 ' ' ASP . . . . . 0.477 ' HA ' HD13 ' A' ' 70' ' ' ILE 0.255 30.0 t70 . . . . . 0 C--O 1.257 1.453 0 C-N-CA 131.472 3.909 . . . . 0.0 117.448 -174.327 . . . . . . . . 2 2 . 1 stop_ save_